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Abstract 
Given that, by and large, Information and Communication Technologies (ICTs) are aimed at increasing 
efficacy of workflows, faster and more accurate transfer of information, and decreasing cumbersome 
procedures, at least some ICTs are directed towards promoting a high quality of life. Particularly, if 
technologies are used to enhance services, ensure or increase safety and security, promote independence, 
and/or facilitate social interaction, they impact domains specifically measured in quality of life assessments. 
As there is no cure for most dementias, the focus of care is largely on the individual’s quality of life, applying 
technologies to this area of health and social care would seem an appropriate fit. One of the aims of 
technology solutions to benefit aging adults is to improve quality of life and capability to live independently 
and healthily; however, improvements in life quality are difficult to measure, and showing the effectiveness 
of gerontechnology-based solutions is problematic.  
This research investigated the quantitative data to see if technology use was indeed a facilitator of increased 
quality of life. The hypothesis was that the older adults and their caregivers would report a positive influence 
on their quality of life after using the technologies. The end users gave reports via questionnaires on quality 
of life while metrics, such as frequency of use of a technology and time of use were recorded through the 
technology system. The work is based on data collected through the clinical intervention trial, and the 
courses, publications, independent analysis, and interdisciplinary collaboration during the PhD study. The 
PhD was with the Department of Electronic Systems at Aalborg University in Aalborg, Denmark. The 
research has been funded through Aalborg University and the European Union Information and 
Communication Technology Policy Support Program Pilot Type B Project ISISEMD (Intelligent System for 
Independent living and SElf-care of seniors with cognitive problems or Mild Dementia). Conclusions drawn 
from the study show that gerontechnology can indeed have a positive influence on quality of life in dementia 
care; however, significant effects on life quality were confirmed only in the caregivers. There are still 
knowledge gaps in evaluating quality of life outcomes from using technology in dementia care, and more 
homogenous, rigorous studies need to be done in this field. Without careful operationalization of the concept, 
it will be difficult for researchers to interpret the (clinical) outcomes into meaningful results that can be used 
by other researchers, caregivers, and medical professionals. 
Objective:  Intervention analysis on the efficacy of telecare services in home-based dementia care after 15 
months. 
Design:  Multinational, non-blinded, quasi-experimental, clinical intervention trial (nonpharmacological)  
Setting:  Homes of individuals with dementia in North Ireland, Denmark, Finland, and Greece 
Participants:  From 63 individuals with dementia and their caregivers, 31 intervention dyads are compared 
to 22 control dyads.   
Intervention:  A telecare system consisting of domotics with a centralized architecture aimed to support 
safety, independence, and quality of life, and to reduce caregiver burden through the transfer of tasks and 
care support.  
Main outcome measures:  Physical functioning (ADL and IADL), quality of life (QOL-AD and SQLC), 
caregiver burden (ZBI) are comparative outcomes, and global responses provide exploratory outcomes in the 
intervention group. The statistical analysis applies t-tests to verify significant differences in means and 
Pearson correlations to test for linear relationships within the data, all using 95% Confidence Interval.  
Results:  There is a highly significant difference in caregiver burden between the technology intervention 
and control groups (p=0,02**). The intervention group showed a non-significant reduction in caregiver 
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burden (p=0,51) while the control group showed a highly significant increase in caregiver burden (p=0,01**). 
The intervention group shows improvement in home safety (80,6%), a high level of user satisfaction (88,7%), 
and the majority expresses desire to continue using (90,3%) the telecare services and a willingness to pay for 
such services (53,2%). 
Conclusion:  This study showed that the use of telecare intervention to support dementia care has 
protective and positive effects for the informal caregivers, but overall does not measure as performing 
significantly different than usual care. The evidence suggests telecare can be beneficial but methodology 
limitations prevent definitive conclusions.  
Trial registration:  The Phase I clinical intervention trial did not require registration. The trial was funded 
by the European Commission Competitiveness and Innovation Programme - Information and 
Communication Technology - Policy Support Programme. The pilot type B.2008.1.4 project ISISEMD was 
executed from 01/03/2009 to 31/08/2011. Reference:  CIP-ICT-PSP-2-238914. Trial information can be 
found at the project website http://www.isisemd.eu/. 
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Résumé 
Eftersom informations-og kommunikationsteknologi (IKT) har til formål at øge effektiviteten af 
arbejdsgange, sikre hurtigere og mere præcis overførsel af information, og mindske besværlige procedurer, i 
det mindste på et vist niveau - er IKT også rettet mod at fremme en højere livskvalitet. Især hvis teknologi 
kan bruges til at forbedre services, sikre eller øge sikkerhed, øge uafhængighed og/eller til at facilitere social 
interaktion, får den indflydelse på områder som kan måles i livskvalitetsparametre. Eftersom der ikke 
eksisterer nogen kur for de fleste demenssygdomme er fokus for pleje i høj grad rettet mod den enkeltes 
livskvalitet og anvendelse af teknologi inden for social-og sundhedsområdet kan derfor være velegnet. Et af 
formålene med geronteknologiske løsninger (teknologier til gavn for aldrende voksne) er at hjælpe med at 
forbedre livskvaliteten og evnen til at leve uafhængigt og sundt, men da forbedringer i livskvalitet er 
vanskelige at måle er effektiviteten af gerontechnology -baserede løsninger er problematisk at påvise. 
Denne forskning har undersøgt kvantitative data for at afklare, om teknologianvendelse faktisk var en årsag 
til øget livskvalitet. Hypotesen er, at ældre og deres pårørende vil opleve en positiv effekt på den dementes 
livskvalitet ved brug af teknologierne. Brugerne gav kvalitative rapporter via spørgeskemaer om livskvalitet, 
accept af hjælpemidlerne og tilfredshed, mens kvantitative målinger, såsom hyppigheden af brug af en 
teknologi og brugstidspunktet mv. blev registreret via et IKT-system. Arbejdet er baseret på data indsamlet 
gennem klinisk interventionsforskning, kurser, konferencer og analyse, samt ved tværfagligt samarbejde 
igennem Ph.d studiet. Ph.d. studiet foregik ved Institut for Elektroniske Systemer på Aalborg Universitet i 
Aalborg, Danmark. Forskningen har været finansieret af Aalborg Universitet og EU Informations-og 
Kommunikationsteknologis Policy Support Program Pilot Type B Project ISISEMD (Intelligent System for 
Independent living and SElf-care of seniors with cognitive problems or Mild Dementia). Konklusioner fra 
undersøgelsen viser, at geronteknologi faktisk kan have en positiv indflydelse på livskvaliteten i demenspleje, 
dog blev en betydelig indvirkning på livskvaliteten kun bekræftet af plejepersonalet. Vores viden om 
evaluering af livskvalitetsresultater er stadig begrænset og mere homogene og rigide studier er fortsat 
nødvendige inden for dette felt. Uden omhyggelig operationalisering af konceptet, vil det være vanskeligt for 
forskere at fortolke (kliniske) udfald til meningsfulde resultater, der kan bruges af andre forskere, plejere og 
læger. 
Formål:  Interventionsanalyse af effekten af telebehandlingstjenester i hjemme-baseret demenspleje efter 15 
måneder. 
Design:  Multinational, ikke-blindet, kvasieksperimentel, klinisk interventionsforsøg (ikke-farmakologiske). 
Setting:  Hjemmeboliger for personer med demens i Nordirland, Danmark, Finland og Grækenland. 
Deltagere:  Ud af 63 personer med demens og deres pårørende er 31 interventionsdyader sammenlignet 
med 22 kontroldyader. 
Intervention:  Et teleplejesystem, bestående af domotik, med en centraliseret arkitektur, til formål at 
understøtte sikkerhed, uafhængighed og livskvalitet, og mindske omsorgspersonens byrde gennem overførsel 
af opgaver og plejesupport. 
Vigtigste effektmål:  Fysisk funktion (ADL og IADL), livskvalitet (QOL-AD og SQLC) og pårørendebyrde 
(ZBI), er sammenlignelige resultater, og globale reaktioner giver eksplorative resultater i 
interventionsgruppen. Den statistiske analyse anvender t-test for at kontrollere betydelige forskelle i midler, 
og Pearson-korrelationer til at teste for lineære relationer i data, der alle bruger 95% konfidensinterval. 
Resultater:  Der er en meget betydelig forskel i omsorgspersonens byrde under teknologiintervention og i 
kontrolgrupper (p=0,02**). Interventionsgruppen viste en ikke-signifikant reduktion i omsorgspersonens 
byrde (p=0,51), mens kontrolgruppen udviste en meget betydelig stigning i omsorgspersonens byrde 
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(p=0,01**). Interventionsgruppen viser forbedring i hjemmets sikkerhed (80,6%), en høj grad af 
brugertilfredshed (88,7%), og størstedelen udtrykker ønske om at fortsætte med at bruge (90,3%) af 
telebehandlingstjenesterne, og vilje til at betale for sådanne tjenester (53,2%). 
Konklusion:  Denne undersøgelse viste, at brugen af telebehandling til støtte for demenspleje har 
beskyttende og positive virkninger for de uformelle omsorgspersoner  men generelt ikke lader til at performe 
væsentligt anderledes end normal pleje. Det peger mod at telebehandling kan være gavnligt, men 
metodebegrænsninger forhindrer endelige konklusioner. 
Trial registrering:  Fase I; kliniske interventionsforsøg kræver ikke registrering. Forsøget blev finansieret 
af Europa-Kommissionen for konkurrenceevne og innovation - Informations-og kommunikationsteknologi - 
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Reference: CIP-ICT-PSP-2-238.914. Trial-information kan findes på projektets hjemmeside 
http://www.isisemd.eu/. 
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Preface 
During my undergraduate study of psychology, I became interested in cognitive neuropsychology and the processes to 
store and produce new memories. In particular, I was curious about individuals with neurological damage or disease, the 
selective breakdown of skills, and the coping mechanisms they use to reason about the world they live in. This curiosity 
led to a desire to work with dementia and aging adults. Following the completion of my Master’s in Gerontology, I 
worked as an in-home caregiver to a woman with dementia (Early-Onset Alzheimer’s disease). She and her husband were 
a huge motivation and showed me new aspects of working in dementia care; they have taught me many lessons that I 
continue to realize today. I have thought of them the entire time I have been working on my PhD and cannot find the 
words to express the deep gratitude I have for the influence Carolyn and Mike have had on my personal and professional 
life. 
After moving to Denmark in 2005, I read a nursing article “The Phenomenology of Knowing the Patient” [1] and was 
inspired by the similarities with working and caring for someone with dementia. By then, I was sure I wanted to continue 
a career working with dementia, but had not figured out where the field was going or where I would fit in. While traveling 
in Mexico in 2008, I was overwhelmed by sprawling, vibrant Mexico City, and I started to think about how many people 
with dementia would be living here in the coming decades. In exploring future trends for aging adults, the pervasiveness 
of technology certainly plays a role. The motivation started in thinking about how we develop new technologies to make 
life easier and more enjoyable, basically, to have a positive influence on quality of life. If we are also using technologies in 
health and social care, the idea is that it will also have a positive effect on quality of life. In dementia care, the primary 
treatment is on slowing decline and maintaining or increasing QOL, and technology has strong implications to be a 
successful intervention strategy. A growing body of evidence shows that independent living, telecare, and telehealth 
solutions provide multiple options for health and social care systems to offer the elderly. Many assume that technologies 
obviously make tasks easier to carry out, but these obvious benefits need to be tested in order to determine the overall 
impact of health technology solutions. And the idea for the PhD was born. 
Gerontechnology and quality of life in dementia care 
The participants and data are derived from the multi-national ISISEMD project [2], which helped to fund the PhD study. 
One of the first tasks was to conceptualize quality of life in order to identify areas where technology could have a positive 
impact and to determine the appropriate evaluation tools. The selection of inclusion and exclusion criteria and evaluation 
tools were corroborated with prominent professionals in dementia care. Another major task in the beginning was the 
writing of the research protocol and documents related to legal issues and ethical applications. I also assisted in designing 
and evaluating various GUI adaptations and provided initial insight for the development of the services before being 
tested in the regions, including feedback gathered from a focus group and public education arrangements. Before the 
services were installed, I assisted in the baseline evaluations of participants in Denmark, and spent several sessions with 
the professional caregivers in the region to learn about the (usual) care offered, service delivery, and for more 
information on the participants. As I am not a native Dane, the professional caregivers were instrumental in teaching 
about how dementia and elder care is perceived and managed in northern Denmark. After the assessment periods 
(baseline, mid-term, and final), I would assist with quality checks on the data to ensure that scores were correct and 
within the stated ranges. The project’s statistical analysis was carried out by partners who have a stronger statistics 
background, and I carried out an independent final analysis for the PhD after the project concluded. So, while this thesis 
presents a more detailed statistical analysis of the ISISEMD outcomes than have previously been published, some of the 
results will be different than those reported in the project deliverables and publications due to the reworking of the data.  
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Chapter 1.  Introduction 
Declining fertility rates and increasing life spans are leading to a fast growing proportion of older adults who have an 
increasing risk for developing dementia. The rising number of people living with dementia means that fewer family 
caregivers are increasingly performing complex tasks that have traditionally been carried out by paid professionals, 
providing considerable benefits to their family and society. Without a younger generation’s volunteer caregiving, the 
private and public health and social care systems alone cannot meet the growing demand for long-term care.  
In the 21st Century, technologies are increasingly encountered on a daily basis. Gerontechnology is an interdisciplinary 
field that promotes human health and well-being into old age through the use of technology. Previous studies have 
investigated the efficacy of gerontechnology to support dementia care. In most studies, the results of dementia care 
outcomes are complex to concretely interpret and methodological problems make generalizing the results problematic. 
The thesis focuses on the areas of dementia care and technological solutions that can provide support in the home. The 
outcome of concern is if and how quality of life is affected by these. The aim of the research is to add to a growing body of 
evidence on technology and outcomes in dementia care. As part of the thesis, several papers are included to further 
emphasize on themes and issues encountered in the research. Excerpts from the papers are in the text and the full text is 
available in the appendix and from the publishers. 
 
1. Introduction 
2 
 
The care paradigm is changing as more people are living with chronic conditions (such as diabetes, arthritis, and 
dementia), and health and social care shifts focus from curing ailments to caring for individuals [3]. Without effective 
therapies to modify the course of dementia, intervention strategies focus on other benefits for the patient and their 
caregivers, largely related to quality of life issues. Gerontology (the social, psychological, and biological study of aging) 
finds that a significant part of the aging process involves the use of knowledge and tools to control and adapt an 
environment or to adapt to an environment. Gerontechnology is the interdisciplinary field that merges the sociological, 
psychological, and biological studies of gerontology to promotes human health and well-being into old age through the 
use of technology [4] [5]. Gerontechnology can assist in care provision and promote aging in place. When taking the 
strategy to assist in dementia care by adapting the environment with technology, the key is to allow the home to mediate 
in administering or managing a continuum of care that increases as functional status declines [6]. Aging in place is being 
able to age in one’s own home in lieu of institutional placement [7] [8]. If Information and Communication Technologies 
(ICTs) are used to enhance services, ensure safety and security, promote independence, or facilitate social interaction, 
they impact domains specifically measured in many quality of life assessments. This suggests a higher quality of life 
(QOL) for the individual with dementia, a higher QOL for the caregivers, and increased quality of care (which can be 
measured by the technology itself). Furthermore, aging in place promotes community living, and the majority of older 
adults wish to remain in their own homes instead of living in a care institution [9] [10]. 
The field of gerontechnology is still quite young; there was little published research on gerontechnology in the late 1980s, 
but the field experienced a boom in the early 2000s and is now one of the fastest growing areas of research and 
development. The implications of such investigations influence a multitude of fields in their development and 
applications as well as a better understanding of the outcomes. Psychologists, gerontologists, medical professionals, 
manufacturers, architects, and engineers use evidence-based knowledge to help facilitate optimum living conditions for 
the citizens they serve. In the broader sense, gerontechnology has goals of supporting more active years in the job market, 
encouraging a healthy life span, reducing the digital divide by designing technologies to be more aging-friendly, and 
decreasing costs of living and care in old age. It is a user-driven area of research and application that connects 
gerontological theory with purpose-driven technology. As MP Lawton brought to our attention in 1998 [11], all humans 
who live to advanced adulthood will become users of gerontechnology. This PhD study applies gerontology theory to 
evidence-based research for the development, use, and evaluation of technologies used in dementia care. The results are 
used to determine if and in which ways gerontechnology can influence dementia care. The hypothesized outcomes are 
that the users would report a positive influence on their QOL after using the technologies when compared to a control 
group. The thesis concerns the thematic areas of dementia care and technological solutions that can support them; the 
connecting thread is how quality of life is affected by these. 
Figure 1 represents these components of the thesis. It is not enough to see where technology could provide support, but to 
also examine how that support can be measured, thereby contributing to continued development. This research adds to a 
growing body of evidence on technology and outcomes in dementia care. 
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Figure 1 Central themes of the thesis  
 
In Chapter 2, an overview of the issues involved is given, the rationale for the study is formed, and the state of the art in 
home-based dementia care is examined. The background chapter makes the case that there will continue to be an 
increasing demand for personalized dementia care and using technologies to this end can be beneficial. This chapter 
considers the global trends in population aging and declining birthrates, studying the projected increase in dementia 
prevalence, and investigating recommended and effective methods for dementia care. The theoretical framework used for 
the motivation and subsequent interpretation of the research is described, and particular attention is given to the concept 
of quality of life. The state of the art examins the types and methods of dementia care interventions the effectiveness of 
said interventions, and how they are incorporated into this research.  
Chapter 3 presents the hypotheses and the research questions to investigate if technology use in dementia care has a 
positive effect on quality of life. The research questions narrow the scope of the research to the identified concepts and 
provide structure to study the postulated research outcomes. The primary question in the research is to examine if 
gerontechnology-supported dementia care has different outcomes than usual care, and the supporting questions help to 
answer this and provide a deeper examination of the outcomes. 
Chapter 4 describes the development, implementation, and evaluation methods used in project ISISEMD and in this PhD 
study. The background chapter provides a starting point for determining which interventions have been tested before and 
show promise in real-life application. This influences the methodology by providing a platform for the development of 
the system and services, guidelines for implementing successful dementia care interventions, and care outcomes that 
have previously been investigated through tools known in the field. The theoretical framework helps to define which 
domains of quality of life could be influenced by the intervention and why, and this helps shape the care services and 
determine appropriate evaluation methods. Chapter 4 contains the detailed description of the research project.  
The analysis in Chapter 5 examines the evidence that answers the question if one method of dementia care produces 
different outcomes than the other. The evaluations are from 106 participants in Denmark, Finland, Greece, and North 
Ireland. 62 participants agreed to test the telecare in their homes, and their outcomes are compared to the outcomes 
from 44 usual care (control) participants in 3 of the 4 same regions. Outcomes in physical and independent functioning, 
quality of life, and caregiver stress are compared between the two groups as well as examined within the groups. This 
chapter entails using the data from the assessments to answer the research questions and applyies theories to explain the 
implications of the outcomes.  
Chapter 6 discusses the research as a whole, considering the methods and tools used, strengths and weaknesses of the 
study, and future directions in the field. The study design and research methods necessitate a discussion on the validity 
and generalizability of the results. This chapter also helps to guide further studies by discussing the successful and 
unsuccessful approaches in the research, and beneficial areas of future development. 
Demographic Challenges
Dementia Care Changes
Gerontechnology to Age in 
Place
Quality of Life
•Increasing proportion of older adults
•Increasing risk and prevalence of 
dementia with aging
•Desire to age in place
•Decreasing number of caregivers
•Technology to support caregiving
•Transfer of tasks
•Individuals with dementia
•Caregiver support
•Societal benefits
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The conclusions in Chapter 7 associate this research to the wider sphere of application, rationalizing that even though 
this area of research is theoretically and practically challenging, the fact is that technology is becoming ever ubiquitous 
and the exponential growth of its application to health and social care warrants the development of efficient, cohesive 
methods for measuring and interpreting the implications of its use. The appendices contain auxiliary information, 
comprised of details from the background investigation, the questionnaires used in the research, papers that are included 
as part of the thesis, and supplementary data from the statistical analysis. 
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Chapter 2.  Background 
This chapter shows that there are several issues leading to demographic challenges in providing dementia care. The data 
shows that there are an increasing global proportion of older adults living with dementia, and this is projected to 
continue growing with advancements in longevity and declining birthrates. The data also shows a declining labor force of 
working-age adults to provide care for the increasing number of aging adults with dementia. In this chapter, current 
trends and best-practices on diagnosing dementia are discussed. The theoretical framework used for the motivation and 
subsequent interpretation of the research is presented, and quality of life is examined as it pertains to dementia care. 
Investigating the recommended and effective methods for dementia care entails examining types and methods of 
dementia care interventions and the effectiveness of said interventions and how they can be incorporated into this 
research. This allows for identify the state of the art in technological solutions to address the need for increasing care. 
This chapter presents the formulation of the rationale for the study; there will continue to be an increasing demand for 
personalized dementia care and the appropriate use of supportive technologies to this end can be beneficial. 
Papers included in Chapter 2:   
Paper A provides a discussion on theories used to understand older adults’ experiences of interacting with technology.  
Paper A:  Carrie Beth Peterson, Anelia Mitseva, Albena D Mihovska, Neeli Rashmi Prasad, and Ramjee 
Prasad. “The Phenomenological Experience of Dementia and User Interface Development,” Proceedings of 
2nd International Symposium on Applied Sciences in Biomedical and Communication Technologies 
(ISABEL 2009). IEEE Conference Proceedings: Bratislava, pages 1-5. 
Paper B describes the background study on issues in quality of life studies and identifies the domains found to be 
influential on QOL in dementia.  
Paper B:  Carrie Beth Peterson, Neeli Rashmi Prasad, and Ramjee Prasad. “Framework for Dementia 
Quality of Life Assessment with Assistive Technology,” Proceedings of the International Association of 
Science and Technology for Development (IASTED 2010) in Innsbruck, Austria, Biomedical Engineering 
Volume 1. ACTA Press 2010. ISBN: I: 978-0-88986-825-0/II: 978-0-88986-827-4. 6 pages. 
Paper C presents a description of European projects focused on gerontechnology. 
Paper C:  Carrie Beth Peterson and Neeli Rashmi Prasad. “Easy Life, Intelligent Systems, and LIFE 2.0: 
European Research on ICT for Aging Adults,” Proceedings of the International Association of Science and 
Technology for Development Conference (IASTED 2011) in Washington DC, (746) Internet and 
Multimedia Systems and Applications/747: Human-Computer Interaction. ACTA Press, 2011. ISBN: 978-
0-88986-902-8. 8 pages.  
Paper E offers a discussion on MP Lawton’s instrumental work in quality of life studies, discusses environment as a 
mediator for activity, and theoretical motives for interventions that are focused and based on the individual. This paper 
also contains the details of the literature search for quality of life measurement tools.  
Paper E:  Carrie Beth Peterson, Neeli R Prasad, and Ramjee Prasad. “Assessing assistive technology 
outcomes with dementia.” Gerontechnology 11(2), p. 259. 2012. DOI: 
http://dx.doi.org/10.4017/gt.2012.11.02.414.740. 10 pages. 
Paper F considers the accelerated co-development of technology and society and the opportunity for technologies to 
support people with dementia 
Paper F:  Carrie Beth Peterson, Neeli R Prasad, and Ramjee Prasad. “The future of assistive technologies 
for dementia.” Gerontechnology 11(2), p. 195. 2012. 
DOI: http://dx.doi.org/10.4017/gt.2012.11.02.427.742. 7 pages. 
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2.1. Demographics 
Population aging 
Life expectancy at birth for the world’s population has increased from 48 to 68 years in the span from 1950-2010 [12], 
and more than 60 countries currently have a life expectancy of 75 years or more [13]. Improvements in life expectancy 
have been influenced by reductions in infant and childhood deaths, hygiene, and medical advances, for example to fight 
infectious diseases. In recent history, the main advancements have been in survival at older ages [14]. In addition to 
trends in increased longevity, fertility rates are declining [15] [16]. The proportion of older adults is rapidly growing, 
shown in Figure 2. Declining birthrates lead to fewer working-age adults while increasing life expectancies lead to higher 
proportions of adults living in advanced old age. In many countries, there will be more older adults requiring care than 
there will be adults to the available people to provide care. The United Nations Population Division summarizes that 
population aging is an unparalleled, pervasive, global phenomenon that is long-term, and will have profound 
implications for every man, woman, and child [16]. 
Figure 2 Global population aging 1950-2050 [17] 
 
With declining birthrates, those aged 65+ will outnumber children under the age of 5 around 2020 for the first time in 
recorded history [18]. And by 2050, those over 60 will outnumber all children under age 14 [17]. With longevity, adults 
over the age of 80 make up one of the fastest growing cohorts around the world, shown in Figure 3. The over-80 age 
group is predicted to increase by 233% between 2008 and 2040 [18] [19]. The oldest populations have tripled in 
percentages since 1950 and comprise 5% of the total Organization for Economic Co-operation and Development (OECD) 
population1 [20]. For the first time, the majority of middle-aged adults have living parents [21], and tighter labor markets 
are expected as the proportion of older adults will equal or exceed the proportion of taxable work force in many countries. 
The world’s population is rapidly aging and these statistics demonstrate a broader, global need to understand aging 
issues and to acknowledge older adults as influential members of society.  
Figure 3 Global increase in aging adults [22] [23] [24] 
 
                                                        
1 OECD Countries include:  Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, Germany, 
Greece, Hungary, Iceland, Israel, Italy, Japan, Korea, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, 
Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, and United States [356]. 
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Increase in dementia prevalence 
With population aging, one must also consider increases in disability and disease, and the resulting use of care services. 
Older adults are reported to consume health services at a rate of up to 5 times as much as younger cohorts [25] [26]. Yet, 
Grün et al. found that older adults who are not in good health, but are also not close to death, do not require any more 
costly care than their younger counterparts having the same conditions [27], and other studies indicate an increase in 
active years over 65 and decreasing number of years with severe disability [28] [29] [30] [31]. Some research shows 
reductions in severe disability in late life yet increases in others, and this is largely due to significant disparities in health 
and life expectancies across and within countries [32]. Globally, dementia is one of the main causes of disability in later 
life2, and those over 85 have a 50% risk of developing some form of dementia, shown in Figure 4.  
Figure 4 Risk for developing dementia (2012) [33] [34] [35] [36] 
 
Despite inconclusive and even contradictory data on disability rates in late life3, we do know that the aging adult 
population is expected to grow. One significant cost is due to the increased prevalence of individuals living with 
dementia. In 2010, the global cost of formal dementia care was more than 1% of global Gross Domestic Product ($604 
billion4) [33] [37]. That figure does not include volunteer, unpaid, and family caregiving, which was valued at an 
additional $450 billion in 20095 [38]. That means that globally, over $1 trillion was spent on dementia care in roughly 
one year. Figure 5 shows the projected increase in individuals living with dementia. It should also be noted that up to 
50% of those who would meet the criteria for a dementia do not have a formal diagnosis6 [39], so the figures given only 
reflect reported instances of dementia.  
                                                        
2 According to the WHO Global Burden of Disease report, disability from dementia was higher than any other condition, with the 
exceptions of spinal cord injury and terminal cancer. Dementia contributed 11.2% of years lived with disability among all people 60 years 
and older; that is more than stroke (9.5%), musculoskeletal disorders (8.9%), cardiovascular disease (5.0%), and all forms of cancer 
(2.4%) [359]. The societal costs of dementia were valued around €27 billion, which is almost as much as the societal costs of cancer (€14 
billion), heart disease (€9 billion), and stroke (€6 billion) combined. Strikingly, as far as research is appropriated, for every €1 million in 
costs of dementia, around €150.000 was spent on cancer research, almost €85.000 on heart disease research, and only about €5.600 
was spent on dementia research [33]. 
3 [25], [354] and [355] warn against comparing health indicators as data can be derived from different methodologies and interpreted in 
a conflicting manner. Inconsistent and incompatible data trends show an evident need to further explore morbidity, disability, disease, 
and implications for aging and health resources. 
4 If dementia care was a country, based on costing over 1% of worldwide GDP, it would be the 21st largest economy, globally, ranking 
between Poland and Saudi Arabia [33].  
5 If informal dementia care costs were seen as company sales, it would total more than the world’s largest company sales in 2009 (Wal-
Mart at $408 billion) [38].  
6 This would not mean that ~100% of people over age 85 have dementia, but refers to the percentage of people who have symptoms of 
dementia but the type and level of cognitive impairment is not diagnosed. For example, if a 90 year old person has had multiple strokes 
and is showing symptoms of dementia, the family may not seek out an evaluation of cognitive functioning as they are already managing 
other functional issues, e.g. bathing, dressing, and feeding.  
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Figure 5 Projected global increase in the prevalence of dementia from 2012 to 2050 [19] [33] [40] 
 
People are living longer than in previous generations, with more chronic conditions, and there are an increasing number 
of older adults living with dementia (a projected growth to 65,7 million individuals by 2030) [40]. In addressing the 
increase in dementia prevalence, it is beneficial to have an approximation of the labor market of potential caregivers. The 
data show that the proportion of working-age people to retired people7 is rapidly declining around the world. From 2000 
to 2010, the European Union (EU) experienced a 13% decline in populations aged 20 to 39 [23], and the total number of 
working age adults will decrease by at least another 48 million by 2050 as the elderly population increases by another 58 
million in the same time span [14] [41] [42].  
An individual lives with dementia for an average of 4,6 years (7,1 years with Alzheimer’s disease, 3,9 years with Vascular 
dementia [33]); depending on age, type of dementia, and access to quality care, one can live with the syndrome over 20 
years [43] [39]. Dementia is a syndrome, meaning it is not a specific disease but consists of a group of symptoms. The 
most common symptoms are a progressive loss of memory, cognitive functioning, and (at least one of) reasoning, 
language, visual-spatial processes, executive functioning, social behaviors, and personality, and the loss interferes with 
the performance of daily tasks [44] [45]. There are some discernible symptoms of dementia presented in Figure 6. 
Dementia is usually associated with aging and is the leading cause of institutionalization in older adults [34], but it occurs 
at any age8. In fact, studies show that there is a growing proportion of younger adults with dementia [46] [47] [48]. There 
are many different causes of dementia, which can range from dietary deficiencies to head injuries to inherited conditions 
to toxin exposure, and there are over 100 types of dementia [49]. Alzheimer’s disease, which has disease pathology, is the 
most prevalent type of dementia, constituting up to 80% of all dementia cases [39]. Appendix 2 provides a description of 
common types of dementia, symptoms, and prevalence rates. Regardless of the cause of dementia, the syndrome will 
affect each individual and family differently. Each person with dementia has different expressions of their symptoms due 
to different personalities, experiences, and reactions to care interventions. This makes generalizing about dementia very 
difficult and with a higher degree of inaccuracy than when generalizing about other diseases or syndromes. As there is 
currently no cure for most dementias, the main focus of treatment is on maintaining or promoting a high quality of life 
[45]. The core components of dementia care are symptom management, slowing the rate or effects of decline, and 
ensuring a safe environment. 
Individuals with mild impairment are more likely to have functional independence and a lower risk for imminent 
institutional placement, which allows for longer use of the intervention. In recruiting participants with mild to moderate 
dementia, one issue that arises is that many individuals do not seek out professional help or a diagnosis until the 
symptoms are disruptive enough that they need additional coping channels. It is a problem that it is ideal to implement 
the telecare technologies as early in the dementia syndrome as possible, yet difficult to access individuals in the early 
stages of decline. This problem warrants a discussion on the recent advancements in early diagnostics for dementias. As 
mentioned above, up to 50% of individuals who would meet the criteria of a dementia diagnosis do not receive one. Most 
people first speak with their doctor about their memory once issues are presenting a problem in daily life, but there is 
growing interest in early diagnosis due to dementia becoming more prevalent, particularly if there is a risk for genetic or 
familial types of dementia. Several national and international bodies are pushing for increased education and early 
detection of dementias to improve public awareness and diagnosis rates [50] [51] [52] [53] [54].  
                                                        
7 The World Health Organization (WHO) has categorized ages and those belonging to the “old” segment are based on the previous 
retirement age in the UK. In recent years, the retirement age in many developed countries has been extended, largely due to the aging 
trends and lower fertility rates. In gerontology, there is discussion of changing these definitions of “old” as medical and social norms are 
changing and previous models of aging are becoming outdated. 
8 The youngest diagnosis of dementia I have found was a 6 year old girl (in 2008) with a rare genetic disorder (Niemann-Pick disease, 
type C) that leads to dementia [357]. 
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Figure 6 Common cognition problems at the onset of dementia [55] 
 
The two main diagnostic guidelines for dementia are the (American Psychological Association’s) Diagnostic and 
Statistical Manual of Mental Disorders (DSM) and the (World Health Organization’s) International Classification of 
Diseases (ICD). There is a typical process for the timely diagnosis or cognitive dysfunction or dementia [56] [57] [58], 
given in Figure 7. The patient meets with the doctor, who will conduct a medical history and physical exam before 
recommending cognitive testing. Laboratory testing and brain imaging are typically only necessary when differentiation 
is required for treatment or research. Early identification is most commonly achieved through neuropsychological testing 
(i.e. cognitive assessments), sophisticated imaging techniques (i.e. brain imaging), and biomarkers (i.e. genes). 
Figure 7 Expected approach for diagnosing dementia [58] 
 
When looking at methods for early identification, the sensitivity, specificity, and accuracy of the test are chief 
considerations:  
 Sensitivity:  the true positive rate, meaning the actual positive results identified as such (correct diagnosis of 
dementia) 
 Specificity:  the true negative rate, meaning the actual negative results identified as such (correct diagnosis of no 
evidence of dementia) 
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 Accuracy:  the ratio of true positives and true negatives, meaning the proportion of people correctly diagnosed 
by the assessment 
The ideal assessment would correctly identify dementia presence and type 100% of the time; however, the sensitivity and 
specificity change as cut-off scores for the assessments change, resulting in a trade-off between increasing sensitivity or 
specificity. An accurate diagnostic tool for dementia should have a high sensitivity and specificity (>80%) [59] [60] . Of the 
11 dementia diagnostic methods in Appendix 3, only 4 meet the criteria of >80% sensitivity and specificity (i.e. MoCA, 
CT, and PET for Alzheimer’s disease, and CSF). The review of the diagnostic methods shows disconnect between trends 
in early diagnosis and the needed development in accurate testing9. 
It is known that older adults who are acutely admitted to the hospital exhibit cognitive impairment [61] [62], including 
delirium [63] (a sudden, organically-caused cognitive syndrome often exhibiting symptoms similar to dementia). 
Delirium occurs in up to 56% of all hospitalized patients and up to 79% of older patients who are hospitalized [64], 
compared to only 1-2% in the general community [65]. Full recovery from delirium is common [66] [67], and implies that 
screening for dementia in a hospital setting may not be the most accurate method to diagnose dementia. Additionally, the 
neuropsychological test results vary based on age, comorbidity, education level, and diagnostic cut-off point, so it would 
be irresponsible to use one test and assume it is valid for all individuals being screened. In addition to those with acute 
cognitive impairment or delirium, individuals with a dementia diagnosis have an average of 3 comorbidities10 [68]. The 
number of comorbidities has been positively correlated with dementia severity [69], and dementia severity is a 
significant, independent risk factor for hospitalization [70]. There are more incidences of cognitive impairment and 
dementia found in hospitals or clinical settings, making them ideal locations to screen for dementia. However, an early 
diagnosis has a powerful impact on the individual and their loved ones, and caution should be taken as there is an 
increased risk for a false positive diagnosis. An early diagnosis, that is, before symptoms are noticeably present, such as 
in the case of families wishing to have genetic testing for their risk of developing dementia, is even more uncertain. 
Currently, there are no validated biomarkers for Alzheimer’s disease, the most common form of dementia; without this, 
there is a greater likelihood of false positive diagnoses of dementia. Furthermore, the Alzheimer’s Association [71] does 
not recommend routine clinical testing for Alzheimer’s disease genes since no preventative or curative therapies are 
available11. In the case of a true positive dementia diagnosis, there is still no way to definitively tell the patient what their 
prognosis is for the next 1-5 years. In the 100+ years that Alzheimer’s disease and dementias have been studied, there is 
still no single test that can definitively predict whether or not an individual will develop a dementia nor determine the 
progression of their symptoms. The use of biomarkers to diagnose Alzheimer’s disease has not been justified, and should 
not be used, based on ethical and clinical rationales. 
It is argued that earlier diagnosis allows individuals to better plan for their future by arranging power of attorney, 
advance directives, care options, insurance, wills, and estate planning. Yet it could be argued that these are key issues for 
all aging adults:  as the risk of developing dementia is 20% in those over age 80 and 50% in those over age 85, medical 
professionals could easily recommend all their patients in these age groups put their effects in order without costly 
diagnostic procedures. Especially for older adults, would the probability of an early diagnosis of dementia be any more 
reliable than the general risk based on age? Furthermore, if older adults are in the hospital or visiting their General 
Practitioner, they most likely have multi-or comorbid conditions, and it would still be wise to advise them to arrange 
legal, financial, and care plans.  
As Alzheimer’s disease and most other dementias cannot currently be reversed or prevented, most therapies treat the 
symptoms and address quality of life. With the increased awareness and screening for dementia, the population is given 
the impression that there are effective treatments. When seeking medical help for cognitive changes, the individual or 
family perceives that there will be a valuable reason for doing so– and not merely a dementia diagnosis, but a plan for 
action to alleviate the symptoms. Awareness campaigns, although they may be successful in raising public awareness on 
the symptoms and resources for dementia, have also heightened public fear of dementia. Particularly among older adults 
and their family members, there is the fear of undiagnosed or undetected dementia, and an increasing desire to prevent 
or detect the dementia as early as possible. The advancement of dementia education and diagnosis is needed; however, 
there are also some major concerns with governments declaring dementia finding schemes that proactively screen all 
patients over age 75 for dementia [51] [52]. Early detection and accurate diagnosis are dependent on diagnostic criteria, 
                                                        
9 It should be noted that the data in Appendix 3 Methods to diagnose dementias, is not based on an exhaustive review of diagnostic 
methods, as this is not the focus of the study. 
10 Over 50% of all adults over age 65 have an average of >3 multimorbidities, and the number of multiple and chronic conditions 
increase with age:  >4 multimorbidities in 30% of adults 65-74 years old and 55% of adults 75 years and older [358]. 
11 For a description of therapies for dementia, please see Appendix 4 Dementia treatments. 
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which are influenced by the pharmaceutical industry (i.e. DSM12). New therapies being developed are dependent on early 
detection and accurate diagnosis for testing, and individuals who are seeking out early detection of dementia due to fear 
are opening a market for diagnostics to become a potentially lucrative business. The influence of pharmaceutical interests 
in the early detection of dementia fuels a financial stratagem in the dementia industry (commercial, health, and 
pharmaceutical industries who aim to develop products to treat dementia). There is a potential to misdiagnose and over 
treat patients, incurring avoidable expenses and distracting resources from individuals who have a (timely) diagnosis of 
dementia and a rational need to seek support [72]. Screening for dementia must be evaluated the same way as any other 
diagnostic screening would, and health care professionals should conduct memory assessments and referrals in an 
appropriate manner. However, with proactive, early screening, patients are not voluntarily being screened for dementia, 
since health professionals would screen patients opportunistically, effectively removing a patient’s opportunity to 
consider their options for screening. If patients know they will be screened for dementia regardless of why they seek out 
clinical care, they may be likely to avoid seeking medical care when it is needed13, which poses a significant risk to their 
health and well-being.  
Thus far, it is not clear that the benefits of proactive screening outweigh harms, and there is no robust evidence for the 
benefit of early dementia diagnosis over timely diagnosis. If the expected, effective treatments are not available, will 
medical professionals feel the pressure to introduce new services which have no proven evidence of success? Perhaps the 
most convincing argument against early diagnostics is that while people at risk may be identified or diagnosed, 
interventions with a successful evidence-base are lacking. Here, we must ask ourselves, to what end is early diagnosis, if 
we cannot recommend a treatment? Are there sufficient resources to support these patients? What is the benefit of 
spending thousands on sophisticated imaging and biomarker detection if no course of treatment is available? Would 
early detection be crucial to the care of the individual? Would it even be beneficial? Particularly when giving a probable 
or preclinical dementia diagnosis to patients who did not seek out cognitive testing, ethical, personal, and societal 
consequences run high. It would seem that early diagnostic testing would largely benefit research and the dementia 
industry, which may not translate into benefits for the patient. Even if significant clinical evidence is found for an 
individual to likely develop dementia, the primary recommendation is lifestyle management. Conceivably, mental and 
social health liaison services will need to be better integrated in order to educate, and provide counseling for individual 
and family coping. There is no high quality evidence showing that it is beneficial to diagnose dementia before the patient 
presents symptoms and, if there is no research showing that patients are better off with an earlier diagnosis, this should 
not be unnecessarily forced on them. Only a clinical trial can tell if there are actually benefits for screening for dementia. 
Furthermore, with the projected shortage of human resources to provide dementia care, earlier and more prevalent 
diagnosis will tighten the demands for quality care. Clinical, medical care should practice methods that show proven 
benefits to enhance patient well-being, not with methods based on an opinion that it should help. The UK National 
Screening Committee [73], World Health Organization [33], and Alzheimer’s Association [71], among others, advise that 
early screening should not be offered.  
Demographics summary:   
Declining birthrates result in fewer working-age adults while increasing life expectancies result in higher proportions of 
adults in advanced old age. The global phenomenon brings profound effects as many countries will have more older 
adults requiring care than adults available to provide care. The effects are further intensified by the growing prevalence of 
dementia in an aging world. Efforts are being made educate society on dementia, and to identify and treat those with the 
syndrome as early as possible; however, proactive screening for dementias is not recommended as the appropriate 
diagnostic tools are still developing and no therapies are found to be reliably beneficial.  
                                                        
12 The surprising majority (7 out of 10) of the DSM-V task force members have financial ties with the pharmaceutical industry [330].  
13 An example from the ISISEMD study, the Finland region found that local residents were becoming weary of visiting memory clinics 
due to a fear of an Alzheimer’s diagnosis. 
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2.2. Caregiving 
In a 1989 document on research and policy on the care of older adults, the Institute of Medicine were aware of the 
economic, social, and health implications of caregiving, and the benefits that caregivers serve to public health [74]. The 
vast majority of caregiving activities are provided by informal caregivers (ICGs), who are often family and friends. 
Caregivers are prone to experience strain due to the demands of caregiving, often termed “caregiver burden” [75]. The act 
of caregiving combines the emotional expression of caring and the physical act of care providing, and both of these come 
into play to influence caregiver burden. Many caregivers contribute from their personal expenses to support care needs, 
often without financial retribution [33] [38] [76]. The American Association of Retired Persons found that 23% of 
caregivers cut on their own dental and preventative health care, 27% of reported a “moderate to high degree of financial 
hardship” directly related to their caregiving, 34% use their own savings to cover costs, and 38% diminished or altogether 
stopped saving for their own future [38]. Globally, annual out-of-pocket expenses for dementia care are 14% in high 
income countries and 50% in low income countries [33]. Aside from direct expenses on the family and caregivers, 
caregiving affects the economy through the paid workforce. 69% of caregivers were found to adjust their employment due 
to caregiving, including cutting back on office hours, changing jobs, or having to quit their job, often leading to a 
reduction or halt in employment benefits, health insurance, and retirement savings [38]. In particular, those who live 
with the loved one, are the most likely to adjust their paid employment hours [76].  
Non-caregivers have better physical health, reduced risk of chronic problems, and more leisure time than caregivers. 
Caregiving for a person with dementia is associated with decreased immunity, slower wound healing, greater 
cardiovascular reactivity, reduced engagement in preventative health behaviors, and an increased risk for serious 
illnesses and mortality [33] [76] [77] [78] [79] [80]. Up to 85% of informal caregivers have symptoms of clinical 
depression, and up to 50% of that group have symptoms of major depression [38] [78] [80], and caregivers living with 
the person with dementia that they are caring for are exposed to more psychological problems and social isolation than 
caregivers who live separately [38] [38] [80] [81]. Caregivers tend to have poorer sleep hygiene, and 22% report that they 
are exhausted by the time they go to bed [79]. The greatest sources of negative stress contributing to caregiver burden are 
Behavioural and Psychological Symptoms of Dementia, such as wandering and aggression [77] [82] [83] [84] [85]. 
Functional decline has been identified as the most significant predictor of caregiver burden, accounting for 16% of 
burden [86]. A high level of dependence is a valid health outcome measure in Alzheimer’s disease [87], and higher levels 
of caregiver burden are associated with placement of the person with dementia into formal care [78]. Dementia-related 
cognitive decline is one of the most common reasons for institutional placement [82]. Caregiver burden affects all facets 
of life and, at its worst, both physical and psychological strength is drained. Figure 8 illustrates the physical and 
emotional stress that informal caregivers report in the 2012 United States study.  
Figure 8 Role-related stress reported by caregivers for individuals with dementia [39] 
 
Dementia caregiving has been the most common type 
of caregiving represented in research literature [77], 
and the negative effects are frequently studied in 
attempts to understand and mitigate caregiver burden. 
While caregivers may experience social isolation, 
feelings of helplessness, embarrassment, and anger, 
caregivers also report positive effects from their role. 
Caregivers have reported feeling closer to their relative 
or friend after the diagnosis of dementia and positive 
feelings were fostered by the act of showing care 
through physical and emotional support. 55-90% of 
caregivers experience togetherness, sharing activities, a reciprocated bond with their care receiver, feelings of 
accomplishment, mastery, and personal and spiritual growth [78]. Despite the involvedness, risks, and financial drain, 
millions of unpaid volunteers willingly continue to provide informal care to someone with dementia and gain great 
satisfaction from it [38] [78]. 
Research has attempted to capture the essential elements of the experience of developing dementia through personal 
accounts and qualitative studies [88] [89] [90] [91] [92]. Evidence shows that people with dementia, even in the later 
stages, can maintain their identity [93] [94] [95], ability for emotional expression [96], and can convey their mood [97], 
and quality of life [98]. A significant part of the aging process involves the use of knowledge and tools to control and 
adapt an environment or to adapt to an environment. When we look at the characteristic symptoms of the syndrome 
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given in Figure 6, we can see how living with dementia could severely impair an individual’s ability to use knowledge, 
tools, and crafts to adapt to an environment. However, in the same light, we can see how it would be better to adapt the 
environment to the individual to accommodate the symptoms. There is an increasing wealth of knowledge on how to 
manage multiple chronic conditions for citizens:  it calls for the proper coordination of care across service sectors, an 
optimal mix of disciplines and skill sets, and for integration, not fragmentation of knowledge and services [14] [99] [100] 
[101]. Coyte, Goodwin, and Laporte note that there is a growing trend in Europe in policy and practice to reduce 
institutional care and promote care-at-home services [99]. The American Association of Retired Persons (AARP) reports 
that over 90% of people over 65 want to stay in their own homes and age in place  [102]. Aging in place allows individuals 
to proactively create their own life, connect with others, and acknowledges the influence of quality of life on individuals 
and the community [45]. Community living is found to defer or delay the need for public assistance and 
institutionalization, is more affordable and less excessive than institutional care, and supports an individual’s ability to 
support themselves [7]. The benefits of living in the community are painfully evident to anyone who has spent an 
extended amount of time in a clinical setting [45]: depersonalization, immobility, and mental, physical, and economic 
suffering often accompany extended clinical treatment [74]. Meanwhile, aging in place enhances the positive 
psychological, sociological, physiological, and financial effects of aging and supports independence despite functional 
decline [8]. Preventing institutionalization and accommodating the public’s wishes to remain at home have obvious 
benefits for the individual, the community, economy, and public health systems [103]. However, this also increases the 
need for private caregiving, both professionally and informally. Caregivers living with the person with dementia are 
inclined to higher levels of burden and detrimental outcomes to their own well-being. Caregiver support is necessary in 
order to achieve the long-term goals of individual, community, economic, and public health benefits of aging in place. 
Gerontechnology can help to minimize hindrances, enhance personal abilities (including counteract facilities lost during 
aging and disease processes), augment the ability to provide quality care and influence research trends [104]. 
Technologies can automate some actions, thus increasing the independence and autonomy of the person utilizing them. 
Technologies can also facilitate or absorb some of the caregiving tasks from nurses and family members, and is one way 
to collect data about the individual, their environment, and health and care outcomes. If caregivers could use e.g. a 
passive monitoring system to support their caregiving, they could have more peace of mind in knowing that the home is 
safe and that they will be notified immediately if anything should require their attention. The Technology and Dementia 
in the North study examined data from 29 older adults with dementia in Finland, Norway, Iceland, Denmark, and 
Sweden [105]. All participants used gerontechnologies to support them in daily life, the results of which showed that 
technologies helped older adults with dementia to maintain daily activities and social inclusion. The work of Marilyn 
Cash [106] further states that the early identification of dementia makes it easier to support independence by utilizing 
gerontechnology tools that address personal user needs, that is, to match the right technologies for the individual.  
Trends in caregiving summary: 
The majority of caregiving activities in dementia care are provided by informal caregivers, often family and friends of the 
person with dementia. These caregivers are likely to experience strain due to the demands of caregiving, which can have 
lasting and holistic effects on the individual and family’s mental, physical, and financial well-being. The majority of 
adults wish to age in place in their own homes, which is shown to provide an array of benefits; but this creates more 
demand for private caregiving, often falling on the families and informal caregivers. Support for caregivers is needed to 
attain the goals and benefits of aging in place. Gerontechnology can help to coordinate care, promote aging in place, 
support caregivers, and assist with independent abilities. 
2. Background 
14 
 
2.3. Theories used in the research 
The theoretical foundation sets the stage to define the components to be studied and the framework in which results will 
be interpreted. As researchers, we use theories to build upon a body of knowledge and expand understanding, to provide 
a method to systematically and cumulatively assimilate data. The theories used must accurately explain a larger set of 
observations as well as make explicit predictions for the results of subsequent observations. In gerontechnology research, 
a lack of theoretical foundation essentially means that the results do not add to the cumulative body of knowledge, but 
produce a once-only, restricted application and significance of information. The research is vulnerable to uncertainty 
when the measurement tools are inconsistent with conceptual definitions and intended goals. The process of aging can be 
eased through the use of ICTs and gerontologists are needed in the area of technology development to inform designers 
how to best meet the desires and requirements for support and enjoyment [11] [107] [108]. Gerontology is over a century 
old and a variety of information about aging has been collected during its history. Examining the biological processes of 
aging provides a great deal of information about the cellular processes, aging at the molecular level, and on the 
pathological changes in memory formation and retrieval that occur in old age. The sociological study of aging gives 
insight into socio-cultural variations in aging and a framework to explain age-related health, family, and socialization 
behaviors. Investigating the psychological aspects of growing older contributes an understanding of concepts such as 
loss, wisdom, person-environment fit, and life quality. As gerontology is the social, psychological, and biological study of 
the aging process, gerontechnology is the applied study of how technology can be used to control or adapt an 
environment through the lens of the social, psychological, and biological aging processes. It provides a specified 
understanding of aging adults as technology users and a holistic interpretation of (health) technology outcomes.  
Theories of aging 
ISISEMD aimed to positively influence quality of life through an integrated prototype of services which would support 
independence in the home and keep the caregivers informed on the activities of the person with dementia. Selecting the 
tools to evaluate quality of life required considering what quality of life is and how the construct could be measured. This 
section presents the gerontology theories that are used to understand the research outcomes and to support a framework 
for interpreting the implications. Phenomenology it is discussed as promoting user-driven design through tailoring care 
services, and rationalizes that the best interpretation of quality of life and application of the telecare is at the individual 
level. Exponential growth is discussed as a driver in the modernization of applied technology and a motivation for 
gerontechnology research.  
Previously, it was believed that late-life development followed a negative curve, and loss was a fundamental theme in 
many aging theories. However, investigations during the past few decades show that older people, on average, were 
continuing to live and develop just as well, if not better, than younger cohorts, and these models of social and emotional 
aging were reconsidered. This presents a paradox where the previous models of aging focused on loss and subsequent 
observations demonstrated that growing older, for many, means continued growth and development. The paradox of 
aging refers to older people coping well in old age; despite losses, aging adults maintain good mental health and enjoy 
valuable social relationships. Successful aging has been a central concept in gerontology since the 1980s. It is loosely 
understood as the absence of physical and cognitive impairment in old age. Loosely is noteworthy, as one review of the 
literature found 29 different definitions of successful aging in 28 studies, concluding that, although the majority of 
definitions quantify physical and cognitive functioning, there was no consensus on a definition of successful aging [109]. 
It has been based on a biomedical model, which precludes people with chronic illnesses from “aging successfully.” When 
definitions have a bias towards negative health outcomes and rely on health being the absence of disease and disability, 
there are few successful agers (15%) [110]. There is also a gap between how individuals and researchers define success:  
the majority of older adults (50% [111] and 92% [112]) self-rated themselves as aging successfully, yet only a stark 
minority (19% [111] and 5% [112]) of those would be considered successful agers when using biomedical criteria. 
Successful aging has also been observed among people with dementia. After interviewing 224 people with Alzheimer’s 
disease over a period of 18 months, successful aging was directly predicted by mental health and social relationships, 
rather than general health or severity of cognitive decline [109].  
Discussed in the introductory chapters, advances in science and medicine have reduced the prevalence of communicable 
diseases as leading causes of mortality and morbidity; likewise, increasing life expectancy has also influenced chronic and 
non-communicable diseases accounting for a higher percentage of mortality and morbidity rates. With an increasing life 
span and increasing risk for chronic health conditions, one could understand why some gerontologists (e.g. bio-
gerontologists) would perceive an increasing percentage of years spent with disability or disease as not aging successfully 
2. Background 
15 
 
[113] [114]. Perspectives on dementia care have seen profound changes in recent decades; the major paradigm shift was 
from a cure-based, medical model to a care-based, medico-psychosocial model. The cure to care paradigm puts 
emphasis on the experiences of the individual, which provides information on behavioral expressions and how the care 
environment influences them [3]. By adjusting the paradigm for care, new ideas for goals and treatments can be 
incorporated, which lead to the continued development of new methods. One example of the changing care paradigm is 
in applying rehabilitation strategies to palliate the symptoms of dementia, proposing continued development rather than 
merely managing decline.  
Behavioral dependency is viewed within the relationship the person has with their environment, where the behaviors and 
their significance give comprehension to the global construct of dependence. Learned dependency could be internally 
fostered if the person, for example, has a fear of falling and does not dare to walk without physical support, which reduces 
physical ability due to nonuse14. This is getting closer to the model of the psychological state of learned helplessness. 
Learned helplessness can impede health interventions when the individual perceives they are unable to carry out a 
skilled function or successfully participate in a situation and thusly assumes that they are further unable to function in 
other situations. Learned helplessness is also fostered in relationship dynamics where the caregiver overcompensates for 
the aging adult, even for activities that they could still do themselves. As aging adults adapt to their environment, the 
concept that elderly increasingly rely on others to provide assistance (e.g. informal caregivers) could be partially due to 
the social connection that the assisting relationship provides. Margaret Baltes [115] reported that older adults who were 
dependent on others had more social interaction than older adults who did not. In this light, the model of learned 
dependency may relate to continuity theory. This theory states that people will continue their former lifestyles into old 
age by adapting behavioral strategies. Continuity theory would infer that the older adult is maintaining social activities 
through an adjusted strategy of engagement. The caregivers in the home can become a primary source of socialization. 
Baltes also presents a comparison of institutional teaching and institutional caregiving, saying that there appears an 
expectation of incompetence (as opposed to actual incompetence) that erroneously feeds models of long-term care:  
where educators modify their helping behaviors to match the student’s competence level, caregivers often assume 
incompetence and go into efficiency mode [115]. When the environment is used as a mediator to facilitate tasks, an 
environment that is too responsive may overcompensate for remaining capabilities and facilitate the loss of independent 
behaviors. The caregiving relationship can be environmentally supportive and emotionally rewarding, but over-ambitious 
caregiving can infantilize the person in their environment and cause emotional harm. To truly serve the aging adult, a 
balance needs to be made in caregiving activities that will support the older adult without teaching them that they are 
unable to participate. Determining the appropriate amount of (gerontechnology) assistance also includes reassessing how 
technologies are fulfilling care goals and serving the individual’s needs. 
In gerontology, activity theory posits that thriving in old age would be facilitated by staying active and continuing 
(socialization) activities. The idea is that activities are plastic in nature, subject to transformations, which in turn spurs 
further transformations; the individuals adapt to and advance activities while activities also adapt and advance 
individuals in a cycle of co-creation. This theory is a conceptual framework by which to understand and analyze activities 
and their significance through the consideration of, e.g. the individual, their history and culture, the environment, 
motivation for activity, role of mediating artifacts, and the complexity of activities. Activity theory supports a positive 
correlation between activity and life quality, conversely postulating that those who do not maintain or increase activity 
will consequently experience a lower or declining life quality. Yet, this is not causally accurate. This theory has been 
criticized for marginalizing those who do not participate in activities, and for overlooking the health and economic 
disparities that could prevent aging adults from participating [116]. Aaro Toomla took a critical view of activity theory 
and formulated 5 flaws in the theory [117] [118]: 
1. “It relies on unidirectional instead of a dialectical view of culture-individual relationships 
2. It focuses on analyses of activities without taking into account the individual involved in the activity at 
the same time 
3. It underestimates the role of signs and the importance of focusing on sign meaning 
4. It approaches mind fragmentally, without understanding the holistic nature of mind 
5. It is fundamentally a-developmental and therefore not appropriate for understanding emerging 
phenomena, including mind.” 
The social constructivist theory posits that technology and society co-construct each other; there is continued 
development between social practices and technological artifacts (both in design and in use). Susanne Bødker [119] [120] 
                                                        
14 I had worked with a woman who had senile dementia and, even though she was 98, she many times thought she was in her 70’s and 
had recently had her hip replaced. She would say she could not walk due to the surgery, and the caregivers came up with a range of 
tactics to support her walking as independently as possible so as not to foster her belief that she could not do it. 
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made an excellent point that a new technology can only be analyzed by observing the use in the real-life context. There 
have been some studies that support non-interactive technologies for dementia care [121] [122], and others that support 
that older adults [123] [124] [125] and those with dementia [126] [127] find value in interacting with the technologies put 
in place for their care and safety. Two articles found that participants enjoy health robots, name them, talk to them, 
watch them for entertainment, and anticipate they will miss them when the trial is finished [128] [129]. This population 
made emotional connections with robotics as an adjusted strategy of engagement for socialization [130]. This example 
could also be explained through continuity theory, which would posit they continued their lifestyles of social activities by 
engaging with the robotic vacuums. 
Phenomenology considers the basic nature of objects and events, and their perceptions in human consciousness [131] 
[132]. It highlights the personal experience a person has and is particularly interesting to apply to dementia care; 
removing a pre-defined reality and focusing on how the user defines their experiences. Anne Morris describes how 
participants have experienced a technological device as having a single use (realistic) as well as in relation to their 
perception of self (existential) [127] . This means that we do not experience technology exclusively by its predetermined 
design, but also by its usefulness and consequences [133]. When using technologies for dementia care, phenomenology 
will hold that the user’s relationship with the technology is a product of the particular way they view and conduct 
themselves in and towards the world. Understanding the phenomenology of interacting with gerontechnology while 
living with dementia will be of great importance, for example, how an older adult with dementia uses a touchscreen 
computer versus how an engineer has designed it to be used. It is likely that there will be no one theory to guide 
development for and to interpret the use of technologies by people with dementia when the individual and their context 
provide meaning for usefulness. Paper A provides a deeper discussion on phenomenology and older adults’ experiences 
of interacting with technology:  
Carrie Beth Peterson, Anelia Mitseva, Albena D Mihovska, Neeli Rashmi Prasad, and 
Ramjee Prasad. “The Phenomenological Experience of Dementia and User Interface 
Development,” Proceedings of 2nd International Symposium on Applied Sciences in 
Biomedical and Communication Technologies (ISABEL 2009). IEEE Conference 
Proceedings: Bratislava, pages 1-5. 
“Nygård [126] explains how people with dementia are conscious of their preferences and actively apply 
them to their choices, even if they may not be capable of describing or reflecting on them. By recognizing 
their motivations, conceptualization, perceptions, and employed coping strategies, we have useful 
information to ascertain individual needs. Morris [127] validates that participants develop their own 
methods of interacting, illustrated through the account of one woman with dementia who would print a 
blank page from her printer each morning in order to keep track of the date. This was not the intended use 
for installing an intricate system in her home, but such demonstrations epitomize how people with 
dementia can come up with innovative methods to make use of their environment for support. 
 
Participatory design techniques actively collaborate with end users throughout the design process. A user 
sensitive inclusive design recently put forth by researchers at the University of Dundee, addresses an array 
of attributes typical of people with dementia to improve customized, adaptive interfaces [134]. However, as 
each person with dementia is individualistic, each study dealing with the population is subject to 
idiosyncratic reformulations and alterations. Even traditional user-centered design methods did not 
provide the greatest understanding of designing for the inexperienced, cognitively impaired, older adult. 
Traditionally, design practices have used data and technique as their means to acquire user requirements, 
rather than using the design theory to permit end users to express themselves, encounter issues, and 
stimulate innovation [135] [131]. Working by the latter approach allows for the significance of the 
interaction to modify not only the design, but the value of what is produced.” 
 
Martin Heidegger points out that our current understanding of everyday technology is inadequate, with definitions 
limiting technology to instrumental (as means to an end) or anthropological (human activity) [136]. He states that “the 
essence of technology is nothing technological,” and emphasizes further study of the perception of technology [137]. 
Activities cannot be accurately understood outside of their context, and part of the context is the mental capabilities of 
the user. From social psychology, we can use Kurt Lewin’s heuristic explanation that behaviors are the functions of both 
the person and their environment, and the significance of the behavior is in the transitory context [138]. Older adults who 
have the lower (mental and physical) functioning also have lower fit with their environment and face the greater 
challenges in environmental press [139]. This involves taking a phenomenological perspective and appreciating the 
meaning in the context [140]. Both (mental) dexterity to use the technology and behaviors (including problem behaviors) 
can be seen as a temporary reaction to their context (e.g. ability, state, and environment). But this is not to take a view of 
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quality of life and technology use that is too phenomenological so as not to be experimentally tested. Stevan Hobfoll’s 
stress model of conservation of resources describes that the home and objects are resources whose perceived value is 
based on what they can provide. Individuals build, protect, and retain valuable resources, and the potential or actual loss 
of these resources is what is distressing [139]. He holds that an individual’s locus of control is shaped by their personality 
characteristics, their life conditions aggravate or alleviate stress, and that socialization aggravates or alleviates stress in 
other resources. Paper E discusses environment as a mediator for activity further: 
Carrie Beth Peterson, Neeli R Prasad and Ramjee Prasad. “Assessing assistive technology 
outcomes with dementia.” Gerontechnology 11(2), p. 259. 2012. DOI: 
http://dx.doi.org/10.4017/gt.2012.11.02.414.740. 10 pages. 
“The environmental press theory incorporates an individual’s personal competencies (i.e. cognitive, 
social, physical and psychological capabilities) and their environmental demands (i.e. support or 
hindrances when interacting with their surroundings) [141] [142] [143] [144] [145] [146] [147] [148] [149] 
[150] [151] [152] [153]. This theory explains the person-environment fit which rationalizes that too 
much or too little challenge for the personal competencies result in adverse effects in response to the 
environment [141]; the home would serve best in facilitating equilibrium. Here, the competence-
environmental press model [141] [152]  is used to analyze the relationship between the home and 
functional outcomes, emphasizing that each individual person will have optimal combinations between 
their coping capabilities and environmental factors that will facilitate optimum outcomes. It is a model to 
derive the best person-environment fit through the viewpoint that the less competent a person is, the more 
impact the environment will have. In 1939, Lewin presented his equation for behavior to explain how 
nature and nurture combine to shape a person, thus to better explain the person-environment interaction 
[138]:  ሾܤ ൌ ݂ሺܲ, ܧሻ	ሿ 
 
The first textbook on gerontechnology, published in 2000, gives three concepts that are central to gerontechnology as a 
field [154]: 
I. “The dynamics of society is driven by technological developments, in particular related to information 
and communication technology. If older people are to remain integrated into society, technology should 
explicitly be directed to the fast growing segment of independent older citizens. 
II. Age-associated differences in ambitions and in functioning of men and women can be met by 
improvements in the technological environment. Suitable information and communication tools can 
for example serve an ambition. A task that may seem very difficult to an older person in one situation 
may be easier to accomplish with suitable environmental modifications. The very idea of age grading of 
ambitions and of abilities cannot be considered independently of the technological environment. 
III. Older citizens should remain in control of their technological environment, i.e. they should be enabled 
to decide what they want to be automated. This refers to the concept of the user interface between older 
users and useful technology.”  
In engineering, matrices are often used as guides for evaluation by listing factors, assigning weights, and deriving a final 
assessment. The gerontechnology impact matrix connects domains of activity and classes of technology use [155] [156]. 
Table 1 provides an example of aims and applications of telecare technologies for healthy aging, based on the 
gerontechnology matrix. Some of the classes of technology and domains of activity are not fully descriptive as they are 
currently presented. For example, prevention and engagement are grouped together as a class of technology, suggesting 
that one technological device or service addresses both prevention and engagement. Likewise, the domains of activity 
insinuate connection with life domains, which are measured in quality of life assessments. Since the field of 
gerontechnology is still so young, the matrix needs further development and could be used as a starting point for 
expansion.  
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Table 1 Technology support for dementia care based on the gerontechnology impact matrix [4] 
Desired activity Tasks Domain of activity Goal of technology 
Physical, cognitive, and 
emotional support 
Fall prevention, medication 
management, nutrition management, 
physical training and cognitive 
stimulation 
Psychological and 
Physiological Health 
Prevention and Engagement 
 delay or defer restrictions in 
functioning 
Independence, safety, daily 
living tasks (ADLs15 and 
IADLs16) 
Support and training activities (physical 
and cognitive) 
Housing and Daily 
Living 
Compensation and Assistance 
 compensate for loss 
 support remaining abilities 
Movement in and outside of 
the home Mobility aids, Assistive Technology 
Mobility and 
Transport 
Engagement, Assistance 
 promote engagement in the 
environment 
Connect with others, 
socialization 
Social inclusion, eInclusion, enhanced 
communication, foster interaction 
Communication and 
Autonomy 
Prevention, Engagement, 
Satisfaction 
Health monitoring and 
prevention 
Access medical records, access to 
medical and social assistance Governance 
Care Support 
 devices for physical support 
 organization of care 
Continue to work if desired, 
appropriate work spaces and 
processes 
Ergonomically designed equipment Work Compensation and Assistance 
Learning, knowledge sharing 
and recreational activities 
Support hobbies and leisure activities, 
volunteer or employment Leisure 
Enhancement and Satisfaction 
 enjoyment of activities 
Law of accelerating returns and the exponential growth of outcomes 
Earlier in this chapter, it was discussed how social constructivist theory regards technology and society as co-creating 
each other, and activity theory regards activity and the individual co-creating each other. Many countries will 
simultaneously experience a dramatic shift in their population age structures. The world is likely to be more integrated 
via trade, technology, and financial links, creating the potential for expanded global development. Paper F considers the 
accelerated co-development of technology and society and the opportunity for technologies to support people with 
dementia: 
Carrie Beth Peterson, Neeli R Prasad and Ramjee Prasad. “The future of assistive 
technologies for dementia.” Gerontechnology 11(2), p. 195. 2012. 
DOI: http://dx.doi.org/10.4017/gt.2012.11.02.427.742. 7 pages.  
”In the era of the digital divide, we are just starting to learn how to gather and interpret information on 
how older adults interact with technologies. The Law of Accelerating Returns implies that with the 
exponential growth of technology, we realize more effective and efficient ways to execute activities and 
achieve knowledge [157]. Even though this is largely correlated with technology, it is not hard to imagine 
how other elements of life are affected as a result (i.e. health care and socialization). It is expected that 
future generations will be more familiar with technology; there will be more homogeneity as everyone has 
lived their entire lives with the influence of technology. The technology will also become more personalized 
to individual needs and user requirements, and social and health care services will have streamlined 
electronic records and communication. By then, we will have a better understanding of how humans 
interact with technology which can help researchers to better distinguish between individual changes (e.g. 
preferences, needs and mood states). Some projected future trends in technology development discussed 
here are in anticipation of developments in context awareness, intelligent data processing, Ambient 
Assisted Living (AAL), robotics, the Internet of Things and Cloud Computing.” 
 
The Law of Accelerating Returns speculates that through technological evolution, the increasing rate of 
(technological) progress throughout history will continue, and, in the future, faster and more complex technological 
processes can be expected [158].The law of accelerating returns supports an explanation of how technology, society, and 
practice become increasingly entangled in an escalating number of ways, and it will become more difficult to draw 
distinctions between them. The accelerating progress of technology would also mean the accelerating progress of socio-
                                                        
15 Activities of Daily Living (ADLs) consist of self-care tasks, including:  Personal hygiene and grooming; dressing and undressing, 
independent eating; functional transfers (getting into and out of bed or wheelchair, getting onto or off toilet, etc.); continence; and 
ambulation (walking with or without use of an assistive device such as walker, cane, crutches, or wheelchair). 
16 Instrumental Activities of Daily Living (IADLs) are not necessary for fundamental functioning, but promote an individual’s ability live 
independently and include:  housework; medication management; finance management; shopping; use of telephone or other 
communication; use of technology; transportation within the community; meal preparation and eating. 
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cultural meaning and in shaping people’s lives. When smart phones were first created, this was a great technological 
breakthrough, and phones could carry out functions we previously could only imagine (mobile video conversations, touch 
screen interfaces, etc.). Only a few short years later, these smart phones have a wide range of applications (e.g. internet 
access, passive health monitoring, and location-based services) and implications (i.e. data eavesdropping, GPS, privacy). 
When the application of these technologies also continues to grow, the proper utilization of information gathered from 
eHealth, video from public security networks, smart homes, and smart cities could lead to a wealth of benefits for 
individuals and communities. In sum, the use of a technology grows exponentially, in all directions at the same time:  
processes and information both expand. 
Exponential growth is related to gerontechnology in that there is an accelerating rate of technological development 
and processing power. Technologies become more pervasive and data can be gathered, interpreted, and used at 
accelerating rates. Not only are there advancements in the development of technology, but there are continued societal 
advancements in the use of technology and in the information it provides. However, particularly in the area of health 
technologies, the evaluation and interpretation of outcomes of using such technologies is accelerating at a much slower 
rate. The technologies that have previously been tested in residential dementia care occurred in less-understood 
circumstances than technologies being tested now. The context of the ability, experience, and interpretation of the results 
is different because the technology, service development, and understanding of implications have changed based on the 
interpretation of previous results. By the time we have an understanding of how the care situation was influenced, the 
technology has continued to evolve – things are changing so rapidly that previous frameworks may not be a reliable 
guide.  
Theory discussion and summary: 
This chapter described the theoretical foundation for the research, highlighting gerontology theories and how they relate 
to technology use among aging adults, in dementia care, and the continued development of health care technologies. 
Technologies continue to evolve, despite understanding the implications of their use still lagging steps behind. 
Accelerated exponential growth also poses challenges in understanding the implications of integrating technology further 
into social and health care services. This type of scientific investigation does not stand alone in the classic sciences (does 
it function?) nor is it alone in the arts (how and in which ways does it function?). Multiple factors are examined in order 
to evaluate whether or not technologies in dementia care increases the quality of living in a home setting. 
Multidisciplinary studies play a central role in understanding aging and dementia behaviors, the relevance of home care 
for quality of life, and integrating and evaluating technologies in caregiving. 
Sometimes scientists cannot explain the presented problems and the research runs into unpredicted or undefined areas 
when there are inadequate explanations for the information within the current paradigm. At this point, the 
understanding of the scientific study is primed for a revolution, when the previous paradigm is no longer suitable to 
explain the scientific knowledge. Kuhn contends that the change to a new paradigm cannot be founded on logical reason 
alone [159]; rational knowledge is not the only valid knowledge, and usefulness is one way to enhance the intervention 
evaluation [160]. A specific paradigm, such as the bio-medical view of health, provides exponential growth until the 
methods outgrow the paradigm and it must shift, i.e. to the medico-psychosocial model of health. In the new paradigm, 
we can still build upon knowledge from the old paradigm and exponential growth continues. The increasing prevalence of 
multidisciplinary collaboration will further the scientific revolution as explanations found in one field of science could be 
influenced and described by another field of science.  
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2.4. Quality of Life 
With motivation taking basis in the understanding that technology serves to maintain or increase the quality of living, 
one must go back to the basics and investigate what quality of life means and how it can be studied. Particularly when 
focusing on people who have dementia, the meaning becomes even more perplexing. This section first explores the 
concepts associated with life quality and how they relate to dementia, and then connects technology to quality of life. In 
studying whether or not technologies have a positive influence on quality of life in dementia care, one must have an idea 
of how technologies influence aging and quality of life. As this section will show, there have been divergent definitions of 
quality of life and how it could be measured and interpreted in dementia care. Improvements in QOL are difficult to 
measure and showing the effectiveness of interventions is problematic without careful operationalization of the concept.  
Relative deprivation will assert that individuals determine what they have, desire, and are deprived of when 
comparing to other people as the standard17. On a personal level, relative deprivation theory asserts that perceptions of 
life quality are more likely to be based on one’s expectations for their own life in comparison to themselves and others 
than to be based on biological needs. Relative deprivation theory is also used to explain why caregivers often report lower 
quality of life for the person with dementia than the individual themselves, in that they compare the person with 
dementia’s life now to what it was before and against their own life now. When incorporating proxy reports of the quality 
of life of a person with dementia, it is important to consider how the proxy is interpreting this concept:  is it from the 
viewpoint of how they would feel if they were in the other person’s situation or how they view the other’s situation from 
their current standpoint, or how they think the individual themselves would answer? This also brings up the issue of self-
evaluating life quality: is it how the individual determines others are living or relative to their individual life history and 
expectations? The extent to which selfhood or identity is preserved has been an important focus in many observational 
studies, and results show that manifestations of selfhood persist even in severe dementia [93] [94] [161] [162]. 
Phenomenologists will argue that quality of life is largely dependent on the individual and how they make interpretations 
and perceive their individual life. As Robert Ziller [163] reasons, QOL should be approached “through the eye of the 
experience:  a phenomenological approach.” 
Quality of life does not have one formally agreed upon definition; as a result, most researchers cite the World Health 
Organization, who created their definition back in 1994 [164], or create their own definition. The WHO [164] defines 
QOL as “the individual’s perceptions of their position in life in the context of the culture and value system in which they 
live, and in relationship to their goals, expectations, and standards.” By definition, it is the individual perception that is 
represented, thus assessed, in a measurement. Here, one can see that a distinction of what is considered an individual 
perception is required in order to separate data from that which is sought after and that which is not.  
It is not uncommon that different measures (e.g. UN, Economist, and OECD) are quantifying different domains. QOL is 
an elusive concept that is not well defined, which makes research in the field more difficult, particularly in demonstrating 
construct validity. Because it is not well defined, quality of life could easily be misconstrued into something that the 
general public no longer understands to be the general meaning. To illustrate how the definition of quality of life can 
change the evaluation and interpretation of the concept, take the example of Denmark being rated as having one of the 
world’s highest quality of life ratings [165] [166]. In the Economist report [165], nine domains that were based on life 
satisfaction surveys were used to determine a national quality of life score. While reading them, keep in mind how closely 
they would come to your own definition of quality of life, and how relatable they would be to someone with dementia. 
1. Health: Life expectancy at birth (in years) 
2. Family: Divorce rate (per 1,000) 
3. Community: Rate of church attendance or trade-union membership 
4. Material well-being: GDP per person 
5. Political stability and security: Political stability and security ratings 
6. Climate and geography: Latitude, to distinguish between warmer and colder climates 
7. Job security: Unemployment rate 
8. Political freedom: Political and civil liberties 
9. Gender equality: Average male and female earnings 
                                                        
17 Likewise, in a consumer-driven society, relative deprivation could easily be distorted if significance is placed on societal expectations, 
such as having the latest technology. Materialistic deprivation aside, this theory may be a more modern version for current times where 
technological advances have accounted for many basic securities and the societal focus on development is towards high quality psycho-
social returns. 
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While there would be some agreement on the importance of these domains, particularly to a nation, it is also clear that 
these are not universal, particularly at an individual level. Trying to investigate the multidisciplinary nature of being a 
human through the dimensions of socialization, economic level, health, etc. seems to imply the philosophical view that 
humans are an accumulation of all the stated dimensions, self-reflective, and capable of independent actions. And 
although it may indeed hold true that a human’s life can be measured through the stated dimensions, it also needs to be 
considered if this is to interpret a longitudinal view of their life quality (e.g. for care assessment) or a snapshot of their life 
in one point in time (e.g. to rank a population). 
Reductionism claims that a concept can be reduced to one or more items or ideas if all of the statements about the 
concept can be applied to the items or ideas. So a complex concept (i.e. QOL) is reduced to the sum of its parts and can 
thusly be understood by defining the individual components (i.e. domains) separately. Health-related quality of life 
(HRQOL) has been seen as one of the foremost tools used to measure needs satisfaction in relation to health and health 
service provision. Despite being widely used, HRQOL is unsatisfactory as a measurement concept as the focus is on 
health states, which are prone to decline through the aging process, plus health is a limited predictor of life quality, and 
certainly not the only influential factor in long-term care. Furthermore, generic HRQOL assessments often are not 
written for use by people with dementia and do not accommodate the cognitive impairments, meaning this population 
must rely on proxy reports to evaluate their HRQOL. Within the field of HRQOL, Quality Adjusted Life Years (QALYs) 
are used to denote health gains in regards to service allocation at the general level (e.g. politically and economically 
motivated), not necessarily to evaluate care outcomes for an individual. One issue with the QALY is that measurement 
scales are often created for or used in clinical settings in attempts to derive which factors of a disease or disability most 
affect life quality and in which ways. For example, nausea may have a lot of weight on HRQOL for those who have cancer, 
but not the same for those who have dementia. Proponents state that QALY values are based on information gathered 
from public surveys and are therefore representative of the whole population [167] [168]. However, John Stuart Mill 
[169] might likely find this “the tyranny of the majority,” as public surveys do not necessarily represent the whole 
population and most certainly do not represent a minority population (i.e. those living with dementia). Furthermore, 
research has found that subjective quality of life has more importance than a low probability of disease, showing older 
adults rating themselves as aging successfully despite the objective health criteria not being met [112]. 
In 1982, Carl Cohen made note that merely listing domains of quality of life is not enough to measure life quality; we do 
not know all the important domains to consider, their weight on QOL, nor how they interrelate with eachother or 
unknown domains [170]. This is additionally problematic when adding technologies to factors that affect quality of 
life;these are prone to change over time with new cohorts of aged adults, further research in psycholgoical and 
sociological effects of aging and living with dementia, technologies that are integrated into daily life, and so on. Diverging 
from a reductionist philosophy, humanistic psychology holds that humans supersede the sum of their parts and cannot 
be reduced to components. In humanistic interventions, the therapist must have the ability to take the view of the client 
and view the world through their eyes. It means the therapist must ignore their external frame of reference and take care 
not to come across as the authority. Taking a non-pathological view, and conveying empathy and unconditional positive 
regard for the patient are paramount. Gestalt therapy, rooted in humanistic psychology, lays focus on the transient 
present state, ignores preconceptions, and is attentive of non-verbal cues as indicators of emotions. Dementia care 
interventions that take a holistic view of the person may be more effective in enhancing QOL, but interventions that can 
reduce the concept of QOL into measurable terms may provide more robust outcomes.  
Mark Rapley discusses the concept of QOL and its use in measuring the success of larger paradigms, including technology 
development, policy, services such as care and education, and modernization of society [171]. To influence the 
modernization of society, quality of life is best applied at the population – not individual – level [172]. Policy is made at 
the national and international levels based on quality of life, such as the World Health Organization’s Health 2020 policy 
framework [173]. It is increasingly being used as a scientific, measurable term – a goal to attain, and has become the 
focus of numerous policies. However, these policies do not necessarily address conceptualizing quality of life or how it 
can be measured. Perhaps because quality of life is such a difficult idea to define and measure, it is seen as a notion that 
can be used with the general public understanding its general meaning. But, if it is not defined, how will we know when 
we’ve attained our goal? If there is no agreement as to its definition, and problems in relation to measurement, can 
improved QOL be a sensible goal of research and policy initiatives? By trying to assess QOL at the individual level, the 
seriousness of the deficiencies in its conceptualization in evaluation methodology becomes apparent. It could be that 
measurement tools for quality of life are too simplified or too multifaceted to show any measurable effect, and the 
concept emerges as so complex that one is left wondering “Is ‘quality of life’ a meaningless term?” Despite the macro 
issues, it must be kept in mind that the goal of this thesis is not to present a concrete conceptualization of the meaning of 
quality of life but to give an assessment of how QOL was influenced by technologies in dementia care. This research takes 
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the view that, in dementia care, it is the individual that matters (i.e. QOL at the point of care), taking a bottom-up 
approach to understand the concept at the individual level, from large enough groups of individuals, before generalizing 
the effects. Paper E offers a discussion on MP Lawton’s instrumental work in quality of life studies and theoretical 
motives for interventions that are focused and based on the individual:  
Carrie Beth Peterson, Neeli R Prasad and Ramjee Prasad. “Assessing assistive technology 
outcomes with dementia.” Gerontechnology 11(2), p. 259. 2012. DOI: 
http://dx.doi.org/10.4017/gt.2012.11.02.414.740. 10 pages. 
”Although the WHO is the main authority cited for defining QOL, there has been incongruence in how QOL 
should be defined and discrepancy in the theoretical basis of how that can be measured; this presents 
obvious issues in determining how to view QOL and effectively assess it. MP Lawton [174] recommended a 
hierarchical view that holds behavioral capabilities and subjective life quality as central divisions and 
psychological wellbeing as the desired outcome [175]. Lawton’s conceptualization of QOL in dementia has 
thus far been the most prominent influence in the development of disease-specific instruments and many 
of the tools are modeled after his constructs. Lawton’s work is influential here in that he proposes the 
environment as a criterion or facilitator to achieve psychological well-being, yet Jonker, et al., [176] report 
that there is a lack of research that presents a paradigm to explain the underlying correlations between 
QOL and the domain of home environment.  
 
With the intentions of using AT in the home to increase life quality, the authors recognize several 
perspectives. One is the subjective experience of the individual whose QOL is being assessed (e.g. the 
person with dementia), another being objective measures (e.g. biological outcomes, closer related to 
HRQOL) and finally the subjective perception of the proxy individual (e.g. physician or caregiver). 
Formerly, researchers thought it was impossible to ask the persons with dementia to accurately rate their 
QOL due to the nature of cognitive impairment and perceived lack of insight; therefore, proxy ratings of 
patient QOL were the focus of development. Fortunately, later research has shown that those with 
dementia can still convey their wishes and desires about their life quality to caregivers and researchers [98] 
[177] [178] [176] [179] [180]. Current theoretical modeling emphasizes incorporation of the individual view 
of QOL by directly asking older adults with cognitive impairment what is important to them in life quality 
and why [181] [177] [182] [183] [184] [185], which also shifts the theoretical paradigm of QOL towards 
individual perceptions and desires. Although it proves most beneficial to directly ask the older adult with 
dementia about their QOL, the proxies bring another dimension to the understanding of the situation and 
care outcomes; they are certainly not discouraged to give reports of QOL, but they are no longer the 
primary source of QOL information.” 
Wisdom is known to be a powerfully influential variable on life satisfaction [186] [187]. One aspect of wisdom in old age 
is the ability of persons to accept limitations and death as fundamental aspects of human life; they are thus more likely to 
report satisfaction with their lives despite objective (i.e. medical) criteria showing poorer life quality [188]. Wisdom has 
been studied and identified among people with dementia, however with cognition being a key component of wisdom, 
there are discernible differences between wise older adults and wise older adults with dementia. One study finds that 
individuals with dementia tend to have significantly strong (loss-based) negative attitudes towards aging than those 
without dementia, and that this negative attitude can intermediate between the individual’s level of insight and self-
reported QOL [189]. The authors conclude that negative attitudes towards aging have a direct impact on the person with 
dementia’s self-report of quality of life. Older adults report optimism, socialization, successful coping techniques, and 
community involvement as more significant to successful aging than the objective (physical and mental) health criteria, 
and subjective quality of life has been strongly correlated with resilience, confidence, emotional and mental strength and 
similar psychosocial protective traits [110] [190] [191] [192] [193]. This further supports the paradigm shift in separating 
predictors of successful aging and good life quality from objective health states. Definitions of successful aging and of 
objective health states tend to define success by the judgment of others (i.e. proxy) by omitting the perceptions of the 
aging adults, and focus on functioning and health state as success criteria. This would put many older adults in the 
“unsuccessful” category:  older adults have a higher risk for the prevalence of disease or disability than younger cohorts 
[110] [194] and defining life quality primarily based on health would inherently assume older adults have lower quality of 
life than younger cohorts. 
It is accepted that functioning can indeed increase with age and in old age. Physical and mental health and psychosocial 
functioning can improve and also serve to protect as age-associated wisdom supports coping strategies in late life, which 
can in turn lead to increased health and psychosocial functioning. In studies focusing specifically on brain growth and 
dementia, the neuroplasticity of aging still exists [195] [196] [197]. This may also provide insight into why dementia 
symptoms have such a wide range from person to person. Different people will perceive different levels of quality on the 
2. Background 
23 
 
same subject, and this can become even more problematic when one of the people has cognitive impairments. Research, 
however, finds that people with dementia can not only form and convey their subjective opinions (even into late stages of 
dementia) [178] [181] [198], but that they often rate their own quality of life more accurate than their proxy [45] [177] 
[181]. Several articles report interviews with individuals with dementia on quality of life domains that are important to 
them, allowing the target population to identify and define what would constitute a good life quality [177] [181] [182]. 
Those found to be most influential are:  affect, self-esteem and self-image, social contact, attachment, (physical and 
mental) health, enjoyment of activities, sense of aesthetics, security and personal privacy, being useful, financial 
situation, self-determination and freedom, and spirituality [140]. Another article reports that the most influential factors 
for the individuals with dementia are mood, (engagement in) pleasant activities, and ADLs, and the most important 
domains for caregivers are mood, (engagement in) pleasant activities, and physical and cognitive functioning [199]. The 
self-reported influential domains of quality of life are further described in Paper B. 
Many patient-based outcome measures consist of questionnaires that are subjective in nature. Objective outcome 
measures risk overlooking the individual patient and their real-life implications by combining data in order to quantify 
costs and prove benefits to a reasonable degree of certainty. There are many issues with defining the concept of and in 
evaluating quality of life [45]. One administration hindrance is that the methods are pen-and-paper and conducted in 
person, which makes the evaluation subject to interviewer influence. The metrics used to interpret the results can present 
analysis problems, as determining the (e.g. clinical) significance of having a better quality of life is difficult. Researchers 
need to be aware of the issue that increased human contact (i.e. technicians installing and maintaining systems, nurses 
and social workers conducting interviews and observations, scientists procuring results of the trials, media carrying out 
interviews which aid in dissemination, etc.) also has an influence on end user quality of life. Having others come into the 
residential dwelling, expressing a deeper personal interest in the person with dementia, their family and caregivers, and 
reaffirming the contribution that they are making to science unintentionally influences the end users18. The individual 
who is the focus of the care may be happy that a person is visiting with them and may answer more positively than then 
normally would, or they may be agitated by the people and the bustle in the house, and that transient mood is captured as 
data. It is well known that interviewer bias is found when care staff or researchers conduct assessments in person, and 
can lead to arriving at conclusions  post hoc ergo propter hoc:  the misinterpreted deduction that technology alone must 
be the variable influencing QOL.  
The awareness of interviewer bias serves as support to develop and standardize quality of life evaluations in electronic 
form so as to reduce administration factors (i.e. environment, setting, other persons, etc.) as well as to be administered 
consistently and longitudinally. Evaluations in this context are important because assessing quality of life outcomes can 
also supplement evaluations of technology as a treatment intervention. Collecting assessment information on the 
intervention and QOL digitally and over the Internet provides an effective method for meta-analyses on multiple groups 
and in diverse locations. For more discussion of the need and development of an electronic OQL assessment to be used in 
dementia care, please see Papers A, B, E, and F. This would have remarkable implications for Randomized Controlled 
Trials, longitudinal and ethnographic studies, and to increase the ability and reliability in evaluating gerontechnology 
outcomes [200].  
The WHO is developing an International Classification of Health Interventions (ICHI) to provide a common tool to 
statistically report health interventions [201]. Although ICHI does not have a specific focus on quality of life outcomes, 
classifying health interventions, including health technologies, is advancement in the right direction. The National 
Institute of Health is funding a group to establish a domain framework to analyze clinical treatment outcomes, the 
Patient-Reported Outcomes Measurement Information System (PROMIS19). [202] [203]. Likewise, the Patient–Reported 
Outcome and Quality of Life Instruments Database (PROQOLID20) group, developed and managed by the Mapi Research 
Trust, aims to make patient-reported outcomes as well as quality of life assessment tools available for clinical use and 
study [204]. Both are striving to provide structure and evidence for clinical decision making and will be valuable as 
health technologies continue to develop. These classifications and databases are further described in Paper E. If services 
are well designed with the end user in mind, Assistive Technologies (ATs) can positively impact general as well as specific 
domains of quality of life. As there is no cure for dementia and medications offer only marginal positive effects, it is easier 
to affect quality of life than it is to affect the progression of the dementia. Once quality of life is understood from a 
theoretical point of view, and the influential factors (domains) are identified, the next step is to determine a method to 
measure this concept. An appropriate evaluation for the study addresses Assistive Technology and quality of life 
                                                        
18 Unintentionally is used in the sense that although the intentional goals are to maintain or improve QOL, it is intended that this is 
through the use of technologies in the home, not through the researchers involved in the study. 
19 PROMIS is a system of assessment tools that measure patient–reported health status. http://www.nihpromis.org/default  
20 PROQOLID aims to identify and describe instruments to choose appropriately and facilitate access to them. http://www.proqolid.org  
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outcomes in home dementia care. A literature search will identify an appropriate QOL assessment tool. First, the 
inclusion and exclusion criteria are defined before beginning the literature search: 
Inclusion criteria: 
 Dementia-specific  
 Assesses quality of life 
 Incorporates the individual with dementia’s 
assessment 
 Is specific to technology by having been 
tested with telecare intervention 
 
Exclusion criteria: 
 Is not dementia-specific  
 Does not assess quality of life 
 Does not incorporate the individual with 
dementia’s assessment 
 Does not allow for technology intervention or 
has not been tested with telecare intervention 
 
The key words to describe to the assessment in the literature search includes the terms “quality of life,” “dementia,” 
“telecare,” and so on, as described in Paper E. Five assessments (QOL-AD, CBS, D-QOL, DEMQOL, and QOLAS) were all 
found to be dementia-specific, assess quality of life, and incorporate the individual with dementia’s assessment. These 
five met all of the inclusion criteria except being specific to telecare.  
Carrie Beth Peterson, Neeli R Prasad, and Ramjee Prasad. “Assessing assistive 
technology outcomes with dementia.” Gerontechnology 11(2), p. 259. 2012. DOI: 
http://dx.doi.org/10.4017/gt.2012.11.02.414.740. 10 pages. 
Particularly when working with a person with dementia, it is much easier for care providers to affect QOL 
than it is for them to affect the course of the disease process, which is highly individual. As mentioned 
earlier, one of the focus areas in measuring QOL is in assessing the efficacy of treatment; the idea is that if 
we assess QOL, then we are also a step closer to better assessing AT. This section presents current QOL 
outcomes measurement tools relevant to ATs for dementia care. The Cochrane Library Collection supports 
systematic reviews of health care outcomes; specifically, the Patient Reported Outcomes (PRO) methods 
group is interested in “health status, quality of life, adherence to treatment recommendations and 
satisfaction with treatment”  [205]. The Cochrane search for “Alzheimer’s Disease,” “dementia,” “quality of 
life” and “Health Technology Assessment” resulted in 3 documents. One was on pharmacological 
interventions, one as a proxy report and the last on neuroimaging techniques. Health and QOL Outcomes 
(HQLO) [206] is an open access, peer-reviewed journal that disseminates information on Health-Related 
QOL. The HQLO search for “technology” and “dementia” resulted in 19 documents, all of which were 
related to severe dementia, frail elderly, other conditions than dementia, and other assessments than 
straightforward QOL. The Patient-Reported Outcomes and Quality of Life Instruments Database 
(PROQOLID) [207] was also searched for “Alzheimer’s Disease” and “dementia,” which resulted in a total 
of 22 instruments, none of which are administered via computer or in electronic format. 
 
 7 were designed for caregivers alone, excluding self-reports by person with dementia 
 10 tested other measures than QOL, such as memory or apathy 
 The 5 remaining, all modeled after Lawton, include: 
 
1. QOL-AD – Quality of Life in Alzheimer’s Disease [178] is a questionnaire answered by the person 
with dementia and caregiver separately and weight is given to the older adults responses but it is not 
AT-specific 
2. CBS – Cornell-Brown Scale for Quality of Life in Dementia [208] is a semi-structured joint interview 
with the person with dementia and their caregiver, if discrepancies in responses occur, weight is given 
to the proxy and it is not AT-specific 
3. D-QOL – Dementia Quality of Life Instrument [180] is an mixed interview and questionnaire self-
report but is not AT-specific 
4. DEMQOL – Measurement of Health-Related Quality of Life with Dementia [209] is another 
interview-based tool that is not specific to AT 
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5. QOLAS – Quality of Life Assessment Schedule [210] is also interview-based for the person and their 
caregiver which can be tailored to fit the individual but is not AT-specific 
 
 No tools were found to be dementia-specific evaluations of QOL and allow for AT influence. 
 
As no assessment met all of the inclusion criteria, this indicates an area for the future development of a dementia-
specific QOL assessment tool that is valid for telecare interventions. Regarding the five tools, the reported 
psychometrics provide further information on their use, reliability, validity, and other indicators that aid in 
determining which will be the best suited for this study. Based on information gathered during the literature 
search, Table 2 provides the metrics that aid in interpreting quality of life results. 
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Table 2 Metrics of the assessment tools that evaluate quality of life in dementia care 
Tool Domains Scoring Consistency and reliability Validity Other 
Identification of 
the assessment and 
primary source of 
information 
Which concepts are measured 
as influencing QOL 
How QOL is rated How consistent the tool is across 
items, in similar conditions, 
between raters, and across 
administration points 
To what degree the tool 
accurately measures QOL  
Additional information on the tools to 
help guide decision-making 
QOL-AD 
Quality of Life in 
Alzheimer’s 
Disease [178] 
13 domains of physical health, 
energy, mood, living situation, 
memory, family, marriage, 
friends, self, ability to do chores 
around the house, ability to do 
things for fun, money, and life 
as a whole. 
13 items rated on a 4-point Likert 
scale (1 = poor, 2 = fair, 3 = good, 
4 = excellent) 
Range of 13 to 52, where higher 
score = higher quality of life. 
Internal consistency reliability is 
good for both patient (α=0,84) 
and caregiver reports (α=0,86). 
Internal reliability is good (α 
range0,88 to 0,89). 1-week test-
retest reliability intraclass 
correlations is 0,76 for patients  
and 0,92 for caregivers. 
Validity was supported by 
the correlation of higher 
QOL-AD scores with lower 
depression levels, better 
day-to-day functioning, and 
higher activity level. 
Patient-caregiver internal 
validity (r=0,40, p<0,01) 
[98]. 
QoL-AD is, internationally, the most 
widely used quality of life measure for 
people with dementia [211]. Incorporates 
patient and proxy assessment and gives 
weight to the patient responses [212]. 
CBS 
Cornell-Brown 
Scale for Quality of 
Life in Dementia 
[208] 
5 domains of mood, ideational 
disturbance, behavioral 
disturbance, physical signs, and 
cyclic functions. 
19 items rated on a 5-point scale 
with positive and negative poles (-
1=mild or intermittent, -2=severe or 
chronic, 0=neither positive or 
negative, +1=mild or intermittent, 
+2=constant). 
Good internal consistency 
reliability (α=0,81), and inter-
rater reliability (intraclass 
r=0,90). 
Criterion validity through a 
positive correlation 
between QOL scores and 
visual analogue mood 
ratings (Spearman’s 
ρ=0,63). 
Reliability and validity were not 
adversely affected by patient cognitive 
impairment. Incorporates patient and 
proxy assessment. 
D-QOL 
Dementia Quality 
of Life Instrument 
[180] 
5 domains of positive affect (6 
items), negative affect (11 
items), feelings of belonging (3 
items), self-esteem (4 items), 
and sense of aesthetics (5 
items). 
29 items , plus one global item 
("Overall, how would you rate your 
quality of life?") on a 5-point visual 
scale. 
Internal consistency reliability 
range α 0,67to 0,89 (acceptable 
median α=0,80). Two-week test-
retest coefficient range α 0,64 to 
0,90 (acceptable median α=0,72). 
Convergent validity by 
correlations with Geriatric 
Depression Scale scores and 
DQoL sub-scales (r=-0,48 
self-esteem, r=-0,61 
positive affect, r=-0,64 
absence of negative affect, 
r=-0,42 feelings of 
belonging) [180]. 
Only incorporates the assessment by the 
person with dementia. 
DEMQOL 
Measurement of 
Health-Related 
Quality of Life with 
Dementia [209] 
5 domains of daily activities and 
looking after yourself, health 
and well-being, cognitive 
functioning, social relationships 
and self-concept). 
28-item DEMQOL  
31-item DEMQOL-Proxy 
Patient DEMQOL internal 
consistency is good at α=0,87 and 
test-retest reliability range is 
acceptable to good (α range 0,76 
to 0,84). DEMQOL-Proxy 
internal consistency range is good 
to excellent (α range 0,87 to 0,92) 
and test-retest reliability is good 
at α=0,82. 
DEMQOL-Proxy is 
moderately correlated with 
the age of the person with 
dementia, but not of carers. 
Not appropriate for those with 
MMSE<10 (severe dementia). 
QOLAS 
Quality of Life 
Assessment 
Schedule [210] 
Persons with dementia rate 2 
constructs per domain out of 
the 5 domains of physical, 
psychological, social/family, 
work/economic, and cognitive. 
Each domain has a maximum 
score of 10. 
The person with dementia rates the 
extent of their problems on a 6-
point scale (0=no problem, 1=very 
slight problem, 2=mild problem, 
3=moderate problem, 4=big 
problem, and 5=it could not be 
worse). Scores range 0 to 50 with 
higher scores reflecting poorer QOL. 
Internal consistency reliability is 
acceptable at α=0,78 for patients 
and caregivers. 
Acceptable criterion and 
construct validity. 
QOLAS is the only dementia-specific tool 
that is tailored to individuals and uses 
both qualitative and quantitative 
measurement. Caregivers nominate QOL 
items they feel are most important for 
the person with dementia and assess 
how they perceive the QOL of the person 
with dementia to be. 
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Quality of life summary: 
The work in the field of quality of life research has been limited in its philosophical basis (i.e. reducing an end user to a 
disease or disability and related outcomes) and application (i.e. provision of services but not necessarily a better 
understanding of the disease or disability). It could be said that many quality of life tools, but particularly HRQOL tools, 
promote the dualistic view of good versus bad, meaning that the measurement will essentially imply that the person has 
good or poor life quality rather than seeing quality of life as a neutral and plastic concept. Ann Bowling [213] further 
illustrates this point by saying that researchers who have constructed HRQOL assessment tools rarely have the 
philosophy or theoretical background to soundly support their work and are not so concerned with discussions and 
conflicting views of what “quality of life” means to individuals and groups. It is not sufficient to use one theoretical 
perspective to understand this multifaceted research – quality of life and gerontechnology involve multiple theories, as 
do health and social care. 
Research in the area of health and care technologies is advancing, including studies to enhance or evaluate dementia 
care. Technology systems are being commercially developed and offered, and individuals and health organizations are 
already using them, despite a weak evidence-base to support clinical decision-making. Perhaps it is because these 
technologies seem to have such apparent use, that consumers are likely to take up use. Sometimes the simplest uses of 
ICT have such an obvious benefit, that they easily achieve widespread adoption [214]. An example would be PERS 
alarms, e.g. a Person Emergency Response System pendant that is worn and pressed if the person should require 
assistance. These are easily and quickly implemented, yet a standardized assessment is often lacking, and the full effects 
(personal, social, medical, economic, or otherwise) may not be realized. Promoting a humanistic (psychosocial) approach 
to dementia care could be misinterpreted (or misused) to justify a consumer-based approach to developing 
gerontechnology. In fact, the two approaches may have similar goals, but a consumer-based approach would focus on the 
possibility of increasing quality of life through increased choice of services, and a humanistic approach will focus on what 
shows evidence for increasing quality of life through meaningful, individual outcomes [215]. The former takes a macro 
view of quality of life and the latter takes a micro view. There is no evidence to make a clear conclusion on whether one 
approach is different than the other in achieving outcomes, but the psychosocial approach is focused on in this thesis. 
Access to ICT-supported services will broaden innovation chains, but appropriate evaluation methods need further 
research and development for the full scope of use to be realized. Incorporating individual preferences is not a new 
concept in dementia care (person-centered) or in matching technologies with the person (consumer-based). This has 
greatly aided in the understanding of quality of life and its influential domains and dimensions, serving as a basis for 
future research. However, it is difficult to integrate personal inclinations into quality of life assessments as the dementia-
specific measurement tools are generalized. With a foundation for conceptualizing individual quality of life, now that we 
are living in a digital age where technologies are increasingly personalized, it is apposite to include individuation in 
quality of life. 
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2.5. State of the Art in gerontechnologies for dementia care 
Once the evaluation tools have been identified, the next step is to be able to evaluate the effectiveness of the technologies 
through longitudinal, real-life application. Assistive Technologies and complex technology systems have a strong 
potential to positively influence quality of life [216]; context-aware technologies that utilize sensing and machine learning 
can autonomously perceive the environment, learn from the context, and adapt to the user, carrying out predefined, goal-
directed tasks in real-time [200]. They can aid in tasks that require learning and decision making (two characteristic 
limitations in dementia). Current high-tech technologies21 can connect best practices in caregiving to supportive and 
enhancing technologies. This thesis does not strive for nor advocate gerontechnology replacing human caregiving 
practices in dementia care, but to add to an evidence-base for determining technologies which can supplement dementia 
care and accommodate demographic trends that necessitate changes in health care provision. A range of long-term 
services that are adaptable to address the emotional, physical, and mental stresses of dementia care are needed. Formal 
care services are most supportive when they are tailored to the unique challenges of dementia and recognize that the 
dementia caregivers’ experience is different when compared with other caregivers [38] [78] [82] [217] [218] [219]: 
 Interventions aimed at individual caregivers and their families, including the care receiver, are more 
likely to relieve caregiver stress than those targeted just at caregivers.  
 Allowing caregivers to co-create the interventions by identifying problems to be addressed, methods to 
address them, and the timing and frequency of the interventions are more likely to achieve desired 
outcomes than interventions that are fixed in terms of what, how, and when they are delivered.  
 Multi-component interventions are more effective in relieving stress and burden than interventions 
that have narrower strategies and goals.  
Technologies for in-home dementia care 
Advancements in ICT allow for sophisticated solutions to be incorporated into telecare22. Telecare is currently in its 3rd 
generation [220] [221] [222]. The first generation consisted of devices used to activate alarms; these technologies 
required a user to activate them (e.g. PERS pendants). The second generation of telecare included sensors and detectors 
that were used to monitor the care environment parameters (e.g. biosignals or fall detectors) and automatically transmit 
data to the care manager. The third generation of telecare adds wireless and multimedia technologies to support virtual 
care through e.g. GPS locating or ambient intelligence. Some commonly used high-tech technologies include [200] [223]: 
 Communication technologies allow connecting with others, sharing information, and communicate 
about the environment (e.g. real-time alarms, access to telecare networks). 
 Robotic technologies are increasingly popular and can perform duties such as domestic services (e.g. 
vacuum or assistance with toileting), or companionship activities (e.g. robotic pets). 
 Home automation technologies monitor and ensure home safety (e.g. fire alarms, automatic doors). 
 Sensors can monitor and collect data (e.g. motion detection, temperature, radiofrequency transmitters, 
user recognition). 
As mentioned in relation to social constructivist theory in section 2.3, some studies on robotics and aging adults have 
found that the older adults would form social and emotional bonds to the robots:  naming them, talking to them, or 
finding entertainment through watching the robotic vacuums. For more on this, please see Paper F:  The future of 
assistive technologies for dementia. For a more detailed description of comparable European projects, please see Paper 
C:  Easy Life Intelligent Systems, and LIFE 2.0:  European research on ICT for aging adults, and Paper G:  Zarit Burden 
Interview shows reduction in caregiver burden in European dementia study.  
Telecare can support access to services and provide new methods to provide care. One intervention strategy is to support 
care by transferring tasks from the individual to the telecare system. When aiming to transfer tasks from human 
caregivers to services through technologies, the technology needs to carry out tasks that were previously performed by 
humans. When combining State of the Art technologies with the best practices for dementia caregiving, it is important to 
                                                        
21 Low-tech interventions include handrails or ergonomic tools such as walkers, and are not expanded upon in this work. 
22 It should be noted that gerontechnology applied to aging adults living with dementia is the focus in this research, as encompassing all 
ICTs and Assistive Technologies would be too broad. The technologies and services that are evaluated are done so with the design and 
benefit of the aging adult in mind. Health technologies that are designed for other user groups (i.e. care management such as electronic 
health records) are beyond the scope of this thesis.  
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remember that the best care is provided when the individual symptoms of dementia are appreciated. The Alzheimer’s 
Association manual, “Dementia Care Practice Recommendations for Professionals Working in a Home Setting” [224] 
describes best practices for in-home dementia care and highlights six core recommendations: 
1. Recognize the signs of dementia and behavioral indicators and to detect changes 
2. Communication with the person with dementia and their family as well as coordination with other care 
providers 
3. Apply and assess nonpharmacological methods to the care plan through person-centered techniques 
4. Encourage proper nutrition and hydration 
5. Medication management 
6. Manage home safety issues 
In person-centered care, the person is considered the authority in their life history and needs, and the therapist or 
intervention facilitates in meeting the needs of the individual [225]. The humanistic and phenomenological philosophy of 
psychologist Carl Rogers’s person-centered therapy was first applied to dementia care by Tom Kitwood [226]. The 
transient state of quality and the individual’s views on participating in their own lives are respected and supported, and 
maintaining personhood is the primary aim of dementia care support [227]. Person-centered or relationship(dyad)-
centered care have become key theoretical models associated with quality dementia care as they accentuate the history, 
personality, habits, and preferences of the person rather than solely addressing the medical or behavioral state [228]; the 
dyad are viewed as the experts on the situation. An application of person-centered dementia care to interventions focused 
on communication skills is based on the VIPS model (Valuing people with dementia and their caregivers, treating people 
through Individualized care, taking the Personal perspectives of the person with dementia, and a positive Social 
environment). One study reporting on the VIPS model in a long-term care facility finds the intervention is highly feasible, 
and that the depersonalization of people with dementia decreased while empathy and hope increased among the 
caregivers, and caregivers used more specific communication strategies [225]. Another method that systematically 
applies person-centered care is the Dementia Care Mapping (DCM) Method [229]. It was originally developed to be used 
as a clinical tool in dementia care, and has gained popularity in quality of life research as well [230]. DCM is perhaps 
better designed for assessing components of both quality of care and quality of life through academia than through 
practical application due to complex scoring (including inter-rater reliability) and time consuming methods 
(recommended 6 hour observation) [231]. Studies have reported underdeveloped evidence on reliability, but find good 
face validity, and acceptable concurrent validity of the DCM with clinical outcomes (pressure sores) and quality of life 
proxy scores, [232]. However, further research is needed to grow the evidence-base. The DCM checklist allows raters to 
record the frequency of indicators of well-being [233]: 
1. Being able to assert one’s own will and desires 
2. Being able to show a range of emotions, including pleasure and sadness 
3. Initiates contact with others 
4. Showing self-respect 
5. Enjoying humor 
6. Showing pleasure 
7. Being able to relax 
8. Being helpful 
9. Has signs of ill-being 
10. Has distress or despair 
11. Has intense anger 
12. Has physical discomfort or pain 
13. Has fear or anxiety 
Gerontechnology encompasses a wide range of technologies, with the primary stipulation being that they are focused on 
aging through their design and use. While not a theory in itself, the gerontechnology impact matrix helps to categorize 
the type of technology and activities they support. The gerontechnology matrix is not used to evaluate gerontechnology 
interventions or to assign weights to QOL domains. Essentially, a QOL domain could connect with each technology 
separately or with multiple technologies, depending on the use of the technology. For example, one person may use their 
hearing aid to listen to the television (compensation and assistance) whereas another may use it to participate in social 
situations (engagement), and both uses are related to the enjoyment of activities (enhancement and satisfaction). It was 
not a goal of the research project to address all areas of activity identified by the matrix, but this is a good exercise to see 
which domains of life are focused on. Technologies for dementia care are only part of the scope of gerontechnology, and 
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individuals with dementia comprise only a portion of aging adults. As this research combines both elements, it is 
important to address the classes of gerontechnology and how they contribute to healthy aging with dementia [4] [155] 
[234]: 
1. Prevention and engagement – delay or defer restrictions in functioning and promote user 
engagement in their environment, monitor to prevent additional problems (e.g. games, such as 
Nintendo Wii, motion-activated lights to prevent falls).  
2. Compensation and assistance – compensate and assist with shortcomings due to the aging process 
(e.g. increased lighting when reading or large buttons on a mobile phone).  
3. Care support and organization – physical support (e.g. lifts for transferring) and organization (e.g. 
medications management) used for self-care and provided caregiving.  
4. Enhancement and satisfaction – services to enhance the enjoyment of activities, and reinforce new 
activities (e.g. ambient lighting, music, virtual reality, and social activities).  
While it seems straightforward to connect the recommendations for dementia care with appropriate gerontechnology, it 
proves complex to connect the practice of dementia care with the self-reported domains of quality of life that have been 
identified as highly desirable. Technology has the ability to facilitate matching QOL domains to dementia care, thus 
supporting dementia care provision. Table 3 presents examples of appropriate gerontechnology interventions that could 
match the recommendations for the home care environment. This table is based on information first presented in Paper 
B. The technologies can encompass various uses and produce multiple outcomes, and the ones presented are offered as 
examples. 
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Table 3 Self-reported quality of life domains, recommended care practices, and related gerontechnology  
Self-reported 
QOL domains Aspects of dementia care  Technology intervention 
Class of 
gerontechnology 
Affect Ability to recognize the signs of 
dementia and to detect change 
 Positive influence 
 Foster expression of emotions  
 Ambience, e.g. music to alleviate 
symptoms of Sundowner’s syndrome 
 Machine Learning builds upon patterns of 
interaction and detects changes in 
behavior (e.g. increased night wandering) 
Enhancement and 
Satisfaction 
Self-esteem 
and self-
image 
Apply and assess 
nonpharmacological, person-
centered methods to the care  
 Viewed as a person contributing to their 
life  
 Endorse intact abilities  
 Promote self-care 
 Independence-enabling technology, e.g. 
reminders for meal times 
 Electronic calendar; 
 Technologies can be tailored to the 
personal care plan 
Compensation and 
Assistance 
Social contact Communicate with the individual, 
their family, and coordinate with 
care providers 
 Develop and maintain social 
relationships 
 Foster interactions with family, friends, 
and society  
 Videophone to encourage socialization 
 Online social networking  
 Robotic companions 
 Mobile and fixed devices (e.g. email, video 
conference, mobile phone) 
Engagement  
Enhancement and 
Satisfaction 
 
Attachment  Feeling imbedded in home and 
community 
 Reinforcing social and familial bonds 
 AAL to promote the environment as a 
place to feel relaxed and useful 
 GPS tracking to allow safely enjoying 
surroundings 
Engagement 
Health 
(physical and 
mental) 
Proper nutrition and hydration 
Medication management 
 Discourage being viewed as a person 
with disabilities 
 Reduced environmental barriers 
 Document behavioral and somatic 
symptoms 
 Electronic medication dispensing systems  
 Cognitive stimulation through games 
 Access to patient records through eHealth  
 Biomedical sensors 
 Smart refrigerators can determine if food 
is being eaten regularly  
Compensation and 
Assistance 
Care support and 
Organization 
Enjoyment of 
activities 
 Provide a range of interesting activities 
 uphold decision-making about activities 
 Ambience control, e.g. lighting 
 Offer activities for pleasure, e.g. digital 
pictures 
Engagement 
Enhancement and 
Satisfaction 
Sense of 
aesthetics 
 Familiar situations 
 Promote comfortable atmosphere  
 Appropriate level of stimulation 
 Ambient Assisted Living, e.g. 
temperature, music 
 Reduce distractions in the environment, 
e.g. adjust lighting to reduce glare 
Enhancement and 
Satisfaction 
Security and 
personal 
privacy 
Manage home safety issues 
 Peace of mind by reducing anxiety 
 Ensure physical safety 
 Facilitate privacy 
 Motion sensors for wandering alerts  
 GPS locating outside the home 
 Accelerometers for fall detection 
 Actuators shut off stove 
 Automatic door locks  
Prevention 
Care support 
Being useful  Promote using skills retained 
 Encourage participation in household 
activities 
 Electronic calendar with reminders for 
tasks and activities 
 Robotic vacuum, e.g. supplement cleaning 
Engagement 
Enhancement and 
Satisfaction 
 
Known outcomes of interventions in dementia care 
Previous research on outcomes in dementia care interventions has shown promise for the ability to positively effect 
factors that are found to influence QOL. Cognitive stimulation programs show significantly improved mood, memory, 
cognitive functioning, and reduced behavioral disturbances when compared to controls [235] [236] [237]. Studies show 
that behavioral treatment interventions result in 40% more significant improvement in depression when compared to 
controls [238] [239] [240] [241] [242], reduces the frequency and duration of nighttime awakening by 32%, significantly 
increases exercise, and significantly reduces depression [243]. Interventions focusing on exercise and behavior 
management find that over 80% of caregivers can successfully learn to guide patients in exercise, and the intervention 
results in significantly more exercise, better general physical functioning, fewer restricted activity days, higher quality of 
life, and fewer depressive symptoms at 24 months [244]. In a preliminary exercise-based intervention for cognitively 
impaired adults who live alone, after 9 weeks, participant results include attending 90% of classes and increasing mean 
exercise time by over 170 minutes per week, increased physical functioning, general health, emotional well-being, and 
significantly improved cholesterol [199]. Environmental modifications and problem-solving strategy interventions show 
significantly reduced frequency of problem behaviors and significantly lower caregiver distress when compared to 
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controls after 12 months [245] [246], and significantly reduced agitation [247]. Environmental-based skill building has 
significantly reduced ADL decline, improved caregiver skills, effect, and affect, and has reduced behavioral problems and 
caregiver distress from behavioral disturbances when compared to controls [248] [249] [250]. A multicomponent 
environmental (physical and occupational therapy and home modifications) and behavioral intervention (problem-
solving and care training) for older adults with chronic conditions shows that intervention participants have fewer 
hazards in the home, less difficulty with ADLs and IADLS (specifically bathing and toileting), less fear of falling, higher 
utilization of adaptive strategies, and improved self-efficacy [251]. Occupational therapy (OT) interventions have been 
shown to influence significantly higher levels of positive affect and self-care independence, and significantly lower levels 
of caregiver burden after an average of only 2 months [252]. Compared to controls, participants with dementia who 
receive OT interventions functioned significantly better in ADLs and their caregivers report feeling significantly more 
capable in dealing with dementia after 12 weeks [253]. Activities and interventions involving music are also gaining 
popularity in dementia research, showing that music can foster engagement in activities, promote empowerment, 
support social and emotional bonding, and enhance the enjoyment of activities [254]. Even in people with severe 
cognitive impairments, the presence of and involvement in music can increase quality of life. Additionally, support group 
interventions, while often reported to show mixed outcomes, has been shown to significantly decrease family conflicts 
and result in improved quality of life (including less decline) [255].  
The non-technological interventions show promise in dementia care, however, the scientific literature on technology 
interventions for dementia care reveals the need for further research and development in this area. In evaluating the 
outcomes of gerontechnology interventions in non-institutional dementia care, there are several primary areas of 
consideration:  
 The effectiveness of the intervention is the ability to achieve desired outcomes (e.g. influence quality of life),  
 The efficiency of the intervention is the ability to effectively use the intervention (e.g. technology use matches 
the best practices in dementia care),  
 The efficacy of the intervention is the ability to produce the desired effects (e.g. a functional intervention that 
positively affects quality of life), and 
 The satisfaction with the intervention within the predefined context (e.g. usability  and user acceptance of and 
satisfaction with the intervention [256]).  
Research shows that the most important benefits that technology provides to caregivers are in saving time (77%), easing 
care logistics (76%), safety (75%), increasing feelings of effective caregiving (74%), and reducing stress (74%); caregivers 
will be most interested in technology interventions that will support them in delivering, monitoring, tracking and 
coordinating care [76]. Authors often state that the results are skewed by the heterogeneity of the population (e.g. age, 
gender, education level, symptom expression, etc.), varying methodologies (e.g. aims, intervention components, study 
design, and outcome measurements), or are too premature to generalize [33] [78] [257] [258] [259] [260] [261] [262]. 
One review found that most studies demonstrate feasibility only or have small sample populations, and finds no evidence 
on the effects of smart home technologies on health outcomes, and that the evidence for the clinical impact of technology 
use was insufficient [263]. In one international study, the caregivers of 233 individuals with Alzheimer’s disease watched 
a 5-minute video on an (upcoming) ICT system designed to support the independent living of people with dementia. The 
study reports that 66,4% of caregivers thought the ICT system could improve quality of life, care (56,1%), safety (87%), 
monitoring (80,7%), medication management (87,4%), environment (85,2%), and communication (83,4%) [264]. They 
further find that the ICT is perceived most useful for people with moderate dementia, aged 75-84. One study from focus 
groups finds that the primary concerns of caregivers are in maintaining roles, relationships, and lifestyles, and ensuring 
the safety of the person with dementia [265]. In a follow-up focus group, the caregivers were shown a demonstration of 
an Internet-based monitoring system which includes cameras, sensors, a portal to view activities, and automatic 
messaging to mobile phones. They report that the caregivers reacted positively to the monitoring system and agree that 
the technology could be helpful in managing their primary concerns. The study goes on to report on the installing and 
evaluating a monitoring system for dementia care in the homes of 19 families after 24 weeks [265]. They discuss the 
importance of training the users, disruptions associated with technical issues, and describe the caregivers’ evaluation 
through open-ended questions. They report that the participants felt the benefits of the technology outweighed the 
problems, and 86% responded that the monitoring system made life easier, 79% answered that the system positively 
affected how the caregivers spent their time, and 19% report the system had positive influence on the dyad relationship. 
They also find that 44% replied that the system made life more difficult, and equal numbers found positive and negative 
effects in relationships with other family members (13%) and with friends (6%). One study examined a commercially-
available monitoring system in the homes of 14 adults with dementia over 9 months [266]. The authors report improved 
safety and security, reductions in caregiver burden, financial benefits, and demonstrates the potential of monitoring and 
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early warning systems to maintain aging in place. Another study focusing on caregivers of people with dementia finds the 
literature to reveal that Assistive Technology can support independence and increase quality of life in the dyad, delay or 
defer institutionalization, and promote safety [267]. They utilized focus groups of caregivers to investigate their 
conceptions of technology and conditions for incorporating the technology. The caregivers are found to take a utility 
perspective on the technology, and the results show positive attitudes and readiness among the caregivers regarding the 
use of Assistive Technology; however, there is concern among the caregivers that technology can oversimplify tasks and 
weaken intact abilities (e.g. learned dependence) and that there is stigma of visible technologies in the home, especially 
among younger old adults. 
A systematic review on environmental control systems and smart home technologies (not specific to dementia care) 
identifies only 11 out of 1739 studies could be included for analysis, and those studies have small sample sizes and wide 
diversity [268]. They find limited effects in IADLs remaining stable in intervention groups, increased independence and 
ability to perform activities, increased satisfaction with activity performance and control over the environment, improved 
social activities, improved quality of life, increased psychosocial function, feelings of self-worth, and happiness, and 
satisfaction with the control systems. The authors conclude that although the technologies seem promising and should be 
considered, evidence is lacking and no collective outcomes could be extracted. An investigation of the clinical significance 
of dementia caregiver interventions (not exclusively technology-based) finds that the interventions largely consist of 
psychosocial, environmental, behavioral, and pharmacological interventions [262]. The clinical outcomes investigated 
include symptomatology (e.g. changes in depression, hostility, anxiety, physical health, blood pressure, exercise, needed 
level of care, number of prescriptions), quality of life (e.g. life satisfaction, social activities, caregiver burden), social 
significance (e.g. the impact on society and service provision), and social validity (e.g. the acceptability of the intervention 
and impact). The authors find small to moderate improvements in symptomatology and mixed positive effects on quality 
of life (depression, stabilizing benefits for anxiety, distress, anger, hostility, and physical health), social significance 
(differential rates of institutionalization, mixed results on service utilization and time spent giving care), and positive 
outcomes in social validity (80-100% of participants report the intervention as having positive value). 16 of 33 studies 
report a positive impact on caregiver burden, ranging from 1,5%-14% improvement when compared to controls, while 17 
of the studies find no effectiveness of their interventions on caregiver burden. The authors summarize that in some 
caregivers, significant reductions in caregiver burden can be achieved. They conclude that accrediting specific outcomes 
to direct causes is challenging as most interventions are multifaceted and have methodology problems, and there is still 
no consensus on significant levels of change for the results to be considered meaningful. The capacity to improve overall 
quality of life is reported as small; however, specific attributes of global quality of life show positive outcomes and 
assessing multiple outcome indicators (e.g. mood, social support, coping strategies, burden, or marital satisfaction) may 
provide a more comprehensive evaluation of quality of life. 
State of the Art summary: 
When studies do report results, mild to moderate changes or no discernible differences are frequent conclusions. There is 
clearly a gap in the research on high quality, evidence-based outcomes of technology interventions. Demonstrations of 
feasibility are important for development, but the dissemination of results, particularly on significant impact and clinical 
health outcomes, are needed to build an evidence-base in the field of gerontechnology. Multiple studies indicate that a 
technology intervention in dementia care has implications for improving quality of life and shows promise in this area, 
even if the results do not give strong support for that view. This research study views these broad implications as 
motivation for the research, to collect and investigate quantitative evidence on quality of life outcomes from using 
gerontechnology in non-institutional dementia care.  
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Background discussion and summary: 
This chapter shows that the world is aging faster due to an increasing life expectancy and decreasing fertility rates. 
Current and future generations will most likely continue to experience increasing life spans as technology and medicine 
continue to advance. There are many factors that influence how long one will live with dementia, such as age, gender, 
comorbidity, and type of dementia. How people age will be the primary influence on preventative education, age-related 
health expenditures, and health services. With a growing prevalence of chronic conditions, such as obesity, diabetes, and 
mild disabilities, the full implications for the general population is yet to be revealed. It is clear, however, that there is a 
need in global preparation for the projected increase in health and social care needs. 
The earlier a dementia diagnosis is obtained, the sooner individuals and families can start to gather information on 
dementia, access support networks, plan for future living and care, review employment, insurance, and financial options, 
participate in clinical research trials, benefit from therapeutic interventions and care support services, and health and 
social care programs can better prepare for the projected need in care. Coyte, Goodwin, and Laporte [99] report that 
informal care is receding, perhaps due to the declining number of adult children as potential caregivers (recall the 13% 
decline in populations aged 20 to 39 [23]). With health and social care systems providing different factions of care, it is 
largely up to the family caregivers to bring the total package of care together for their loved one, serving as the care 
managers and caregivers. As health and social care systems are changing to adapt to a growing aging population, this 
should be increasingly based on evidence of best practice for organization, coordination, provision, and assessment of 
services. Complex technology systems have strong potential to positively influence quality of life. Technologies can 
perceive the context of the user’s environment to aid in tasks at the point of care. To understand the effects of integrating 
advanced technologies into dementia care, assessment methods and tools need to be developed for this context. 
Furthermore, it is not enough to match technologies with the level of need, as that would not paint the entire picture of 
how individuals interact with their home environment nor the technologies implemented in them. Continued work is 
needed in developing services that extend beyond addressing physical and mental health needs and that are better suited 
to matching quality of life domains that have been identified by the target patient populations.  
Post hoc ergo propter hoc translates from Latin into “after this, therefore because of this”, and refers to a logical mistake 
in identifying a cause simply because it happened first, summarized often as correlation does not equal causation. ICT 
use for specific applications most likely has benefits, but there is little research evidence demonstrating that technology 
use has a definitive impact on quality of life. When conducting research, the variables, i.e. domains, need to be identified 
to take a before and after measurement of the same issues, so some reflection on the concept is warranted in order to 
understand what the variables consist of (development), what the goal of the technology intervention would be 
(methodology), and interpret what their results say (conclusions). When investigating non-pharmacological and 
palliative interventions, determining clinical significance is difficult. For example, how many points does caregiver 
burden need to be reduced on a particular scale in order to achieve clinically significant results? Determining statistically 
significant differences between test and control groups through experimental models and quantitative outcomes is the 
most widespread method to evaluate intervention outcomes. However, statistical significance is not synonymous with 
clinical significance, and the clinical significance of the interventions is obscured when the results from such a 
heterogeneous group cannot be analyzed cohesively.  
The field of gerontechnology is quite young and has yet to build an extensive body of evidence, and there is little 
definitive knowledge on the relationship between the clinical features of dementia and dementia caregiving, and 
technology’s suitability to intervene on specific symptoms. Clearer conceptual links will support demonstrated 
effectiveness and assure that indicators of success are useful and meaningful to the individuals that the interventions are 
aimed towards helping [269]. Using mixed methods research is beneficial when evaluating complex interventions and to 
provide insight when analyzing multifaceted outcomes. People, including medical and social care professionals, address 
problems in dementia with both words and numbers to understand and manage the situation, so it is more accessible to 
describe and evaluate the intervention in a similar manner. Furthermore, the usefulness of the results are supported 
when they can are described in both numbers (quantitative) and words (qualitative). Caregivers will likely not be as 
motivated by p-values as they will by whole percentages (i.e. 20 out of 31, or 64,5%, of caregivers who used the 
technologies had positive effects on their caregiver burden) and success stories they can relate to (i.e. wandering 
detection in the middle of the night). However, when using mixed methods, the study complexity is increased, which 
means more efforts are required to fully analyze the results [270]. A standardized ontology to classify the technologies 
and their outcomes will be beneficial for the multidisciplinary teams that work in this field. Several classification systems 
were discussed, yet none fulfill the requirements to provide uniform evidence for clinical decision making. It is 
envisioned that if research and development does not quickly proceed in this area, the technologies will continue to 
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advance much faster than the understanding of the implications. To illustrate this, a brief description of what dementia 
care could look like in the near future was given, touching on specific devices as well as large, advanced systems of service 
is given in Paper F. There are important goals that are necessary for technology advancements in dementia care; for one 
thing, a common system to seamlessly integrate devices and functions into a tailored care plan, and secure network 
channels are needed to accomplish this. The continued development of technology, particularly in intelligent and 
ambient technologies that collect and incorporate contextual data to infer situational user requirements, additionally 
necessitates continued development in how to translate the outcomes of the care interactions to make meaningful 
interpretations of the data. 
This chapter presented the motivation for this research and background information on the topics, showing that 
demographic changes are creating an urgent need for successful dementia care interventions. The state of the art on high-
tech telecare technologies for dementia is presented, including technologies that are currently used and those under 
development. Linking technologies to recommendations for in-home dementia care provides an overview of how to use 
technology to supplement best practices in caregiving. Finally, motivating results found in the literature on dementia care 
interventions are presented. A distinct knowledge gap in the evidence-base of technology intervention outcomes has been 
identified. The next chapter presents the hypotheses and research questions to be tested. 
Papers supporting Chapter 2:   
Paper A supports the background by providing a discussion on theories used to understand older adults’ experiences of 
interacting with technology and Paper B discusses the background work on quality of life studies and identifies influential 
domains of QOL for individuals with dementia. Paper F present a description and discussion of research projects focused 
on gerontechnology. Paper E offers a discussion on instrumental work in quality of life studies, environment as a 
mediator for activity, and theoretical motives for the interventions. Paper E also describes a search for quality of life 
measurement tools. Paper F considers the accelerated co-development of technology and society and the opportunity for 
technologies to support people with dementia. 
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Chapter 3.  Hypothesis and research questions 
Related research has been conducted before; however, there is a lack of cohesive theoretical basis and methodological 
strategies, which makes understanding the relationship between dementia, quality of life, and gerontechnology evasive 
and complicated. Generalizing or even comparing results is difficult as it has been a complex and uncertain area of 
research, and implications are hard to determine. The previous sections have described the increasing need for and use of 
technology in dementia care despite the lack of evidence to support its effectiveness and efficacy. It seems as though 
technology-supported care would bring such obvious benefits that people take up its use based on intuition, but this does 
not explain why results are so difficult to validate for generalization. The rationale for the thesis is grounded in the 
evidence on the need to understand and further develop technologies that are being used in dementia care (promote the 
understanding of the use). It is focused on answering the question if technology has a measurable effect on quality of life, 
and if that effect is positive. Research questions narrow the focus of the research by identifiying the concepts to be 
investigated, and provide structure to interpret the results. The primary question in the research is to examine if 
gerontechnology-supported dementia care has different outcomes than usual care, and the supporting questions help to 
answer this and provide a deeper examination of the outcomes. 
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This research aims to provide evidence on quality of life outcomes by testing gerontechnology as a dementia care 
intervention against usual care. The null hypothesis (HO) is that there will be no differences between the quality of life 
outcomes from receiving usual care and from using the gerontechnology, meaning that the alternative dementia care (i.e. 
gerontechnology) is not a significantly different option for the majority of people. The alternative hypothesis (H1) is that 
the alternative dementia care (i.e. gerontechnology) yields positive effects when compared to the control group. The 
ISISEMD-related sub-hypotheses (H2) are achievement goals that the project set to attain in order to validate the 
effectiveness of the intervention [271] [272]. 
Hypothesis Statement:  Gerontechnology use will have a positive effect on the 
quality of life of older adults with mild dementia and on their caregivers when 
compared to controls 
HO:  There is no effect on quality of life; there is no relationship between using 
gerontechnology in dementia care and quality of life  
H1:  Gerontechnology use in dementia care improves quality of life  
H2:  ISISEMD-related sub-hypothesis  
“Positive” effect is used because maintained physical functioning can delay or defer the need for institutionalization; thus, 
maintaining quality of life status is viewed as positive. It is challenging to attempt to slow decline, as the individual’s 
syndrome is unique to their experiences, personality, and environment; there is, effectively, nothing to compare the rate 
of decline to. For the null hypothesis, rather than stating “negative” effect, the hypothesis is no effect. The rationale is 
that a negative effect could still indicate that the quality of life had a relationship with the technology use. A negative 
relationship still gives valuable results to further examine why it was negative and if and how it could be made positive. 
Additionally, a possible decline in QOL is not an unlikely outcome, especially for participants who have had little to no 
technology experience, and who may become initially distressed by having a care technology system installed in their 
home. The research questions from the ISISEMD project help to narrow the indicators for testing the hypotheses. The 
research questions define what the research will be investigating to determine the significance of the outcomes: 
1. Will using gerontechnology have positive effects on physical and independent functioning? 
2. Will using gerontechnology have positive effects on the quality of life of the individuals with dementia  
3. Will using gerontechnology have positive effects on the quality of life of the caregivers? 
4. Will using gerontechnology have positive effects on caregiver burden? 
5. Will using gerontechnology have positive effects on safety in the home? 
6. Will people be satisfied with the intervention system? 
7. Will people want to use services like these in dementia care? 
8. Will people be willing to pay for services like the ones offered? 
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Chapter 4.  Methods  
Development, implementation, and evaluation of the telecare intervention 
This chapter describes the methodology to test the priori hypothesis that using gerontechnology in dementia care would 
improve quality of life in participants when compared to a control group. The previous research reveals that the capacity 
to have positive effects on overall quality of life may be measured by assessing specific elements thought to indicate 
quality of life (i.e. physical functioning, functional independence, quality of life, caregiver burden). To this end, this 
research study compares multiple indicators of quality of life, under the assumption that these individual elements will 
have an effect on overall quality of life, and by viewing quality of life from several influential angles that will provide a 
more holistic view of the construct. A network of adaptable technologies were installed in the homes of individuals as part 
of their dementia care during a 15 month testing period in the four European locations of North Ireland, Finland, Greece, 
and Denmark. This intervention group was compared to n=26 control participants in 3 of the 4 regions23. All older adults 
had a designated caregiver and were living in their own homes and all participants gave informed consent. The ISISEMD 
clinical intervention trial tested 80% power against a Type I error with the null hypothesis that there would be no 
significant difference in outcomes between two types of care. All intervention group participants discussed the telecare 
plan with project partners before the installations in order to tailor the services and provide the most support. The 
expected benefits would be more maintenance or even improvement in the key areas when compared to a control group 
of usual care. The harms that are addressed as primary concerns are increased frustration/stress due to adapting to the 
new technology and issues related to data security. To acquire information on the user requirements outside of academic 
investigations, a triangulation of methods consisted of standardized tools, semi-structured interviews, and observations 
by professionals. In this way, representative end users could introduce ideas, experiences, practical knowledge, and 
preferences. The basic requirements help to determine which services will be beneficial, have the most impact, be 
considered acceptable, etc. Since these derived requirements were preliminary, they were continually revised and 
assessed during the rest of the project, particularly during the integration and implementation phases when the scenarios 
were no longer models but based on actual individuals. The telecare intervention was tailored, multi-component, and 
long-term, all of which have been recommended for effective dementia care interventions [273].  
The outcomes were measured by quantitative data gathered from the ICT system and through observations, interviews, 
and questionnaires to the end users. The ISISEMD project consulted with relevant national experts in the countries on 
criteria and assessment tools. Determining statistically significant differences between test and control groups is the most 
widespread method to evaluate clinical outcomes. However, statistical significance is not synonymous with clinical 
significance. Mixed methods are used to evaluate the multifaceted intervention. It is often difficult to determine the 
clinical significance of non-pharmacological and palliative interventions. For example, what is the minimum detectable 
change in quality of life needed (or, in which domains, or in which assessment tool) in order for the outcome to be 
clinically significant? Well-defined clinical relationships help determine the appropriateness of the intervention’s 
objectives, yet the clinical features of dementia and dementia caregiving are not well understood. When describing a 
complex intervention that is intended to enrich people’s lives, it can be more effective to communicate the outcomes in a 
way that puts meaning on the usefulness of the intervention, both in numbers (quantitative) and words (qualitative).  
 
                                                        
23 The end user region of Denmark could not recruit enough participants to effectively be randomized into control and test groups; as a 
result, there was not a control group included from this region. 
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Papers included in Chapter 4:   
Paper B supports this chapter by discussing a prototype for an electronic quality of life assessment for use in dementia 
care.  
Paper B:  Carrie Beth Peterson, Neeli Rashmi Prasad, and Ramjee Prasad. “Framework for Dementia 
Quality of Life Assessment with Assistive Technology,” Proceedings of the International Association of 
Science and Technology for Development (IASTED 2010) in Innsbruck, Austria, Biomedical Engineering 
Volume 1. ACTA Press 2010. ISBN: I: 978-0-88986-825-0/II: 978-0-88986-827-4. 6 pages. 
Paper D defines the ISISEMD development, implementation, and evaluation methods as well as an additional 
explanation of the services. 
Paper D:  Anelia Mitseva, Carrie Beth Peterson, Christina Karamberi, Lamprini Ch. Oikonomou, 
Athanasois Mpallis, Charalampos Giannakakos, and George E Dafoulas. “Gerontechnology: Providing a 
helping hand when caring for cognitively impaired older adults – intermediate results on the satisfaction 
and acceptance of informal caregivers from a controlled study.” Current Gerontology and Geriatrics 
Research, Hindawi Publishing, Article ID 401705, 2012. DOI:  10.1155/2012/401705. 19 pages. 
Paper E reports a literature search for dementia-specific quality of life assessment tools that could be used to evaluate 
telecare impact. This paper also considers revisions to the proposed electronic QOL assessment prototype.  
Paper E:  Carrie Beth Peterson, Neeli R Prasad, and Ramjee Prasad. “Assessing assistive technology 
outcomes with dementia.” Gerontechnology 11(2), p. 259. 2012. DOI: 
http://dx.doi.org/10.4017/gt.2012.11.02.414.740. 10 pages. 
Paper F presents a cutting-edge description of gerontechnology use, evaluation, and continued development that is 
accelerated through advancements in technology, indicating a need for electronic QOL assessment methods.  
Paper F:  Carrie Beth Peterson, Neeli R Prasad, and Ramjee Prasad. “The future of assistive technologies 
for dementia.” Gerontechnology 11(2), p. 195. 2012. 
DOI: http://dx.doi.org/10.4017/gt.2012.11.02.427.742. 7 pages. Awarded “Best Paper” at the International 
Society for Gerontechnology conference, 2012. 
Papers G and H describes the methods used in the study.  
Paper G:  Carrie Beth Peterson, Lars Bo Larsen, Poul Svante Eriksen, and Ole K Hejlesen. “Zarit burden 
interview shows decrease in caregiver burden with technology intervention in European dementia study.” 
Submitted for publication to the British Medical Journal, 2014.  
 
Paper H:  Carrie Beth Peterson. “Results from a clinical trial on gerontechnology in dementia care and 
caregiver quality of life outcomes.” Technical report, 8 pages, 2013. 
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4.1 Recruitment and retention of participants 
In this study, the focus is on older adults with milder forms of dementia. The study required participants who will adapt 
to using technology in the home and to the telecare services, as well as have the ability to give their assessment. The goal 
of the inclusion and exclusion criteria for participation in the clinical trial was to acquire a group of end users who have 
the experiential knowledge of living with and caring for dementia and are able to give their evaluation24. As the MMSE is 
the most widely used cognitive assessment in dementia evaluations, the cut-off for exclusion was based on mild to 
moderate range of dementia, corresponding to a score between 10 and 25. However, there are known fallacies with the 
MMSE as diagnostic criteria for dementia, and there are wide variations among individuals with dementia. Depending on 
educational level, age, and other personal history, it is feasible that a person can present symptoms of dementia yet show 
a score of no impairment. As discussed earlier, not every person who meets the criteria of symptoms will have a dementia 
diagnosis. The inclusion criterion is intended to exclude participants with severe dementia, who may not be able to 
provide their evaluation of the intervention, so participants scoring within the normal range of cognition (<26) are 
included in this study if presenting symptoms of cognitive impairment or dementia. The project did not focus on 
diagnosis or differentiation of dementias, but aimed to exclude participants who had dementia secondary to head trauma, 
psychological conditions that were similar to dementia, and misuse alcohol or medications; furthermore, those who have 
had more than 3 acute hospitalizations in the past year are at an increased risk for a confounding delirium or reversible 
cognitive impairment would also be excluded. This was to avoid possible variations of cognitive impairment that did not 
have the same etiology and needs as the intended population sample. In the same light, those with known 
Frontotemporal dementia were excluded as their syndrome will have different symptoms and they are prone to different 
mood and behavioral changes. As one of the goals of the gerontechnology intervention was to improve socialization and 
independence, individuals who are bedbound are believed to have needs and user requirements outside of the scope of 
the project.  
Caregivers were required to be consenting adults (over age 18, no dementia themselves), have a history of caregiving, and 
were excluded if they were undergoing active treatment for cancer. Caregivers needed to have a history of caregiving so 
the role and responsibilities would not be a new adjustment in their lives (which could indicate an initial increased 
burden), and so they could have a better perception for personalizing the dementia care. Active treatment for cancer is a 
significant experience which can leave the person physically and mentally depleted, and could present spurious outcomes 
in caregiving. There also needed to be some stability of the home environment in order to test an intervention in that 
context, so participants were excluded if there were plans to move during the duration of the trial. An ideal description of 
the participants is given in Table 4, and includes community-dwelling older adults with dementia and their adult 
caregivers who are experienced and able enough to give an assessment of their quality of life. 
Table 4 Inclusion and Exclusion criteria for the ISISEMD pilot trial [274] [275] 
Participant group Inclusion criteria Exclusion criteria 
Individuals with 
dementia 
> 60 years of age 
Mild to moderate symptoms of dementia 
(measured by MMSE >9) [276] 
Live in their own home (alone or cohabitating) 
Have an informal caregiver 
Can give consent 
Dementia secondary to head trauma 
Frontotemporal dementia 
Dementia that is reversible 
Psychological condition similar to dementia or long-
term psychological conditions  
Misuse alcohol or medication 
Bedbound (20 hours a day for 4 of 7 days) 
Malignant illness 
Under active treatment for cancer or other terminal 
diagnosis 
>3 acute hospitalizations that were not dementia-
related in the past year 
Planning institutionalization in the next 6 months 
 
Informal 
Caregivers 
Over the age of 18 
Live with or near the participant with 
dementia 
Currently involved in care for >6 months 
Have no plans to move during the duration of 
the intervention trial 
Under active treatment for cancer 
Have dementia themselves 
                                                        
24 These main inclusion/exclusion criteria have been consulted with Bodil Gramkow, chief physician at Department of Psychological and 
Gerontology in Brønderslev, Denmark and Kasper Jørgensen from the National Research Center for Dementia for Dementia in 
Denmark.  
4. Methods 
42 
 
The assessments used in this PhD study were administered before the trial began and again after the 15 month trial 
period was over. The assessment tools used have been designed and recommended for research in dementia care and 
quality of life outcomes (i.e. physical functioning and independence, quality of life, and caregiver burden), and are 
administered in the local language. The results of these assessments will be compared, based on significant change from 
the baseline assessment and on significant differences between the control and intervention groups’ outcomes. The 
control group will have care as usual (both formal and informal, and allowed to change as needed). Before participants 
could be recruited, all regions obtained approval from Data Protection Authorities for the collecting, treating, and storing 
of personal information and Ethical Committee approval where necessary [273] [277]. The national and international 
regulations on the privacy and ethical treatment of participants and data were respected, and this is further described in 
Paper D. The ethical applications began in September, 2009 and all were approved by April, 2010. For detailed 
information on the European and National ethical guidelines and approval for the ISISEMD project, see the public report 
“Specification of tests and test groups, update,” [274]. The trial protocols included guidelines on oral and written 
information for the participants, lists of equipment, informed consent forms, etc; however, no registration is required for 
Phase I clinical trials testing medical or therapeutic devices.  
The trial is quasi-experimental (non-randomized) with repeated measures, and the results are gathered through mixed 
methods. Additionally, the research is exploratory, since so little is known on technology interactions in dementia care 
and on the outcomes of such interactions. A non-inferiority framework is used in order to demonstrate that the 
gerontechnology intervention provides at least the same benefits to the dyad as usual care.  
Health care systems did not have access to people in the early stages of dementia as they usually do not seek out formal 
support services until the dementia is advanced enough to cause problems. Therefore, it was difficult to find participants 
in the earliest stages of dementia. Particularly when working with milder forms of dementia, symptoms can change 
rapidly and some participants may not be suitable for the entire duration of the trial, so it is expected that a certain 
number of participants will withdraw from clinical trials. The participants from the four countries (Denmark, Finland, 
Greece, and North Ireland) were recruited using multiple channels, consisting of general practitioners and nurse 
practitioners, dementia clinics, and regional organizations working with dementia populations. The majority of referrals 
were contacted via memory clinics or by the home-care personnel in the municipalities. It was not uncommon that the 
medical providers in the regions were unfamiliar with the telecare technology, and did not understand the scope of the 
project, which made it difficult for them to refer appropriate patients. Unfortunately, many of the referred individuals did 
not meet the criteria to participant, often due to more advanced dementia. Television and radio channels were also used 
to announce the pilot study and to attract interested participants, and regional partners set up demonstration rooms for 
live or televised demonstrations of the services. Here, the participants could see and experience the telecare system prior 
to joining the clinical trial, the formal caregiving staff could interact with the system for technical feedback and training, 
the technical partners could test services and updates, and other members of the community could learn more about the 
telecare system through demonstrations.  
An average QOL-AD score is reported as 39,5, with a Standard Deviation of 5,3 [178]. ISISEMD aimed to measure a 6% 
increase in QOL-AD score, with 95% Confidence and 80% power, so n=37 participants per group were needed for 
validation [274] [275], and ISISEMD aimed to recruit 40 in each group (10 per group in four sites) to accommodate for 
attrition. N=71 older adults with probable mild to moderate dementia and their caregivers (i.e. dyads) were assessed for 
appropriateness to participate in the project. Of these, n=63 were suitable for the project; however, n=6 out of 45 (13,3%) 
withdrew from the intervention group and n=2 out of 26 (7,7%) withdrew from the control group before the final 
evaluation. The most common reasons for withdrawing from the project were due to a deterioration in health or family 
life (i.e. overall health status declined, hospitalization, stroke, death), internet connectivity issues necessitating removal 
from the intervention group, and one dyad withdrew in Denmark due to an inconvenient number of technical issues and 
the belief that the person with dementia was well enough to manage without additional care [275]. After withdrawals, 
n=55 dyads (87,3% of those appropriate) completed the length of the trial. The initial methodology was to randomize 
participants in each of the regions; however, due to recruiting difficulties, ISISEMD amended the methodology to 
prioritize accruing participants in the intervention group. In the Denmark region, the consortium decided that all 10 
would be assigned to the intervention group in that region (n=4 of whom later withdrew). Additionally, the exclusion 
criteria specified dementia secondary to head trauma and being bedbound; however, one participant was both bedbound 
(in a wheelchair) and suffered cognitive impairment secondary to a head trauma (due to a fishing industry accident years 
ago). This dyad was discussed, and it was decided they could remain in the trial. Furthermore, some of the participants 
lived in mountainous areas with poor connectivity, and they were reallocated to the control group as it was not 
technically feasible to offer the services.  
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4.2 Service development and implementation 
Telecare services all will consist of a network layer, platform layer, and user layer, but the services often overlap and there 
are divergent classifications of technologies and services. The technical capabilities of the gerontechnology system 
allowed scalable services and supported user requirements being met in terms of functionality, privacy and security, 
speed, capacity, accuracy, and standards. The technical partners determined which equipment would best match user 
needs and designed the scalable services. The technical partners ensured that the user requirements were met by 
technical capabilities in the working version and fall back solutions, and were maintained throughout the trial. The care 
professionals in the regions ensured that the services were appropriate for the end users. All project partners assisted in 
testing, debugging, and adapting the services. Table 5 presents examples of the ISISEMD telecare services and 
technologies in the gerontechnology matrix. 
Table 5 ISISEMD services and technologies in the gerontechnology matrix 
Class of 
technology 
Area of activity 
Health and self-
esteem 
Housing and 
daily living 
Mobility and 
transport 
Communication 
and governance 
Work and leisure 
Enhancement and 
satisfaction 
Access to telecare 
services 
Lifestyle pattern 
monitoring 
GPS device with 
mobile communication 
Carebox contact 
button 
Digital pictures in 
Memory Lane service 
Prevention and 
engagement 
Reminders for 
meals 
Motion sensors 
for wander alert 
Bed sensor Carebox contact 
button 
Brain games on 
Carebox 
Compensation 
and assistance 
Reminders for 
medication  
Kitchen 
equipment 
control 
GPS device with 
mobile communication 
Reminders for date 
and time 
Reminders for 
activities 
Care support and 
organization 
Patient records in 
the telecare 
system 
Overview of the 
home via the 
portal 
Better coordination of 
visits by checking GPS 
Reminders entered 
by caregivers  
Coordination of care 
and support for 
caregivers 
 
The services were designed to be more passive for the adult with dementia. Their main interaction with the system would 
be through the Touchscreen computer, and a graphical user interface (GUI) needed to be developed particularly for them. 
Caregivers are also often aging adults, so their GUI is designed to be appropriate for their needs and abilities as well. A 
group of experts working in the field of Human-Computer Interaction (HCI) focused specifically on GUIs that are 
appropriate for all potential users and set parameters for design that accommodate aging adults’ needs [278] [279]. In 
this research, these design parameters were used when creating the GUI for the person with dementia, and in the 
information and training materials. The design parameters for functional changes associated with aging include: 
 Vision – declining sharpness, contrast and glare sensitivity, visual color discrimination, etc. 
 Psychomotor abilities – reduced reaction time, finger dexterity, and arm-hand steadiness 
 Attention – declining ability to concentrate and manage multiple tasks simultaneously 
 Memory – reduced working memory (ability to retain information) 
 Learning – speed of information processing is slower 
 Intelligence – fluid intelligence (i.e. ability to think and reason, speed at which information is 
analyzed) and crystallized intelligence (i.e. accumulation of information and problem solving) are 
reduced 
 Expertise – older adults are typically not proficient in the latest technologies or their processes 
Applying activity theory to HCI provides a framework to understand the co-creation between human activities and 
technology that promote long-term well-being. In this way, the theory provides a perspective on the user’s situation and 
focuses on the interaction, with the emphasis on the interaction in the transient context. There are care and living 
requirements for the person and the place, and notifications and alarms are dependent on the user and the device. This 
helps to make the important distinction between which technologies are usable and which are useful. For example, a door 
opening at night may be normal and acceptable for one user but signify a serious threat for another. In the first case, the 
movement would be recorded in the system but would not require the immediate attention of the caregiver; in the second 
situation, the movement is recorded in the system and an alarm is generated to the caregiver. These requirements may 
change during the course of the trial and are expected to change over the lifetime as the syndrome advances. The 
ISISEMD Carebox GUI is designed for simplicity and minimal interaction. In the interface for the adult with dementia, 
there are no pop-up windows, dialog boxes, or menus to cause unnecessary distractions. The GUI is displayed on the HP 
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TouchSmart Desktop PC (models are either with a 20” or 23” screen), and the components of the GUI are in fixed 
positions based on 4 areas of use, presented in Figure 9.  
Figure 9 Graphical User Interface components and their fixed position [275] 
The top left side of the screen displays information 
on the structure of the day (date, day, time, 
upcoming activities). 
The top right side of the screen 
displays the pictures in the Memory 
Lane service. 
The bottom left side presents messages and 
reminders. This is enhanced through sound and the 
options for audio messages and confirmation button 
(for when activities have been performed). 
The bottom right side presents the 
video phone and Brain Games 
services. 
 
   
 
The integrated prototype consists of an infrastructure including diverse Hardware (HW) devices (i.e. fixed and mobile 
devices) and Software (SW) components, which required adaptations in order to realize the desired infrastructure. There 
were some integration issues with physical and virtual allocation on the network (i.e. debugging, faulty equipment, 
temperature sensing when cooking, connectivity), and all were resolved. The servers were installed in a web farm at 
Alcatel-Lucent Multimedia Communication Center in Milano, Italy [280]. The web farm offers Internet and WiFi 
connectivity, web hosting, data storage, a mail server, and authentication and encryption of data. The physical 
architecture is comprised of physical servers and virtual machines, based on the servers installed in the Demilitarized 
Zone (DMZ) Network at Alcatel. The DMZ Network adds additional security against external attacks. A virtual appliance 
hosts the SW stack of the Ecosystem (i.e. operating system and networking, remote access, security, etc.). The virtual 
appliance has minimal overhead and makes it easier to compartmentalize and administrate the various technical 
domains involved (i.e. changing underlying HW components, modify operating systems, reduce SW interference, etc.). 
The ISISEMD system architecture can be seen in Appendix 6.  
The technical verification, replication, and testing ensures that the technical components and services will run according 
to the defined requirements. The testing has been carried out in three sub-areas of integration, functions, and Carebox. 
The integration testing ensures the basic integration of sub-systems, their communication, and operation through the 
portal. These tests were conducted while the ISISEMD partners were in a conference call so that appropriate partners 
could provide input. Errors are corrected immediately and the test is run again until all integration was tested on the 
servers and portal. The integration test shows that the different sub-systems are successfully integrated and have 
functional communication. The functional testing focuses on the actual use of the system and actual functionality of the 
services. After passing the integration tests, the ISISEMD portal is accessed and tested to verify that the system behaves 
as expected. Any system bugs are corrected and the function is tested again, this is repeated until the platform passes all 
functional testing. The Carebox is tested to confirm that the home PC performs appropriately for the end users. The 
Carebox and GUI are tested by simulating activities that the caregivers or individuals with dementia would carry out, and 
includes verifying that GUI items were displayed properly, services can effectively be modified (i.e. reminders, scheduling 
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events, pictures can be uploaded and displayed), and notifications via SMS and email are successfully delivered. There 
were minor issues with the pressure needed to activate the touchscreen (i.e. contact button), and this is specifically 
addressed in the training where participants with dementia would test the button to get used to the amount of pressure 
(this also helps to reduce the inexperienced user’s feelings of apprehension about breaking or damaging the system). The 
Carebox not only provides the human-machine interface, it performs as the domotics controller (connects the home 
automation components) and serves as a communication device. The home automation server and the GUI are tested 
separately, and then together to verify the Carebox functionality. This testing guarantees that messages and information 
are received and appropriate action follows (i.e. alerts or alarms displayed through text, audio, SMS, or email). Once the 
services and components have been tested, the services are set up (i.e. loading the interface, modifying services and 
parameters, adding phone numbers and email addresses, etc.), and ready to be implemented in the homes.  
Due to the varying individual requirements and to the progressive nature of dementia, the services are grouped in three 
bundles of increasing care, presented in Table 6. Some of the basic services (lower level of care) include sensors for 
temperature, and fire and flood sensors, while the more advanced services (higher level of care) include meal and 
appointment reminders, medication management, indoor/outdoor activity sensing, and lifestyle pattern detection. Paper 
D provides a further description of the services. The technology skills among the end users can also vary, which is why in-
person training as well as user manuals, and online information are used [274]. For the adults with dementia, the system 
requires as little interaction for them as possible. The participants have the freedom to choose which services would best 
serve their living situation and care preferences.  
Table 6 Technology-enabled services offered through the ISISEMD project [281] 
Service group Service summary 
Basic 
Home safety 
 Kitchen equipment control (stove and oven) 
 Smoke, fire, and flood detectors 
 Door monitor (for wandering) 
Basic 
Reminders 
 Daily schedule (reinforce structure of the day) 
 Date and time (orientation) 
 Medication 
Basic Brain games  Exercise cognitive functions 
Medium Motion detection  Bed sensor 
Medium 
Away from home 
 Register when leaving and returning home 
 Notification to caregivers if away from home longer than pre-defined 
Medium Internet telephony  Contact through Carebox touchscreen contact button 
Medium 
Memory lane 
 Enjoyment of activities 
 Picture files displayed on the Carebox 
High 
Positioning 
 GPS when outdoors 
 Panic button 
 Mobile telephony 
High Lifestyle pattern  Detect deviation from normal behavior 
 
Different levels of user support are used. The first level is provided by the trained professional caregivers in the regions 
(i.e. super-users), who train the participants and receive the subsequent requests for help. If the formal caregiver cannot 
resolve the problem, they create a detailed request ticket for the technical partners. The ticketing system helps to define 
user support roles and responsibilities, service level agreements, allows for tracking the progress in resolving the issues, 
and in the dissemination of the problem-solving. The second level of user support is assisted by the IT Infrastructure 
Library and is service-focused. The web-based portal contains a Help Desk area with forms that the participants (i.e. 
formal and informal caregivers) can use to classify and request support, and the backend of the portal processes the 
requests (i.e. assigned, replied, archived, etc.). The Help Desk also has a hot line to facilitate communication between the 
caregivers and the service support partners (both technical and care-related).  
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The services need to be understandable and adjustable for the end users, particularly the caregivers. For example, the 
system would make an alert if the windows are left open past a certain hour in the night, and this could be adjusted if it 
was summer and acceptable to keep the windows open. Similarly, the event notifications could be adjusted for shorter 
periods if, for example, there is a family event and the caregivers wished to turn off the “door open” notification as there 
will be many people entering and leaving the house that day. This requires training to encourage a deeper understanding 
of how the gerontechnology system works, so the caregivers can accurately interpret the information recorded in the 
system as well as make adjustments that work best for the individual. During the installation phase, formal caregivers 
and technical partners carried out the majority of the face-to-face training, which includes going over the printed 
material and their instructional pictures on how to set up, use, and manage the services. The regions had variations in the 
time for installations, largely due to the number of wires, sensors, and technical issues. Installations took from 1 hour to 1 
day, with the average being a few hours per home. It was found effective to first explain and demonstrate the service, and 
then ask the participants to try it out. The amount of time spent on training the end users varies (several hours per 
home), and there are differing levels of expertise with technology. All users received manuals with instructions and 
picture guides tailored to their user level and their technical level As with the user interfaces and service functions, the 
user manuals are in the local language for the individuals with dementia, the informal caregivers, and for the formal 
caregivers. Training on the personalization of settings for the reminders and alarms was specifically addressed. The 
portal had a user manual and Frequently Asked Questions (FAQ) file that was tailored to be appropriate for the type of 
end user (informal or formal caregivers). After the installation of the telecare system in the home, the participants could 
request further or ad hoc training and had access to supplementary information. The regional experiences with 
installations, training, and user support are summarized in Table 7.  
Table 7 User support and installations in the telecare pilot [272] [281] 
Region Installation Support 
Lappeenranta, 
Finland 
From 1 hour to 1 day, depending 
on type of installation (number 
of wires, sensors, technical 
issues). 
Training took approximately one hour per user, specifically, the reminders 
and alarms services were addressed. Caregivers were trained in using the 
portal and to modify the settings. Users were supported through ad hoc 
training. On site visits for subsequent problems proved effective in 
enhancing the system. 
Frederikshavn, 
Denmark 
Installations were more time 
consuming than education. The 
system was found to be complex 
to install. 
Educating the users took up to 4 hours per family. It was effective to train 
the caregiver and person with dementia together, and it promoted unity in 
the dyad. However, to have the dyad together required training outside of 
business hours. It was important to teach the caregivers about the details in 
personalizing the services, so they feel confident in using the system. 
Trikala, Greece 
Installation varied from 2 to 5 
hours, depending on type of 
installation (number of sensors). 
Professional caregivers worked in the same place as the technical partners 
and were easy to train. This seemed to positively influence smoother 
running of the pilot. More advanced training and education materials were 
given to more advanced users, specifically, on personalizing the services. 
Belfast, North 
Ireland 
Installations varied. Problems 
with Internet coverage increased 
the time spent on installations. 
Face-to-face training was given in a demo room and at the home, during 
installations. The participants required more support than was anticipated. 
Summary of 
recommendations: 
Technical and regional partners 
are recommended to have 
established plans for the 
installations so the process is 
more consistent. 
Make “how-to” video clips to enhance caregiver training and education. It 
is a challenge for caregivers (both professional and informal) to learn how 
to use the system, and what it can and cannot do. Formal caregivers were 
further trained by project technical members, and additional training was 
made available.  
 
Through the telecare portal, caregivers can log in to see the status of the home, recent activities, and adjust the 
parameters for an individual’s allowed activities. Alerts are generated when the system has detected an activity (or lack 
of), but it does not require immediate or emergency-level action (e.g. a yellow light). For instance, an individual with 
dementia typically gets out of bed to go into the bathroom 3-5 times a night; an alert would be generated to the 
designated caregiver if this person goes beyond those parameters, e.g. goes into the bathroom more than 5 times in one 
night or does not go to the bathroom at all in a night. In general, the alerts mean that the system detected activity outside 
the pre-defined parameters and encourages a closer look at the issue or situation. Alarms are generated when the system 
has detected activity (or lack of activity) that requires immediate or emergency-level action (e.g. a red light). Examples of 
alarms generated would be if the fire detector is activated. The alarms are connected with the central unit in the home 
(the Carebox, as it was called in this project), which sends out the messages about the type of alarm. The Carebox serves 
both as a domotics controller in the home and as a communication device. Figure 10 presents an example of the formal 
caregiver’s overview of the home telecare system. 
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Figure 10 Example of the ISISEMD formal caregiver’s overview of the home status for a patient  
 
GPS tracking with mobile phone communication for outdoor positioning 
Particularly in dementia care, tracking technologies have been used in social services and locating systems. For the 
individuals, the use of this technology can increase (a sense of) independence by knowing that they can push a button to 
call for help or to be found if they become disoriented. The device shown in Figure 11 provides localization through GPS 
(Geographical Positioning System) and GSM (Global System for Mobile communication), and functions as a mobile 
communication device through SMS (Short Message Service) or GPRS (General Packet Radio Service). It has only one 
distinct, red button that supports 2-way voice communication (initiates a mobile call to the designated caregivers and to 
receive an incoming call from the caregivers) and contains an accelerometer to detect movement and falls. The model 
used in the project is the personal Lommy (www.flextrack.dk). The Lommy costs around €350 and is roughly the size of a 
deck of cards, is water resistant and dust protected, and takes under 5 hours to recharge after 40 hours of active use. This 
device is used for locating the person when they are outside of the home and for communication. For example, in 
Denmark, it is common to take walks outdoors, and the formal caregiving staff would first check the location of their 
patients to make sure they were in the house before driving out for a home visit. Alternatively, some older adults resumed 
outdoor walks once they had the GPS device because they were less afraid of becoming lost and no one finding them.  
Figure 11 End user with the GPS-enabled device 
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Daily schedule and reminders through the touchscreen interface 
With dementia, there is a characteristic difficulty in creating and keeping the structure of the day, and this is often one of 
the first symptoms noticed in early dementia. The electronic calendar, shown in Figure 12, provided orientation as to the 
time of day, the date, month, and year, as well as prompted the structure of the day through reminders, i.e. to take 
medication, prepare or eat a meal, or scheduled visitors to the home. It was intended that there should be minimal 
interaction from the end user, unless they expressed a desire for more interaction, e.g. to add reminders to the calendar 
themselves.  
Figure 12 Example of the structure of the day and contact button on the touchscreen interface [282] 
 
The caregivers could add, remove, or change calendar events, shown in Figure 13. The formal caregiving staff could add 
to the schedule if they were going to make a house call, and some of the caregivers also used the system for personalized 
reminders, such as to enjoy a glass of wine with dinner [275]. In addition to the calendar providing reminders and 
prompts, it also has the capability to display alerts. For example, if the stove has been left on for too long (based on the 
user-defined parameters), an alert would read across the screen, first promoting the aging adult’s independence by giving 
them the opportunity to resolve the issue. The alert is also sent via SMS or email to the caregiver. Depending on the 
action taken, the caregiver could also receive a message that the issue had been resolved or was now at alarm status if the 
issue was not resolved during a predetermined and individual user-defined amount of time. 
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Figure 13 The caregivers can personalize reminders to be displayed on the ISISEMD Carebox 
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Communication with family and caregivers through the touchscreen interface 
Aside from the contact allowed by the GPS device, the older adult could contact their family or caregivers in other ways. 
On the older adult’s touchscreen computer interface, there was a call button that would call to landline or mobile phones, 
shown in Figure 14. Although the initial design of this service was intended to be for emergency contact, at least one older 
adult had lost their ability to use the home telephone and would use the touch-screen phone to make regular calls to their 
caregivers. In this case, it was noted as a normal parameter of use and no longer raised alarms for the caregivers. This 
exemplifies the innovative adaptation to the environment by people with dementia. 
Figure 14 Activating the contact button on the Carebox touchscreen interface 
 
 
 
Access control to the home 
Many aging adults enjoy the independence of going to shop, taking walks, or attending local activities. For this service, if 
the person with dementia has not returned to the home after a pre-defined time, an alarm is raised. This service is also 
adaptable, so that in the case that the person is no longer safe to leave the house alone, the alarm is immediately 
generated to caregivers when the front door is opened. Figure 15 gives an example of the door sensor, which uses electro-
magnetic switching to register door and window opening and closing. In the Nordic countries (Denmark and Finland), it 
can become very cold in the winter and losing a disoriented loved one outdoors is a fear that causes worry and stress 
among caregivers. The model used in ISISEMD project is the Sunwave SD-8561W and costs around €2 each 
(www.sunwave-america.com).  
Figure 15 Access control sensor used in the project 
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Kitchen equipment control 
Initially, the kitchen monitoring service was to provide control through the parameters of time and temperature, but 
during the installation phase, it was realized that many people like to open their kitchen windows when cooking and this 
skews the temperature sensors and causes false-negatives. To accommodate the end users, this service controls the 
cooking safety through time-based parameters and actuators will disconnect the electricity when the cooking time is 
exceeded. Each person has a pre-defined amount of time to carry out their cooking activity (i.e. if the end user only boils 
water for coffee or tea, the amount of time is shorter than for the end user who prepares meals), shown in Figure 16. 
Figure 16 Example of caregiver portal overview of cooking activity 
 
Smoke and fire detectors are also used, the Cooper M12 model costs around €15 (www.coopersecurity.co.uk). This device 
uses dual in-line switching and alerts for smoke and fire through 4 programmable detection capabilities:  optical 
(detecting light scattering due to smoke), optical and the rate of the rise in temperature, rate of rise in temperature 
(proportional to the external temperature), and fixed temperature (detects a high temperature). In-home motion 
detection was integrated through the Bosch Blue Line P1 (www.bosch.co.uk), shown in Figure 17. The device costs €15 
and works as a Passive-Infrared (PIR) detector, using a Fresnel optical lens and First Step Processing (FSP), which 
delivers a nearly instant response to human movement and reduces false alarms due to air circulation, insects, and pets 
in the home. The Cooper Safety 1450 detects flooding in the homes and the changeover relay outputs to the domotics 
controller when an event is sensed (www.coopercsa.it). The device, shown in Figure 18, costs €20 and detects moisture 
and flooding through the resistance between the 4 gold-plated feet and the internal coils. To monitor nighttime and 
restful activities of the person with dementia, the RECORA bed occupancy sensor is used in the homes and costs around 
€75 (www.recoraco.thomasnet.com), shown in Figure 19. The sensor (mat or strip) is about ½” thick stainless steel 
(some models have gold plated stainless steel for higher conductivity) and works on smooth surfaces (e.g. chairs, 
mattress, wheelchairs). The low voltage contacts are normally open and will close when the presence of more than 5 lbs. 
of weight is detected. The sensor is connected to the domotics system and notifications are raised if, for example, the 
individual has not returned to bed in the middle of the night after a predetermined time. 
Figure 17 Passive-Infrared 
motion sensor  
Figure 18 Moisture and flood sensor 
[282] 
Figure 19 Bed occupancy sensor 
[282] 
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The ASUS PL-X31, shown in Figure 20, is the Ethernet Powerline Network adapter bridge in the homes and costs around 
€50 (www.asus.com). It has an AC power port (AC 100-240/50-60Hz) for up to 200 Mbps, and a PLC 10/100 Ethernet 
port using a RJ45 connector. The ASUS can communicate up to approximately 300 meters, covering a 465 square meter 
home, and uses 128-bit Advanced Encryption Standard (AES) for the encryption of data. Quality of Service is 
implemented through IEEE 802.1p. The RAMOS Mini C, shown in Figure 21, is the sensor control module in each home. 
It connects to a network, sensors, and a power supply, and costs around €400 (www.conteg.com). The device has 4 
inputs and 2 outputs, connecting up to 4 sensors at a time, each with a unique sensor ID (e.g. flood, motion, front door, 
and fire). The output contact switch can send email or SMS alarms to several recipients (e.g. caregivers and technical 
partners). 
Figure 20 Ethernet network adapter bridge [282] Figure 21 Sensor control module [282] 
  
 
The primary objective of the integration tests were to ensure that HW and SW components will perform properly and 
that the ISISEMD platform is capable of successful functioning. The technical components of the system were 
successfully integrated, tested, and implementation and training were effectively carried out. The next phase of the 
project involves validating the system in real-life deployment.  
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4.3 Assessment methods 
A comparative analysis of the data between the intervention and control groups helps to draw quantifiable conclusions on 
the usefulness of the intervention. When aiming to increase quality of life, a relativist validation is a continual method 
that accumulates knowledge on the outcomes, including heuristic and non-precise outcomes. In engineering design and 
palliative intervention research, problems do not have a single best solution and draw from multiple disciplines to 
provide solutions. Attempting to only use objective standards to understand the effectiveness of gerontechnology in 
dementia care is unsupported [160] [283], so relative validity (contextual usefulness) is also a studied outcome. 
Quantitative evaluations can validate the intervention objectives, but can fail to validate the external relevance, thereby 
making generalizations weaker by not addressing the intervention’s usefulness [160]. Figure 22 depicts the evaluation 
timeline for the ISISEMD project. 
Figure 22 Testing and evaluation time schedule 
 
The regional partners, who recruited participants, helped to install the equipment in the homes, train the participants, 
and administered the user evaluations throughout the trial. The data is reported by the interviewers, who were the 
professionals or students in the regions. The information is coded and entered into spreadsheets that the project 
participants have access to. When the scanned assessments are available to the assessment team, the results are double 
checked. Participants were ordered by the date of joining the study in each region; the data is coded as follows: 
 EP FR 01 represents the Elderly Person with dementia in Frederikshavn, Denmark in dyad 1 
 ICG BEL 02 represents the Informal Caregiver in Belfast, North Ireland in dyad 2 
 LAPP FCG 03 represents the Formal Caregiver in Lappeenranta, Finland for dyad 3 
 TR 04 represents dyad 4 in Trikala, Greece 
 BEL EP01, Baseline ADL would indicate the baseline ADL score of the older person in Belfast dyad 1  
When unprompted or additional information is conveyed to the interviewers or professional caregivers, they are usually 
noted and available to the project’s assessment team. Unintended and adverse effects were communicated to the project 
partners and remedied to the extent possible. While information related to the assessments and qualitative information 
on the living and care situation are mostly handwritten notes, information related to the services and technology are 
addressed through the Help Desk and ticketing system.  
Among the participants, there are expected to be differences in beliefs on the stigma of dementia, coping strategies, levels 
of awareness, and personality traits that affect how the person views their situation. The participant experience will be 
shaped by their expectations, observations, and personal values. Since researching intervention outcomes in dementia 
care is multifaceted, it is helpful to elicit evaluation information from various angles. Different methods expose several 
Standardized assessments (MMSE, MoCA, ADL, IADL, QOL-AD, SQLC, and ZBI) 
Non-standardized assessments (user satisfaction and acceptance, global outcomes) 
Triangulation of methods (standardized assessments, interviews, and observations) 
Small scale pilot (system stability, matching user requirements) 
Full scale intervention (implemented telecare and care as usual) 
0 Months 
2 Months 
6 Months 
12 Months 
Intervention group Control group 
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attributes of the situation, and together provide more information with which to interpret the outcomes. User 
requirements were collected through a triangulation of methods (standardized questionnaires, semi-structured 
interviews, and professional observations), which were used for service development. The process evaluation is based on 
data gathered from the telecare system and through questionnaires and interviews administered before the technology 
was installed, approximately six months after installation, and again at the end of the 15 month trial (this analysis 
examines only pretest-posttest). Statistical analysis was carried out through Excel 2010 and Mat Lab R2012b, and 
consisted of t-tests and Pearson’s correlations. National experts in the four countries were consulted regarding 
standardized assessments to use in the research project: 
Denmark 
 Dr. Bodil Gramkow Andersen, Chief Physician at the Department of Psychiatry and Gerontology 
 Kasper Jørgensen, neuropsychology consultant, from the National Research Center for Dementia 
Finland  
 Olli-Pekka Ryynänen, Professor and leading researcher in quality of life testing at the University of Kuopio 
Greece  
 Ms. Sakka, external scientific advisor for the project  
 Ms. Areti Efthymiou, Chairwoman of Athens Association of Alzheimer's Disease 
North Ireland 
 Dr. David Craig and Dr. Ben Knapp, consultants from the Memory Clinic at Belfast City Hospital and Senior 
Lecturers at the Queen’s University, Belfast 
 
When carrying out the initial interviews to determine user requirements, semi-structured interviews and observations 
were conducted simultaneously and complemented each other. The interviews were a fast, structured way to elicit the 
desired information, but it was easy for participants (particularly the person with dementia) to conceal difficulties they 
did not want to discuss. The observations made it easy to distinguish the environmental and functional problems in the 
home, and it was easier to visualize subsequent solutions that would be appropriate. The observations were an effective 
method, but were time consuming and are susceptible to weakness if the dyad is “performing” during the interview, and 
if the observer is seen as an obtrusive element of the context. A known challenge in this type of research, the methods to 
obtain the information affects the information itself [284] (i.e. they provide information only on the defined constructs, 
interviewer bias, Hawthorne effect). The assessments are summarized in Table 8, additionally described in Paper D,and 
the full questionnaires can be found in Appendix 2. 
Table 8 Summary of the assessment questionnaires used in the clinical trial [273] 
Variable Tools Example of what is evaluated Score range Score interpretation 
Cognition 
MMSE 
Changes in cognition, memory, 
orientation, and visuo-
construction 
0 to30 
>26 = Normal 
19-25,5 = Mild impairment 
10-18,5 = Moderate impairment 
0-9,5 = Severe impairment 
MoCA 
Milder changes in cognition, 
attention, abstraction, and 
delayed recall 
0 to30 
> 26 = Normal 
19-25,5 = Mild impairment 
10-18,5 = Moderate impairment 
0-9,5 = Severe impairment 
Physical functioning 
and independence 
ADL 
Bathing, eating, continence, and 
basic physical functioning 
independence 
0 to 6 
Higher score = higher independence 
3-4 = moderate dependence 
0-2 = severe dependence 
IADL 
Food preparation, medication 
management, and higher level 
physical functioning 
independence 
0 to 8 Higher score = higher independence 
Quality of life 
QOL-AD 
QOL of person with dementia, 
health, living situation, and ability 
to do things for fun 
13 to 52 Higher score = higher quality of life 
SQLC 
QOL of the caregiver, professional 
activities, social and leisure 
activities, and caregiving 
responsibilities 
0 to 149 
141-149 = Effective adaptation of the caregiver 
100-140 = Mild effect on QOL 
86-99 = Moderate effect on QOL 
<85 = Severe effect on QOL 
Caregiver burden 12-item ZBI Personal strain and role strain 0 to 48 Higher score means higher burden >17 = clinically significant burden 
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Assessment of cognitive functioning of the older adult with dementia 
To assess cognitive functioning, the most widely used assessment form is the Folstein Mini-Mental Status Examination, 
or MMSE [285]. The MMSE assesses attention, naming, following instructions, language, memory, visuo-construction, 
and orientation. Questions include asking the patient to count backward from 100 by 7s, to repeat a short phrase after the 
examiner, and to draw a clock face and geometric figure. Since the MMSE is so commonly used, the interviewers in the 
regions were already trained in administering this assessment, which takes around 10 minutes. Authorized translated 
versions of the MMSE are available in Danish, Finnish, Greek and UK English. The MMSE is best suited for determining 
global cognitive functioning, and has demonstrated a specificity of 96,8%, but has a low sensitivity (71,8%) to Alzheimer’s 
disease and other dementias (59,8%) [286]. The MMSE is reported to have a low sensitivity to mild cognitive 
impairments (18%), so a secondary cognitive assessment that is sensitive to mild cognitive impairments (90%) [287] is 
used to evaluate the level of cognitive functioning [287]. This secondary assessment, the Montreal Cognitive Assessment 
(MoCA) [288], screens for mild changes in attention, concentration, executive functioning, language, conceptual 
thinking, calculations, memory, visuo-construction, and orientation. MoCA has a sensitivity of 90% and a specificity of 
87% to detect mild cognitive impairments; furthermore, the sensitivity and specificity for detecting early Alzheimer’s 
disease is reported at 100% and 87%, respectively, and the internal consistency of MoCA is reported at α=0,83 [287]. The 
MoCA assessment is designed to be administered by any type of caregiver and takes around 5 minutes; furthermore, it is 
available free on the Internet and has been validated in over 20 languages, including the 4 languages used in the project.  
Assessment of physical functioning of the older adult with dementia 
The Katz’s Activities of Daily Living (ADL) [289] and Lawton and Brody’s Instrumental Activities of Daily Living (IADL) 
[290] are two extensively used assessments for physical functioning in older adults. The test-retest reliability is reported 
as κ=0,76 for ADL, and κ=0,88 for IADL [262]. The ADL assessment consists of 6 items that are binary (dependent or 
independent) and takes around 5 minutes to administer. A score of 0 indicates greater physical dependence and 6 
indicates greater independence, with a score of 4 as the cut-off for moderate dependence and a score of 2 for severe 
dependence. The IADL scale takes around 10 minutes to administer, and is 8 items that are also rated as dependent or 
independent, a score of 0 indicates greater functional dependence and with a score of 8 indicating greater independence. 
Both assessments have been correlated to the need for long-term care and to quality of life [45]. The results are obtained 
via observations from the formal caregivers (i.e. occupational therapists or other skilled professional) and supplemented 
by the informal caregivers when needed.  
Activities of Daily Living (ADL) assesses physical independence in: 
a. Bathing 
b. Dressing and undressing 
c. Using the toilet  
d. Transferring from bed or chair 
e. Continence 
f. Eating 
Instrumental Activities of Daily Living (IADL) assesses functional independence in: 
a. Using the telephone 
b. Shopping 
c. Food preparation 
d. Maintaining the house (housekeeping) 
e. Laundry 
f. Using transportation 
g. Medication management 
h. Financial management 
Assessment of quality of life  
Quality of life is recognized as one of the most important indicators of the impact of dementia care interventions [199]. 
Improving quality of life is a central goal of interventions in dementia care (as well as strengthening cognitive and 
functional ability, moderating psychological and behavioral symptoms, and postponing further decline, which are 
believed to influence overall QOL). The standardized assessment of quality of life for attempts to portray an objective 
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picture of the individual’s quality of life by eliciting evaluations of domains that are found to be influential on overall 
quality of life in people with dementia. 
The quality of life of the individual with dementia was measured through the most widely used dementia-specific 
measure [211], the Quality of Life – Alzheimer’s disease (QOL-AD) questionnaire [178]. Translations and cultural 
adaptations are available in Danish, English for the UK, Finnish, and Greek by the Mapi Research Trust [207] [291]. The 
reliability is reported to have a Cronbach’s range of 0,83 to 0,90 [178], and the agreement between the patient and proxy 
ratings has been reported as p<0,01** [98]. The QOL-AD is administered to both the older adult (EP) and the caregiver 
(ICG) in efforts to obtain a more accurate portrayal of life quality by not using the person with dementia’s assessment 
alone, as they may not have awareness of their living situation (i.e. anosognosia), and also by not using the proxy (i.e. 
ICG) assessment alone, as proxies have a tendency to rate lower than the person with dementia themselves [177] [181] 
[182] [292]. Because it is an evaluation of the individual with dementia’s life quality, their score is weighted by doubling 
the score before averaging with the caregiver’s score [181] [212]: 
ܧܲ ൅ ܧܲ ൅ ܫܥܩ
3 ൌ ܹ݄݁݅݃ݐ݁݀	ܱܳܮ െ ܣܦ	ݏܿ݋ݎ݁ 
The previous section on quality of life revealed that people with dementia have identified domains that are important to 
them [177] [181] [182]. The QOL-AD is found to include several of the self-identified important domains of QOL, and 
when combined with incorporating patient and proxy evaluations, good psychometrics, and easy administration, the 
QOL-AD tool is recommended for use in longitudinal studies [181]. The assessment takes 5-15 minutes to complete, 
consists of 13 items that are rated on a 4-point Likert scale from poor to excellent, and total scores range from 13-52 with 
higher scores indicating higher quality of life. 
Quality of Life – Alzheimer’s disease (QOL-AD) assesses the domains of: 
1. Physical health  
2. Energy (physical and mental health) 
3. Mood (physical and mental health, affect) 
4. Living situation (attachment, security and personal privacy) 
5. Memory (mental health) 
6. Family (attachment, social contact) 
7. Marriage (attachment) 
8. Friends ( social contact) 
9. Self as a whole (self-esteem/image) 
10. Ability to do chores around the house (ability to contribute, being useful) 
11. Ability to do things for fun (leisure, enjoyment of activities) 
12. Money (financial situation) 
13. Life as a whole 
Caregiver quality of life is measured through the Scale of Quality of Life of Caregivers (SQLC) questionnaire [293]. The 
assessment consists of 16 questions that evaluate the professional activities, social and leisure activities, and caregiving 
responsibilities. Scores range from 0-149 and higher scores indicate higher quality of life. The authors of the scale find 
that 141-149 points mean full adaptation of the caregivers, 100-140 points mean mild disadaptation, 86-99 points mean 
moderate disadaptation, and less than 85 points means severe disadaptation. The internal consistency has been reported 
as high, α=0,87 [294].  
Scale of Quality of Life of Caregivers (SQLC) assesses: 
 professional activity of the caregiver (work and volunteering) 
 social and leisure activities (family and friends, attending events) 
 responsibilities of the caregiver (tasks to ensure the daily activities of the person with 
dementia) 
Caregivers of individuals with dementia often experience stress related to the responsibilities of caregiving tasks (i.e. lack 
of time for self) as well as from the natural psychosocial involvement of the relationship (i.e. feelings of guilt). To measure 
the level of caregiving-related stress, the Zarit Burden Interview short form (ZBI) is used [295]. It is a 12-item assessment 
where answers are given on a 5-point Likert scale of 0 (never) to 4 (nearly always). The ZBI has been the most frequently 
studied and used burden measurement instrument in the caregiving literature [295] [296] [297] [298]. The 12-item ZBI 
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is endorsed as the best short-form version to use [299], and is reported to have an internal consistency of α=0,88 [295], 
Bédard and colleagues cautiously suggested that a score > 17 on the ZBI short form is suggestive of clinically significant 
caregiver burden [295]. However, since the ZBI is used as a continuous measurement instrument (to assess the care 
interventions) rather than as a screening instrument for diagnosing caregiving-related depression, a cut off score is not 
used in this research. It is mentioned here as an indicator of what is considered in the medical research field as a 
significantly high level of caregiving-related stress. The assessment has been translated by the Mapi Institute [204] into 
English for the UK, Finnish, and Greek; the Danish version was translated from English by the regional partners and the 
National Research Center for Dementia in Copenhagen. 
Zarit Burden Interview, short form (12-item ZBI) assesses care-related stress in the following: 
1. Time for self 
2. Stress between roles 
3. Feelings of anger 
4. Effects on other relationships 
5. Feeling strained 
6. Effects on health  
7. Privacy 
8. Social life 
9. Feeling loss of control 
10. Feelings of uncertainty 
11. Feelings of guilt 
12. Feeling inadequate 
In addition to the standardized assessment tools, the project partners also inquired about the global quality of life of the 
end users by asking additional questions to the intervention group in order to elicit global outcome indicators. The 
additional questions provide information on the perceived efficacy of the system. These questions are not standardized or 
validated, and were designed to supplement in the data in the ISISEMD research project [281]. The purpose of using the 
qualitative questions is to complement the statistical analysis and to provide initiation as to what factors may be 
influencing intervention participants’ quality of life and why. The exact additional questions and informal interviews are 
not recommended for direct use in other studies; however, it is beneficial to further develop methods to elicit additional 
information from participants for a more holistic evaluation of the intervention. The questionnaire is based on the 
Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) [300] and the Everyday Technology Use 
Questionnaire (ETUQ) [301]. QUEST 2.0 can be used to evaluate an individual’s satisfaction with their use of an Assistive 
Technology Device (ATD) without the requisite of considering device performance. The ISISEMD system is not a single 
ATD so the QUEST 2.0 questionnaire is not directly used, but serves as a model [272]. ETUQ has been developed to map 
perceived relevance and competence of use for everyday technologies for aging adults with cognitive impairment; 
however, it evaluates commonly used technology and not necessarily assistive or telecare technology and is therefore also 
used as a model for the ISISEMD global questions [272]. The following global questions will be addressed in this thesis: 
1. Your overall change in feeling of quality of life by using the services 
3. It increases more than I thought it would 
2. It increases 
1. No change, no influence 
0. It decreases 
 
2. Overall change in feeling of quality of life for your relative by using the services 
3. It increases more than I thought it would 
2. It increases 
1. No change, no influence 
0. It decreases 
 
3. Overall support in independent living by using the services 
3. It increases more than I thought it would 
2. It increases 
1. No change, no influence 
0. It decreases 
 
4. Methods 
58 
 
4. Your overall feeling of care responsibilities by using the services 
3. It decreases more than I thought it would 
2. It decreases 
1. No changes, no influence 
0. It increases 
 
5. Your overall feeling of safety about the home environment 
3. I feel significantly safer 
2. I feel safer 
1. I do not feel safer 
0. I feel less safe 
 
6. Your overall feeling of satisfaction about the system 
3. I am more satisfied than I thought I would be 
2. I am satisfied 
1. I am not satisfied 
0. I am disappointed 
 
7. Would you want to use a system like this one after the study? 
3. I definitely would use a system like this  
2. I would consider using a system like this 
1. I would not consider using a system like this 
0. I would not use a system like this 
 
8. Would you be willing to pay for a service system like this?  
3. I would definitely pay for all of these services 
2. I would definitely pay for some of these services 
1. I would consider paying for some of these services 
0. I would not pay for these services at all 
 
The tools used for validation, and hypothesized outcomes are presented in Table 8, above. The measurement instruments 
have been selected based on their appropriateness and feasibility for the research, and on their psychometric properties. 
Table 9, below, summarizes the standardized instruments used, primary and secondary outcomes, and how significant 
results will be determined.  
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Table 9 Research questions and methods to validate outcomes 
Research question Variable and outcome Assessment for validation 
Method of 
aggregation Hypothesized outcome 
1. Will using gerontechnology have positive 
effects on physical and independent 
functioning? 
Physical and 
independent functioning 
 
Secondary outcome 
ADL and IADL Compared means between groups 
H1:  Intervention group will show improvement or less decline than 
the control group 
H0:  Intervention group shows no significant difference from the 
control group 
 
Physical and 
independent functioning 
 
Secondary outcome 
Non-standardized questionnaire 
on feeling of change in 
independent living 
Mean post hoc from 
intervention group 
H1:  Intervention group will report an increase in independent living 
H0:  Intervention group will report no change or decrease in 
independent living 
2. Will using gerontechnology have positive 
effects on QOL in the person with 
dementia? 
Quality of life 
 
Primary outcome 
QOL-AD Compared means 
H1:  Intervention group will show improvement or less decline in 
QOL-AD than the control group 
H0:  Intervention group shows no significant difference from the 
control group’s QOL-AD 
 
Quality of life 
 
Secondary outcome 
Non-standardized questionnaire 
on feeling of change in QOL 
Mean post hoc from 
intervention group 
H1:  The intervention group will show an increase in QOL for 50% of 
participants with dementia 
H0:  Intervention group will report no change or decrease in QOL 
3. Will using gerontechnology have positive 
effects on QOL in the caregivers? 
Quality of life 
 
Primary outcome 
SQLC Compared means 
H1:  Intervention group will show improvement or less decline in 
SQLC than the control group 
H0:  Intervention group shows no significant difference from the 
control group’s SQLC 
 
Quality of life 
 
Secondary outcome 
Non-standardized questionnaire 
on feeling of change in QOL 
Mean post hoc from 
intervention group 
H1:  The intervention group will show an increase in QOL for 70% of 
caregivers 
H0:  Intervention group will report no change or decrease in QOL 
4. Will using gerontechnology have positive 
effects on caregiver burden? 
Caregiver burden 
 
Secondary outcome 
ZBI Compared means 
H1:  Intervention group will show improvement or less decline in ZBI 
than the control group 
H0:  Intervention group shows no significant difference from the 
control group’s ZBI 
 
Caregiver burden 
 
Secondary outcome 
Non-standardized questionnaire 
on feeling of change in care 
responsibilities 
Mean post hoc from 
intervention group 
H1:  The intervention group will show reduced care responsibilities 
by 60% 
H0:  Intervention group has no effect on or increases care 
responsibilities 
5. Will using gerontechnology have positive 
effects on safety in the home? 
User acceptance 
 
Secondary outcome 
Non-standardized questionnaire 
on feeling of safety in the home 
environment 
Mean post hoc from 
intervention group 
H1:  Participants will report feeling safer with the telecare system 
H2:  The intervention group will show an increase in feeling of safety 
in 30% of participants 
H0:  Intervention group has no effect on or decreases feeling of safety 
6. Will people be satisfied with the 
intervention system? 
User satisfaction 
 
Secondary outcome 
Non-standardized questionnaire 
on feeling of satisfaction 
regarding the system 
Mean post hoc from 
intervention group 
H1:  Participants will report being satisfied with the telecare system 
H2:  75% of participants will report being satisfied with the telecare 
system 
H0:  Intervention group has no effect on or increases care 
responsibilities 
7. Will end users be willing to pay for 
gerontechnology services? 
User acceptance 
 
Secondary outcome 
Non-standardized questionnaire 
on willingness to pay for 
services. 
Mean post hoc from 
intervention group 
H1:  Participants will report willingness to pay for telecare services. 
H0:  Participants will not be willing to pay for telecare in place of 
usual care. 
8. Would people want to use services like 
these? 
User satisfaction 
 
Secondary outcome 
Non-standardized questionnaire 
on willingness to use services. 
Average of post hoc 
responses 
H1:  Participants will report a desire to continue using telecare 
services. 
H2:  75% of intervention caregivers will report a desire to continue 
using services 
H0:  Participants will not want to continue using telecare services. 
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Methodology summary: 
This chapter described the methodology used to develop and test the telecare services for dementia care. When using 
technologies in real-life, longitudinal application, there is a growing awareness in developing individualized assessment 
tools. In dementia care research, personalized assessments would support the phenomenological view that quality of life 
is unique to the individual. However, the administration and scoring for the vast majority of quality of life assessments 
are still not digitized, is time consuming, and is outdated (e.g. pen-and-paper testing of cutting-edge technologies) when 
compared to the modern technologies they evaluate. To promote personalized assessments, computerizing them would 
be a good start. A literature review in Paper E revealed that there were no QOL tools that were dementia-specific and 
allow for telecare impact. Several of the papers discuss the speculative development of a prototype that could be 
integrated in dementia care as part of the Assistive Technology services (Papers B, E, and F).  
The principal summary measures are based on the difference in means between two assessment points or two groups. A 
thorough assessment, although somewhat limited in the scope of the content of the questionnaires, evaluates the 
statistical significance of the changes. Overall, this research takes a holistic view on quality of life, and that QOL is 
potentially influenced by all the domains assessed, so outcomes in any of the assessments are theorized to affect overall 
QOL (i.e. indicators of quality of life). The criteria for participants and how they were recruited was given. The telecare 
system and service components were described, with examples from the project to illustrate. The standardized 
assessment tools that were used to measure change in quality of life over the course of the research trial were also 
presented, naming which parameters are evaluated, and reporting psychometrics. Finally, non-standardized questions 
that were posed to the end users on their global feelings of change from using technology during the project were given.  
Papers supporting Chapter 4:   
Paper B supports this chapter by discussing a prototype for an electronic quality of life assessment for use in dementia 
care. Paper D describes the ISISEMD development, implementation, and evaluation methods, and by explaining the 
services. This paper also describes baseline and intermediate results of the trial. Paper E reports a literature search for 
dementia-specific quality of life assessment tools that could be used to evaluate telecare impact. This paper also considers 
revisions to the proposed electronic QOL assessment prototype. Paper F presents a cutting-edge description of 
gerontechnology use, evaluation, and continued development that is accelerated through advancements in technology, 
indicating a need for electronic QOL assessment methods. Papers G and H additionally describe the ISISEMD 
methodology. 
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Chapter 5.  Evaluation of the outcomes 
This chapter describes the analysis to evaluate the outcomes of a gerontechnology intervention in dementia care. The 
data is analyzed by comparing the intervention to the control group (i.e. differences between groups) through 
independent t-tests, and by looking for significant changes within the intervention and control groups (i.e. within group 
differences) through paired t-tests. These tests are made both at the group level and at the country level. Pearson 
product-moment correlation coefficient tests evaluate the strength of the linear interdependence between two variables, 
e.g. ZBI and IADL. In addition to comparing the baseline and final scores of the control and intervention groups, 
subgroup analyses will provide additional exploratory data on the intervention outcomes. A deeper analysis of the data 
involves apportioning the intervention and control groups by variables to test for significant associations and 
correlations. This is done by taking the median value, such as median age, and analysing the results of the younger and 
older participants. All tests are run with α=0,05 and 2-tails, and the 95% Confidence Intervals (CI) are based on a 
student’s t-distribution rather than a normal distribution as the true population standard deviation is unknown. The 
results of p-values <0,05 indicate a significant probability, and p-values <0,02 indicate highly significant probability, 
denoted by * and **, respectively. As Denmark did not have a control group of participants, some results include the total 
intervention population (incl. DK) as well as with the Denmark sample removed (excl. DK). The results of the non-
standardized questionnaires are presented and compared to the standardized outcomes. A qualitative analysis is given on 
the intervention group participation, outcomes, and implications. 
Papers included in Chapter 5: 
Paper D includes the mid-term evaluation of the ISISMD project and qualitative results from the participants. 
Paper D:  Anelia Mitseva, Carrie Beth Peterson, Christina Karamberi, Lamprini Ch. Oikonomou, 
Athanasois Mpallis, Charalampos Giannakakos, and George E Dafoulas. “Gerontechnology: Providing a 
helping hand when caring for cognitively impaired older adults – intermediate results on the satisfaction 
and acceptance of informal caregivers from a controlled study.” Current Gerontology and Geriatrics 
Research, Hindawi Publishing, Article ID 401705, 2012. DOI:  10.1155/2012/401705. 19 pages. 
Paper E discusses issues in assessing quality of life outcomes as a result of technology interaction and presents qualitative 
results from the research. 
Paper E:  Carrie Beth Peterson, Neeli R Prasad and Ramjee Prasad. “Assessing assistive technology 
outcomes with dementia.” Gerontechnology 11(2), p. 259. 2012. DOI: 
http://dx.doi.org/10.4017/gt.2012.11.02.414.740. 10 pages. 
Paper G specifically addresses the outcomes in caregiver burden, including qualitative information. 
Paper G:  Carrie Beth Peterson, Lars Bo Larsen, Poul Svante Eriksen and Ole K Hejlesen. “Zarit burden 
interview shows decrease in caregiver burden with technology intervention in European dementia study.” 
Submitted for publication to the British Medical Journal, 20 pages, 2014.  
Paper H focuses on outcomes in caregiver quality of life. 
Paper H:  Carrie Beth Peterson. “Results from a clinical trial on gerontechnology in dementia care and 
caregiver quality of life outcomes.” Technical report, 8 pages, 2013. 
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5.1 Description of the participants  
To treat the data, the responses from the assessments were transferred from the raw form (i.e. copies from the regions) to 
a master assessment in English. This ensured that the data was uniform before being analyzed. Figure 23 shows the 
participant flow from enrollment to analysis. Of the n=55 dyads, a further 3,6% (n=2) are removed from the control 
group in a list-wise deletion, resulting in 84,1% (n=53) which have complete data sets for analysis. Missing data is 
considered missing at random (i.e. reporting errors or otherwise missing scores) and is therefore treated with list-wise 
deletion so that only available data is analyzed for comparison. It is not hypothesized that the intervention would have a 
significant effect on cognition scores; therefore, incomplete MMSE and MoCA data do not exclude participants during 
the list-wise deletion. There are n=31 in the intervention group, and n=22 dyads the control group that are available for 
analysis (i.e. baseline and final for assessments for physical functioning, independent functioning, quality of life of the 
person with dementia, quality of life of the caregiver, and caregiver burden).  
Figure 23 Participant flow diagram (by dyads) [273] 
 
The participants are 66% female, and 41,5% of the participants with dementia live alone. Just under half of the caregivers 
are children of the individual with dementia, 37,7% are spouses, and 13,2% have another type of relationship (i.e. 
neighbor, friend, or other relative). Further descriptive statistics on the participant population are given in Figure 24, 
Table 10 and Table 11. 
Analysis
Follow up
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Intervention 
(n=37)
Withdrew (n=6)
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(n=31)
Control (n=26)
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Figure 24 Gender, care relationship, and living arrangement of the participants, by number 
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with 
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caregivers 
18
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caregivers 
15
Spouses as 
caregivers 9
Others as 
caregivers 7
Live alone 
15
Cohabitate 
16
Intervention group, n=31
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with 
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caregivers 
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caregivers 11
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caregivers 11
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Control group, n=22
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Cohabitate 
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Table 10 Descriptive statistics of the control group at baseline, n=22 
 MMSE MoCA ADL IADL QOL-AD SQLC ZBI EP Age ICG Age 
 n=22 n=21 n=22 n=22 n=22 n=22 n=22 n=22 n=22 
Mean 22,95 17,90 5,59 4,95 33,68 90,73 12,45 80,64 63,23 
Median 22,50 18,00 6,00 5,50 33,83 92,00 11,50 81,50 62,50 
Mode 29,00 18,00 6,00 6,00 35,00 103,00 10,00 80,00 57,00 
Standard Deviation 5,07 3,71 0,85 2,19 6,31 13,12 8,92 7,56 14,02 
Standard Error 1,08 0,81 0,18 0,47 1,35 2,80 1,90 1,61 2,99 
Sample Variance 25,66 13,79 0,73 4,81 39,80 172,02 79,50 57,19 196,66 
Kurtosis -1,63 -1,05 3,50 -0,33 -1,03 -1,07 1,26 0,88 -0,81 
Skewness 0,14 0,15 -2,08 -0,50 0,15 0,06 1,05 -0,76 -0,10 
Range 14,00 12,00 3,00 8,00 21,00 41,00 34,00 32,00 47,00 
Minimum 16,00 12,00 3,00 0,00 23,67 72,00 0,00 62,00 37,00 
Maximum 30,00 24,00 6,00 8,00 44,67 113,00 34,00 94,00 84,00 
Sum 505,00 376,00 123,00 109,00 741,00 1996,00 274,00 1774,00 1391,00 
 
Table 11 Descriptive statistics of the intervention group at baseline, incl. DK n=31 
 MMSE MoCA ADL IADL QOL-AD SQLC ZBI EP Age ICG Age 
 n=29 n=28 n=31 n=31 n=31 n=31 n=31 n=31 n=27 
Mean 22,07 16,89 5,26 4,39 34,32 84,48 16,42 77,32 54,26 
Median 22,00 17,50 6,00 4,00 35,00 85,00 16,00 75,00 55,00 
Mode 23,00 16,00 6,00 4,00 34,67 92,00 9,00 75,00 57,00 
Standard Deviation 3,99 4,43 1,24 1,69 5,78 20,33 8,80 7,02 12,94 
Standard Error 0,74 0,84 0,22 0,30 1,04 3,65 1,58 1,26 2,49 
Sample Variance 15,92 19,65 1,53 2,85 33,41 413,12 77,52 49,29 167,51 
Kurtosis -0,27 -0,05 10,58 -0,08 -0,18 0,44 -0,54 -0,89 -0,16 
Skewness 0,39 -0,27 -2,90 0,36 -0,19 -0,67 0,07 0,13 0,36 
Range 15,00 19,00 6,00 7,00 22,33 83,00 33,00 26,00 52,00 
Minimum 15,00 7,00 0,00 1,00 23,00 33,00 0,00 65,00 30,00 
Maximum 30,00 26,00 6,00 8,00 45,33 116,00 33,00 91,00 82,00 
Sum 640,00 473,00 163,00 136,00 1063,83 2619,00 509,00 2397,00 1465,00 
 
There are some differences in the basic data on the assessment outcomes between the intervention and control groups. 
Average decline in cognition measured by MMSE is expected around 2-4 points per year [285] [302], and both of the 
control and intervention group participants exhibit less than previously reported cognitive decline. The control group 
exhibits more decline in MMSE, but less decline in MoCA than the intervention group. This could be expected if the 
intervention group had milder forms of dementia (which MoCA is sensitive to). The control group has higher cognition 
mean scores in both assessments, and at both evaluation times. The individual MMSE scores range from moderate to no 
impairment, but this is still acceptable to the study, as it is known that some individuals who have impairment may score 
within normal ranges on cognitive assessments. The mean MoCA scores meet the criteria for moderate impairment, and 
the individual scores range from severe to no impairment, both are considered acceptable for the study since the MoCA 
test is not the primary cognitive assessment, and is known to be more sensitive. The one participant who scored 7 on the 
baseline MoCA also scored 23 on the MMSE during the same assessment period, and the two participants who scored 9 
on the final MoCA also scored 19 and 23 on the final MMSE.  
The control group has higher ADL and equal or higher IADL scores; the intervention group shows more decline than the 
control group in both assessments. Research shows that when the person with dementia has higher levels of dependence 
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(physical and cognitive), caregivers tend to have higher levels of burden [82] [86] [87]; therefore, it could be expected 
that the intervention group caregivers would have higher ZBI scores. When looking at the data, the intervention group 
does show higher caregiver burden at both baseline and final assessments. Quality of life is also associated with abilities, 
dependence, and caregiver burden. The results show that the intervention group has higher QOL-AD scores at both 
evaluation times, but experienced more mean decline than the control group. Conversely, the control group has higher 
SQLC scores at both evaluations and experienced more mean improvement than the intervention group. While the 
quality of life score outcomes are the opposite of what is hypothesized, the data analysis between the two groups will 
expose if these differences are statistically significant.  
5.2 Analysis of the difference between intervention and control groups 
Having n=53 dyads attains a power of 35% when testing between groups. No significant differences were found between 
the intervention and control group assessment scores at baseline; however, there are some possible confounding 
variables which may present bias at the study level and influence the outcomes. The control group caregivers are an 
average of 8,97, years older (p=0,02**), and half are spouses. The average caregiver is an adult female relative of the 
person with dementia [78] [217]; both wives and daughters are at risk for experiencing caregiver burden. Middle-aged 
caregivers are in the sandwich generation, meaning they likely care for both their parents and their children. Caregivers 
with high levels of burden are more likely to seek out formal support services, so it is possible that there is a degree of 
self-selection among the intervention group caregivers participation due to higher levels of burden. Younger cohorts are 
statistically higher users of advanced technology [303], and could be more motivated to join a telecare study. However, 
caregivers as a whole are known to be higher technology users than the general population, and are more likely to use the 
internet for health-related activity [303]. The difference in caregivers between the two groups is assumed to be 
representative of that which would occur in the general population and is therefore acceptable as interventions are aimed 
at supporting all caregivers for individuals with dementia. Figure 25 represents the mean change of each group’s 
assessments from baseline to final evaluation.  
Figure 25 Difference from baseline to final mean scores for the control and intervention groups, n=53 
 
To observe whether or not gerontechnology has a positive effect, an analysis of the differences between the groups 
provides more information. The between groups t-tests are independent tests, meaning the scores in one sample (i.e. 
intervention group) are not dependent on the scores in the other sample (i.e. control group). The outcomes from the 
assessments are compared between the groups. Table 12 shows the results of the independent t-tests when the control 
group is compared to the intervention group, excluding Denmark. For significant results, the result including Denmark is 
also given.  
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Table 12 Results of independent t-tests between the control and intervention group mean changes, excl. 
DK n=47 
Outcome tool Outcomes between groups Outcomes within groups 
MMSE p=0,75 
Intervention declined (μ -0,91) 
Control declined (μ -0,64) 
MoCA p=0,57 
Intervention declined (μ -0,61) 
Control declined (μ -0,10) 
ADL p=0,23 
Intervention declined (μ-0,40) 
Control declined (μ -0,09) 
IADL p=0,53 
Intervention declined (μ -0,76) 
Control declined (μ -0,50) 
QOL-AD p=0,36 
Intervention declined (μ -2,36) 
Control declined (μ -1,21) 
SQLC p=0,61 
Intervention improved (μ 1,44) 
Control improved (μ 3,23) 
ZBI p=0,02** (p=0,03* incl. DK) 
Intervention improved (μ -1,00) 
Intervention improved incl. DK (μ -0,71) 
Control declined (μ 2,45) 
Sum p=0,017 (p=0,44 incl. DK) 
 
 
Independent t-tests show that the two groups do not have significantly different outcomes from each other, except for in 
caregiver burden (ZBI). The statistical analysis shows that the caregivers who used the technologies have improvement in 
their caregiver burden while those in the control group show increased caregiver burden, and that this is the only 
significant result between the two groups. Histograms with the distribution fit are made for the assessment change from 
baseline in both groups and can be found in Appendix 6. Figure 26 shows the histograms for the control and intervention 
groups ZBI change from baseline to final assessment. This difference in caregiver burden is further examined as a 
comparative outcome of the intervention inPapers D and G. 
Figure 26 Control and Intervention ZBI histograms with distribution fit [273] 
Control group n=22 Intervention group incl. DK, n=31 
Mean change from baseline= 2,45 
p=0,01** 
95% CI [0,66 to 4,25] 
Mean change from baseline= -0,71 
p=0,51 
95% CI [-2,89 to 1,47] 
 
T-tests are ran on the groups by country to look for significant differences. In North Ireland (n=15), the intervention 
group has significantly lower scores in SQLC (p=0,007**) and higher ZBI (p=0,002**) at baseline, and lower MMSE 
(p=0,05*) and IADL (p=0,03*) and higher ZBI (p=0,003**) scores at final assessment. There is only a significant 
difference in mean change in MMSE (0,03*); the aggregate difference between North Ireland control and intervention 
groups is non-significant (p=0,72). In Denmark (n=6), there is no control group to compare to and there were no 
significant outcomes found within the intervention group. Finland (n=16) has a significant difference in baseline QOL-
AD (p=0,03*) between the two groups. There is a significant difference in QOL-AD (0,01**) and SQLC (p=0,04*) 
outcomes, the intervention group shows decline while the control group shows improvement in both. The aggregate 
difference between the control and intervention groups in Finland is non-significant (p=0,08). In Greece (n=15), there is 
a significant difference in baseline QOL-AD (p=0,02**), but not at final assessment; the control scores are higher, but 
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show significant decline. In mean outcomes, there is a significant difference in MoCA (p=0,03*), QOL-AD (p=0,03*), and 
in ZBI (p=0,003**). The intervention group shows a highly significant improvement in ZBI (p=0,004**) while the 
control group shows a significant increase (p=0,05*). The control group also has a significant decline in QOL-AD 
(p=0,04*), but the aggregate difference between the two groups in Greece is non-significant (p=0,76). Paper D provides 
more discussion on the regional outcomes up through the mid-term evaluation.  
Summary of the analysis between groups 
Overall, the intervention produced an effect that is not significantly different from the effect of usual care on quality of 
life except for a highly significant difference in caregiver burden outcomes, and this is significant both with and without 
Denmark’s intervention group included. Within the countries, there is no significant difference in the overall outcomes 
between control and intervention groups.  
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5.3 Analysis of the difference within the intervention and control groups 
The paired t-tests investigate if the baseline and final scores were significantly different from each other, presented in 
Table 13. Testing within the intervention group achieves a power of 67% (n=31), and n=22 participants achieves a power 
of 52% when testing within the control group. Both groups exhibit a significant decline in instrumental physical 
functioning (IADL). The intervention group further shows a significant decline in QOL-AD, and there is a highly 
significant increase in the control group’s caregiver burden.  
Table 13 Results of the paired t-tests on the differences from baseline to final scores 
Assessment Intervention Incl. DK n=31 
Intervention 
Excl. DK n=25 
Control 
n=22 
MMSE p=0,46 p=0,24 p=0,16 
MoCA p=0,29 p=0,36 p=0,87 
ADL p=0,13 p=0,09 p=0,33 
IADL p=0,05* p=0,03* p=0,03* 
QOL-AD p=0,04* p=0,02** p=0,16 
SQLC p=0,24 p=0,56 p=0,19 
ZBI p=0,51 p=0,35 p=0,01** 
Overall p=0,75 p=0,19 p=0,51 
 
As physical functioning and independence has previously been correlated with caregiving-related stress, [82] [86] [87], 
the results indicate that the use of technology defers increases in caregiving-related stress despite an increase in 
caregiving responsibilities due to functional decline. This is examined further in Paper G. The IADL and ZBI scores are 
given in Table 14. The Standard Deviation (SD) shows the variation from the mean within the participant scores, and 
scores that are more than one SD away from the mean are significantly different. This data shows the variance of the 
population for a particular assessment. The Median Absolute Deviation (MAD) is the median of the absolute values of the 
deviations from the mean. This data shows the middle of the range of variation. And the Interquartile Range (IQR) shows 
the middle 50% when the total range is broken down into quartiles. Where the SD measures variation, the MAD 
measures central tendency, and the IQR measures variation within the middle 50% of scores. Table 15 presents an 
overview of the t-test results, both between and within the groups, which can also be found in Paper H. 
Table 14 Results for IADL and ZBI and paired t-test significance [273] 
Group Measure Baseline mean (SD) Final mean (SD) Mean change (MAD/IQR) 
Significance 
of change 
Control n=22 
IADL 4,95 (2,19) 4,45 (1,97) -0,50 (1/1) 0,03* 
ZBI 12,45 (8,92) 14,91 (8,55) 2,46 (2/4) 0,01** 
Intervention incl. DK n=31 
IADL 4,39 (1,69) 3,81 (1,85) -0,58 (1/2) 0,05* 
ZBI 16,42 (8,80) 15,71 (9,13) -0,71 (4/7) 0,51 
Intervention excl. DK n=25 
IADL 4,36 (1,52) 3,60 (1,83) -0,76 1/2) 0,03* 
ZBI 19,20 (7,13) 18,20 (7,39) -1,00 (4/7) 0,35 
All incl. DK n=53 
IADL 4,62 (1,91) 4,08 (1,91) -0,55 (1/1) 0,005** 
ZBI 14,77 (8,98) 15,38 (8,82) 0,60 (3/5) 0,42 
All excl. DK n=47 
IADL 4,64 (1,87) 4,00 (1,92) -0,64 (1/1) 0,003** 
ZBI 16,04 (8,62) 16,66 (8,04) 0,62 (3/5,5) 0,40 
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Table 15 Summary of the assessment score outcomes from baseline to final evaluation [304] 
Assessment  Control  n=22 
Intervention  
incl. DK, n=31 
MMSE Range of scores Baseline 16 – 30 Final 14 – 30 
Baseline 15 – 30 
Final 14 – 30 
 Mean score Baseline 22,95 Final 22,32 
Baseline 22,07 
Final 21,82 
 Mean change within groups; [95% CI]; significance -0,64; [-1,55 to 0,28] p=0,16 
-0,50; [-1,85 to 0,85] 
p=0,46 
 Difference between group mean outcomes; significance 0,14; p=0,87 
MOCA Range of scores Baseline 12 – 24 Final 11 – 29 
Baseline 7 – 26 
Final 9 – 29 
 Mean score Baseline 17,90 Final 17,80 
Baseline 16,89 
Final 16,29 
 Mean change within groups; [95% CI]; significance -0,10; [-1,36 to 1,16] p=0,87 
-0,61; [-1,76 to 0,55] 
p=0,29 
 Difference between group mean outcomes; significance 0,51; p=0,55 
ADL Range of scores Baseline 3 – 6 Final 3 – 6 
Baseline 0 – 6 
Final 0 – 6 
 Mean score Baseline 5,59 Final 5,50 
Baseline 5,26 
Final 4,97 
 Mean change within groups; [95% CI]; significance -0,09; [-0,28 to 0,10] p=0,33 
-0,29; [-0,67 to 0,09] 
p=0,13 
 Difference between group mean outcomes; significance 0,20; p=0,40 
IADL Range of scores Baseline 0 – 8 Final 1 – 8 
Baseline 1 – 8 
Final 0 – 7 
 Mean score Baseline 4,95 Final 4,45 
Baseline 4,39 
Final 3,81 
 Mean change within groups; [95% CI]; significance -0,50; [-0,95 to -0,05] p=0,03* 
-0,58; [-1,16 to -0,001] 
p=0,05* 
 Difference between group mean outcomes; significance 0,08; p=0,83 
QOL-AD Range of scores Baseline 23,67 - 44,67 Final 22,33 - 41,67 
Baseline 23 – 45,33 
Final 23 – 43,33 
 Mean score Baseline 33,68 Final 32,47 
Baseline 34,32 
Final 32,56 
 Mean change within groups; [95% CI]; significance -1,21; [-2,93 to 0,51] p=0,16 
-1,76; [-3,39 to -0,13] 
p=0,04* 
 Difference between group mean outcomes; significance 0,55; p=0,64 
SQLC Range of scores Baseline 72 – 113 Final 72 – 119 
Baseline 33 – 116 
Final 27 – 130 
 Mean score Baseline 90,73 Final 93,95 
Baseline 84,48 
Final 87,39 
 Mean change within groups; [95% CI]; significance 3,23; [-1,78 to 8,23] p=0,19 
2,90; [-2,00 to 7,80] 
p=0,24 
 Difference between group mean outcomes; significance 0,32; p=0,93 
ZBI Range of scores Baseline 0 – 34 Final 0 – 35 
Baseline 0 – 33 
Final 0 – 34 
 Mean score Baseline 12,45 Final 14,91 
Baseline 16,42 
Final 15,71 
 Mean change within groups; [95% CI]; significance 2,45; [0,66 to 4,25] p=0,01** 
-0,71; [-2,89 to 1,47] 
p=0,51 
 Difference between group mean outcomes; significance 3,16; p=0,03* 
SUM    
 
Significance of the change within groups when 
comparing baseline to final mean assessment 
scores  
p=0,51  p=0,75  
 
Significance of the difference between groups 
when comparing mean change in assessment 
scores 
p=0,44  
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Correlation analysis 
The Pearson’s product-moment correlation coefficients measure the strength of the linear dependence between two 
variables. If no linear relationship is found, the result is 0. A positive relationship would mean that both the scores 
changed in the same direction, i.e. both increased. A negative relationship would mean that the two scores changed in 
opposite directions, i.e. one increased and one decreased. The closer the correlation coefficient r is to +1, the stronger the 
evidence of a linear relationship. Based on the significant results from the t-tests, the Pearson’s correlations investigate 
linear relationships in the intervention and control groups.  
The dyad QOL-AD scores are tested in both the intervention and control groups by comparing the person with dementia’s 
rating with the caregiver rating. The results are interesting because in both groups, the person with dementia rates their 
quality of life higher but with more decline than the caregivers do. There are strong correlations between the individual 
with dementia’s and the weighted QOL-AD mean change (r=0, 97 in control, r=0,93 in intervention), this is expected 
since the individual with dementia’s score is the doubled score. In both of the groups, the individual with dementia and 
caregiver scores do not have a significant correlation (r=0,10, p=0,66 in control; r=0,24, p=0,19 in intervention), which 
indicates a low inter-rater agreement. This reveals that the caregivers in both groups perceived a lower quality of life but 
with less decline than the individuals with dementia did. The control group has non-significant decline in QOL-AD, and 
the intervention group shows significant decline.  
The change in QOL-AD score reported by the person with dementia has significant, positive correlations with both ADL 
(r=0,44, p=0,01**) and IADL (r=0,39, p=0,03*) outcomes in the intervention group and there is a high probability that 
these variables are influencing quality of life for the person with dementia. This correlation has also been reported in 
previous research on QOL-AD and ADL/IADL [178]. It is interesting that that the person with dementia’s self-reported 
QOL-AD score is highly correlated with assessments of their physical functioning, whereas the caregiver’s and not even 
the weighted score show a significant correlation. The weighted QOL-AD outcomes do not have significant correlations 
with ADL or IADL in the intervention group and the control group results do not show significant correlations with QOL-
AD and ADL or IADL.  
Pearson’s correlations are made to see if the IADL outcomes are correlated with SQLC and ZBI outcomes, both resulting 
in non-significant correlations in both groups. SQLC and ZBI are also found to have non-significant correlations in both 
groups [304]. Although IADL and ZBI both show significant changes in the control group, there is no evidence for a 
strong linear relationship [273]. Contrary to previous research, there is no evidence of strong correlations between 
declines in independent functioning and increases in caregiver burden; in both groups, IADL and ZBI to not have a 
significant correlation.  
Summary of the analysis within groups 
Both groups exhibit a significant decline in instrumental physical functioning (IADL), the intervention group shows a 
significant decline in QOL-AD, and there is a highly significant increase in the control group’s caregiver burden (ZBI). 
The overall change was not significant in either the control or intervention group. The correlation analysis finds several 
significant results:   
 QOL-AD score reported by the person with dementia is correlated with both ADL (p=0,01**) and IADL 
(p=0,03*) outcomes in the intervention group 
 The QOL-AD scores reported by the individual with dementia and the caregiver do not have a strong correlation, 
indicating low inter-rater agreement in both the intervention and control groups 
 Declines in IADL do not have strong correlations with declines in QOL-AD, SQLC, or ZBI 
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5.5 Subgroup analysis 
This section discusses the subgroup analysis of the intervention and control groups. Participants were allocated to groups 
based on age, living status, caregiver relationship, and by caregiver burden outcomes. The independent t-tests are applied 
to test for significant differences between the groups in order to determine if there are influential variables in the 
assessment outcomes. The t-tests are run on all assessment results (MMSE, MoCA, ADL, IADL, QOL-AD, SQLC, and 
ZBI) as well as on length of use for the intervention group. The purpose of this analysis is to examine the data from 
another angle, to see if there are patterns within the subgroups, which could help identify confounding variables. It also 
provides a deeper analysis of the participants, and to help guide decisions on which subgroups would gain the most 
benefit from care interventions. Subgroup analyses are made for the following variables in this section: 
 Cognition (grouped by higher and lower scores) 
 Age (grouped by higher and lower ages) 
 Living status (grouped by living alone or cohabitating) 
 Caregiver relationship (grouped by spouse as caregiver, adult child as caregiver, or other as caregiver) 
 Quality of life (grouped by positive and negative outcomes) 
 Caregiver burden (grouped by positive and negative outcomes) 
Outcomes by cognition 
Higher and Lower MMSE scores 
The control group has n=8 participants with maintained or improved MMSE and n=14 with declined MMSE. The paired 
t-tests show that those with positive effects in MMSE have significant decline in ZBI (mean 3,25; 95% CI [0,29 to 6.21]; 
p=0,04*). The control participants with negative effects in MMSE have a significant declines in MMSE (mean -1,86; 95% 
CI [-2,24 to -1,47]; p=0,0000001**), IADL (mean -0,50; 95% CI [-0,94 to -0,06]; p=0,03*), and QOL-AD (mean -2,52; 
95% CI [-4,92 to -0,12]; p=0,04*), and a significant increase in SQLC (mean 4,50; 95% CI [0,14 to 8,86]; p=0,04*). The 
independent t-tests show the two control subgroups have significant differences in MMSE (p=0,00001**), QOL-AD 
(p=0,03*), and age of the person with dementia (p=0,05*), but that the outcomes between the two subgroups are not 
significantly different (p=0,62). 
The intervention group has n=15 participants with positive outcomes in MMSE and n=13 with negative outcomes in 
MMSE. Paired t-tests reveal that the positive effects subgroup have a highly significant increase in MMSE (mean 1,73; 
95%CI [0,35 to 3,11]; p=0,02**), and the negative effects subgroup have significant declines in MMSE (mean -3,08; 95% 
CI [-4,65 to -1,51]; p=0,001**) and MoCA (mean -2,00; 95% CI [-3,81 to -0,19]; p=0,03*). The independent t-tests show 
that the two intervention subgroups have highly significant differences in MMSE (p=0,00003**) and MoCA (p=0,02**), 
but the outcomes between the two subgroups are not significantly different (p=0,77). 
Higher and Lower MoCA scores 
The control group has n=11 participants with positive effects in MoCA and n=9 participants with negative effects in 
MoCA. The paired t-tests show that those with positive effects have significant negative effects in IADL (mean -0,82; 95% 
CI [-1,60 to -0,03]; p=0,04*) and ZBI (mean 3,27; 95% CI [0,44 to 6,11]; p=0,03*). The participants with negative effects 
in MoCA have a highly significant decline in MoCA (mean -2,00; 95% CI [-3,22 to -0,78]; p=0,01**). The independent t-
tests show a highly significant difference in MoCA between the two control subgroups (p=0,002**), but the overall 
difference in outcomes between the groups is not significant (p=0,14). 
The intervention group has n=17 with positive effects in MoCA and n=11 with negative effects in MoCA. The paired t-tests 
show that the positive effects subgroup has a highly significant increase in MoCA (mean 1,12; 95% CI [0,19 to 2,04]; 
p=0,02**). The negative effects subgroup shows a highly significant decline in MoCA (mean -3,27; 95% CI [-4,92 to -
1,62]; p=0,001**) and a significant decline in QOL-AD (mean -2,79; 95% CI [-5,37 to -0,21]; p=0,04*). The independent 
t-tests show that there is a highly significant difference in MoCA outcomes between the intervention subgroups 
(p=0,00001**) but that the overall difference in outcomes is not significant (p=0,15). Figure 27 shows the mean 
outcomes in cognition scores for the participants. 
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Figure 27 Mean outcomes in cognition 
 
Outcomes by age 
Younger and Older participants with dementia 
The control group, when dichotomized by the person with dementia’s age (median age 81,5), has n=11 participants with 
dementia who are <81 years old (mean age 75,2), and n=11 who are >82 years old (mean age 86,1). The younger 
participants with dementia show a highly significant decline in quality of life (p=0,03*), and the older participants with 
dementia show a non-significant increase. The difference between QOL-AD in the two groups is highly significant at 
baseline and final evaluation, and also in the mean change (p=0,02**). Despite the younger control participants showing 
highly significant decline in IADL (p=0,02**), they have highly significantly higher ADL and IADL at both assessment 
points; however, the difference between the mean outcomes is not significant. While both subgroups show increases in 
ZBI, the younger group shows a highly significant increase (p=0,01**). A correlation test reveals that the younger control 
group’s IADL and ZBI do not have a significant correlation (p=0,39). The mean change in the two control subgroups 
dichotomized by the person with dementia’s age do not show a significant difference (p=0,25). 
The intervention group adults with dementia (median age 75) has n=16 who are <75 (mean age 71,5) and n=15 who are 
>76 (mean age 83,5). In the intervention group, the older participants have a lower baseline mean QOL-AD, but show 
less decline, where the younger group has a highly significant decline in QOL-AD (p=0,01**). An independent t-test on 
the mean change between the two intervention subgroups reveals there is not a significant differences (p=0,31).  
Younger and Older caregivers 
When the control group is dichotomized by caregiver age (median age 62,5), there are n=11 in each group. The younger 
(<62) group of caregivers have a mean age of 52, and the older (>63) caregivers have a mean age of 74,5. The 
independent t-tests find a significant difference between the two groups in QOL-AD outcomes (p=0,02**). The younger 
group shows decline (p=0,03*) and the older group shows non-significant increase. There are no other significant 
differences between the control subgroups. The mean change in the two control subgroups dichotomized by caregiver age 
do not show a significant difference (p=0,59). 
When dichotomized by caregiver age (median age 55), there are n=13 intervention group caregivers <54 (mean age 43,5) 
and n=14 caregivers >55 (mean age 64,3). Within the younger subgroup, there is a significant decline in QOL-AD 
(p=0,02**), while the older subgroup shows a non-significant decline. The mean change in the two intervention 
subgroups dichotomized by caregiver age do not show a significant difference (p=0,27). 
Within all of the younger subgroups, there were significant decreases in quality of life, and the older control subgroups 
both show increases in quality of life. The younger control group shows a highly significant decline in IADL and highly 
significant increase in ZBI. The intervention groups both show declines in QOL-AD, and both of the younger subgroup 
shows highly significant decline. In the control groups, there are highly significant differences between the ages of both of 
the younger and older subgroups, whereas there are no significant differences in age between the intervention groups.  
Figure 28 shows the mean ages of the control and intervention participants at baseline evaluation. 
MMSE 1,50 MoCA 1,45
MMSE -1,86 MoCA -2,00
MMSE 1,73
MoCA 1,12
MMSE -3,08 MoCA -3,27
Control with positive effects
Control with negative effects
Intervention with positive effects
Intervention with negative effects
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Figure 28 Mean ages in the groups 
 
Outcomes by living status 
The control group is dichotomized by adults with dementia who live alone (n=7) and those who cohabitate (n=15). The 
paired t-tests within each group show no significant differences in the assessments. The independent t-tests on the 
control group, shown in Table 16, shows a significant difference (p=0,03*) in caregiver age between the two groups. This 
is most likely due to the cohabitating caregivers largely being spouses, who will typically be older, and this is supported 
by the data (n=12 of those who cohabitate, have their spouse as caregiver). The independent t-tests also show a highly 
significant difference between final QOL-AD scores (p=0,02**) but not in mean outcomes. The control participants who 
live alone have lower scores at both assessments, and show more decline than the participants who cohabitate. Although 
neither of the control subgroups show significant declines in QOL-AD, the participants who cohabitate with their 
caregivers show that their QOL-AD scores are higher and more stable. Aside from the difference in QOL-AD outcomes, 
the control group shows no other significant between-group differences.  
The same dichotomization is done for the intervention group, where n=15 live alone and n=16 cohabitate. The paired t-
tests within each group show that there are significant differences within the groups living alone and cohabitating, shown 
in Table 16. There is a highly significant decline in the IADL of participants living alone (p=0,02**, mean decline=-1,07), 
even though they have significantly higher baseline ADL and (highly) significantly higher IADL scores. It is not surprising 
that those who live independently alone exhibit higher physical and independent functioning. The caregivers for the 
individuals who live alone also have (highly) significantly higher SQLC and lower ZBI scores at both assessment intervals. 
It could be expected that caregivers who do not live with the person with dementia will have higher scores in their quality 
of life and lower levels of burden, due to fewer care tasks and psychological strain. Although there are several highly 
significant differences between the subgroups at each assessment, there are no significant differences between the score 
outcomes. 
There is an unexplained highly significant difference in the length of using the technology, with those who live alone 
using the telecare system over 3 months longer than those who cohabitate. One explanation could be that since the 
majority of the service training took place when both the person with dementia and caregiver could be present; this could 
have delayed installations in the shared homes. The difference could be due to the time that participants joined the study 
and received the installations, which was delayed in some regions due to the European economic crisis in 2009. Another 
explanation could be that individuals with dementia who live alone may be more likely to seek out formal support 
services, as those who cohabitate have a caregiver in the home who provides support. Table 16 shows the significant 
results within the groups when separated by living arrangement. 
Younger participants
with dementia
Older participants
with dementia
Younger caregivers Older caregivers
75,2
86,1
52,0
74,571,5
83,5
43,5
64,3
Control group Intervention group
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Table 16 Significant differences between intervention participants who cohabitate and who live alone 
Variable Independent t-test result 
Alone group mean score 
(MAD) 
[95% CI] 
Cohabitating group mean score 
(MAD) 
[95% CI] 
CONTROL GROUP n=7 n=15 
Final QOL-AD p=0,02** 29,05 (5,67) [23,60 to 34,50] 
34,07 (1,67) 
[32,29 to 35,84] 
Caregiver age p=0,03* 53,7 (2) [45,98 to 61,45] 
67,7 (14) 
[59,86 to 75,47] 
INTERVENTION GROUP n=15 n=16 
Baseline ADL p=0,04* 5,73 (0) [5,48 to 5,99] 
4,81 (1) 
[3,98 to 5,64] 
Baseline IADL p=0,001** 5,40 (1) [4,52 to 6,28] 
3,44 (1) 
[2,82 to 4,05] 
Baseline SQLC p=0,001** 96,20 (12) [89,73 to 103,67] 
73,50 (13) 
[62,97 to 84,03] 
Final SQLC p=0,01** 98,07 (8) [90,47 to 105,66] 
77,38 (18,50) 
[64,37 to 90,38] 
Baseline ZBI p=0,0002** 10,80 (3) [7,32 to 14,28] 
21,69 (4) 
[17,67 to 25,71] 
Final ZBI p=0,01** 11,40 (5) [7,04 to 15,76] 
19,75 (4,5) 
[15,20 to 24,30] 
Length of use of services p=0,001** 245.00 (41) [204,44 to 285,56] 
143,19 (67,50) 
[99,07 to 187,30] 
 
Living alone 
The control participants living alone have caregivers who are significantly older than those who cohabitate. They also 
have lower QOL-AD scores and show more (non-significant) decline. The intervention participants who live alone have 
highly significantly higher IADL and significantly higher ADL, although they show highly significant declines in IADL. 
The intervention caregivers of those who live alone show highly significantly better SQLC and ZBI scores than the 
caregivers of the cohabitating subgroup. The results indicate that the intervention participants who live alone have higher 
independent functioning, and their caregivers have higher quality of life and less caregiver burden. This is consistent with 
the previous research on caregivers who live with the person they provide care for. 
Cohabitating 
The control participants who cohabitate have caregivers who are significantly younger than those who live alone, and 
they have higher QOL-AD scores that also show little change. This could suggest that they experience more stability in 
their home and daily lives. The intervention participants who cohabitate have highly significantly lower ADL and IADL 
scores, and their caregivers have highly significantly worse SQLC and ZBI scores. These participants also used the 
technology for a highly significant shorter amount of time than the intervention subgroup who lives alone. Figure 29 
shows the number of participants who live alone and who cohabitate in the control and intervention groups. 
Figure 29 Living arrangement of the participants with dementia, by number 
 Live alone Cohabitate
7 1515 16
Control group
Intervention group
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Outcomes by caregiver relationship 
The control group is separated by their caregiver role, with n=11 in each subgroup of spouses and children. In the spouses 
subgroup, the MMSE score has a significant decline (p=0,05*) and the SQLC score has a significant improvement 
(p=0,04*). The subgroup of adult children as the caregiver shows significant decline in IADL (p=0,05*) and a highly 
significant increase in ZBI (p=0,01**). The subgroup’s highly significant increase in caregiver burden could be explained 
by the significant decline in IADL, and will be examined further in a correlation test. It is interesting that the adult 
children also show a (non-significant) increase in the caregiver’s quality of life, despite such an increase in caregiver 
burden. The independent t-tests show a highly significant difference in the final QOL-AD scores (p=0,02**) between the 
spouses subgroup (mean 34,76) and the children subgroup (mean 30,18). 
When the intervention group is separated by caregiver role, there are three groups:  n=15 children who are caregivers, 
n=9 spouses who are caregivers, and n=5 who classify themselves as other. The paired t-tests within each of the 
subgroups reveal few significant changes. The group who have children caregivers show a significant decline in IADL 
(p=0,03*). The caregivers classified as other show a highly significant improvement in ZBI (p=0,02**). The subgroup 
who have spouses as caregivers do not show any significant within-group differences. Table 17 presents the significant 
results between the intervention group’s 3 types of caregivers. 
Table 17 Significant differences between the intervention participants when separated by caregiver 
relationship 
Subgroups tested by 
independent t-test 
Baseline 
MMSE 
Baseline 
MoCA 
Final 
MoCA 
Baseline 
IADL 
Final 
IADL 
Final 
QOL-AD 
Caregiver 
Age 
Child and Spouse 0,03* 0,001** 0,001** 0,17 0,73 0,55 0,0002** 
Child and Other 0,28 0,64 0,70 0,09 0,01** 0,02** 0,34 
Spouse and Other 0,45 0,01** 0,02** 0,003** 0,01** 0,29 0,01** 
 
There are several significant differences between the three subgroups, shown by the independent t-tests in Table 17. Only 
the variables that are significantly different are shown, the other results are non-significant differences. The intervention 
group participants who have spouses as caregivers show the highest overall cognitive scores, and those who have adult 
children as caregivers show the lowest overall cognitive scores. This explains the significant difference between the 
baseline MMSE scores and the highly significant difference in MoCA scores. The participants who have spouses as 
caregivers have the lowest mean independent functioning at baseline, but show very little statistical difference between 
intervals (p=1,00). The subgroup of children as caregivers are the only subgroup to have significant decline in their IADL 
(p=0,03*), while the subgroup of others has the highest lowest IADL scores, thus explaining the significant difference 
between spouses and others. The subgroup with children as caregivers shows the lowest quality of life scores (both QOL-
AD and SQLC). Both subgroups of children and spouses show declines in QOL-AD, while the participants with others as 
caregivers show a non-significant increase. This explains the significant difference between the subgroups with lowest 
and highest means on QOL-AD. The subgroup of others also shows highly significant improvement in their caregiver 
burden (p=0,02**). The spouses are significantly older than the other two subgroups, who show similar ages. As could be 
expected, the caregivers who are adult children and those who are spouses would have significantly different ages. 
Although, of the n=7 caregivers who were classified as other, only 4 gave their age, so the data is too small to make 
assumptions about.  
Spouse 
The control subgroup who have spouses as caregivers show a significant decline in MMSE and a significant improvement 
in SQLC. The control spouse has a highly significantly higher final QOL-AD score when compared to the adult children 
subgroup. The intervention subgroup of spouse caregivers has higher ZBI scores, but show (non-significant) 
improvement, whereas the control subgroup shows (non-significant) decline. Both subgroups with spouses as caregivers 
show (non-significant) declines in QOL-AD. In both the control and intervention groups, the subgroup with spouses 
show the highest overall cognition scores.  
Adult child 
Both of the control and intervention subgroups with adult children as caregivers show significant declines in IADL, (non-
significant) declines in QOL-AD, and (non-significant) increases in SQLC. In the total participant sample, those who have 
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adult children as the caregiver show the lowest quality of life scores (both QOL-AD and SQLC – except baseline SQLC in 
the control group). In both the control and intervention groups, the subgroup with adult children show the lowest overall 
cognition scores. The main difference between the intervention and control subgroups who have adult children as 
caregivers is that the control subgroup shows highly significant increases in ZBI while the intervention subgroup shows 
non-significant increases in ZBI. 
Other 
The intervention subgroup with others as the caregiver show (non-significant) improvement in quality of life (both QOL-
AD and SQLC), and a highly significant improvement in ZBI. They also presented the highest ADL and IADL scores of the 
intervention group. The control group did not have any caregivers classified as other.  
Outcomes by effect in quality of life 
The control and intervention groups did not have significant differences between their QOL-AD and SQLC outcomes. 
Further tests investigate if there are any associations or correlations within the subgroups ‘ quality of life outcomes. The 
results show that there are not significant differences between subgroups who show positive and negative improvement.  
Quality of life of the person with dementia 
The control group split by improvement in QOL-AD (n=10) and decline in QOL-AD (n=12) show non-significant 
difference between the mean outcomes (p=0,90), and only show a significant difference between QOL-AD outcomes. In 
those who improved, there is a significant correlation with increase ZBI score (r=0,84, p=0,002**). The control group 
with declines in quality of life of the person with dementia did not have any significant correlations with QOL-AD. 
The intervention group has n=13 with improvement in QOL-AD and n=18 with declines in QOL-AD. The difference 
between the two subgroups’ mean outcomes is non-significant (p=0,95) and the only significant difference between them 
is in QOL-AD outcome. In the subgroup with improvement, QOL-AD has strong linear correlations with ADL decline (r=-
0,71, p=0,02**) and SQLC improvement (r=0,58, p=0,04*). The intervention subgroup who shows decline also shows 
significant correlations with ADL declines (r=0,58, p=0,01**) and IADL declines (r=0,60, p=0,01**). 
As the weighted score is considered a valid portrayal of QOL-AD [212] [305], this suggests that declines in independent 
functioning and quality of life for the person with dementia have a strong linear correlation in the intervention group 
participants. Figure 30 shows the proportion positive and negative outcomes in quality of life for the participants in each 
group. 
Figure 30 Outcomes in quality of life, by percentage 
 
Quality of life of the caregiver 
In the control group, n=15 improved SQLC score and n=7 has declines. The two groups show significant differences 
between SQLC (p=0,003**), the ages of the person with dementia (p=0,03*), and caregiver ages (p=0,005**); however, 
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the difference between the mean outcomes in the control subgroups is non-significant (p=0,77). Those who show 
improvement do not have any significant correlations within the outcomes, and those who have declines in SQLC show 
significant correlations between SQLC outcomes and IADL (r=-0,89, p=0,01**), MMSE (r=0,-0,82, p=0,02**), and ZBI 
(r=-0,83, p=0,02**).  
In the intervention group, n=11 shows decline in SQLC, and this is found to be significantly correlated with their decline 
in MoCA scores (r=0,65, p=0,03*). There are n=20 who show improvement in SQLC, and the improvement is not 
strongly correlated with any other variable, Between the intervention subgroups, there are significant differences 
between MMSE (p=0,003**), IADL (p=0,04*), SQLC (as expected), and ZBI outcomes (p=0,05*), and in length of use 
(p=0,04*); however the difference in outcomes between the intervention sub-groups is non-significant at p=0,86. A 
discussion on the quality of life results for the caregivers is given in Paper H 
Outcomes by effect in burden 
The independent t-tests show no significant differences in the baseline and final assessment scores between the 
intervention and control groups. The only significant difference is between the ZBI score changes. The intervention group 
ZBI score improved by a total of 22 points (4,3%) while it declined by a total of 54 points(19,7%) in the control group. To 
test ZBI further, the caregivers are dichotomized by positive effects in burden (<0) and negative effects in burden (>0) to 
explore if other assessment outcomes are associated with ZBI change. The independent t-tests first look for differences 
between the positive and negative effects groups, and the paired t-tests will tell if there are outcomes within the groups 
that influence the difference between the groups. The independent t-tests show a significant difference in ZBI outcomes, 
and the paired t-tests find this is due to a highly significant decline in the control group’s ZBI. The t-test results on 
caregiver burden are given in Table 18.  
Table 18 Results of the t-tests between the dichotomized ZBI score changes [273] 
 
Positive effect 
on ZBI (<0) 
Negative effect 
on ZBI (>0) 
Independent t-test on 
IADL between groups 
Paired t-test on IADL within groups 
[95% CI] 
Control (n=22) (n=7) 31,8% (n=15) 68,2% 0,009** 
p=0,004** in negative effects group  
[-1,42 to -0,32] 
Intervention 
incl. DK (n=31) 
(n=20) 64,5% (n=11) 35,5% p=0,40 
p=0,04* in negative effects group  
[-1,78 to -0,04] 
Intervention 
excl. DK (n=25) 
(n=16) 64% (n=9) 36% p=0,45 
p=0,04* in negative effects group  
[-2,16 to -0,06] 
All participants 
incl. DK (n=53) 
(n=27) 50,9% (n=26) 49,1% p=0,08 
p=0,0004** in negative effects group  
[-1,33 to -0,44] 
All participants 
excl. DK (n=47) 
(n=23) 48,9% (n=24) 51,6% p=0,11 
p=0,0004** in negative effects group  
[-1,43 to -0,48] 
 
The younger caregivers and the children caregivers subgroups both show significant declines in IADL and significant 
increases in ZBI, indicating possible correlations between age, IADL, and ZBI. Both the control and intervention groups 
have significant declines in IADL, and the subgroups who show decline in ZBI also show significant declines in IADL. 
This relationship between IADL and ZBI is examined further for both groups, divided by ZBI outcomes, presented in 
Table 19. In the intervention group, declining ADL and IADL scores are correlated with declining QOL-AD scores, 
exhibiting strong, positive linear relationships and a high probability of physical and independent functioning influencing 
declines in the person with dementia’s quality of life.  
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Table 19 Significant correlations when divided by ZBI outcomes, n=53 
 Correlated domains in the 
control group 
Correlated domains in the intervention group 
Improved ZBI 
Control n=7 
Intervention n=20 
SQLC improvement and caregiver age 
(r=0,80, p=0,03*) 
 MMSE and MoCA declines (r=0,61, p=0,004**) 
 MMSE decline and SQLC improvement (r=-0,59, p=0,01**) 
 MoCA decline and SQLC improvement (r=-0,73, p=0,003**) 
 MoCA and ADL declines (r=-0,51, p=0,02**) 
 ADL and IADL declines (r=0,67, p=0,001**) 
 ADL and QOL-AD declines (r=0,44, p=0,05*) 
Declined ZBI 
Control n=15 
Intervention n=11 
IADL decline and SQLC improvement 
(r =-0,53, p=0,04*) 
 ADL decline and caregiver age (r=-0,73, p=0,01**) 
 SQLC improvement and caregiver age (r=-0,61, p=0,05*) 
 
The only significant difference found from the tests on IADL outcomes, was between the control subgroups. For both the 
control group and intervention group, the subgroups who have negative effects in burden show significant declines in 
IADL. While all the negative ZBI subgroups show significant decline in IADL, only the control group shows that this 
difference is significant between the subgroups. In the intervention group, the significant declines in IADL are still not 
significantly different from the IADL in the positive effects subgroup; however, this is likely due to the lower overall IADL 
scores in the intervention group. The intervention group (incl. DK) shows highly significant improvement in ZBI 
(p=0,0001**) while the control group with positive results in ZBI shows non-significant improvement. Previous research 
shows that significant declines in physical functioning are associated with increases in caregiver burden, and it will be 
investigated if this is also the case in this study. The intervention participants also show a significant difference from each 
other in the length of using the services. Interestingly, the group who show negative effects in caregiver burden used the 
technology for a mean longer time. A further discussion on the outcomes in caregiver burden is offered in Paper G. 
Positive effects 
Of the participants who have improvement in caregiver burden, both the control and intervention groups show non-
significant improvement in IADL. The intervention subgroup shows a highly significant improvement in ZBI while the 
control group shows non-significant improvement.  
Negative effects 
Of the participants who have increases in caregiver burden, both the control and intervention groups show significant 
declines in IADL. However, the control subgroup shows a highly significant decline in IADL, and it is highly significantly 
lower than in its counter subgroup. The intervention subgroup with negative outcomes in ZBI used the intervention for a 
significantly longer time than the subgroup with positive outcomes. Figure 31 shows the proportion of participants with 
positive and negative outcomes in caregiver burden. 
Figure 31 Outcomes in caregiver burden (ZBI), by percentage 
 
31,8
68,2
Control group
Positive effects
Negative effects
64,5
35,5
Intervention group
Positive effects
Negative effects
5. Results 
79 
 
Subgroup analysis summary 
In both the control and intervention groups, the older caregivers provide care to older individuals with dementia. The 
control subgroups who are older have higher scores on QOL-AD and show a non-significant increase. The difference in 
QOL-AD outcomes between the older and younger control groups is significant (highly significant when dichotomized by 
the person with dementia’s age). Being younger is associated with significant declines in IADL, QOL-AD, and ZBI. 
Regardless of the younger control participants showing highly significant decline in IADL, they have higher ADL and 
IADL, and to a highly significant degree. The younger intervention subgroup also shows significant declines in IADL, and 
all intervention subgroups except for the older caregivers, show (non-significant) improvement in ZBI. However, the 
independent t-tests on the intervention groups show no significant differences between the groups, indicating that age is 
not a confounding variable for the intervention group.  
The control participants who live alone have lower QOL-AD scores at both assessments, and show decline when 
compared to those who cohabitate, though neither of the control subgroups show significant declines in QOL-AD. The 
intervention participants who cohabitate are younger and show (non-significantly) higher cognitive scores. The 
participants who live alone and have others as caregivers both have the highest independent functioning and have the 
highest quality of life scores (both QOL-AD and SQLC). The intervention group results indicate that there are 
associations with older age, living alone, and having higher independent functioning, which influence higher overall 
quality of life. However, the results from the control group show that the participants who cohabitate with their 
caregivers are younger, show less decline in independent functioning, and have higher and more unvarying QOL-AD 
scores, suggesting more stability in their home environment and daily lives. 
In the control subgroup with spouses as the caregiver, there is a significant increase in caregiver quality of life and (non-
significantly) higher QOL-AD, even though the MMSE score has significant decline. Having an adult child for a caregiver 
in the control group is associated with significant declines in IADL and highly significant increases in ZBI. The 
intervention subgroup with others as caregivers, where the majority live alone, is the only of all of the intervention 
subgroups to show (non-significant) increases in QOL-AD (the control subgroups who are older both show non-
significant increases in QOL-AD as well). In the intervention group, having a spouse as a caregiver is associated with 
significantly higher scoring on cognitive assessments, particularly on assessments sensitive to milder cognitive changes, 
despite this subgroup having the lowest independent functioning. Comparably, the participants who have adult children 
as caregivers have significantly lower cognitive assessment scores. The intervention group results show that both having a 
spouse as a caregiver and cohabitating with the caregiver is related to higher cognitive scores and less decline, 
particularly in milder declines (i.e. MoCA scores).  
The control group shows a highly significant increase in caregiver burden while the intervention group shows non-
significant improvement. In comparing the caregivers who have positive effects in caregiver burden with those who have 
negative effects in burden, there is a highly significant difference between the IADL scores of the control group. For all 
the participants who have negative effects in caregiver burden, there is a significant association with declines in 
independent functioning. It is reasoned that the significant declines in physical functioning are associated with increases 
in caregiver burden, but the results do not indicate strong linera relationships.  
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5.6 Analysis of gerontechnology use outcomes 
From the previous analysis on the intervention group, significant declines in IADL and QOL-AD are found to be 
correlated with high significance. It is furthermore shown that the intervention group does not have a significant decline 
in ZBI as the control group has, indicating possible protective effects of using gerontechnology to prevent an increase in 
caregiver burden. This section expands on the data on the use of the gerontechnology services by the intervention group.  
Outcomes based on the length of use 
The descriptive statistics on the type, function, percentage of use, and length of use are presented in Table 20. The 
intervention group is dichotomized by length of use to test if longer use is associated with positive differences. First, t-
tests are made within and between the dichotomized groups to identify significant differences, then Pearson correlations 
look for linear relationships between the length of use and outcomes.  
Table 20 Descriptive statistics on the use of the telecare services by the intervention group 
Type of service Functions of the service 
Percentage of use 
(n=31, incl. DK) 
Mean length 
of use (days) 
Increased contact Contact button on the Carebox touchscreen for the older adult 71%, n=22 198 
Reminders Reminder for date, time, meals, medication, appointments, etc. 67,7%, n=21 209 
Multimedia for 
cognition 
Memory stimulation with digital photos (reminiscence) 54,8%, n=17 210 
Training for mental ability and performance (brain games) 41,9%, n=13 173 
Intelligent front 
door 
The service monitors door use and caregivers are notified if the 
person is leaving the home or has been gone too long 
41,9%, n=13 227 
Home safety 
Stove and oven monitor (temperature sensor, use monitor, and 
actuator for automatic shut-off), reminds the person to turn off the 
appliance and generates alarms to caregivers if necessary 
41,9%, n=13 229 
Smoke detector and fire alarm to authorities in an emergency 54,8%, n=17 225 
Reminder if the water is left running (kitchen and bathroom) 3,2%, n=1 412 
Sleeping sensor 
Senses how long they have been in bed and if they are leaving the bed 
at night (frequency and length) 
35,5%, n=11 199 
Medication 
assistant 
Medicine reminders communicated through the Carebox, alert is 
generated if the reminder is ignored 
29%, n=9 293 
Outdoor safety 
GPS device for the location of the person outdoors 41,9%, n=13 190 
Panic button with GPS tracker if the person becomes lost 19,4%, n=6 145 
GPS device with a fall alarm to caregivers if a fall is detected 9,7%, n=3 144 
 
To look deeper into the relationship between technology use and quality of life, the length of technology use is 
dichotomized into groups of longer and shorter use. The median length of use is 203 days, and n=16 used the services 
203 days or less and n=15 used the services 204 days or more. T-tests are made to test between the groups. Table 21 
shows the descriptive statistics on the services by dichotomized length.  
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Table 21 Summary of the telecare services used by the dichotomized intervention group (incl. DK, n=31) 
 <203 days, n=16 >204 days, n=15 Total, n=31 
Mean 120,69 269 192,45 
Standard Error 14,85 12,89 16,66 
Median 122 267 203 
Mode 203 N/A 203 
Standard Deviation 59,41 49,94 92,76 
Sample Variance 3528,89 2494,43 8605,06 
Kurtosis -0,88 4,27 -0,31 
Skewness -0,11 1,71 -0,01 
Range 187 208 396 
Minimum 16 204 16 
Maximum 203 412 412 
Sum 1931 4035 5966 
95% Confidence Level 31,65 27,66 34,03 
 
Independent t-tests compared the score differences between the two groups of length of use (i.e. shorter use against 
longer use). This investigated the probability that longer use would provoke better outcomes. The results in Table 22 
show that the length of use has a significant association with caregiver quality of life (SQLC).  
Table 22 Results of the t-tests on the intervention group score changes and length of use (incl. DK, n=31) 
Outcome tool Significance of the difference between groups Mean change within groups 
MMSE p=0,40 
Short use group declined (-1,07) 
Long use group improved (0,07) 
MoCA p=0,85 
Short use group declined (-0,71) 
Long use group declined (-0,50) 
ADL p=0,90 
Short use group declined (-0,31) 
Long use group declined (-0,27) 
IADL p=0,78 
Short use group declined (-0,50) 
Long use group declined (-0,67) 
QOL-AD p=0,18 
Short use group declined (-0,71) 
Long use group declined (-2,88) 
SQLC p=0,05* 
Short use group improved (7,38, p=0,04*) 
Long use group declined (-1,87) 
ZBI p=0,83 
Short use group improved (-0,94) 
Long use group improved (-0,47) 
All p=0,28  
 
The analysis on the outcomes based on length of using the services shows that there is a highly significant difference in 
caregiver quality of life:  those who used the technology less than 204 days had significant improvement in their SQLC, 
influencing a significant difference between the two groups. Overall, the difference in the outcomes between the groups is 
non-significant. A Pearson’s correlation finds significant linear relationships in both groups. In the group who used the 
intervention 203 days or less, a highly significant, positive relationship is found between basic (ADL) and instrumental 
(IADL) activities of daily living, (r=0,68; p=0,004**), and a significant negative correlation between length of use and 
ADL (r=-0,50; p=0,05*). The group who used the intervention 204 days or more show highly significant, negative 
relationships between length of use and IADL (r=-0,60; p=0,02**), length of use and SQLC (r=-0,65; p=0,01**), and a 
significant negative relationship between IADL and ZBI (r=-0,53; p=0,04*) and QOL-AD and ZBI (r=-0,51; p=0,05*). 
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Outcomes based on non-standardized questionnaires 
In the evaluation of user acceptance and satisfaction with the ISISEMD telecare system, the project partners used 
explorative questions on global domains relating to quality of life [272]. The results are presented in Table 23. This 
comparison is to show the outcomes between the quantitative evaluations and the qualitative evaluations as another 
angle on the quality of life of the participants. Out of 62 participants (31 older adults and 31 caregivers), 61 responded to 
the question regarding the older adult’s quality of life and 55 responded regarding the caregiver’s quality of life (the 
adults with dementia in Denmark did not answer this question about their caregiver’s quality of life). Only the caregivers 
were asked the question about care responsibilities, and one did not answer. All other questions had 61 responses [272] 
[281].  
Table 23 Intervention group outcomes from the standardized assessments and additional 
questionnaires, incl. DK n=62 
Variable Standardized questionnaire results  (n=31, mean change) 
Additional questionnaire results 
(n=61) 
Quality of life of 
the adult with 
dementia 
QOL-AD 
41,9% show positive effects (2,32) 
58,1% show negative effects (-4,70) 
Paired t-test shows significant decline (-1,76, p=0,04*) 
62,9% report increase 
37,1% report maintenance 
0% report decrease 
Quality of life of 
the caregiver 
SQLC 
64,5% show positive effects (9,85) 
35,5% show negative effects (-9,73) 
Paired t-test shows non-significant improvement (2,90, p=0,24) 
70,9% report increase 
19,4% report maintenance 
0% report decrease 
Independent 
living 
ADL 
80,7% show positive effects (0,12) 
19,4% show negative effects (-2,00) 
Paired t-test shows non-significant decline (-0,29, p=0,13) 
IADL 
61,3% show positive effects (0,47) 
38,7% show negative effects (-2,25) 
Paired t-test shows significant decline (-0,58, p=0,05*) 
61,3% report increase 
37,1% report maintenance 
0% report decrease 
Change in care 
responsibilities 
ZBI 
64,5% show positive effects (-3,95) 
35,5% show negative effects (5,18) 
Paired t-test shows non-significant improvement (-0,71, p=0,51) 
61,3% report decrease 
35,5% report maintenance 
0% report increase 
Safety in the 
home 
environment 
 
80,6% report increased safety 
19,4% report maintained safety 
0% feeling less safe 
Satisfaction with 
the telecare 
system 
 
88,7% report satisfaction 
11,3% report dissatisfaction 
1,6% report disappointment 
 
While nearly half of the QOL-AD scores show there were positive effects, the larger percentage of participants show 
greater negative effects, and the overall QOL-AD outcomes shows a significant decline. However, none of the individuals 
with dementia and their caregivers reported that they felt the quality of life of the adult with dementia declined, and over 
72% reported improvements in the global questions. There were nearly twice as many caregivers who had positive effects 
in their SQLC than those who had negative effects, although the paired t-test shows a non-significant difference. All of the 
participants who responded feel that the quality of life of the caregiver had positive effects, with over 70% reporting 
increases. The majority of the participants show positive effects in their physical and independent functioning, but these 
effects are outweighed by the overall negative effects in the ADL and IADL scores. In comparison, the majority of the 
participants report that they felt independent living increased for the person with dementia and no one reported declines 
in independent living. Almost 65% of the caregivers show positive effects in their ZBI, and that corresponds with almost 
62% reporting decreases in their care responsibilities. However, the 35,5% who show negative effects in ZBI corresponds 
with the same percentage of those who report maintained care responsibilities, while none of the caregivers reported 
increases in their care responsibilities. All of the participants report either maintained or enhanced safety in the home 
environment and nearly 90% report satisfaction with using the system. 
While the responses may bring more questions than answers, they are representing the phenomenological perspective of 
the end users in their interaction with the telecare system. The variation in outcomes between the standardized 
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assessments and the additional questions could be explained by the questions themselves. It could be that the non-
standardized questionnaires were not valid to assess the domains (i.e. care responsibilities has a different meaning than 
caregiver burden), and it could be that the standardized assessments miss some valuable domains that were affected by 
the intervention. The standardized assessments asked closed questions on specific, defined domains, whereas the global 
perception of the domains allows the participant to include other factors that influence the overall quality of life. Another 
possibility could be that the standardized tools are better at detecting declines. All participants will have different 
personalities and outlooks that shape what they perceive to be improvement, maintenance, and decline, and will have 
differing levels of insight into the situation, which will affect how they respond. An interesting aspect of these outcomes is 
that the responses were recorded at the same interview and participants answered questions on the standardized 
assessments before being asked about their global perceptions.  It is recognized that there is some disconnect between 
defined and global responses, and that this could be due to lack of insight among the participants. As an example of this, 
the participant who reports the highest increase in ZBI (17 points), also responds that the intervention has increased 
quality of life in the dyad and that the technology has helped to decrease care responsibilities.  
Intervention group participants were asked about their willingness to use and pay for services like the ones in the project 
[272] [281]. 48,4% of caregivers and 35,5% of adults with dementia definitely would use a system like this, and another 
41,9% of caregivers and 54,8% of adults with dementia would consider using a system like this. In total, 90,3% of the 
intervention group reports a willingness to use services like these, and 9,7% report that they are not willing to use a 
system like ISISEMD. In total, 53,2% of participants report willingness to pay for services like the ones offered; 58,1% of 
the adults with dementia and 48,4% of the caregivers are willing to pay for these services (12,9% did not answer). The 
ISISEMD project reports that if the participants were consumers, the total cost of the system (for all services) is €3.470 
per user and €60.000 for the regional care service providers [306]. Despite the direct costs to the stakeholders, there are 
additional values when compared to traditional dementia care services (e.g. the control group). The regional care 
providers can benefit from telecare through increased efficiency in information collection and processing, improved 
billing processes, increased management capacity, more convenience, faster accessibility, and resource savings for 
medical and care professionals. Based on the average cost to receive formal care in the regions, e.g. the potential annual 
savings per person from using a home telecare system, Table 24 shows the willingness to pay and the average costs of 
formal care [272]. 
Table 24 Potential regional savings in the annual costs of formal care for one person 
 
DENMARK 
(n=6 dyads) 
NORTH IRELAND 
(n=7 dyads) 
GREECE 
(n=10 dyads) 
FINLAND 
(n=8 dyads) 
Mean length of use 215 days 160 days 137 days 273 days 
Participants 
willingness to use 
100% of adults with 
dementia 
100% of caregivers 
71,4% of adults with 
dementia 
57,1% of caregivers 
90% of adults with 
dementia 
100% of caregivers 
100% of adults with 
dementia 
100% of caregivers 
Participants 
willingness to pay 
66,7% of adults with 
dementia 
0% of caregivers  
(16,7% did not answer) 
57,1% of adults with 
dementia  
(14,3%¤ did not answer) 
42,9% of caregivers 
(14,3%¤ did not answer) 
50% of adults with 
dementia 
70% of caregivers 
62,5% of adults with 
dementia 
62,5% of caregivers 
(12,5% did not answer) 
Annual amount 
participants are 
willing to pay 
€135-940 for the 
equipment 
€12-408 €1.200-3.600 €360-1.200 
Annual costs of 
formal care 
€48.000 for nursing 
home placement 
€23.676 for nursing 
home placement 
€15.600-20.400 for 
hospitalization 
€8.400-9.600 for 
formal care in the home 
€36.000 for dementia 
care home placement 
 
Outcomes based on qualitative information 
The qualitative information presented here serves to provide another angle of looking at the research. Ultimately, it is 
hoped that other dementia intervention programs can benefit from lessons learned in the ISISEMD project. More 
information on the qualitative outcomes from the project can be found in Papers D, E, G, and in ISISEMD project reports 
[272]. 
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The reliability of the platform and availability of the service were some of the most crucial requirements of the telecare. 
The telecare system had some instability, especially in the beginning of the testing. The number of visits to the 
participants’ homes was more than expected, largely due to technical issues and training. Many of the issues were with 
the surrounding technical infrastructure (i.e. operating systems and ADSL connectivity). A high number of initial false 
alarms can have negative effects by disrupting the caregivers, unnecessarily causing concern, and some participants with 
dementia also expressed concern over their caregivers having “false scares.” Of those who found the instability 
bothersome but remained in the trial, many understood that the project was developing and testing the services and 
knew some problems were to be expected. As one of the most crucial requirements is the reliability of the system, the 
conclusion is that the small-scale testing of the technologies should have been longer to ensure a reliable system before 
starting real-life testing. The system’s stability issues mean that during the testing period, the system was still being 
optimized. This not only can influence the outcomes in quality of life due to overcoming technical difficulties, but there 
are ethical concerns with testing unstable services in the homes of individuals with dementia. Furthermore, with 
installation difficulties and delays in service availability, credibility can become an issue for the end users.  
One element of the research that is not given as much attention is the outcomes for the professional caregivers. They are 
the primary local contact points for the participants to the project. The formal caregivers had significant roles in the 
evaluation administration, and found the questionnaires were difficult to understand and required them to become 
familiar with research skills and methods. They emphasized keeping the number of assessment tests as limited as 
possible, since it is taxing on the participants to answer so many in one interview. The professional caregivers also 
expressed concern over the appropriateness of the assessments, ZBI in particular, and felt that it was an ethically gray 
area if the wording could provoke poorer opinions on quality of life. They acknowledge that technical skills are 
increasingly important in elder care, but found acquiring the new skills challenging. The professional caregivers also 
conducted the majority of the training for the participants. They needed the skills to use the internet to access the 
telehealth portal, to adjust the services, and to explain the functions to the participants. Their feedback and collaboration 
directly helps to improve the system. The formal caregivers did not need to understand all technical aspects, as the 
regions had local IT support to handle problems. The regions report increased awareness and knowledge of eHealth and 
smart homes, solutions in elderly care, and how other countries provide elder care.  
For the individuals with dementia, it is challenging for them to use technologies they have never previously used, thus the 
interactive services were more difficult for them to access than the non-interactive services. The interactive services 
would be better suited for individuals in earlier stages of cognitive impairment, and all involved need to ensure that 
technical partners have a clear comprehension of the technical abilities (and desires) of the participants. For example, 
several informal caregivers were frustrated by receiving text message alarms during all hours of the day, reporting that 
this made them feel they should be “on duty” 24 hours a day. To alleviate this, some alarms are directed to email or 
through the formal caregivers first, depending on the needs of the dyad. The informal caregivers report that the largest 
impact they notice is reassurance for the safety of the person with dementia (through checking activities in the home, 
location outside of the home, notifications for unusual events, and easy contact through the Touchscreen). The 
reminders, orientation to the day and for the structure of the day, tracking (GPS) device, home activities monitoring, and 
Touchscreen contact button are viewed most positively. They provide awareness about the activities of the person with 
dementia, increased feelings of safety and independence, peace of mind, and helped save time and costs associated with 
phone calls and visiting the person with dementia to check in on them. The reminders service was widely used and is a 
flexible service that the caregivers can adjust. For some of the dyads, the individuals with dementia were more likely to 
listen to the “third person” Carebox, and the reminders helped improve the relationship and reduce aggressiveness. 
However, the service was also identified as less useful with degradation in cognition.  
The formal caregivers report that all participants seem to feel safer and less anxious, emphasizing that the caregivers 
being more aware of and reassured about the home situation through the monitoring reduces stress. They find the 
telecare system has improved and supported independence in the daily life for the person with dementia, and has 
benefitted the caregivers even more. The project provides the opportunity to gain knowledge from testing the dementia 
care intervention in realistic conditions and on the quality of the intervention experience. The qualitative information, 
and the responses to global questions, provide complementary angles to interpret the quantitative results.  
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Summary of gerontechnology intervention outcomes: 
The intervention services were used for a mean of 193 days. The actual range is broad, due to cutbacks in the public sector 
in the 2009 European economic crisis; the Greece region has the lowest mean length of use at 137 days. The intervention 
group shows significant declines in IADL and QOL-AD, which are found to be significantly correlated. When 
dichotomized by length of use, there is a highly significant difference between the groups in SQLC, and it is the short use 
group that shows significant improvement (mean length 109 days). Furthermore, the short use group IADL shows a 
highly significant correlation with ADL, which is not present in the long use group. When the intervention group is 
divided by positive and negative effects in ZBI, the group with positive effects also used the intervention for a shorter 
mean length (167 days). In this same subgroup, there is a significant correlation between length of use and SQLC (non-
significant) improvement. There is no significant evidence that using the gerontechnology intervention longer brings 
more positive outcomes.  
One of the main conclusions that can be made about the results of the additional (non-standardized) questionnaires, is 
that there are some differences between how the participants report global outcomes from the intervention, and what the 
standardized assessments (defined domains) reveal. Both sets of results are based on participant reporting so both are 
considered to be honest evaluations; however, since the construct validity is unknown for the additional questions, 
comparisons with the standardized questionnaires is speculative. In the additional questions, none of the participants 
report decline and the majority report improvement in the 4 domains assessed. When looking at raw percentages, there is 
some agreement among the standardized and the non-standardized questionnaires. For physical and independent 
functioning, over 80% of participants show positive effects in ADL and around 61% show positive effects in IADL. To 
compare, around 61% of participants report an increase in independent living on the non-standardized questions. Just 
under half of the participants show positive effects in QOL-AD, and over 62% report increases through the additional 
questions. However, the negative effects in the standardized assessment outcomes are greater than the positive effects, 
and there is an overall (non-significant) decline in ADL, significant decline in IADL, and significant decline in QOL-AD. 
For the caregiver’s quality of life, over 70% of participants reported increases, which agrees with nearly 65% showing 
improved SQLC scores. When the intervention participants are separated by living arrangement, the caregivers of 
individuals with dementia who live alone, have higher SQLC scores but smaller improvements. When dichotomized by 
length of use, the participants who use the technology longer, mostly live alone, also have significantly higher SQLC 
scores, but show decline that is highly significantly different from the shorter group’s increase in SQLC. For caregiver 
burden, over 61% report decreases in care responsibilities, and almost 65% show positive ZBI outcomes. Furthermore, 
the 35,5% who show negative effects in ZBI corresponds to the same percentage of those who report maintained care 
responsibilities. The standardized assessment outcomes concerning the caregivers show (non-significant) improvement 
in SQLC and ZBI, indicating that the intervention has more direct positive effects for the caregivers than for the person 
with dementia. The two regions who used the intervention longer than the overall mean of 193 days both show 100% 
willingness to use services like the ones offered. 62,5% of the intervention participants report that they would be willing 
to pay for services like the ones offered, and this attitude aligns more to the results of the non-standardized assessments 
(where none report decline in conditions) than to the standardized assessments (where the caregivers show small 
improvements). 
The project collected a wide range of information from testing and evaluating the gerontechnology intervention for 
dementia care. It was highly motivated, but complex, research that analyzes data from real-life testing from multiple 
angles. The qualitative information gives more insight into the development, use, and evaluation of the dementia telecare 
intervention. The reliability, stability, and accuracy of the telecare system are essential not only as technical 
requirements, but for the service functioning. Although all were achieved in the ISISEMD project, there were more 
technical problems encountered than were anticipated. This led to more home visits to resolve technical issues and 
reinforce training, and meant that the system was being optimized during testing. While it is unclear if the initial 
technical problems influenced the assessment outcomes, the recommendation is that the testing of the technologies 
should ensure a reliable system before starting real-life testing. This not only will help to resolve technical issues and 
perceptions on service credibility, but alleviates ethical concerns about testing unstable telecare services in the homes of 
people with dementia.  
It is challenging for the adults with dementia to use technologies that are new to them, this is noticed particularly for the 
interactive services. Some services that are appropriate for individuals in the earlier stages of dementia will not be 
appropriate for those in the later stages. For example, caregivers noticed that the reminders service, although helpful, is 
less useful as cognition declines. It is important that the technical partners receive well-defined user requirements (as far 
as technical competency and service requests). Despite the challenges encountered, the system provides a secure living 
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situation and effective risk management, which promote aging in place and benefit those involved in the dementia care. 
Services that are predominantly found useful are the Carebox services (reminders, orientation to the day, structure of the 
day, and contact button), sensors for home activity monitoring, and GPS locating services. The individuals with dementia 
conveyed increased feelings of safety and independence; however, the benefits seem to be greater in the caregivers. 
Previous research shows that the most important benefits that technology provides to caregivers are in saving time (77%), 
easing care logistics (76%), safety (75%), increasing feelings of effective caregiving (74%), and reducing stress (74%); 
caregivers will be most interested in technology interventions that will support them in delivering, monitoring, tracking 
and coordinating care [76]. Similar desired results are found from the ISISEMD project, adding strength to the external 
validity. The intervention allows caregivers to have an awareness about the person with dementia and their activities, 
which provides reassurance for safety, and saves time and costs on phone calls and visits. The intervention appears to 
bring the psychological benefits of reduced stress (anxiety, worry) and brings peace of mind. The fact that the caregivers 
give positive global and qualitative evaluations and express a desire to continue using it, indicates that they perceive the 
intervention to have had a noticeable and positive influence on their dementia care and lives. This information did not 
come across in the standardized assessments, and it is likely that there are other assessments that would more closely 
match the caregivers’ perception on the usefulness of the system. A cautionary recommendation for such future research 
would be to keep the number of assessments to a minimum to avoid burdening the participants, and to consider the 
psychological effects of the questions in the assessments. The formal caregivers in the regions are a crucial part of the 
research project, in recruiting and training participants, and in administering assessments. Furthermore, they enhance 
the project cohesion with other partners, and provide valuable insight into the participants’ context. Integrating them 
further into the research as partners will be beneficial.  
5.7 Discussion of the analysis 
The null hypothesis will be rejected if the results show maintained or increased physical and independent functioning, 
quality of life, and maintained or decreased caregiver burden when compared to the control group. The hypothesis is 
tested by looking for significant differences and between the groups, and the use of the technology is tested by looking at 
changes within the intervention group. The results of the hypothesis testing are given in Table 25. 
Physical functioning of the individual with dementia 
Both intervention and control participants exhibit statistically significant declines in instrumental physical functioning 
(IADL). This in itself was not an unexpected result, as dementia is a syndrome characterized by a progressive loss of 
abilities. Declines in IADL could be related to quality of life for both groups of participants, as the adults with dementia 
have less independence in self-care abilities and the caregivers have more tasks. When looking at the proportion of the 
intervention group who shows positive effects in both ADL and IADL, the majority of participants do show positive 
effects (80,7% and 61,3%, respectively), but this is quite similar to the control group’s proportions (86,4% and 54,5%, 
respectively). When the outcomes in basic (ADL) and instrumental (IADL) activities of daily living are tested for a linear 
relationship, the intervention group shows a highly significant correlation and the control group shows a non-significant 
correlation. When the intervention group is further split into groups of short and long use, the group who used the 
technology 203 days or less show a highly significant linear correlation between the declines in ADL and IADL. Despite 
this, 100% of the intervention group participants gave positive results on the global question of support in independent 
living, with 61,3% reporting an increase in independent living. Although no comparative global view is available from the 
control participants, we can see that the intervention group did not find that the telecare impeded independent living. 
These results are not necessarily in contrast to the percentage of positive ADL and IADL outcomes, but show incongruity 
with the statistical significance of the defined decline.  
The statistical results cannot reject the null hypothesis as the groups show similar decline. These results do not support 
the hypothesis that using technology would have a positive effect on quality of life. 
Quality of life of the individual with dementia 
Paired t-tests reveal that the intervention group has a significant decline in QOL-AD and the control group has a non-
significant decline. 58% of the intervention participants show declines in their QOL-AD; in comparison, 54,5% of the 
control group shows QOL-AD decline. The intervention group’s significant decline in QOL-AD is measured against the 
significant decline in IADL through a Pearson’s correlation. The highly significant linear relationship shows that 
declining instrumental physical functioning and declining older adult quality of life have a high probability of influencing 
each other in the intervention group. There is disagreement in the positive global feeling of maintained or increased 
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quality of life in the older adults, and the intervention group’s significant decline in QOL-AD; 63% of the participants 
report global quality of life as being improved, this is slightly higher than the 42% who show positive effects through 
QOL-AD. Although it is unknown how they arrived at the overall conclusions, the majority of the intervention group 
perceived the services to have a positive effect on quality of life. Aside from the linear correlation with IADL decline, the 
available data does not allow for a concrete interpretation of why QOL-AD would decrease or how older adults arrive at 
conclusions about their QOL. It could be hypothesized that the QOL-AD is assessing specific domains that may be more 
likely to be associated with loss of ability or activity, but more research is needed.  
The statistical results cannot reject the null hypothesis as the intervention group shows more decline than the control 
group. These results do not support the hypothesis that using technology would have a positive effect on quality of life. 
Quality of life of the caregiver 
The intervention and control groups both show increases in caregiver quality of life (SQLC). The independent t-test 
between the two groups show that there was low probability that the intervention group has different outcomes than the 
control. An analysis on the intervention length of use and quality of life shows that there is a highly significant difference 
between caregiver quality of life (SQLC) in the intervention groups based on length of use. The caregivers who used 
technologies longer have a mean decline in SQLC, while the caregivers using technologies less than 204 days have a mean 
increase in SQLC, and this difference in SQLC is significant difference between the short and long use intervention 
groups. One could expect that longer use of assistive technology would yield better quality of life outcomes, particularly if 
there was an adjustment period and technical issues when the intervention was first introduced. However, since the 
SQLC scores do not have a linear relationship with any of the other assessment scores, the probability of the 
improvement in caregiver quality of life being due to the shorter use of the intervention is low. The conclusion cannot be 
made that using technologies, or using technologies for a longer amount of time, results in more positive effects on 
quality of life. Nearly 65% of the intervention participants show positive effects in their SQLC outcomes, and 68,2% show 
positive effects in the control group. There is some agreement regarding the global feeling of maintained or improved 
caregiver quality of life and the non-significant improvement in SQLC. Regarding the global question on the caregiver’s 
quality of life, 1oo% of the intervention participants who responded report positive effects and 70,9% of those report that 
it increased. While the intervention group reports that the telecare increased quality of life, there is no evidence of a 
significant relationship between using the intervention and better QOL outcomes for the caregivers.  
The statistical results cannot reject the null hypothesis as the groups show similar improvement. These results do not 
support the hypothesis that using technology would have a positive effect on quality of life. 
Caregiver burden and responsibilities 
Comparing caregiver burden (ZBI) between the control and the intervention group caregivers shows a highly significant 
difference in outcomes between the two groups. A Pearson’s correlation tests if the control group’s significant decline in 
IADL was influential on the significant increase in ZBI. There was no evidence of a strong linear relationship and there 
was a low probability that the two of these influence each other; the decline in instrumental physical functioning did not 
increase caregiver burden in the control group. The result is that those who did not use technology experienced a highly 
significant increase in caregiver burden, and the caregivers who did use technology had a non-significant reduction in 
their caregiver burden. There is a significant difference in caregiver burden between the two groups and a statistical 
association (but a weak linear correlation) between IADL and ZBI in the control group. The Pearson’s tests find no 
evidence that any changes in assessment scores to have strong linear relationships to ZBI scores in either group, 
including after dichotomization. The intervention group’s non-standardized responses show maintained or decreased 
care responsibilities and the ZBI confirms that caregiver burden decreased, though non-significant at p=0,51. Again, 
100% of the intervention caregivers report maintained or improved care responsibilities and almost 65% show positive 
effects in their individual ZBI scores, compared to only 31,8% of individuals showing positive effects in the control group.  
The statistical results can reject the null hypothesis as the intervention group shows more improvement than the control 
group. These results support the hypothesis that using technology would have a positive effect on quality of life. 
5. Results 
88 
 
Overall difference in outcomes from using gerontechnology intervention  
The changes in the groups are compared in an independent t-test. The mean outcomes from the assessments (MMSE, 
MoCA, ADL, IADL, QOL-AD, SQLC, and ZBI) are tested to reveal if the differences in the groups is less than 5% due to 
chance. The results show that the difference between the outcomes is not significant at p=0,44.  
The statistical results cannot reject the null hypothesis as the outcomes from being in one group or the other are not 
significantly different. These results do not support the hypothesis that using technology has a positive effect on quality 
of life. 
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Table 25 Results of research questions and hypothesis testing, incl. DK n=53 
Research question Variable and outcome 
Assessment for 
validation 
Method of 
aggregation Hypothesized outcome Observed outcome 
1. Will using gerontechnology have 
positive effects on physical and 
independent functioning? 
Physical and 
independent 
functioning 
 
Secondary 
outcome 
ADL and IADL Compared means between groups 
H1:  Intervention group will show 
improvement or less decline than 
the control group 
H0:  Intervention group shows no 
significant difference from the 
control group 
H0:  The two groups do not show significant 
differences in ADL (p=0,40) or IADL (p=0,83) 
outcomes 
 
Physical and 
independent 
functioning 
 
Secondary 
outcome 
Non-standardized 
questionnaire on 
feeling of change in 
independent living 
Post hoc mean from 
intervention group 
H1:  Intervention group will report an 
increase in independent living 
H0:  Intervention group will report 
no change or decrease in 
independent living 
H1:  The intervention group reports an increase in 
independent living for 61,3% of participants and 
maintained independent living in the remaining 
37,1% 
2. Will using gerontechnology have 
positive effects on QOL in the 
person with dementia? 
Quality of life 
 
Primary outcome 
QOL-AD Compared means between groups 
H1:  Intervention group will show 
improvement or less decline in 
QOL-AD than the control group 
H0:  Intervention group shows no 
significant difference from the 
control group’s QOL-AD 
H0:  The two groups do not show significant 
differences in QOL-AD outcomes (p=0,64) 
 
Quality of life 
 
Secondary 
outcome 
Non-standardized 
questionnaire on 
feeling of change in 
QOL 
Post hoc mean from 
intervention group 
H1:  The intervention group will show 
an increase in QOL for 50% of 
participants with dementia 
H0:  Intervention group will report 
no change or decrease in QOL 
H1:  The intervention group shows an increased QOL 
for 62,9% of participants with dementia and 
maintained QOL for the remaining 37,1% 
3. Will using gerontechnology have 
positive effects on QOL in the 
caregivers? 
Quality of life 
 
Primary outcome 
SQLC Compared means between groups 
H1:  Intervention group will show 
improvement or less decline in 
SQLC than the control group 
H0:  Intervention group shows no 
significant difference from the 
control group’s SQLC 
H0:  The two groups do not show significant 
differences in SQLC outcomes (p=0,93) 
 
Quality of life 
 
Secondary 
outcome 
Non-standardized 
questionnaire on 
feeling of change in 
QOL 
Post hoc mean from 
intervention group 
H1:  The intervention group will show 
an increase in QOL for 70% of 
caregivers 
H0:  Intervention group will report 
no change or decrease in QOL 
H1:  The intervention group shows an increase in 
QOL for 70,9% of caregivers and maintained 
QOL for the remaining 19,4% 
4. Will using gerontechnology have 
positive effects on caregiver 
burden? 
Caregiver burden 
 
Secondary 
outcome 
ZBI Compared means between groups 
H1:  Intervention group will show 
improvement or less decline in 
ZBI than the control group 
H0:  Intervention group shows no 
significant difference from the 
control group’s ZBI 
 
H1:  The intervention group has significantly better 
outcomes in ZBI (p=0,03*) 
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Research question Variable and outcome 
Assessment for 
validation 
Method of 
aggregation Hypothesized outcome Observed outcome 
 
Caregiver burden 
 
Secondary 
outcome 
Non-standardized 
questionnaire on 
feeling of change in 
care responsibilities 
Post hoc mean from 
intervention group 
H1:  The intervention group will show 
reduced care responsibilities by 
60% 
H0:  Intervention group has no effect 
on or increases care 
responsibilities 
H1:  The intervention group shows care 
responsibilities were reduced in 61,3% of 
caregivers and care responsibilities were 
maintained in the remaining 35,5% 
5. Will using gerontechnology have 
positive effects on safety in the 
home? 
User safety 
 
Secondary 
outcome 
Non-standardized 
questionnaire on 
feeling of safety in 
the home 
environment 
Post hoc mean from 
intervention group 
H1:  Participants will report feeling 
safer with the telecare system 
H2:  The intervention group will show 
an increase in feeling of safety in 
30% of participants 
H0:  Intervention group has no effect 
on or decreases feeling of safety 
H2:  The intervention group shows an increase in 
feeling of safety in 80,6% of participants and 
maintained feeling of safety in the remaining 
19,4% 
6. Will people be satisfied with the 
intervention system? 
User satisfaction 
 
Secondary 
outcome 
Non-standardized 
questionnaire on 
feeling of 
satisfaction 
regarding the system 
Post hoc mean from 
intervention group 
H1:  Participants will report being 
satisfied with the telecare system 
H2:  75% of participants will report 
being satisfied with the telecare 
system 
H0:  Intervention group has no effect 
on or increases care 
responsibilities 
H2:  88,7% of participants report being satisfied with 
the telecare system 
7. Will end users be willing to pay 
for gerontechnology services? 
User acceptance 
 
Secondary 
outcome 
Non-standardized 
questionnaire on 
willingness to pay 
for services. 
Post hoc mean from 
intervention group 
H1:  Participants will report 
willingness to pay for telecare 
services. 
H0:  Participants will not be willing to 
pay for telecare in place of usual 
care. 
H1:  58,1% of participants with dementia and 48,4% 
of caregivers report willingness to pay for telecare 
services. 
8. Would people want to use 
services like these? 
User satisfaction 
 
Secondary 
outcome 
Non-standardized 
questionnaire on 
willingness to use 
services. 
Post hoc mean from 
intervention group 
H1:  Participants will report a desire 
to continue using telecare 
services. 
H2:  75% of intervention caregivers 
will report a desire to continue 
using services 
H0:  Participants will not want to 
continue using telecare services. 
H2:  90,3% of intervention participants report at 
least considering continuing to use the services 
Overall difference Primary outcome ADL, IADL, QOL-AD, SQLC, and ZBI 
Compared mean 
changes in the 5 
assessments 
H1:  Intervention group Participants 
will have significantly different 
(better) outcomes. 
 
H0:  The two types of care do not show significant 
differences in outcomes (p=0,48) 
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The background chapter described the increasing demand for dementia care. It is a specific area of caregiving that 
requires adapting to the individual’s transient and declining state; it is truly person-centered care. There is also an 
increasing use of supportive technology in dementia care. Assistive Technology is perceived as beneficial by focus groups, 
based on their intuitive knowledge of caregiving. People will use and seek Assistive Technology that has obvious benefits 
for their needs, and to assist with dementia care is to take action to improve the health and safety of a person with 
dementia. The very nature of the intervention is intended to improve quality of life, i.e. assisting with care. If both the 
need (e.g. support in monitoring and ensuring the safety of the person with dementia) and motivation (e.g. personal 
weighing of pros and cons) for using ATs are present, and the technology is perceived as beneficial, it remains a quagmire 
that the obvious perceived benefits are not represented in data. One possible reason is insufficient consistency in the 
research, which makes comparing results complicated and uncertain. With many methodological strategies, the field can 
become as heterogeneous as the study population themselves. Using the theories can provide structure to understanding 
the scope of the results; the theories should explain the observations and make projections for the results of subsequent 
observations.  
Phenomenology motivates user-driven design and person-centered care, and can shed light on the variation in outcomes 
at an individual level. Exponential growth is a motivation for further gerontechnology research and application. 
Gerontology theories can be applied to interpret the outcomes. According to the biomedical model, the participants with 
dementia in ISISEMD are precluded from aging successfully as there is the presence of physical and cognitive 
impairment. However, research shows that successful aging can be predicted by mental health and social relationships 
[109]. Assessing one aspect of mental health through the MMSE and MoCA scores shows that both groups, on average, 
declined. The group mean changes show evidence of cognitive impairment, while the majority of the individuals show 
maintained or improved cognition. The quantitative results can be used to both demonstrate and negate the successful 
aging of the participants with dementia. In the intervention group, 15 out of 28 (53,6%) showed maintained or improved 
MMSE scores, and 17 out of 28 (60,7%) maintained or improved MoCA scores. In the control group, only 8 out of 22 
(36,4%) maintained or improved MMSE scores, and 11 out of 20 (55%) maintained or improved MoCA scores.  
There was no indication of learned dependency during the ISISEMD project, although it should be considered with 
longer use of telecare. Regarding learned helplessness, if anything, examples were found of increased confidence, where 
participants who had been afraid to be alone before, now felt comfortable doing so with the technology. The feedback 
from the participants was used to tailor the services, providing a feedback loop of co-creation, which helped avoid learned 
dependency through supporting intact abilities. For example, when appropriate, the participants with dementia were first 
alerted to turn off the stove so that they had the opportunity to amend the situation before caregivers would be contacted. 
Activity theory and social constructivist theory can be used to interpret the positive effects from the cycles of co-creation. 
Participants exhibited the activity of using the services and provided feedback for further adaptation of the services to 
their needs. Adapting the services required considering the individual, the caregiving dyad, their history, home 
environment, role of the technology as a mediator, and the complexity of the activities and their appropriateness for the 
participant. After the adjustments, users adapt to the services, and the services can be further adapted to the users, in a 
cycle of co-creation of both activity and technology. Allowing the participants to co-create or adapt the services to their 
needs promotes involvement in activities and activity theory would hold that this cycle promotes positive effects on 
quality of life. Social constructivist theory would speculate that the technology and society also co-construct each other in 
the real-life context through the adaptation of social practices (not only in social interactions, but through social and 
health service provision) and the technology (through tailoring the services). Another aspect of tailoring the services was 
the importance of the phenomenology of the end users’ experiences with the telecare. For example, one participant with 
dementia could no longer use a telephone, but he could use the contact button on the GPS device to contact caregivers. 
The device had a realistic use of providing contact to help, and also had an existential effect in that now the participant 
could independently and safely leave the home, which relates to his perception of self. When taken at an individual, 
phenomenological perspective, this one service had real benefits for the dyad, and the impact of this on their lives was 
not observable in the quantitative data. When only the participant’s scores are the overall outcomes, the relative validity 
is overlooked.  
Activity theory would hypothesize that decreased activity would cause individuals with dementia to experience decreasing 
life quality. As discussed in the section on quality of life, activity theory plays a large role in identifying domains to be 
evaluated in quality of life assessment tools for individuals with dementia (i.e. ADLs and IADLs). In the example of no 
longer being able to cook for oneself, it would be limiting in scope to deduce that decreased cooking activities results in 
decreased QOL. It is conversely unfounded to deduce that increased cooking activities with the help of technology results 
in increased QOL. In support of activity theory, some participants used the technology to be active (i.e. taking walks, 
shopping, socialization), but this is not reflected in a global assessment score. Participants in both groups showed decline 
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in independent physical functioning and in quality of life; however, the system fostered independence through 
reminders, and alerts could first be presented to the older adult on the Carebox screen, allowing them to amend the 
situation before a caregiver would be contacted. The intervention group’s correlation between the person with dementia’s 
report of QOL-AD and both ADL and IADL is interesting since the caregiver’s score and weighted score do not have 
strong correlations with ADL and IADL outcomes. The person with dementia’s QOL-AD assessment is highly correlated 
with assessments of their physical functioning, which could support previous research on individuals with dementia and 
their ability to accurately evaluate their own quality of life [45] [177] [181]. However, this could also be related to the 
technology use, since the control group does not have strong correlations with QOL-AD and ADL/IADL. Perhaps using 
the services (and technologies) makes them aware of their abilities (which the person may compensate for when around 
others), that they accurately reflect in their QOL-AD assessment. 
The field of gerontechnology is relatively young and there is not a vast body of evidence to understand older adults’ 
interaction with technology nor about the outcomes from telecare use. As in previous research [307], the ISISEMD 
project found that medical professionals, caregivers, and individuals with dementia did not have clear understanding 
about how technologies can assist in dementia care, and needed to be educated about the options available and expected 
benefits. Problems in dementia care are usually addressed in both numbers and words (e.g. stage of dementia and 
description of the symptoms), and describing intervention outcomes in a similar manner may be more effective in 
reaching medical professionals and caregivers (i.e. 64,5% of caregivers using the technology have positive outcomes in 
caregiver burden and the system successfully alerts for unintended exits in the middle of the night). The data analysis 
alone does not illustrate the full experience of continued growth and development in the older adults. Those who 
interacted with the technology (i.e. GPS device or touchscreen computer) were demonstrating a willingness and 
motivation to learn to use the technology, and this is not represented in the quantitative analysis. In light of social 
constructivist theory, several of the participants would tell of how they would use the technology to suit their needs, often 
in inventive ways that the project partners had not considered. The innovative interaction with the technology also 
supported the phenomenological perspective of the participants, demonstrating how they would find value in the devices 
and services. One woman would use the contact button to call her caregiver, although the project partners had originally 
designed this feature to be for emergencies, they redesigned the contact button GUI to reflect its use for general contact 
rather than emergency help. One gentleman told how he would keep the GPS device in his coat pocket at all times, even 
while it was charging, so he would not forget it when he left the house. Others put a picture of the GPS device on the front 
door, to remind themselves to take it with when they were leaving the house. The results from the non-standardized 
questions pose an interesting contrast to the quantitative results. The responses to the questionnaires show that the 
intervention group older adults and caregivers report feeling positive effects on quality of life for both themselves and the 
other. Likewise, the participants report positive effects on independent living and caregiving tasks. It is intriguing that 
the subjective results would be in such contrast with the quantitative results, and certainly raises the question of whether 
the standardized assessments are more or less accurate in capturing global effects on quality of life. It could be that 
defining the domains of quality of life to be assessed is too narrow or that the participants did not consider what they 
would define as quality of life and answered based on a general feeling. Perhaps the knowledge gap is not only in the lack 
of evidence, but in why it is difficult to attain valid data for the evidence base. 
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Data analysis summary: 
The focus of this research is in collecting evidence on technology use in dementia care and outcomes in quality of life. 
Responses to global (non-standardized) questions on independence, quality of life, and caregiving tasks were also 
reported. The results showed that all of the participants felt positive effects on their own quality of life as well as for the 
other individual. Some of these responses are in contrast to the standardized assessment outcomes.  
There were not significant differences between the control and intervention groups’ outcomes in cognition (MMSE and 
MoCA). Both groups exhibit significant declines in instrumental physical functioning (IADL) but only the control group 
exhibits a highly significant increase in caregiving-related stress. This could indicate that the use of technology defers 
caregiver burden despite significant functional decline. Both groups of older adults have decline in their instrumental 
physical functioning (IADL). Likewise, both groups show decline in their quality of life (QOL-AD), but only the 
intervention group shows significant decline. The intervention group exhibits a highly significant, positive linear 
relationship between QOL-AD and IADL outcomes. When the intervention group is dichotomized by positive and 
negative outcomes in QOL-AD, the participants’ decline in QOL-AD shows a highly significant, positive linear 
relationship with their IADL decline. In the intervention group, significant declines in independent functioning and 
quality of life of the person with dementia are highly correlated. The intervention group has a highly significant 
correlation between caregiver quality of life and length of use; however, it the caregivers who used the technology less 
than 204 days who have greater increases in their SQLC. There are no other significant differences between the short and 
long use groups of intervention caregivers and the shorter group’s SQLC is not strongly correlated with any other 
variable. The conclusion is that there is a low probability that the increase in SQLC is due to shorter use of technology. 
Though the caregivers in both groups have increases in their quality of life (SQLC), only the control group has a highly 
significant increase in their caregiving-related stress (ZBI) as well. This shows that although both groups have increases 
in their quality of life (SQLC), the intervention group has a reduction in their caregiver burden (ZBI) and the control 
group had an increase in theirs. The technology intervention in dementia care has a positive effect for the caregivers by 
reducing their caregiver burden (ZBI). Although this is not reduced by a statistically significant amount within the 
intervention group, it is a highly significantly different from the caregivers who did not use technology. Further tests 
show that no other variable is correlated with the change in ZBI score in the intervention group, so it is deduced that it is 
due to the influence of technology. This difference between the control and intervention group ZBI is the strongest 
objective evidence to support the hypothesis that using technology can improve quality of life in dementia care. 
This study presents the outcomes from using a gerontechnology intervention in dementia care, and compares them to a 
control group. Results are derived from mixed methods (standardized assessments, non-standardized questionnaires, 
observations, and qualitative information), and the theoretical implications are also discussed. The following research 
questions were proposed, investigated, and discussed: 
1. Will gerontechnology use have positive effects on physical and independent functioning? In both 
groups, ADL and IADL has average decline, and there is not a significant difference between the control 
and intervention groups. The exploratory results from the global questions show that gerontechnology 
did have positive effects on independent living. 61,3% of participants in the intervention group report 
increased independent living, and the qualitative information further finds independence is perceived 
as increased. The comparative results show that gerontechnology use did not have significantly 
different effects on functioning than usual care. 
2. Will gerontechnology use have positive effects on the quality of life of the person with dementia? The 
intervention group shows a significant decline in QOL-AD, but the outcomes are not significantly 
different from the control group. In contrast, the exploratory results show that gerontechnology did 
have a positive effect on quality of life for the person with dementia as 62,9% of the intervention 
participants self-report improved QOL in the global question. The comparative results show that 
gerontechnology did not have significantly different effects on quality of life for the person with 
dementia than usual care did. 
3. Will gerontechnology use have positive effects on the quality of life of the caregiver of the person with 
dementia? While SQLC increased in both groups, there is not a significant difference between the two 
groups. The exploratory results do show that gerontechnology has positive effects on the quality of life 
in caregivers as 70,9% of participants report increased quality of life for the caregiver in the global 
question. The comparative results show gerontechnology use did not have significantly different effects 
on caregiver quality of life than usual care. 
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4. Will gerontechnology use have positive effects on caregiver burden? There is a significant difference in 
ZBI between the control and intervention groups. The control group shows a significant increase in 
burden while the intervention groups shows a non-significant improvement. The exploratory results 
from the intervention group show that gerontechnology has a positive effect on caregiving 
responsibilities as 61,3% report decreased care responsibilities on the global question. The exploratory 
results corroborate with the 64,5% of the intervention caregivers who have positive effects in their ZBI 
outcomes. The comparative results show that gerontechnology use did have positive effects on 
caregiver burden that were different from in usual care. 
5. Will people feel safer when using the telecare system? 80,6% of the adults with dementia and their 
caregivers report increased feelings of safety. The exploratory results show that gerontechnology use 
did have a positive effect on feelings of safety 
6. Will people be satisfied with the telecare system? 88,7% of the participants reported being satisfied. 
The exploratory results show that users were satisfied with the telecare system. 
7. Will people want to use dementia care intervention services like these? 90,3% of all the intervention 
group participants would consider or definitely want to use an intervention like this. The exploratory 
results show that users will want to use services like these. 
8. Will end users be willing to pay for gerontechnology intervention services like this? 53,2% of the 
intervention group participants would be willing to pay for the services. The exploratory results show 
that users are willing to pay for services like these. 
Post hoc ergo propter hoc cautions that before-and-after is not synonymous with cause-and-effect, reminding us that 
correlation does not equal causation. The data analysis shows more positive effects for the caregivers than for the person 
with dementia, and caregiver burden is the only significant outcome between the two groups. The results show that the 
technology intervention has more positive effects for the caregivers than for the older adults with dementia. The global 
and qualitative results show positive perceptions of the intervention and that it improved key areas considered indicative 
of quality of life. Furthermore, the majority of intervention participants are willing to pay to use such services, and it is 
unlikely that they would rate global outcomes so positively and be willing to pay for services that provide only marginal 
benefits for caregiver burden, as the statistical analysis suggests. To summarize, there is evidence of an association 
between gerontechnology in dementia care and positive outcomes in caregiver burden; however, there may be 
confounding variables (e.g. education level, type of dementia, length of caregiving). The global and qualitative results 
indicate that the intervention has a positive effect on independent living, safety, caregiver responsibilities and stress, and 
quality of life. The research goal is to add to the evidence-base on gerontechnology outcomes in dementia care. While the 
technologies are effective at supplementing best practices in dementia care, the two types of care did not produce 
significantly different outcomes. Both methods of caregiving have similar effective on quality of life and the null 
hypothesis cannot be rejected.  
Papers supporting Chapter 5: 
More information on the outcomes from the project can be found in Papers D, E, G, H,  and in ISISEMD project reports. 
Paper D presents results up to the mid-term evaluation of the ISISMD project and includes qualitative information from 
the participants. Paper E presents outcomes as well as lessons learned from the research project. Paper G specifically 
addresses the outcomes in caregiver burden, including qualitative information, and Paper H focuses on outcomes for 
caregiver quality of life. 
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Chapter 6.  Discussion of the research 
The purpose of this research is to investigate the outcomes of using technologies in home-based dementia care, as much 
of the current information is anecdotal. The data analysis showed that using technologies in dementia care has a positive 
effect on the quality of life of the caregivers by preventing significant increases in burden. However, taking the results at 
face value can be misleading, so a discussion of the research and results is presented, considering the methods and tools 
used, strengths and weaknesses of the study, and future directions in the field of gerontechnology. The hope is that these 
outcomes are taken into consideration so that evidence-based decisions can be made about technologies in dementia 
care. 
Papers included in Chapter 6: 
The results of the mid-term evaluation are given in Paper D. Paper D also describes changes to the methodology.  
Paper D:  Anelia Mitseva, Carrie Beth Peterson, Christina Karamberi, Lamprini Ch. Oikonomou, 
Athanasois Mpallis, Charalampos Giannakakos, and George E Dafoulas. “Gerontechnology: Providing a 
helping hand when caring for cognitively impaired older adults – intermediate results on the satisfaction 
and acceptance of informal caregivers from a controlled study.” Current Gerontology and Geriatrics 
Research, Hindawi Publishing, Article ID 401705, 2012. DOI:  10.1155/2012/401705. 19 pages. 
Paper F discusses future perspectives of technology in dementia care.  
Paper F:  Carrie Beth Peterson, Neeli R Prasad, and Ramjee Prasad. “The future of assistive technologies 
for dementia.” Gerontechnology 11(2), p. 195. 2012. 
DOI: http://dx.doi.org/10.4017/gt.2012.11.02.427.742. 7 pages. Awarded “Best Paper” at the 
International Society for Gerontechnology conference, 2012. 
A literature search in order to compare results in ZBI can be found in Paper G, which specifically discusses the outcomes 
in caregiver burden. A deeper discussion on the significance of the outcomes for caregivers and the relevance for 
individuals, health and care providers, and policy makers can be found in Paper G.  
Paper G:  Carrie Beth Peterson, Lars Bo Larsen, Poul Svante Eriksen, and Ole K Hejlesen. “Zarit burden 
interview shows decrease in caregiver burden with technology intervention in European dementia study.” 
Submitted for publication to the British Medical Journal, 2014.  
A detailed discussion specifically on the differences in SQLC across the regions can be found in Paper H 
Paper H:  Carrie Beth Peterson. “Results from a clinical trial on gerontechnology in dementia care and 
caregiver quality of life outcomes.” Technical report, 8 pages, 2013. 
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6.1 Discussion of the methods and tools 
Standardized evaluation tools were used to assess the quality of life of the end users in both groups. From an 
administration point of view, the evaluation of the outcomes was a complex task. First of all, there were concerns that the 
number of assessments was too many to administer in one sitting. In all, 7 standardized assessments were given at the 
baseline and final evaluations (i.e. MMSE, MoCA, ADL, IADL, QOL-AD, SQLC, and ZBI), with some regions also 
administering assessments during a mid-term evaluation. The results of the mid-term evaluation are given in Paper 
D.The intervention group answered additional questions through non-standardized assessments of their acceptance and 
satisfaction with the system and services. The sheer number of questionnaires can cause stress and fatigue. Furthermore, 
the fact that they were administered face-to-face and in a serial order, poses the possibility of carryover and order effects, 
and interviewer bias.  
Although widely used in both healthcare and research, there have been criticisms of the MMSE, most notable are the 
differences in administration methods and score interpretation (not always done by neuropsychologists) [308] [309]. 
Authorized translations in Danish, Finnish, Greek, and UK English are available from Psychological Assessment 
Resources, Inc. (PAR) at http://www.minimental.com. Across cultures, the educational level, language ability, age, co-
psychopathology (i.e. symptoms of both dementia and depression), and socioeconomic status of individuals can influence 
the ability to give responses to the assessment, and thus influence the validity of the interpretation [310]. Furthermore, 
individuals with different geographical and cultural backgrounds perceive and manage daily problems in different ways. 
The difficulty of the questions, the range of competencies that the questions can differentiate, and the ability to guess 
(correct) answers can all be affected in cultural translations. It is unknown if participants outside the Denmark region 
were minorities who did not have the cultural background of the region they were living. Although information can be 
found on the use of the MMSE in Denmark [311] [312], Finland [313], Greece [314], and Ireland [315], the cultural 
validity in the countries is yet unknown.  
While transferring the raw assessments from the regions to the original English versions, several major impediments 
came to light. Although they were standardized and approved assessment tools, there were important differences that 
had not been discovered before (either by the partners or in the literature review). Variations in the assessments were 
noted specifically for the IADL, SQLC, and ZBI instruments. It is unknown why there are differences among the 
assessments, and further research in this area would be beneficial. A detailed discussion specifically on the differences in 
SQLC can be found in Paper H. The differences in ZBI have been discussed with Dr. Steven Zarit and are being looked 
into by the Mapi Research Trust. 
1. In the Greek version of IADL, there is the additional option of “does not participate in (activity),” that 
is not in the original English version of the other translated versions used in the study.  
2. The Danish and Finnish versions of SQLC have different points than the original English version for 
question #10 “Does the regular everyday care and attention to the chronically disabled person make 
you depressed?” 
3. The Finnish version of SQLC has different points than the original English version for question #3 
“Did you change your work because of your relative’s disease?” 
4. The Finnish version of the ZBI short form only has 11 questions, whereas the original English and 
other translated versions have 12 questions, including “Do you feel you could do a better job in caring 
for your relative?” 
5. Greek partners in the project chose not to ask ZBI question #9 to the participants, shown in Figure 
32. They found this question to be specifically stressing to the caregivers and the project partners 
worried about the ethical implications of inducing distress. Upon further investigation, it was found 
that the Greek version mentions the relative’s illness in a way that refers to death. It is unclear as to 
whether the implication of death was a cultural translation or if it was a translation error. This 
question was not removed from the other region’s assessments.  
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Figure 32 Zarit Burden Interview question #9 in English and Greek 
 
Even when studies use the same tools, the results are still difficult to generalise. For example, one study reports outcomes 
of the 12-item ZBI in 413 caregivers over 6 months, but did not use technology intervention [295]. The mean ZBI was 
20,59 (SD 15,64) at baseline, and 20,97 (SD 17,35) at follow-up, with an average increase of 0,35 (SD 12,21). We could 
expect similar results in our control group; however, the ISISEMD control group shows lower burden at both the baseline 
and follow-up evaluations (and smaller SD), but a greater increase in ZBI. The increase in ZBI could have been influenced 
by a number of factors (i.e. time between testing, age, caregiver relationship, gender, cognitive functioning, intervention, 
etc.), all of which differed between the two studies. This provides an example to illustrate the difficulties in comparing 
results from different studies, even when they use the same quantitative measures. Since the ZBI is the most discussed 
tool to evaluate caregiver burden, a literature search was conducted in order to compare this study’s ZBI results with 
similar studies. The search was limited to reports which investigated technology services for dementia care, reported 
outcomes in caregiver burden, and were available in full text. Articles were excluded if they did not pertain to the 12-item 
ZBI, dementia caregiving, or technology intervention, and if they did not report results. Three relevant articles were 
identified but none provided comparable evidence to analyze. Searching the Cochrane Library for 12-item Zarit Burden 
Interview and dementia results in one study protocol that does not give results [205]. A PubMed search for 12-item Zarit 
Burden Interview, dementia, and technology intervention returns zero papers [316]. A Scirus search for the same 
keywords results in 282 hits [317], only 3 of which are relevant. Further discussion on this can be found in Paper G. 
1. A 12 month trial on a night time monitoring system (bed and door sensors and alarms) with 53 
participants in the USA assesses caregiver burden with the 12-item ZBI [318]. They report a mean 
baseline score of 2,79 (five times lower than the ISISEMD total mean of 14,44), and that the control 
group has significantly higher ZBI than the intervention group at baseline. However, change in 
caregiver burden is not one of their main hypotheses, so detailed information on burden outcomes is 
not given. They conclude that the monitoring system proves to be a reliable support for caregivers to 
manage night activity and find that the intervention group is 85% less likely to experience incidents 
than the control group.  
2. A systematic review on intervention programmes for family caregivers finds, when excluding 
telephone-based support, no study is identified as a technology-based intervention [319].  
3. A literature search on systematic reviews of interventions for caregivers identified 112 full text articles 
[320]; 15 of the reviews met the quality criteria, and only three of those pertained to technology-based 
interventions in dementia care. The authors find evidence on the effectiveness of technology-based 
interventions lacking in controlled studies, but uncontrolled studies indicate that GPS systems can be 
beneficial. 
Not all the raw data was available to compare the assessment items for all individual with dementia and caregiver dyads, 
and a list-wise deletion was carried out in order to run statistical analysis on the dyads with complete data sets. This 
meant that some participants were eliminated from the analysis due to missing one or more scores for the assessments to 
be evaluated for the PhD study (i.e. ADL, IADL, QOL-AD, SQLC, and ZBI). It is noted that the 22-item ZBI was 
administered in Greece and the 12-item outcomes were taken from this, whereas the other regions used the 12-item form. 
This did not pose any statistical challenge as the 22-item form contained all 12 questions, but is a noted shortcoming of 
the project methodology due to the potential bias of administration error. Additionally, some of the adults with dementia 
had more than one informal caregiver provide data during the study (n=3), and the secondary caregiver data was not 
included in this analysis. The assessment tools evaluate a set number of indicators and the intervention services would 
most likely influence some domains and not others (i.e. ability to do chores around the house is more likely to be 
influenced than money). In this light, smaller global improvements were expected from the standardized assessments, 
but this weakens the significance of the overall quantitative results of the study. By looking at domains that the 
assessments measure, the individual real-life application of the intervention proves another angle of the usefulness than 
what the assessment outcomes can show. By assessing the scores in this way, a (cautious) comparison can be made for 
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the changes that would typically occur in usual care and changes which may be influenced by the technology. By the 
conclusion of the 15 month the testing period, the control group shows more positive effects in QOL-AD scores (41,9% of 
intervention participants and 45,5% of controls) and SQLC scores (64,5% of intervention, 68,2% of controls). In the 
intervention group, physical functioning (ADL) outcomes were more positive than in the control group (80,7% of 
intervention, 86,4% of controls), as well as higher-level functioning (IADL:  61,3% of intervention, 54,5% of controls), 
and caregiver burden (ZBI:  64,5% of intervention, 31,8% of controls). While sufficient enough raw data (i.e. digital 
copies of the questionnaires) is not available to make the same comparison for the control group, the intervention group’s 
detailed results exhibit real-life improvements in the quality of the lives of the participants. The specific domains and 
construct improvements include [272]:   
 IADL 
o 50% of the intervention participants show positive effects in their ability to make phone calls 
o 40% show improvement in medication management 
o 60% maintained their ability to use transportation 
o 50% had positive effects in their ability to shop 
 QOL-AD 
o 40% of of the intervention participants with dementia report maintained living situation 
o 50% report mixed maintained/declined living situation 
o 60% the intervention participants with dementia show maintained or improved relationships 
o 40% show maintained social life 
 SQLC 
o 60% of the intervention caregivers had maintenance or improvement in their social life 
o 80-100% of the caregivers report maintained or improved employment status 
o caregiving tasks were maintained or improved in 60% of the caregivers 
 ZBI 
o 64,5% of the intervention caregivers had maintained or improved caregiver burden, twice as 
much as in the control group 
Yet, despite these positive effects that individuals actually experienced, the statistical analysis shows that the intervention 
did not have an overall significant effect. One explanation could be that the ability to answer the questionnaires does not 
imply that the questions have been understood; in longitudinal studies including self-reports by people with dementia, 
the questions (and constructs) can be perceived differently at separate assessment points [321]. When developing the 
assessment methodology, the choice of instruments were found to be robust and used in previous research on dementia 
care outcomes. It was hypothesized that the range of assessments would provide a multifaceted portrayal of the 
intervention’s effects on overall quality of life in the dyad. However, the concept of quality of life has no gold standard to 
compare against leaving construct validity inexact, especially when comparing among individuals. It could be that global 
questions are easier to comprehend and report than defined constructs that require at least an understanding of the 
definition (i.e. social life); but, when attempting to intervene on domains that are suffering, defined constructs are 
necessary. The qualitative feedback does not support the quantitative results, which leaves doubts about the study’s 
methods and the instruments’ ability to detect meaningful outcomes. Researching changes in individual QOL in order to 
generalize wider population relevance presents a challenge of whether quality of life is considered a reliable and valid 
measure of the actual construct. The standardized questionnaires, although valid to assess their domains, could be 
missing some latent variables when attempting to evaluate the quality of life outcomes from a clinical intervention. This 
would help explain the disagreement between the statistical analysis and the qualitative analysis. It could be that there 
are closer outcomes than quality of life to detect the effects of the intervention, for example, hours spent giving care, 
environmental adaptation, or pleasant activities may have been better suited.  
Another explanation could be in the nature of the research. This study focuses on non-pharmacological interventions 
which are relatively new to dementia care; it is a developing area between Assistive Technology, health outcomes, and 
gerontology. These areas of research often have different characteristics, methods, and goals from clinical research (i.e. 
the gold standard) [322]. Determining the clinical significance of non-pharmacological and palliative interventions is 
difficult, and this is further complicated by the subjective nature of the user assessment and the mixed methods design. 
Mixed methods has the benefit of providing various angles of the outcomes but increases the complexity of the study and 
interpretation of the results [270]. Correlation is present when two variables are found to modify each other; however, 
when discussing correlations in life quality, there are easily numerous influential variables and correlations become more 
elusive. With so many variables, it can be difficult to prove that the correlations hold absolute, generalized meaning. This 
is additionally complex as one technological device or service could serve multiple meanings to one person, and this will 
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often vary between persons. By the time the implications are understood, the technology is already outdated and replaced 
with something exponentially advanced. The person with dementia and their caregiver dyad are known to have a 
heterogeneous nature; this patient population is best cared for on an individualized basis, and clinical significance can be 
obscured by the wide variations. The clinical gold standard of experimental modeling and quantitative results can fail to 
identify some useful benefits of the intervention that are present but not inquired about. The clinical implication of this 
research is discussed in Paper G on ZBI outcomes. 
Carrie Beth Peterson, Lars Bo Larsen, Poul, Svante Eriksen, and Ole K Hejlesen. 
“Zarit Burden Interview shows decrease in caregiver burden with technology 
intervention in European dementia study.” Submitted for publication to BMJ, 20 
pages. 2014.  
If the majority of these studies have methodological issues, perhaps it is time to adjust the way that non-
pharmacological and palliative dementia care interventions are validated. Holding dementia care outcomes 
to the same standards as traditional (e.g. biological) clinical research is relatively outside of the dementia 
care paradigm, as the syndrome cannot effectively be halted or prevented. How many points does caregiver 
burden need to be reduced in order to achieve clinically significant results? If using technologies to support 
caregivers can help to provide quality care in the home and delay or defer institutionalisation, it has 
implications for clinical significance. One only has to consider the host of problems that caregivers for 
someone with dementia face when they take on the role. As such, not taking action to support caregivers 
has pronounced public health consequences as the global incidence of dementia rises. Even though the 
reduction in intervention group ZBI was not statistically significant, it could be clinically significant for the 
caregivers to protect against significant increases in caregiver burden and the related health and well-being 
implications. As of yet, there is little definitive knowledge on the relationship between the clinical features 
of dementia and dementia caregiving, and assistive technology’s suitability to intervene on specific 
symptoms. Clearer conceptual links are needed to support demonstrated effectiveness and to be sure that 
indicators of success are useful and meaningful to the persons the interventions are aimed towards 
helping. [269] While the qualitative information provides more insight to the intervention group’s 
outcomes, no qualitative insight is available for the control group as to why their burden shows a highly 
significant increase.  
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6.2 Strengths of the study 
One of the strongest points of the study was that it tested the telecare services across different European countries for 
over a year to obtain results on the real-life conditions of the end users. Furthermore, the services were tailored to 
accommodate the needs of the different organizational structures of care providers as well as the individualized user 
requirements of the older adults. Another noted strength of the study was the advantages of working in multidisciplinary 
teams that share expertise across technical, governmental, social care, medical, and academic levels. Although 
communicating the same ideas across the levels of expertise was challenging, the project partners reported that the 
cooperation was fruitful and overall helpful. The technical partners gained a better understanding of how services are 
perceived and used by end users in real life. The regional social and health care partners reported that their 
understanding of how technology could enhance their services to better serve their patient populations was improved, 
leading to more awareness about telecare services for older adults and about the technologies themselves. Additionally, 
they gained a clearer perspective on organization in order to offer eHealth services in their regions or to enhance eHealth 
networks that were already in place.  
Despite the methodological difficulties, not only were the intervention outcomes assessed, but the telecare system was 
evaluated for reliability and robustness. The feedback from participants permitted tailoring of the services to the needs of 
the individuals; for example, some participants felt it was a “waste” to keep the screen on all the time, which was 
accommodated through motion-sensing activation of the screen. By including the participants’ opinions and experiences 
throughout the process, the interventions are targeted and allow the users to co-create their interventions. Despite 
problems recruiting participants, the sample population represents four cultures in Europe and scalable technologies 
were tested for 15 months, which is one of the longer periods reported for telecare interventions. The initial evaluation 
phase was planned for 12 months but was later extended to 15 months to accommodate the difficulties in recruiting 
participants and optimizing the system [275]. Furthermore, the intervention was tailored, multi-component, and long-
term, all of which are recommended for implementing effective dementia care interventions [38] [78] [82] [217] [218] 
[219]. The research utilized mixed methods, which is particularly beneficial to evaluate complex interventions and 
analyze the outcomes, and supports the efficacy of the results as they are presented in both numbers (measured 
performance) and words (appropriateness). 
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6.3 Weaknesses of the study 
In Frederikshavn region, there were not enough participants to comprise both the test and control groups, so it was 
decided that the recruited participants would all be in the test group. It was difficult to recruit at least 10 test and 10 
control participants in each region, and it was decided that highest priority should go to filling the test group. This meant 
that the study was quasi-experimental. Initially, the exclusion criteria excluded participants who have dementia 
secondary to head trauma and those who are bedbound (confined to a bed or chair for 20 hours a day for 4 out of 7 days). 
In the Denmark region, one participant was interested who was both bedbound (in a wheelchair) and suffered cognitive 
impairment secondary to a head trauma (due to a fishing industry accident). This participant was discussed within the 
project consortium, and it was determined that they could remain in the clinical trial as the primary outcomes to be 
measured in the trial were the evaluation of the gerontechnology devices and services and any related effects on QOL, 
which could still be measured in this participant dyad [275]. It should be noted that not all participants had a medical 
diagnosis of dementia and accompanying stage, as many were referred by professionals or relatives who noted cognitive 
impairment or probable dementia. It was a significant difficulty in the research project to recruit participants in the early 
stages of dementia since many of the formal health care organizations are first brought into care management when 
dementia is more pronounced and causing noticeable hindrances [275]. Additionally, there were some participants 
whose cognitive functioning scores ranged outside the inclusion criteria of 9-26. In the intervention group, three 
participants had MSME higher than 26, and seven had MMSE scores higher than 26 in the control group. 
 It is possible that the test and control groups of participants in the study were not equivalent to start 
with, so outliers in either group could distort the results. In fact, it is assumed to a certain extent that 
the two groups of participants are not equivalent as would be in most randomized-controlled trials. It is 
well known that no two individuals with dementia will experience the syndrome equally and there is 
essentially nothing to compare the rate of decline to; the heterogeneity of the populations (those with 
dementia and their caregivers) makes generalizing resultschallenging . This was a known risk to the 
internal validity of the research design. When comparing control and intervention groups in dementia 
care, the following are considered:Comparing test and control groups is not in itself a demonstration of 
validity. 
 The technology services can only help with some of the unmet needs of the test group, as the care 
situation is multifaceted. 
 It is not possible to directly correlate institutional placement during the course of the trials (i.e. 
participants who withdrew) to the use or non-use of the gerontechnology.  
 Some of the differing results between the test and control group may not be explained by or ascribed to 
the gerontechnology intervention. 
o In particular, frequent visits to the participants due to installations, technical problems, and for 
assessments may inadvertently influence their QOL, which is unrelated to the use of the 
gerontechnology services.  
o Likewise, some of the system’s technical issues may inadvertently cause distress among the test 
participants.  
o Changes in cognition cannot be explained by the technology intervention alone. 
The European Economic Crisis was another major setback that was encountered. Specifically, the public sector halted to 
a standstill in Trikala, Greece for six months. This put a hold on recruiting professionals (psychologists) and thus 
recruiting participants, which delayed the starting date in that region. This was also the region with the lowest mean 
length of use (μ=137 days compared to total test group, μ=192,45). In Northern Ireland and in Greece, some potential 
participants lived in the mountains where internet connectivity was not adequate to support the gerontechnology system. 
Unfortunately, these participants could not continue with the project as intended and either withdrew or were assigned 
to the region’s control group. Furthermore, some participants who were able to continue with the project lived in regions 
with low coverage that caused internet stability issues during the testing period which impeded SW updating and caused 
some concern for the participants (i.e. worry about system and service credibility). Working in multidisciplinary teams 
posed difficulties, particularly in communicating technical problems between the (social and health care) regional 
partners and the technical partners. The formal caregivers expressed challenges in explaining the user’s problems to the 
technical partners or in attempting to simulate the problems encountered. It took some months for the consortium to 
find a simpler, common language that all could understand. However, once this was achieved, all partners had a better 
understanding of what was expected and what could be delivered through technical solutions.  
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Similar to previous research, this study also has methodological problems, and this study did not attain minimal 
systematic error. There were instrument and administration errors, and more visits to the home due to technical 
problems and additional training than anticipated. This study also did not attain a high statistical power. Having n=40 
participants per group would have given 80% power, however this analysis has n=53 participants, attaining a power of 
35% when testing the hypothesis between groups. Furthermore, as this is a non-equivalent comparison, the possible 
effects are considered. Although there were no significant differences between the intervention and control group 
assessment scores at baseline (including cognition scores), there are some distinctions which may be influential. The 
control group caregivers were an average of 8,97, years older (p=0,02**), and the majority were spouses. Middle-aged 
caregivers are most likely to be caring for both their parents and their children, i.e. the sandwich generation, which might 
explain the (non-significant) higher baseline ZBI when compared to the control group. Caregivers with high levels of 
burden are more likely to seek out formal support services [76], which may also be a factor in joining the study. Younger 
caregivers, who are typically higher users of advanced technology, may also be more interested in joining the project [79]. 
Since, caregivers in the intervention group may have exhibited self-selection bias in participating due to higher levels of 
caregiver burden and/or an interest in technology to support care, causation is difficult to determine. Though certainly a 
difference between the sample populations, this is still considered acceptable as the average caregiver is an adult female 
relative of the person with dementia, and both wives and daughters are identified as high risk subgroups for experiencing 
caregiver burden [78] [217]. In order for a strong conclusion to be drawn on this outcome, the quality of the research 
needs to be strong:  
1. The difference in caregiver burden must not be before the intervention. The results show there is not a 
significant difference in any of the assessments at baseline.  
2. The highly significant difference in caregiver burden is related to the intervention. The results show  
that the improvement in burden is not correlated to any other variable and cannot otherwise be 
explained by the data.  
3. There are no other confounding variables that could explain the difference in caregiver burden. The 
results show that age and length of use may be confounding variables. Declines in IADL did not have a 
significant correlation with declines in ZBI. 
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6.4 Future directions in dementia care 
Smart Homes have the capability to minimize risks to physical safety and assist with daily activities. When coupled with 
care services, like Ambient Assisted Living , Smart Homes also promote healthy, independent living, and can collect 
information on user patterns to adapt the home environment. Although these types of advanced technological systems 
are not extensively used in present day, the continued advancement of technology and its assimilation into society calls 
for some speculation on what the future of personalized dementia care could look like.  
There are a range of technologies that have already been developed or are near-ready for public markets [10], such as 
accelerometers that can predict falls before they occur [323], and gait sensors that can recommend rehabilitation 
strategies to prevent falls [324]. Smart materials can collect biosignals via surfaces in the home or materials worn by the 
user [325], and affective computing can identify and process fluctuations in human emotions [326]; recognizing 
variations in affect and communication patterns could allow behavioral expressions to be distinguished from cognitive 
distress or symptoms of comorbid conditions (e.g. pain). Likewise, advances in the field of robotics are making great 
strides in incorporating affective computing so that the robots can detect human expressions through facial and body 
language and will have the capability to adapt to the individual’s mood [327]. Furthermore, improvements in personal 
and microcomputers, such as wearable technologies, and embedded bio-sensing devices, will extend the user-defined 
context outside of the home environment. Devices increasingly connected to each other through ICT will allow 
communication over mobile ad hoc (MANET) and mesh networks, as envisioned through the Internet of Things (IOT), 
enabling individuals to interact with their community in new ways (i.e. Smart Cities). For more future perspectives of 
technology in dementia care, please see Paper F. 
Previously, loss was a fundamental theme in many aging theories. It seems that much of the research on dementia 
caregiving postulates a similar negative curve, given that burden tends to increase as functioning declines. People are 
more than the sum of their roles:  as the person with dementia is more than their impairment, just because dementia 
caregivers experience of burden does not mean that is all they experience from caregiving. Perhaps, as there is this 
paradox of aging, there too is a paradox of caregiving. Although the majority of the research on caregiving focuses on the 
negative aspects, there are some studies which report the positive aspects [77] [78] [328]. Up to 90% of caregivers report 
positive feelings were cultivated by the act of showing care and support, improved relationships, togetherness, sharing 
activities, opportunity to show love, reciprocated bonds in the care dyad, feelings of accomplishment, mastery, and 
personal and spiritual growth. This implicates that caregiving, for many, is a means to continued growth and 
development. It is feasible that caregivers can be supported through co-creating and tailoring the telecare, but can be 
further supported by enhancing the methods they already find effective. Caregivers are also aging individuals, and 
gerontology asserts that aging involves using knowledge and tools to control and adapt an environment, or to adapt to an 
environment. It would be interesting research to test if gerontechnology interventions aimed at declining behaviors (e.g. 
wandering) have different benefits than interventions aimed at coping behaviors (e.g. task-focused, or emotion-focused 
coping) [218] [328], or could integrate the two. 
The background discussion on diagnosing dementia emphasized a disconnect between the trends in early diagnosis and 
the critical requirement of accurate testing. After searching the literature, conducting the research, and describing the 
results, it appears there is also a disconnect between the trends in gerontechnology use in dementia care and the essential 
understanding of significant, validated benefits. Exponential growth tells us that technology advancements will continue, 
and at an increasing pace. This will benefit both diagnosing dementias and developing technologies that support the 
safety and well-being of people with dementia. It will be more beneficial to consider what the future of dementia care 
could be, and influence development based on what gerontologists do know about living with dementia and caregiving for 
someone with dementia. This has vast implications in dementia care, as the number of trained caregivers decreasing; 
technology-supported care could greatly complement the demand for intuitive, personalized care. Sensors, cameras, 
social media content, and affective computing, could allow for the early detection of dementia by identifying symptoms 
through patterns of behavior in individuals. This also suggests that the individual could exercise more independence in 
utilizing community services such as local parks or grocery markets, as pervasive computing could detect the location, 
gait, etc. of the person, and contact a designated authority if a hazardous situation arises. Cloud computing will provide 
Internet-based services that can be accessed globally, essentially making computing a public service, and will enhance 
health and social care provision through, e.g. secure transfer of medical history among care professionals, or allowing a 
person with dementia to take holiday with uninterrupted care services. Having immense amounts of data transferred 
through the cloud also provides an avenue for complex analysis of large data repositories. When (anonymous) health data 
is collected, a wealth of information can be analyzed and used to further enhance services. Utilizing Big Data analysis can 
improve the quality of health care as well as improve decision making through evidence-based medicine, which in turn 
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provides an evidence base for policy. This is timely as the World Health Organization issued a report in 2012, urging the 
development of dementia plans that parallel searching for a treatment or cure with advancing evidence-based quality 
care [33]. These more recent advances do not have widespread use as of yet, largely due to major issues in data storage 
and security, system architecture, and service provision management. But they are on the horizon, and beginning a 
discourse on future trends in dementia care will highlight ambitions and contribute to setting goals for the future of 
dementia care services and evaluations. With a growing ability to optimize healthcare, advancements in technology will 
allow for both monitoring and treating in real-time, at the point of care [200]. The ambition is that health technology 
assessment will be as advanced as the technologies it is evaluating.  
In this study, caregivers noticed that the reminder service became less useful as cognition declined, and an interesting 
area of future research would be in the cognitive thresholds for using interactive services, such as reminders. This 
information would be beneficial for clinicians and caregivers as well as for the technical partners, who need well-defined 
user requirements. Another area of gerontechnology research that would be beneficial is in the use behaviors of 
caregivers checking the telecare portal (e.g. frequency, duration, type of information accessed). The success of future 
research projects in this area can be enriched through educating and training professional caregivers on research 
methods and the study design. This will help the caregivers to better identify information that is useful to the research 
and to recognize research outcomes that are useful to their profession. A deeper discussion on the outcomes for 
caregivers and the relevance for individuals, health and care providers, and policy makers can be found in Paper G.  
A substantial criticism when evaluating technology interventions in dementia care is that reliable conclusions are difficult 
to realize. This is often attributed to the challenges in collecting and interpreting data in a unified way (with many studies 
reporting anecdotal evidence), obtaining large enough sample populations, and due to the dementia and intervention 
outcomes being highly individualized. Another major impediment to assistive technology evaluation in dementia care is 
the lack of standardized ontology. Developing, utilizing, and evaluating technologies for dementia care involves the 
collaboration of engineers, health and social care professionals, citizens, psychologists, gerontologists, etc. Without a 
common language to describe the technical components and classify outcomes, it is difficult for multiple levels of 
professionals and users to comprehend the full scope. Furthermore, as the law of accelerating returns continues to be a 
force, it will become increasingly challenging to incorporate the expanded development in technological solutions. To 
date, there are no quality of life assessment tools that are dementia-specific and incorporate technologies as either as an 
influential aspect nor a mode to administer the assessment. Having a computerized procedure for evaluating telecare 
systems’ effects on end users (i.e. QOL), could facilitate drawing reliable conclusions by collecting and interpreting data 
in a unified way and allowing this to take place longitudinally and at the point of care.  
The analysis of the standardized assessment outcomes does not provide evidence that using technologies directly 
increases the quality of life of the older adults with dementia. However, one could start to speculate that improving the 
conditions and life quality of caregivers could have an effect on the individuals with dementia. As well, the benefit of 
assisting the caregivers in their tasks shows promise for future developments to meet the projected growing demand for 
dementia care. The responses to the additional questions show support for the hypothesis, that using technology in 
dementia care will have positive effects on quality of life. Since these responses were to global questions regarding feeling 
of change for quality of life, further investigation into how the participants define their life quality and how they feel the 
technology had improved life quality would be valuable research. The caregivers in the ISISEMD study perceived more 
positive outcomes than the standardized assessments captured, and it is likely that there are outcomes that could be 
measured more effectively than through physical functioning and burden. Future research into how participants arrive at 
their global conclusions, perhaps even allowing them to discuss the difference in outcomes they present in quantitative 
and qualitative, would provide a great amount of information on dementia care interventions and the relative usefulness. 
However, it is cautioned to keep the number of questionnaires to a minimum in order to avoid overloading the 
participants, and to carefully consider the psychological effects of the questions in the assessments. Understanding how 
the end users define and perceive their life quality would not only benefit the conceptualization of quality of life in 
dementia care, but provide some domains to integrate into the development of services. This would help to develop 
services that are meaningful to the end users as well as to target interventions to areas of quality of life to be enhanced. 
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Discussion summary 
The study successfully implemented and tested the telecare services in 4 European countries for over a year. The services 
were tested in real-life conditions and were tailored to accommodate the different organizational structures of care and 
the individual adults using the interventions. 7 standardized evaluation tools were used to assess the quality of life of the 
end users in both groups and the intervention group answered additional questions through non-standardized 
assessments of their acceptance and satisfaction with the system and services. Since quality of life has no gold standard to 
compare against, it was hypothesized that the range of assessments could provide a multifaceted portrayal of the effects 
on overall quality of life. The assessment tools evaluate a set number of indicators and looking at domains that are 
measured can provide a comparison for the changes which may be influenced by the technology. It should be considered 
that lengthy administration of the evaluations can cause stress and fatigue, and administration methods can increases the 
risk of carryover and order effects and interviewer bias. It was challenging to attain the required number of participants 
and the Denmark region did not have a comparative control group, presenting a risk to the internal validity of the 
research. Furthermore, one dyad was allowed to participate despite meeting exclusion criteria and some participants 
were switched from the intervention group to the control group when it was discovered that they lived in areas where 
internet-based services were not feasible. There were also more visits to the homes due to technical problems and more 
training than anticipated, which could have unintentionally influenced the outcomes. Multidisciplinary teams provided 
the advantage of sharing expertise across technical, governmental, social care, medical, and academic fields. Particularly 
in the first part of the project, formal caregivers found it challenging to explain or demonstrate the user’s problems to the 
technical partners. After several months, the consortium found a mix of professional languages where all could 
understand what was expected and what could be delivered through technical solutions. Overall, the ISISEMD project 
was an ambitious undertaking to create and implement a functional telecare system and evaluate quality of life outcomes 
in a span of 30 months. More challenges were faced than expected (both in regards to the technology and to the human 
aspects), and several tasks were more time- and resource-demanding than anticipated. In the pilot, the technical system 
achieved acceptable immediacy (alarms were triggered automatically), discretion (sending notifications to appropriate 
level of help, only immediate alarms are sent by text message), and flexibility (all services can be activated or deactivated, 
personalization of services). 
Several important differences in the IADL, SQLC, and ZBI instruments were identified during the research that have not 
previously been reported in the literature, and it is hoped that continued use and development in this area will provide 
stronger evaluation tools in the future. Although the gerontechnology intervention was well-received by the participants, 
the statistical analysis shows that the intervention did not have a significantly different effect than usual care. The 
qualitative feedback does not appear to reflect the quantitative results, which leaves doubts about the methods and their 
ability to detect meaningful outcomes. It is possible that the constructs that are measured are not influenced by the 
technology as hypothesized or that latent variables are influencing quality of life more than the intervention. Another 
explanation could be in the nature of determining the (clinical) significance of non-pharmacological and palliative 
interventions, especially as one technological device or service could serve multiple meanings to one person, and this will 
often vary between persons. Research in QOL is faced with the theoretical challenge of whether quality of life is 
considered a reliable and valid measure of the actual construct. Particularly when researching interventions for the care 
of chronic and degenerative conditions, consideration should be paid to evaluating not only negative outcomes (e.g. 
problem behaviors, burden, depression) but also positive outcomes (e.g. sharing activities, feelings of accomplishment, 
reciprocated bonding). This would provide a more holistic view of the situation and, therefore, possibly QOL as well as 
provide information on enhancing methods and outcomes that the dyad already find to be beneficial. 
There appears to be a disconnect between the advance in early detection and diagnosis of dementias and the essential 
requirement of accurate testing and appropriate treatments. There also appears to be a disconnect between the use of 
gerontechnology in dementia care and the support of significant, validated, benefits. As with most treatments and 
interventions for dementia, gerontechnology appears to have marginal positive effects. Exponential growth tells us that 
technology advancements will continue to benefit both diagnosing dementias and developing technologies that support 
the safety and well-being of people with dementia. Ambient Assisted Living and Smart Homes can promote healthy, 
independent living, and collect information on user patterns to adapt the home environment. Personalized devices that 
are increasingly connected to each other through ICT will enable individuals to interact with their community in new 
ways (i.e. Smart Cities, Cloud Computing, and wearable technologies). This is an exciting time in gerontechnology, and 
gerontologists are needed to envision and discuss future trends in dementia care, and to identify ambitions and set goals 
to influence the development of these services.  
 
6. Discussion 
106 
 
Key results: 
The comparative analysis shows a significant difference in caregiver burden between the caregivers. All of the dyads who 
show increases in caregiver burden (ZBI) also show significant declines in independent functioning (IADL). The control 
group shows a highly significant increase in caregiver burden and the intervention group shows a non-significant 
reduction in caregiver burden. This indicates that the technology intervention has positive effects on quality of life 
through reducing or preventing a significant increase in caregiver burden. Aside from protective effects in caregiver 
burden, the technology-supported care and usual care do not show significant differences in their outcomes. 
What this study adds: 
 Evaluation tools need more development 
o Current tests may not be measuring what is being affected by the intervention or what is 
important to quality of life. Both broad and specific research and development is need on QOL 
and dementia care outcomes are needed. 
 Conceptualization of QOL is necessary in order to compare results. 
 Technology is changing faster than research methods. It is advisable that gerontechnologists also 
contribute to standards and legislation (privacy and security) and public health (provision and access to 
services) in order to envision where and how gerontechnology capabilities will develop. 
Papers supporting Chapter 6:   
Paper D supports the discussion by giving the results of the mid-term evaluation and describing changes to the 
methodology from the original study plan. Paper F considers future prospects of using technology in dementia care, 
supporting the discussion on future directions in this area of research. Paper G contains the literature search for 
comparable ZBI outcomes and an expanded consideration of the clinical significance of outcomes in caregiver burden, 
including the relevance to individuals, care providers, and policy makers. Paper H describes the specific differences in the 
SQLC tool across the regions. 
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Chapter 7.  Conclusions drawn from the research 
Indeed, assessing quality of life is complex and poses some serious conceptual and methodology issues. Is “quality of life” 
a meaningless term? It does not appear so; in fact, it seems to have many definitions and even more meanings. Perhaps 
multiple conceptualizations are useful as they would allow the concept to be measured across different levels of human 
experience. The notoriously elusive definition could change from the micro to the macro level, from children to advanced 
old age, from healthy humans to those with specific maladies. It could be discipline-specific, population-specific, or role-
based in its meaning. Perhaps it is best to be determined by utility:  is the goal of assessing quality of life to predict, 
inform, or compare. This study used quality of life to compare between similar groups, meaning that the concept of QOL 
was role-based and serves as a comparison outcome. 
The conclusions in Chapter 7 associate this research to the wider sphere of application, rationalizing that even though 
this area of research is theoretically and practically challenging, the fact is that technology is becoming ever ubiquitous 
and the exponential growth of its application to health and social care warrants the development of efficient, cohesive 
methods for measuring and interpreting the implications of its use. The appendices contain auxiliary information, 
comprised of details from the background investigation, the questionnaires used in the research, papers that are included 
as part of the thesis, and supplementary data from the statistical analysis. 
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Without homogeny in the field of QOL research, comparing results across studies is difficult and conclusions drawn from 
comparisons are often consistent only to an extent. There are few studies that were long-term, real-life testing of 
technologies for dementia care. Those that do examine the relationship between technology use and care outcomes often 
consider a specific type of intervention, i.e. occupational or cognitive-behavioral therapy, and not necessarily a specific 
type of technology. It seems that many of the assisting technologies and telecare services are aimed at accommodating for 
functional declines. If the full spectrum of the self-reported QOL domains from individuals with dementia is to be applied 
in future research, there are several domains that are not explicitly addressed in the evaluation tools. As discussed in the 
theory section, activity theory draws a positive correlation between activity and life quality, which reduces QOL to a range 
of activities and neglects to explain how the paradox of aging could exist for adults with dementia. Human experience 
consists of more than quantitative results and further development in assessment methodologies is needed to be able to 
portray a more realistic situation. At the same time, the majority of ATs are directed towards the physical care needs, 
such as the basic and instrumental activities of daily living. True, these are important aspects of care and certainly an 
area where technology can be tailored to fit the requirements of the user, but addressing physical care needs is only 
touching a portion of the domains of quality of life. Investigating the enrichment of (person-centered) life quality and the 
(biomedical and psychosocial) management of decline expands the evidence base and ensures that the intervention 
addresses the unique, individual psychosocial issues as well as physical and mental health. Furthermore, this supports 
that research efforts are focused on interventions that are effective for individuals with dementia and their caregivers to 
receive appropriate services that they are motivated to utilize. Studies on quality of life in this population have yet to 
separate from activity theory, as many assessment tools use engagement in activities as markers indicative of life quality. 
With the accelerated advancement of technology, those who develop health technologies could serve their patient 
populations by also integrating the psychosocial user requirements and addressing the domains identified as influential. 
It is complicated, arduous work, which most likely takes years to realize, but it is a worthy goal to develop services that 
also address attachment to place, feelings of usefulness, and self-image. There are possibly better tools to use and better 
methods for such research, and the continued development will be exciting. 
This thesis focused on the quantitative results of testing the effects on quality of life from technology interaction in 
dementia care in order to add to the evidence base. In order to build confidence in the external validity of the results, the 
variables have been defined, the standardized tools are acceptable to measure the constructs, the methods are 
appropriate for the type of research, the results are applicable within their stated ranges, the effectiveness of the 
intervention is reported through quantitative results, the usefulness of the intervention is reported through qualitative 
results, and the theoretical analysis allows for analytic interpretation. Similar to previous research on technologies in 
dementia care, this study is hampered by methodology weaknesses. Although research in this area is known to be 
complex and unpredictable, other researchers could learn from the methodology and technical setbacks that ISISEMD 
experienced. There is evidence of performance validity that the intervention would be comparably useful in some similar 
cases. The telecare intervention was perceived as useful, and the overall non-significant difference in outcomes also 
means that the gerontechnology is not less effective than usual care. There is not strong evidence to reject the null 
hypothesis, and, based on the threats to the internal validity, the relationship between gerontechnology use and the 
positive effects in caregiver burden are cautiously interpreted from the data.  
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Appendix 1 Papers 
This thesis has been submitted for assessment in partial fulfillment of the PhD degree. The thesis is supported by 
scientific papers and parts of the papers are used in the thesis. Co-author statements are available to the assessment 
committee and to the Faculty. The papers have been reformatted to fit the style of the thesis. Coauthor agreements of the 
PhD student’s contribution are included. 
Papers included in Chapter 2:   
Paper A supports the background by providing a discussion on theories used to understand older adults’ experiences of 
interacting with technology and Paper B discusses the background work on quality of life studies and identifies influential 
domains of QOL for individuals with dementia. Paper F present a description and discussion of research projects focused 
on gerontechnology. Paper D offers a discussion on instrumental work in quality of life studies, environment as a 
mediator for activity, and theoretical motives for the interventions. Paper E also describes a search for quality of life 
measurement tools. Paper F considers the accelerated co-development of technology and society and the opportunity for 
technologies to support people with dementia. 
Papers included in Chapter 4:   
Paper B supports this chapter by discussing a prototype for an electronic quality of life assessment for use in dementia 
care. Paper D describes the ISISEMD development, implementation, and evaluation methods, and by explaining the 
services. This paper also describes baseline and intermediate results of the trial. Paper E reports a literature search for 
dementia-specific quality of life assessment tools that could be used to evaluate telecare impact. This paper also considers 
revisions to the proposed electronic QOL assessment prototype. Paper F presents a cutting-edge description of 
gerontechnology use, evaluation, and continued development that is accelerated through advancements in technology, 
indicating a need for electronic QOL assessment methods. Papers G and H additionally describe the ISISEMD 
methodology. 
Papers included in Chapter 5: 
More information on the outcomes from the project can be found in Paper D, Paper E, Paper G, Paper H, and in 
ISISEMD project reports. Paper D presents results up to the mid-term evaluation of the ISISMD project and includes 
qualitative information from the participants. Paper E presents outcomes as well as lessons learned from the research 
project. Paper G specifically addresses the outcomes in caregiver burden, including qualitative information, and Paper H 
focuses on outcomes for caregiver quality of life. 
Papers included in Chapter 6: 
Paper D supports the discussion by giving the results of the mid-term evaluation and describing changes to the 
methodology from the original study plan. Paper F considers future prospects of using technology in dementia care, 
supporting the discussion on future directions in this area of research. Paper G contains the literature search for 
comparable ZBI outcomes and an expanded consideration of the clinical significance of outcomes in caregiver burden, 
including the relevance to individuals, care providers, and policy makers. Paper H describes the specific differences in the 
SQLC tool across the regions. 
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Paper A:  The phenomenological experience of dementia and user interface 
development 
 
Carrie B Peterson, Anelia Mitseva, Albena Mihovska, Neeli R Prasad, and Ramjee Prasad 
Center for TeleInFrastruktur (CTIF), Aalborg University, and North Denmark European Office 
Aalborg, Denmark 
cbp@es.aau.dk; aim@aalborg.dk; albena@es.aau.dk np@es.aau.dk; prasad@es.aau.dk 
Abstract— This study follows ISISEMD through a phenomenological approach of investigating the experience of the 
Human Computer Interaction (HCI) for someone with dementia. The aim is to accentuate the Assistive Technology (AT) 
from the end user perspective. This paper supports that older adults and those with dementia should no longer be an 
overlooked population and how the HCI community can learn from their experiences to develop methods and design 
interfaces which truly benefit their target population. Guidelines from previous research are incorporated along with 
eclectic, user-centered strategies as the interface designers for project ISISEMD develop appropriate and effective 
modalities. 
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Paper B:  Framework for dementia quality of life assessment with assistive 
technology  
 
Carrie B Peterson, Neeli R Prasad, and Ramjee Prasad 
Center for TeleInFrastruktur (CTiF) 
Aalborg University 
Denmark 
{cbp; np; prasad} at es.aau.dk 
ABSTRACT 
This paper proposes a theoretical framework for a Quality of Life (QOL) evaluation tool that is sensitive, flexible, 
computerized, and specific to assistive technology (AT) for dementia care. Using the appropriate evaluation tool serves to 
improve methodologies that are used for AT assessment, development and improves the understanding of how health 
technology outcomes affect overall care. It will largely serve to develop the competence of technology assessments 
through a more efficient procedure for evaluation. One of the many challenges to assessing QOL is that results are 
subjective and difficult to analyze in an objective, empirical manner. This paper accentuates that this is not a hindrance 
to measuring OQL, but could be emphasized and adapted to create a precise measurement tool; the end-user voice must 
be sought and empowered in determining functional definitions and indicators for QOL. Current QOL measures inspired 
recommendations for a future assessment tool in order to assist investigators and clinicians in selecting the optimal 
method for their needs. The proposed framework is evaluated by means of a theoretical analysis focused on future 
applications, with particular regard to the influx in assistive technologies and their implications as therapeutic 
interventions for dementia care. 
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Paper C:  Easy Life, Intelligent Systems, and LIFE 2.0:  European research on 
ICT for aging adults  
 
Carrie Beth Peterson, Neeli Rashmi Prasad 
Center for TeleInFrastruktur, Aalborg University 
Aalborg, Denmark 
cbp@es.aau.dk; np@es.aau.dk 
ABSTRACT 
Lack of access and accessibility have been two of the largest impediments for older adults and Information and 
Communication Technology (ICT) use, resulting in reduced computer skills, lack of motivation, and aversion to new 
technologies. By looking at these influential barriers, we can see that this is partially due to technologies being designed 
and marketed towards the younger generations and do not allow for inclusive design. Aging is usually not considered 
when designing mainstream products and there can be a distinct lack of industry awareness about the cohort’s 
capabilities. Additionally, even when Assistive Technologies (AT) are developed specifically to help marginalized groups, 
a lack of interoperability can hamper uptake. 
 
Since the 1990’s, the European Union has contributed to the development of eHealth and this has helped to place Europe 
as one of the leading world investors in the field. As a result, the EU is utilizing industrial, scientific, and social resources 
to accelerate product and service synchronization. Innovation and development in these areas not only benefits European 
citizens and residents, but also strengthens the European industry market. 
 
ICT sectors are experiencing a growth in the needs and marketability of tools and services designed specifically for older 
adults. If a service is offering opportunities to emphasize resources and capabilities already available, research must 
incorporate design and functionality requirements and preferences of aging adults. This can help to improve or maintain 
QoL, allow for aging in place and independent living, increase socialization through connection services, and reduce cost 
of care burdens expected with the increase in aged proportions of global populations. 
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The incidence of cognitive impairment in older age is increasing, as is the number of cognitively impaired older adults 
living in their own homes. Due to lack of social care resources for these adults and their desires to remain in their own 
homes and live as independently as possible, research shows that the current standard care provisions are inadequate. 
Promising opportunities exist in using home assistive technology services to foster healthy aging and to realize the unmet 
needs of these groups of citizens in a user-centered manner. ISISEMD project has designed, implemented, verified, and 
assessed an assistive technology platform of personalized home care (telecare) for the elderly with cognitive impairments 
and their caregivers by offering intelligent home support services. Regions from four European countries have carried out 
long-term pilot-controlled study in real-life conditions. This paper presents the outcomes from intermediate evaluations 
pertaining to user satisfaction with the system, acceptance of the technology and the services, and quality of life outcomes 
as a result of utilizing the services. 
 
1. Introduction 
Dementia is a group of syndromes associated with a loss of memory and other intellectual functions that are serious 
enough to interfere with daily task performance. There are around 40 types, or causes, of dementia, the most widely 
known being Alzheimer’s disease. Dementia is commonly associated with aging as the risk for exhibiting symptoms of 
dementia increases with age, nearly doubling every 5 years after the age of 60. The chances of having dementia over the 
age of 65 are one in 50 and that increases to one in 5 for those over 80 years and up to 50% in adults over age 85 [1, 2]. 
Mild cognitive impairment (MCI or CI) is closely related to dementias. Plassman, et al. [3] found in their follow-up study 
that of their participants who had CI and no dementia, nearly 12% advanced to dementia annually. Although MCI is often 
viewed as a precursor to developing dementia, the relationship is not fully understood.  
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With advancements in medicine, economy, and technology, the human lifespan has increased significantly over the last 
decades; additionally, dementia rates have increased [4] and this poses questions about the quality of extended years of 
life. In the context of ISISEMD project, we use quality of life (QOL) to mean “the individual’s perception and evaluation 
of the impact that the disease and its consequences have produced in their lives” [5]. As there is no cure for dementia and 
current treatments serve only to reduce the debilitating effects, a major area of focus in this type of caregiving is on 
maintaining or increasing patient QOL and reducing care-related stress. 
 
By and large, the majority of informal caregiving is carried out by persons (usually family members, close friends, or 
neighbors) who have not had any formal training in caregiving and do not receive any economic retribution for their 
tasks. Both as individuals and as society as a whole, it is not possible to pay for the costs that informal caregiving 
mitigates from formal caregiving services. Needless to say, informal caregivers provide an invaluable service that is 
impossible to remunerate; they are the backbone of long-term care. To be a family caregiver for an older adult with 
cognitive impairment is a heavy task that comes with financial implications for the individual families as well as society, 
as well as the majority of the cases resulting in increased emotional and physical stress. 
 
Aging in one’s own home is a growing demand among baby boomers and the related technological solutions are market 
estimated at €14 Billion by 2020 [6]. The idea of aging in place is not a new one, yet only recently have governments and 
organizations started working towards incorporating appropriate solutions, one of the main modes is through 
information and communication technology (ICT) for aging, also known as gerontechnology. The inspiration of tele-
home care is to have the home environment modified in order to meet the increasing care and safety needs and to reduce 
forced relocation, which often leads to transfer trauma and relocation stress syndrome. Instead of older adults selling 
their homes and moving into retirement communities or care institutions, home modifications allow the living 
environment to become user-friendly to aging adults [7]. The European Commission (EC), in collaboration with the 
Member States, has recently put more focus on the coming challenges of care for older adults with this type of disability 
living in their homes. Likewise, many governments are now focusing on ICT systems for supporting the elderly and 
chronically ill to live as independently as possible and to help citizens to be treated and/or cared for safely in their own 
homes. The European Commission has supported a Policy Support Program (PSP) pilot study exploring the use of 
Assistive Technologies (ATs) for the care of older adults with cognitive impairment (CI) by co-funding the ISISEMD 
project. ISISEMD has taken a holistic approach — examining and meeting the needs of the elder/caregiver dyad as a 
whole. Project ISISEMD (intelligent system for independent living and self-care of seniors with cognitive problems or 
mild dementia) [8] concentrates on adults over the age of 60 who have a documented history of CI and their caregivers. 
The project has developed and tested an innovative set of scalable technologies for the purpose of easing the caregiving 
and care receiving activities associated with dementia care and to have a positive effect on users’ QOL. The project was 
30-months in duration from March, 2009 to August, 2011, and involved 12 partners representing end-user organizations 
(Municipality of Frederikshavn — Elderly Care Department from Denmark, Belfast Health, and Social Care Trust from 
UK, Municipality of Trikala from Greece, Municipality of Lappeenranta-Health and Social Care Department from 
Finland), industrial organizations (Hewlett Packard-Italy, Alcatel-Lucent-Italy), SMEs (Converge ICT Solutions from 
Greece, Eltronic from Denmark, Socrate Medical from Italy ), academia (Aalborg University from Denmark, National 
Technology University of Athens from Greece), and one public office (North of Denmark EU-Office from Denmark). 
During the first year of the project, the focus was to design, adjust, and implement the services which were installed in 
participants’ homes during the second year. The services were tested in four European countries (Denmark, Finland, 
Greece, and UK) in real-life conditions and with the three main end-use groups – elderly with CI, their informal 
caregivers, and the formal caregivers. 
 
ATs for dementia care in the ISISEMD project encompass a broad range of devices that currently exist on the market, 
from a touch screen computer and sensors to determine ambient functions such as temperature, movement, fire/smoke, 
cooking activity to Global Positioning Systems (GPS) to determine where a person is in real time. The aim is to use 
accessible technologies in a new way so that the user-friendliness and interoperability of such systems is increased. The 
goal of all, however, is to maintain or increase the safety of the person living with CI and to have a positive effect on the 
QOL of all involved. 
 
The contribution of this paper is to present results from a controlled study carried out in real-life conditions with older 
adults with CI and their informal caregivers (ICGs) from four European pilot sites. Their homes were installed with the 
technical equipment that gives them and their informal caregivers possibility to use innovative home support services for 
a period of more than six months. The controlled study was carried out for 15 months, with intermediate and final 
evaluations. Results from the intermediate evaluations of the services are presented in this paper, with a focus on 
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informal caregivers and from user acceptance and satisfaction of the technologies view point. Moreover, an analysis of 
the influence on the QOL and the stress of caregiving for the family caregivers are provided. 
 
The rest of the paper is organized as follows: in Sections 2 and 3, we give an overview of the experience and stress of 
caregiving and how the ISISEMD services can help the informal caregiver and their relative with CI. In Section 4 we 
shortly present different aspects of the assessment methods. The main contributions in this paper are presented in 
Section 5—primary and secondary outcomes from intermediate evaluations for QOL, stress of caregiving and user 
satisfaction and acceptance of the AT services. The paper ends with discussions of the findings in Section 6 and 
conclusions in Section 7. As a qualitative feedback from the controlled study, the voice, and perception of test persons 
and their informal caregivers is presented in the appendix by “success stories” from using the home services. 
 
2. Caregivers and Society Experience Caregiving Stress in Dementia 
Individuals who have conditions resulting in chronic illness or disability often face challenges in carrying out their daily 
activities, such as meal preparation, bathing or transportation, which involves a considerable amount of time, devotion, 
perseverance, and patience to perform these tasks. In most dementia situations around the world, caregiving is carried 
out informally by family and friends. Statistically, the majority of ICGs are female family members and most often the 
middle-aged child or spouse of the person with CI [9, 10]. Assistance to the person with dementia is generally provided 
by a single caregiver and this responsibility lasts for an average of 5 years [11]. Caregiving is typically delivered (as long as 
possible) in the residence of the dependent person on a continual basis, ranging from personal safety and psychological 
support to physical care, such as hygiene. Members of the caregiving/supporting team determine who will provide care 
and in which roles and what resources are available; however, caregiving for dementia is rarely a straightforward and 
static arrangement. The total hours of caregiving per week can easily exceed most national standards for fulltime 
employment, especially in the advanced stages of the process, as the person becomes increasingly dependent and 
requires daily, continuous assistance. For many caregivers, the requirement of full-time help often results in a decline in 
the ICGs personal and professional life, ability to manage the household(s), and to perform the range of care and 
personal activities. 
 
It is well documented that the caregivers of persons with dementia experience substantial stress from the caregiving tasks 
they perform [9] and the need for permanent care to the chronically disabled person often leads to a decrease in the QOL 
of caregivers [12, 13]. De Vugt et al. [14], Bauer et al. [15], and others in the field report negative effects on ICGs QOL 
when compared to non-caregivers. According to Deeken [16], the stressors and their resulting effects on ICGs also 
influence when and why ICGs seek out formal caregiving (including institutionalization). In 2008, Adams [17] reported 
that caregivers are more likely to experience depression, anxiety, and physical health issues when compared to non-
caregivers, while also reporting less hope for the future, less happiness, less enjoyment of life and greater degrees of 
sadness, being bothered, and loneliness. Since CI and dementia are typically chronic in nature and there is no determined 
end point of the care needs, caregiving is correlated to reduced physical, psychological and social health [18]. Due to 
research in this area, informal caregiving is respected as a critical stress factor; this is one area of focus that ISISEMD is 
developing solutions for. It is not uncommon that ICGs often experience greater measurable benefits from the use of AT 
than those with dementia themselves. A commonly accepted theory for this phenomenon is that awareness and insight 
into the situation is one major factor influencing fluctuations in QOL, and where those with decreased cognition 
experience an increasing lack of awareness and insight, it becomes more difficult for them to assess their QOL status. 
Meanwhile, the ICGs (typically) maintain their awareness of the situation and thus experiences greater stress from its 
increasing demands as the illness progresses. Furthermore, due to the increasing stress for ICGs, they often project 
negative attitudes on to the elderly persons (EP) QOL and typically rate their loved one’s QOL as lower than the person 
would rate it themselves. This may be due to evaluating EPs QOL as ICG sees it versus as how EP sees it or to anticipating 
that with increasing need for care, QOL will decline. The exact nature of these observations is confounded and an area of 
focus in gerontology and caregiving research that ISISEMD hopes to provide insight to. 
 
It is well known that a disabled person may often disorganize the life of the family, disrupting the previous balance; it is 
also well known that caregivers of persons with dementia experience substantial stress from their caregiving tasks. The 
concept of the “burden of care” was defined by the American gerontologist Zarit in 1985 [19], as the discomfort 
encountered by the primary caregiver of an older family member during their caregiving duration. Caregiver burden 
includes the caregiver’s health, psychological wellbeing, finances and social life, among others. Since 1985, there have 
been numerous studies demonstrating the negative impact of increased caregiver stress on the person with dementia as 
well as caregiver’s overall health [9]. During ISISEMD project, we have observed that the term “burden” has a negative 
connotation and impact on the family caregivers who care for their relative because they care deeply for them and choose 
to carry out these activities themselves. However, as caregiving inherently causes extra stress in their everyday life and 
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this is one of the parameters measured during the project, we use the term “stress” and not “burden” as a more accurate 
and respectful terminology. 
 
By introducing ATs to the care situation, ISISEMD project aims to have a positive impact on the informal caregivers and 
the society as a whole; below, we list the foreseen added value for them. 
 
Foreseen value for the ICGs as a result of using ISISEMD technology services:  
i. reduction or maintenance of the level of the caregiving stress; 
ii. information on the location of their EP when outdoors; 
iii. interaction with the services is easy to manage and with high level of individualization, accommodating ICGs 
who may not have previous experience with computers, also offering initial default settings; 
iv. means to communicate with EP remotely (through video service, mobile phone, or Lommy); 
v. increased feeling of safety regarding the living environment of EP; 
vi. increased feeling of satisfaction in caregiving responsibilities; 
vii. ability to allocate more time for example personal hobbies and social activities. 
 
Foreseen value for society as a result of using ISISEMD technology services: 
i. financial diminution by saving time and expenses for traveling to and from EP home and for making 
telephone calls; 
ii. reduced health and social care costs for the local communities; 
iii. transfer of tasks between caregivers, which includes untrained ICGs to be able to perform caregiving 
responsibilities with enhanced or new methods; 
iv. ability for the formal caregivers (FCGs) to provide better quality care and/or care for more clients as tasks 
become less demanding through the technology; 
v. creation of business opportunities; 
vi. influence on health and social care policies.  
 
Most gerontologists understand caregiving stress to be an outcome of the caregiving situation and as being dependent 
upon variables presented in the situation and in the caregiving relationship. These stressors are also influenced by the 
coping strategies of the caregivers. As mentioned, caregiving for a cognitively impaired person, especially a family 
member, can be straining. It is not uncommon for such caregivers to experience physical symptoms, such as sleep 
deprivation, lapses in memory themselves (which can also be a sign of depression), or social isolation due to reduced 
hours spent on free-time activities. There are resources for caregivers, such as respite programs, but these are not 
accessible or acceptable in every area. They may come with an unwanted stigma or be out of the caregiving budget. These 
factors may also increase the stress a caregiver experiences in their role. Furthermore, when a threshold for stress is 
reached, negative behaviors and feelings — however unintentional they may be — can spill over into the caregiving 
relationship. At the family (micro)level, solutions to support caregiving tasks and health and psychosocial consequences 
are needed. Research on corroborating programs and services aimed at delivering knowledge, skills and support to the 
caregiving experience can in turn promote policies (macro level) to ease the strain of caregiving on the individuals as well 
as society. 
 
3. ISISEMD Services—A Helping (Automated) Hand from Technology 
The ISISEMD services are related to supervising the conditions of the home and any alarming behavior of the person 
with dementia. The system is nonintrusive, it yet provides a way to alert the elderly themselves as well as caregivers and 
emergency services if there would be an event that may pose a danger to them. The ISISEMD system is comprised of 
several technologies that communicate with each other and interoperate on the platform. One of the technical design 
goals was to utilize existing technologies (computer, GPS device, pressure, and smoke/fire sensors, etc.) and provide a 
way for them to interact intelligently. This increases the feasibility of introducing new technologies and services to the 
platform as they will be developed in the future as well as ensures that presently accessible (and affordable) equipment 
will not necessarily become obsolete as soon as newer technology is available, helping to reduce the costs of purchasing 
and maintaining the ISISEMD system. As the devices are integrated into one service platform, they operate in an 
automatic and intelligent manner, recognizing patterns of behavior (e.g., sleep habits and average room temperature) 
and noting fluctuations that may signal a change in status or potential danger. For the caregivers, this means that they 
can spend less time and energy worrying and “checking in” on their older adult because they will be alerted by the system 
when their physical interaction is required. 
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There are two categories of equipment in the ISISEMD system:  interactive devices and non-interactive devices. The 
majority of the devices in the ISISEMD platform is non-interactive and includes temperature and flood sensors, smoke 
alarms, electricity monitors for cooking activity, pressure sensors to determine sleeping patterns, and front and fridge 
door sensors. The interactive devices are chosen or designed to be easy for the end-user to operate; due to the nature of 
the involvement being a gerontechnological system, masking the intervention was not possible and the telecare platform 
was visible and interactive to end users. In particular, the devices that the older adult with cognitive impairment operates 
require minimal interaction or no interaction at all. These include the Carebox (HP Touch Screen computer), Lommy 
(simple GPS device) with only one button which sends and receives phone calls, and internet connection, which is 
provided to the end users through the project funds. A number of the functions and services of the platform are easier to 
access than current mainstream technologies for people with dementia.  
 
The interactive devices are those which exchange contents when prompted by the user and are under the user’s control. 
Examples of interactive devices are for ICG-mobile phone, web portal access on a computer; for EP GPS device and a 
touch screen.  
 
The non-interactive devices are those that, once installed by a technician, do not require any user manipulation. 
Examples of non-interactive devices are home automation controllers including flood detectors, and fire sensors. 
 
The Carebox Touch Screen serves as the graphical user interface to provide information to EP at home. To accommodate 
different user needs, there are three levels of interaction of EP with the Carebox: no interaction at all (EP does not need 
to press any button, just needs to notice the screen from time to time); some interaction via “soft button” — in this case a 
distinct Help Button is shown on the Carebox that EP can activate; more advanced interaction — additional “soft button” 
for confirmation of an activity can appear or a Brain game can be played. There is also the possibility to add the Memory 
Lane service (picture slide show) and a video-call service. The view of the Carebox possesses a high level of flexibility and 
individualization, too – depending on the health status of EP, the “Help Button,” the Brain games, the Memory Lane, and 
the video-call service may be removed from it. Figure 1 depicts the Carebox view with the highest level of interaction. 
 
Figure 1: Screen shot of the Carebox with the Help and Confirmation button from the Reminders Service 
and Memory Lane and Brain Game. 
 
The computer of the Carebox also collects data from the sensors installed in the home and the data is sent over the 
Internet to the ISISEMD web portal. Following the required ethical, privacy, and security requirements, EP designates 
the caregivers that are allowed access to the web portal, where they can view only the information that is related to that 
EP. Depending on the user’s preferences, the system can automatically send notifications, alerts, and alarms to ICG and 
FCG via SMS text messaging or email. Almost all possible aspects of the services are easy to be personalized, based on the 
individual, current needs of both EP and ICG. It also notifies EP via the Carebox Touch screen if there is a dangerous 
situation in the home. 
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Automatic services for EP include: 
i. home and personal safety observations, such as notification if fire/smoke is detected in the home or the front 
door is left open or a cooking activity is going on for too long;  
ii. reminders and prompts for basic daily activities such as meals and medications; 
iii. predefined reminders exist but there is also the possibility to enter and show personalized “free text 
reminders,” such as “Marie is coming to visit at 15:00;” 
iv. locating service when the person is out of the home so that caregivers can find them if they become 
disoriented; 
v. reality orientation by displaying the date and time on the Carebox. 
 
Ad hoc services for EP include: 
i. cognitive stimulation (Brain Games that can be played on the Carebox); 
ii. reminiscence activities (Memory Lane shows a slide show with family pictures on the Carebox); 
iii. video communication with caregivers at the touch of a “soft” button showing telephone image on the 
Carebox touch screen; 
iv. automatic contact button when in the home (soft “Help” button on the Carebox touch screen); 
v. automatic contact button when outside the home (red button on the Lommy device). 
 
Automatic services for IGCs include: 
i. alerts, notifications, and alarm services delivered to mobile phone or email; 
ii. request for help/contact from EP when EP is in the home; 
iii. request for help/contact from EP when EP is outside home, also providing information for the current EP 
position; 
iv. alert if EP has fallen when outside home. 
 
Ad hoc services for ICGs include: 
i. through the ISISEMD web portal, ICG can see an overview of daily activities, notifications and alarms raised 
by the system; 
ii. through the ISISEMD web portal, ICG can see an overview of activity history (lifestyle pattern); 
iii. video-call service for communication with elderly; 
iv. call to the Lommy device when EP is out of the home; 
v. locating EP outdoor via the Lommy GPS device through the ISISEMD portal. 
 
The following paragraphs give more details about the ISISEMD services, defining them and their role in the home care 
environment. In total, ISISEMD offers a possibility of 17 services, which can be selected depending on EP and ICG 
desires. In this way, the system can provide better support via increased care assistance which is accommodating to the 
progression of the dementia impairments. More technical information for the services is provided in [20]. 
 
3.1. Service Information for the Informal Caregivers 
3.1.1. Scheduler.  
The scheduler enables ICGs to define the parameters (time period, temperature, dangerous versus harmless behaviors, 
acceptable distance or time away from the home, etc.) which will activate alarms and alerts in accordance with the 
identified needs of individual elderly person. 
 
3.1.2. Home Safety. 
This application facilitates home automation by using alerts, alarms and sensors at the home to facilitate the home safety. 
Incorporated into this service are kitchen equipment (stove and oven) control, flood, smoke and fire sensors, front door, 
and other equipment or situations that may pose physical threat. The electric cooking guard keeps measurements of the 
time, temperature, and electric current going to the stove and oven. This gives the consumer a predefined time span to 
use the stove (i.e., 45minutes), after which, an alert is shown on the Carebox screen and voice notifies the elderly about 
the cooking activity, giving them the chance to react. If the cooking activities have not stopped after another predefined 
time period, the system automatically sends an alarm to the informal caregiver. 
 
3.1.3. Nocturnal Movement Detectors.  
The bed occupancy sensor generates an alarm if it detects that a user has been out of bed for more than a normal period 
of time, subject to their individual habits. For example, the sensor can register an alert if EP starts leaving the bed several 
times during the night. This could signify that they are using the toilet more often — which could require a change in 
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medication, or if they are experiencing nighttime wandering — which could signify a change in cognition, or if a person 
has not returned to bed—which could indicate they have fallen down while out of bed. 
 
3.1.4. Alerts.  
An alert is when the caregiver will be notified of the information but a response is not urgent. This information requires 
some follow-up to be carried out within a preset period of time. This includes: the refrigerator has been left open, front 
door has been left open, water was left running, the stove has been left on, EP is out of bed for several hours during the 
night, and so forth. By setting individual parameters through the scheduler, the system is set up to interpret the 
information transmitted from the sensors and distinguish between a normal activity pattern and unusual activity, which 
may indicate a change in EP’s condition or needs. This enables caregivers to investigate the reason for the change and 
provide appropriate assistance and amend their support plan accordingly. 
 
3.1.5. Alarms.  
Alarms are sent to caregivers in case of events they wish to know of right away, such as if EP has left the house in the 
middle of the night. The alarm service can be activated automatically and on demand as the alarm sensors are connected 
to the central unit (from the Carebox computer in the home to the ISISEMD web portal) and a message informs the user 
about the nature of the alarm.  
 
Alternative alarms and message flows with escalation can be foreseen in special cases (e.g., the relative is traveling abroad 
or is unavailable on their mobile phone) so that critical issues can be addressed properly. The alarm service itself is not 
only a simple event, notification or message, it can be an overall history of such messages that provides valuable 
information to the caregivers. 
 
Alarms that require immediate action include: 
i. door alarms — the house can be equipped with door alarms which can send an alert when the front door is 
opened (e.g., if EP is not safe to leave the home alone) or if there is unusual activity with the door (e.g., if EP 
leaves the home at odd hours, such as middle of the night); 
ii. refrigerator and cooking monitoring alarm — this generates an audio alarm for EP when the refrigerator 
door has been left open for a specific period (e.g., longer than 7 minutes) and automatically sends an alarm 
to ICG if the door is not closed within a specific period from when the audio alarm is generated (e.g., 
refrigerator door has been opened 7 minutes and the 1 minute audio alarm to EP has not resolved the issue). 
The audio alarm is only generated for a specific period and stops once the alarm has been sent to the 
caregiver. This also enables the recording of a pattern of opening and closing of the fridge to gain perspective 
of the daily habits, for example, if EP is eating meals at appropriate times. The cooking monitoring alarm is 
operating on the same principle — after detecting that the stove is on longer than the predefined time period, 
the system displays an alarm message on the Carebox screen, thus giving the elderly the opportunity to react 
and turn off the stove or oven. The caregiver receives an alarm only when the cooking appliances are still not 
turned off;  
iii. smoke, fire, and flood alarms — these signify imminent danger and audio alarms are generated in EPs home 
as well as alarms sent to caregivers. 
 
3.2. Service Information for the Elderly 
3.2.1. Reminders on Carebox.  
The Carebox Touch screen computer installed in the participant’s house displays text with reminders and relays attention 
sounds or prerecorded audio messages. The service is automatic and the user can see the reminder text and hear the 
attention sound and/or the voice prompt for the activity on the Carebox they are responsible for and enforce the 
structure of the daily routine. This aspect of the ISISEMD system is as non-interactive as possible, as people with 
dementia have difficulty learning to use new devices. The alert tells and shows if there is an upcoming appointment, 
meal, medication, or task. Reminder alerts could be used to prompt EP to take medication, prepare meals, attend an 
appointment or remind them of planned visitors to their home. Reminders can be automatically repeated multiple times, 
at short intervals. The Carebox is also automatically showing the next two events that elderly need to perform under a list 
of next events, but never more than 2 events at a time to avoid invoking anxiety or confusion. Furthermore, the Carebox 
always displays the date and time to help orient EP. 
 
Caregivers — or possibly the elderly person, if they are able — could make a change to this schedule or enter new 
reminders and events (i.e., Happy Birthday), which can be accessed via the portal at any time. There is also an option for 
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ICG to request a confirmation to a specific reminder/activity, such as taking medications. In this case another soft button 
appears on the Carebox screen and if not pressed, the system automatically sends information to ICG (see Figure 1). 
 
3.2.2. Memory Lane with Personal Pictures on Carebox. 
This is a picture slide show that is shown on the upper right corner of the Carebox. The ICGs upload pictures and there is 
the possibility to write a short title to be displayed with each picture and the speed of the picture show can be adjusted. 
EP does not need to interact with this service but it is hoped that it will stimulate memories, conversations and reinforce 
their sense of self. 
 
3.2.3. Brain Games on Carebox.  
This service provides the EP the possibility to play Brain games on the Carebox, such as word finds, appropriate puzzles, 
etc. The type of game can be selected by formal or informal caregiver via the web portal. 
 
3.2.4. Video-Call Service.  
This service is mainly initiated by a caregiver — when a video call is displayed as incoming on the touch screen, EP can 
hear a traditional telephone ringing sound and can accept the call simply by pressing one “soft button” on the screen. If 
desired and able, EP can also use this service to make calls. 
 
3.2.5. Outdoor Safety with the Lommy GPS Device.  
The required technologies for this service are a GPS positioning system and GPRS communication. The GPS is useful if 
the client has a tendency to get confused or disoriented when they are outside the home. When EP leaves the home, they 
take the Lommy device with them. Through this device, they are able to contact their caregiver and can be located should 
the need arise. The GPS is activated when the elderly person leaves the home, and the caregiver can see their positioning 
on a map by logging into the ISISEMD portal. By pressing the red button (the only external feature on the Lommy), the 
Lommy sends a sms with the current position or directly calls the ICG (depending on the individualized settings); 
alternatively, ICGs can call back the Lommy as a regular telephone number and EP only needs to press the red button to 
activate the communication. 
 
Alarms — an alarm is generated when EP presses the red contact button; has left the “safe” geographical area; EP has 
fallen down; and to signify low battery level. The device is about the size of a deck of cards and is fitted to an item the 
person would normally take with them when they go out, such as in the jacket pocket or purse. Additionally, we have 
found that placing a large picture of the device near the main door helps to remind EPs to take the device with them. 
 
4.Methods of the Assessment 
4.1. Primary Research Outcome.  
The project is classified under the PSP Theme 1 (ICT for user-friendly administration, public services, and inclusion) and 
states a strategic objective of using ICT for aging well with cognitive problems by combining assistive and independent 
living technologies. Primary research outcomes consist of measuring the impact on QOL and caregiving stress in end-
user groups. With respect to independent living, the aim was to demonstrate that clients can independently live longer 
and safer in their own home environment through the Assistive Technologies of ISISEMD. Furthermore, as ISISEMD 
develops assistive technologies and services, user satisfaction and acceptance were examined to assess how the end-users 
perceive the set of technologies as well as the services. More information for the evaluation framework for impact 
assessment of the services is provided in [21]. 
 
We defined the following research hypotheses: 
(H1) if the personalised services offered by the ISISEMD platform are based on each client’s specific needs, then the 
feeling of safety, ability for independent living in their home environment, hobbies, and lifestyle will have a 
positive impact on QOL; 
(H2) if the services supporting the informal carers will reduce care-related stress then a positive impact on their QOL, in 
particular increased feeling of safety, and reduced rates of stress levels, will occur; 
(H3) if the regional care providers will be able to offer social services to these groups of clients which are currently not 
included in the traditional care model, then there will be an increase in the access to and quality of social care. 
 
Target variables and expected results: 
(a) increased QOL and feelings of safety, reduced care-related stress, and maintained cognitive ability are assessed by 
standardised questionnaires; 
(b) user acceptance and satisfaction are assessed by specifically designed ISISEMD questionnaires. 
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4.2. Validation of the Services.  
In the four pilot sites, the validation of the services was carried out in two stages — small-scale and large-scale validation. 
The services were first tested in a smaller scale, with a few end-users at each site for a period for 4 months, in order to 
identify if any technical problems existed before large-scale testing with all users during the rest of the testing period. 
This was also in ethical consideration as installing technology that may require adjustments could become a source of 
stress in the home of persons with CI. Additionally, to have multiple persons or multiple visits from project staff could 
also affect QOL, either positively or negatively. After that, the pilot operation and the controlled study continued in full 
scale, involving the rest of the test participants. The cities involved in ISISEMD study were Frederikshavn from Denmark 
(denoted as FRED), Lappeenranta from Finland (denoted as LAP), Trikala from Greece (denoted as TR), and Belfast 
from UK (denoted as BLF). Initially, the overall period of real-life evaluation was planned for 12 months but it was later 
extended to 15 months. 
 
4.3. Inclusion Criteria.  
The eligible population of elderly is:  elderly over 60 years of age diagnosed with stage two (Age Associated Memory 
Impairment) to four (Mild Dementia), according to the GDS, with corresponding to the Mini Mental State Exam 
(MMSE) scores of 19–26 and living in their own homes. 
 
To work with a representative sample of the primary end-users, the recruitment of ISISEMD trial participants for the 
pilot services follows strongly defined inclusion and exclusion criteria. The World Health Organization (2007) 
International Classification of Diseases (ICD-10) was to be used to classify dementia type and used in conjunction with 
the Mini Mental State Examination (MMSE) [22] to determine cognitive status. The main inclusion criterion for primary 
users is the stage of disease (level of cognitive decline). The Global Deterioration Scale (GDS) was to be used as a 
classification standard. The main inclusion/exclusion criteria have been consulted with Bodil Gramkow, chief physician 
at Department of Psychological and Gerontology in Brønderslev, Denmark and Kasper Jørgensen from National 
Knowledge Center for Dementia in Denmark. 
 
For assessing EP status, another mode was to administer the Montreal Cognitive Assessment (MoCA) [23] as an 
academic comparison tool for cognitive functioning measurements (sensitivity 90%) because MoCA is designed to screen 
for MCI and considers attention, concentration, executive functions, memory, language, visuo-constructional skills, 
conceptual thinking, calculations, and orientation in around 10 minutes. In this case, the MoCA score for inclusion would 
be less than or equal to 26 following the same cognitive functioning parameters as for the MMSE. 
 
The eligible population of informal caregivers was adults over 18 years and they were recruited based on their 
relationship with an elderly test participant. 
 
Tables 1 and 2 summarise the inclusion and exclusion criteria for EPs and ICGs. As our research progressed, we needed 
to make modifications to the inclusion and exclusion criteria. They are explained in Section 5. 
Table 1. Inclusion and exclusion criteria for EPs 
Factor Age Medical diagnosis Living arrangement Caregiver 
Inclusion 
Over 
60 
years 
old 
GDS Stage 2-4; MMSE and MoCA score of 19-26 Lives in home dwelling Have ICG 
Exclusion  
GDS beyond stage 4; dementia secondary to head trauma, 
bedbound, malignant illness, psychological conditions similar to 
dementia; misuse of alcohol or medications; frontal temporal 
dementia; more than 3 acute hospitalization sin the past 12 months 
Planning long-term 
care admission in 6 
months or less 
Do not have 
someone in the 
role as ICG 
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Table 2. Inclusion and exclusion criteria for ICGs 
Factor Age Mecial diagnosis Living arrangement Caregiving 
Inclusion 
18 years 
or older 
 
Live with EP; Do not live with EP but provides 
regular, direct assistance; No plans to move for the 
duration of the trial 
Already involved in 
caregiver role for 6 months 
or longer 
Exclusion  Active treatment for cancer; has dementia 
Planned placement of EP in long-term care in 6 
months or less  
 
4.4. Statistical Considerations and Forming of Test and Control Groups.  
ISISEMD-controlled study on intelligent systems for dementia home care is a randomized control trial. Allocation 
concealment was implemented in order to assign the patients in the intervention and in the control arm of the study. The 
intervention/test group was provided the ISISEMD telecare platform while the control group received standard care 
services through their ICGs and municipality. Because of the nature of the intervention, masking of the intervention 
could not be performed (since the telecare platform was visible and some of its functions were interactive). The trial 
followed a single-blinded pattern in which the principal investigators conducting the assessments were not the 
researchers analyzing the data from the evaluations. 
 
The overall hypothesis for ISISEMD project is that ICT services will improve QOL for those with cognitive impairments 
or mild dementia. The end-user partners are not aware of previous research to document such a hypothesis with a 
controlled study. Previous studies in this area have only found that there is a relation (Logsdon [24]). So, in reference 
with Logsdon [24], our assumptions are:  “...it could be expected an average score of QOL-AD at approx. 39.5 points 
(spreading 5.3) among a test group. In ISISEMD project, we will try the ICT service for N = 97.” 
 
We were aiming to be able to measure increased QOL with 6%, spreading 5.3 and P value of 5% is calculated that N = 37 
persons to be used in the test group, in order to prove the hypothesis with significance. Because of this reason, the 
number of test elderly persons was defined to be N = 40 in the test group, meaning 10 persons in the test group and 
additionally 10 persons in the control group for each region. All in all, overall for the controlled study N = 80. 
Additionally, in order to have statically valid test results, the test and control groups of the elderly were planned to be 
randomly selected. This was to be done by a small lottery. 
 
Wilcoxon Test.  
Please note that instead of regressions analysis, which is not a suitable test in our case due to the small number of test 
subjects, a Wilcoxon test was conducted. For small number of observations, we assume that distributions in scores and 
data are non-normal. The Wilcoxon Signed-Rank test detects differences in the distributions of two related variables. 
Small significance values (<.05) indicate that the two variables differ in distribution. 
 
4.5. Ethical Aspects.  
When testing ICT services with human participants, it is necessary to obtain approval from national and regional Ethical 
Committees before the trials begin. This ensures that the ethical rights of the citizens are respected and that the testing is 
carried out according to the national and international regulations. For the ISISEMD controlled study, all required 
approvals from data protection agencies and ethical regional committees were obtained. Consent forms were signed by 
all persons in the study and details of the main person to contact from the social care provider organization were 
provided to all study participants. A short brochure with more information about the ISISEMD services was given, 
together with short description of the project and statement that all data is treated anonymously. As the ISISEMD pilot 
involved human participants, a number of ethical and legal considerations were considered and followed: 
 
i. the right to be informed:  any participant in ISISEMD has the right to know the purpose of the activity they 
are involved in, the expected duration, procedures, use of information collected, their rights as a part of the 
study and any risks, discomfort, or adverse effects. This information was conveyed during the recruitment 
process and then reiterated when the informed consent form was distributed and signed by the participant; 
ii. permission to record:  before recording the voice or image of any individual, permission will be obtained 
through the consent form; 
iii. anonymity:  participants have a right to anonymity, meaning that their information was kept confidential 
and names were never associated with data or other personally identifiable information; 
iv. the right to withdraw:  participants should feel free to withdraw from any activity without penalty; 
v. valid and reliable data:  in every activity, we ensured that the data we collected was free from bias, accurate, 
valid, and reliable; 
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vi. data retention and documentation:  collected original data will be retained only for as long as it is relevant 
for the project. 
 
In Greece, the Institutional Review Board (IRB) of the ISISEMD study was the Independent Authority of Personal Data 
Protection. In Denmark, the ISISEMD project was approved by the Data Protection Authority while the Local Scientific 
Ethics Committee for North Jutland Region was notified about the study with a full description of it and followed the 
rules set by the National Scientific Committee (and the Helsinki declaration). In Belfast, approval was sought from the 
Research Governance Department of the Belfast Health and Social Care Trust and the Northern Ireland Regional Ethics 
Committee and Lappeenranta obtained authorization from the local and national Social and Health Services and Ethics 
Committee. The IRB and the Data and Safety Monitoring Board were the same body. 
 
4.6. Data Collection Tools 
4.6.1. User Acceptance and Satisfaction.  
In [25], Dillon and Morris present user acceptance as “the demonstratable willingness within a user group to employ 
information technology for the tasks it is designed to support.” Davis [26] developed the Technology Acceptance Model 
(TAM), which proposes that the acceptance of AT will be correlated with perceived value and ease of use. User acceptance 
and satisfaction, discussed in this paper from the perspective of the ICG, is assessed from both the technical and 
nontechnical perspectives. By technical perspective, we mean that perspective in which the ICG finds the technology easy 
to use, accurate, and functional for their caregiving responsibilities. 
 
In ISISEMD, user satisfaction is evaluated by the end user’s assessment of the multiple aspects of the service. This means 
that user satisfaction is considered a multidimensional concept, incorporating the perceptions of end users based on their 
personal, subjective attitudes and values. To collect data, we used a triangulation of methods consisting of 
questionnaires, interviews, and structured observations with the users to determine their acceptance and satisfaction 
with the ISISEMD services. ISISEMD questionnaires for user acceptance and satisfaction have been inspired by The 
Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) [27, 28] and ETUQ — Everyday 
Technology Use Questionnaire [29] — and were administered to both EP and ICG groups. 
 
4.6.2. Quality of Life for Informal Caregivers.  
There are few instruments measuring QOL for caregivers of chronically ill patients. A more recent and advanced 
assessing tool for measuring QOL of informal caregivers, specifically designed for carers of patients with cognitive 
problems, is the Scale of Quality of Life of Caregivers (SQLC) [30]. This tool was used in the controlled study, covering 3 
domains:  professional activities, social and leisure activities and responsibilities of caregivers to help patients in 
everyday living. SQLC scoring provides 4 categories of Caregivers’ adaptation:  full psychosocial adaptation (141–145), 
mild disturbance (100–140), moderate disturbance (86–99) and severe disturbance (<85). 
 
4.6.3. Stress of Caregiving. 
Assessing caregiving stress involves an evaluation of how the caregiver experiences the caregiving task to be, involving 
objective parameters (e.g., number of tasks, time per task) and caregiving capacity (e.g., amount of available time, 
proximity to care receiving residence), among others. To measure caregiver stress as well as effects from interventions 
aimed at reducing it, the Zarit Burden Interview (ZBI) short version [31] was used in ISISEMD. Questions are on 
caregiver’s health, psychological wellbeing, finances, social life, relationship between carer and patient, and a lower score 
indicates lower perceived stress. More information about the overall evaluation framework for ISISEMD services with 
description of the mentioned data collection tools is presented in [21]. 
 
4.7. Data Collection Methods.  
Collection of the study data was carried out at three stages — at baseline, at intermediate, and at final stages. The pilot 
started in May, 2010, and final data collection took place in June, 2011. It must be noted, though, that the pilot services 
have been used with different duration in the regions—in Lappeenranta and Frederikshavn since May, 2010, in Belfast 
since July, 2010, and in Trikala since September, 2010. The intermediate evaluations that we describe in this paper took 
place in February, 2011, while the baseline evaluation for the clients was carried out before the services were installed in 
their homes. The participants that carried out the intermediate evaluations in February, 2011 were those who were using 
the services long enough in order to get used to the technology and to observe a difference in their every day. Their 
number is provided in the sections for the primary and secondary outcomes of this study. 
 
The intervention and the control groups of EPs and ICG were administered the same ratings scales and questionnaires 
except the user satisfaction and acceptance. The rating scales for SQLC and ZBI for ICG were administered at baseline, 
Appendix 1. Paper D 
146 
 
intermediate and final stage for the intervention group, while for the control group — the same rating scales but only at 
baseline and final stage. In this paper we present the baseline and intermediate results from these for the test group. For 
EPs, the rating instruments used were MMSE, ADL, IADL, and QOL-AD but the results from them are not the subject of 
this paper. 
 
5. Results 
5.1. Recruitment of Participants.  
The test participants from the four countries were recruited using different channels. The majority of referrals were 
contacted via memory clinics or by the home-care personnel. But we also used TV and radio channels to announce the 
pilot study and attract interested participants. 
 
The control EP group was as characteristically similar to EP group as possible. Participants were also recruited with the 
aid of general and nurse practitioners, memory and dementia clinics, and regional organizations working with dementia 
populations. They were going to be involved as the test participants from the beginning months of the test period and 
relevant tests were applied to them too. Control group was also administered all tests for the test group except test user 
acceptance and user satisfaction because they were not given any technological intervention. 
 
As the regional end-user organizations began to identify potential clients, we have had to make amendments in our 
inclusion criteria and parameters. As none of the care provider organizations were familiar with the GDS scale, it was 
determined that we would classify the level of cognition based on MMSE scores only. Likewise, not all participants had a 
medical diagnosis of dementia and accompanying stage, many were referred by professionals who noted cognitive 
impairment and probable dementia or by their relatives. Since we were not using the GDS as our measurement, we no 
longer were restricted to the 19–26 score range in the cognition scales. We observed that the elderly participants from the 
target group, in most of its majority, were not receiving any dementia care because this type of care is usually offered to 
clients with severe dementia. They were mainly known to the FCGs from receiving traditional home help. We also noticed 
that overall, there is little awareness in the society about the early signs of dementia and the care stress of the informal 
caregivers and that the early stages of illness are not diagnosed. A fact that is also confirmed by a recent study in UK from 
the Alzheimer’s Association. 
 
Additionally, we had initially specified that we would exclude participants who have dementia secondary to head trauma 
as well as those who are bedbound (confined to a bed or chair for 20 hours a day for 4 out of 7 days). In Region 
Frederikshavn, there was one EP who has cognitive impairment secondary to head trauma and is confined to a 
wheelchair due to a work (fishing industry) accident. The case of this participant was discussed with the other care 
provider organizations and it was determined that this subject and the informal caregiver would remain in the trial 
because they are only utilizing the Lommy (GPS) service and both EP and ICG give valuable feedback regarding the 
ISISEMD equipment and services. It is also noted that the main constructive outcomes in this case will be in the 
evaluation of services and QOL rather than in the correlation between cognitive functioning. There was also one 
participant that was not willing to take the tests for the cognitive impairments, neither at the baseline, nor at the final 
evaluations because he felt offended by the questions. Furthermore, there were some EP subjects with MMSE scores 
outside range 19–26. From the intervention group, there were N = 3 with MMSE < 19, N = 2 with MMSE > 26. From the 
controls, N = 5 with MMSE < 19, N = 7 with MMSE > 26. 
 
5.2. Number of Participants.  
The goal of the controlled study was to include 80 elderly patients with MCI or mild dementia (MD) across four regions 
— 20 per trial site (10 intervention and 10 control participants) with respective number of informal caregivers. However, 
it must be noted that it was a very challenging task to recruit test participants for the study due to several reasons. The 
partners from the regional organizations invested a lot of effort in these activities and normally two to three times more 
referrals have been approached and interviewed in order to fit the inclusion criteria. Also, due to some procedural delays 
in some of the regions for obtaining ethical approvals and appointing staff to work on the project, the pilot operations did 
not all start at the same time in all of the four pilot sites. There were also issues with some participants experiencing a 
rapid change in cognitive or health status that excluded them from the trial by the time they began, which is not 
uncommon in this field of research. Therefore, in the selection procedure we could not follow the randomization of the 
test and control participants. Priority was given to include the target number of participants in the intervention group, 
therefore the controls were recruited after the recruitment of the intervention group. In Frederikshavn pilot site it was 
not possible to recruit any participants to be in the control group. 
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Table 3 presents the number of subjects from the intervention and control group and the number of drop outs from the 
intervention group. The most common reasons for drop outs were that the overall health status degraded significantly 
and elderly were admitted to institutional care, or participant had a stroke and was not able to continue the pilot or the 
services could not be installed in their homes due to problems to provide internet connection. Another reason was that 
after signing the consent agreement forms the baseline tests were administered but there was a sudden change in family 
plans and the drop-out took place before the equipment was installed. Other reason for dropouts included family issues. 
Only one dyad dropped out from the intervention group due to the number of false alarms during the initial months of 
the small-scale pilot and because EP considered their own health good enough to manage without trying the services. 
 
Table 3. Number of participants in ISISEMD-controlled study 
Region EP intervention (N=31) 
EP (intervention) 
dropouts since start 
(N=14) 
EP controls (N=26) Total EP participants until end of pilot (N=71) 
FRED (Denmark) 6 4 0 10 
BLF (UK) 7 5 10 22 
TR (Greece) 10 3 5 18 
LAPP (Finland) 8 2 11 21 
Region ICG intervention (N=31) 
ICG (intervention) 
dropouts since start 
(N=14) 
ICG controls (N=26) Total ICG participants until end of pilot (N=71) 
FRED (Denmark) 6 4 0 10 
BLF (UK) 7 5 10 22 
TR (Greece) 10 3 5 18 
LAPP (Finland) 8 2 11 21 
 
5.3. Participant Characteristics 
5.3.1. Characteristics of the ICG Sample.  
In total ICGs N = 71 participated overall in the control study, with N = 45 in the intervention group and N = 26 controls. 
From the intervention group, there were N = 14 dropouts due to a drop out of the elderly. Overall, the female ICGs were 
70.89%, 64.86% intervention, and 76.92% controls. 67.56% of the intervention group had a previous experience with 
computer, while 83.78% of the intervention group had a previous experience with a mobile. 82.28% from all of them 
lived in the same area as their elderly with 83.78% from the intervention and 80.77% from the control. The percentage of 
the children was highest — 57.80% overall (54.05% intervention and 61.54% from the control). The second high was the 
percentage of the spouses — 41.22% overall (32.43% intervention and 50% from the control), the rest were other type 
such as neighbors or some volunteers who were helping the elderly. Mean age, in years in the intervention group was 
54.89 years (N = 27, SD 12,939) while the control group had 62.23 mean age (N = 26, SD 13,131). 
 
5.3.2. Characteristics of the EP Sample.  
In total EPs N = 71 participated overall in the control study, with N = 45 in the intervention group and N = 26 controls. 
From the intervention group, there were N = 14 dropouts due to reasons mentioned above. Overall, the female EPs were 
64.55%, 67.6%, intervention and 61.5% controls. Only 8.1% of the intervention group had a previous experience with 
computer, while 51.35% of the intervention group had a previous experience with a mobile. 47.6% from all of them lived 
alone, with 56.7% from the intervention and 38.5% from the control. Mean age for EPs, in years, in the intervention 
group was 77.38 (N = 37, SD 8.060) while the control group had 80.00 mean age (N = 26, SD 8.23). The cognitive 
functioning for EPs, depicted with MMSE scores, was: for intervention group mean = 22.12 (N = 34, SD 3.79) and for the 
control group mean = 22.29 (N = 24, SD 5.44). After analyzing the data from the regions, we found that that in the 
intervention group (N = 37), the most EPs living alone were in LAP (90%, N = 10) and in FRED (70%, N = 10) and the 
least were in Belfast (14%, N = 7), in TR they were 40% (N = 10). Overall in the intervention group (N = 37), the male EPs 
were less than the female EPs with highest percentage in FRED (50%, N = 10) and the smallest percentage in LAP (10%, 
N = 10), while in BLF it was 43% (N = 7) and in TR it was 30% (N = 10). 
 
5.4. Use of the Services.  
From all services that were offered via ISISEMD service platform and available during the test period of the controlled 
study, not all of the services were tested in each home because each elderly received a subset of all services deepening on 
his and relative’s individual care needs. Figure 2 shows the average use of the services in the four sites. To identify which 
service each elderly needed at baseline, an evaluation of basic activities of daily living (ADL) and the instrumental 
activities of daily living (IADL) was carried out, together with an interview with the informal caregivers about their needs 
and if the elderly had any incidents recently (such as being lost, any falls, cooker turned on and forgotten). 
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Figure 2: Average use of the services in the four cities (N = 31). 
 
5.5. Observations from the Baseline Evaluations.  
We would like to summarize the following observations from the baseline evaluations: 
i. highest percentage of services utilized was in Lappeenranta (Finland) and Frederikshavn (Denmark); 
ii. Trikala (Greece) had the most end users living alone (100%); 
iii. most of the EPs and ICGs were women, which follows global trends for these groups; 
iv. according to MMSE scores, in Belfast (UK), EPs have moderate impairment, while the rest is in mild to 
moderate stage; 
v. in Lappeenranta (Finland) and Frederikshavn (Denmark), ICGs report a “moderate effect” on QOL 
before the intervention, while in Trikala, Greece and Belfast, North Ireland, the effect on ICG QOL was 
reported as “severe”; 
vi. the highest reported caregiving-related stress for ICG is in Frederikshavn (Denmark).  
 
In the following sections we present more detailed information about the results from the intermediate evaluations. 
 
5.6. Primary Outcomes: Quality of Life and Care-Related Stress for Informal Caregivers.  
The participants that carried out the intermediate evaluations in February, 2011 were only from the intervention group 
and those who were using the services long enough in order to get used to the technology and to observe a difference in 
their every day. Their number is provided in each of the tables for the primary and secondary outcomes of this study. 
Table 4 provides data about the nature of the caregiving relationship to the older adult, QOL in the ICGs via SQLC and 
reported level of care-related stress through the ZBI scores from baseline and intermediate assessments. SQLC and ZBI 
rating scales were administered among ICGs at the intermediate evaluation in all three pilot sites except Frederikshavn. 
 
Table 4 is showing that, on average, the adaptation of the caregivers is within the same range — but that range is also the 
lowest, showing severe disturbance to ICGs QOL. However, we can observe that the median (middle score of all 
assessments) SQLC score increased, from severe disturbance to one of moderate disturbance. As well, the mode (most 
commonly reported assessment result) increased from severe to moderate as well as the maximum score increased for 
the follow up. We can also observe that the average (mean) level of caregiver stress dramatically decreased from 31.82 to 
14.83, meaning from on the moderate side to little to no caregiving-related stress. The median (middle score) also 
decreased as well as the most reported score (mode) and the maximum level of stress reported dramatically decreased 
(from 105 to only 24 being the highest reported level of stress). SQLC score at baseline (N = 27) had mean value 81.96 
(SD 21.283), with minimum = 29 and maximum = 113. SQLC score at intermediate (N = 13) had mean value 73.46 (SD 
30.341), with minimum = 26 and maximum = 120. This shows, again, that the reported QOL of ICG has decreased. 
 
Table 4. ICG percentages, SQLC and ZBI baseline and intermediate scores 
 ICG:  
Child 
ICG:  
Spouse 
ICG:  
Other 
SQLC 
baseline 
SQLC 
intermediate 
ZBI 
baseline 
ZBI 
intermediate 
N observations 35 35 35 27 13 7 12 
Missing 0 0 0 8 22 7 23 
Mean/percentage 62,9% 20,0% 17,1% 81,96 73,46 16,06 14,83 
Median - - - 85,00 88,00 21,00 15,00 
Mode - - - 74 92 16 14 
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Boxplots of SQLC scores according to city are presented in Figure 3. Frederikshavn had the highest baseline SQLC score, 
while Trikala and Belfast had the lowest baseline SQLC score. In intermediate scores, Trikala seems to be by far the 
lowest scoring city in SQLC, while Lappeenranta and Belfast seem to be close in scoring; there are no available 
intermediate SQLC scores for Frederikshavn. In terms of difference between baseline and intermediate SQLC scoring, 
Trikala seems to be the city with the largest drop in scores, while Lappeenranta’s scoring seems to range in the same 
levels; Belfast seems to have small increase in SQLC scores, however there are only few data available for intermediate 
scoring in this city. 
 
Figure 3: Boxplots of SQLC scores (baseline N = 27, intermediate N = 13) according to city. 
 
Boxplots of ZBI scores according to city are presented in Figure 4. Trikala seems to have the highest baseline ZBI scores, 
while Lappeenranta and Frederikshavn seem to have the lowest baseline ZBI scores. At intermediate scores, Trikala 
seems to be the lowest scoring city in ZBI, while Lappeenranta and Belfast seem to be relatively close in scoring; there are 
no available intermediate ZBI scores for Frederikshavn. In terms of difference between baseline and intermediate ZBI 
scoring, Lappeenranta seems to be the city with the largest increase in scores, while Trikala’s scoring seems to range in 
the lowest levels; Belfast seems to have a decrease in ZBI scores. ZBI score at baseline (N = 28) hadmean value 16.06 (SD 
8.11), with minimum = 0 and maximum = 33. ZBI score at intermediate (N = 12) had mean value 14.83 (SD 7.095), with 
minimum = 0 and maximum = 24. This shows, again, that the reported care stress of ICG has decreased. 
 
Figure 4. Boxplots of ZBI scores (baseline N = 28, intermediate N = 12) according to city 
 
Table 5 examines the normality in the distribution of values for the SQLC and ZBI scales (baseline, intermediate). When 
P value <0.05 the values do not follow a normal distribution (this determines the choice of the statistical analysis that we 
are using: when variables are not normally distributed we use nonparametric methods). In our case, if we use the first 
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statistical criterion (Kolmogorov-Smirnov), the distribution is non-normal and due to our small sample (small number of 
observations), we assume that distributions in scores and data are non-normal. For the above reason we run a Wilcoxon 
test, as it was not possible to conduct a regression analysis (the criteria for using regression analysis are not met). 
Table 5. Tests of normality 
 Kolomogorov-Smirnov (a) Shapiro-Wilk 
 Statistic Df p-value Statistic Df p-value 
SQLC score 0,195 8 0,200 0,869 8 0,147 
SQLC score intermediate 0,209 8 0,200 0,838 8 0,072 
ZBI score 0,275 8 0,077 0,831 8 0,061 
ZBI score intermediate 0,174 8 0,200 0,951 8 0,721 
 
Table 6 provides results from the Wilcoxon test for SQLC, ZBI. The Wilcoxon test examines whether the SQLC scores 
show significant differences at intermediate evaluation:  The significance, “Sig” (P value), which is larger than 0.05 (P = 
0.153) shows that the differences are not significant (even though at baseline the Mean was 81.96 and at intermediate it 
was 73.46). Similarly, Wilcoxon tests for ZBI and SQLC scores found no significant differences between baseline and 
intermediate (with P = 0.123 and P = 0.536, resp.). 
 
Table 6. Wilcoxon test for baseline and intermediate results of the Scale of Quality of Life of Caregivers 
and Zarit Burden Interview 
 SQLC score intermediate – SQLC score ZBI score intermediate – ZBI score 
Z -1,428 -1,542 
Asymp. Sig. (2-tailed) ,153 ,123 
 
For these two (SQLC and ZBI), showing no significant difference, we would like to state that this has, statistically, shown 
that ISISEMD services can at least maintain QOL in family caregivers. It appears that the lack of sufficient data at present 
does not permit us to conclude that there is a significant difference (in either direction) between baseline and 
intermediate. 
 
5.7. Primary Outcomes — User Satisfaction.  
Intermediate evaluation for user satisfaction with the services was carried out with 17 EPs and 17 ICGs from the 
intervention group from the four regions and gave positive results overall—on average 70.45% for EP and 65.12% for 
ICGs and 88.25% of both groups indicate that they would like to continue to use the home support services after the end 
of the project. Access to care for elderly was increased with 100% for all test elderly persons because they did not receive 
this type of care before. Another positive effect of using the services for the informal caregivers is that they give them 
possibility to save time and money on travel and phone calls to the elderly, gives them more freedom for their personal 
life and free-time interests, reassurance and peace of mind. 
 
Figure 5 presents the results from user satisfaction and willingness to use the services after the pilot finishes, in 
percentage for the four regions separately. For satisfaction 100% = full satisfaction, 0% = not satisfied; for willingness to 
use 100%= I would definitely use a system like this, 0%= I would not use a system like this. They are based on the flowing 
number of subjects: TR-EP N = 4; ICG N = 4; LAP-EP N = 7; ICG N = 7; BLF-EP N = 2; ICG N = 2; FRED-EP N = 4; ICG 
N = 4. 
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Figure 5. User satisfaction results from the intermediate evaluation – overall for EP and ICG 
participants (intervention group) 
 
 
It must be noted that, from a technical perspective we faced some unexpected technical issues with stability and 
availability of the services in real-life conditions during the first couple of months in Frederikshavn and Belfast which 
influence the results from this intermediate evaluation and thus shows lower percentage of satisfaction. For the final 
evaluations, we will be investigating correlations between particular age group of ICGs and their changes (using 
regression analysis) and correlations between living status of ICGs to EPs. 
 
5.8. Secondary Outcomes — The Services Are Appreciated Differently in the Four Regions.  
During the intermediate stages of the project, when we were designing the needed services, the care provider 
organizations and end-users from all four pilot sites participated in collecting user requirements. So the list of services to 
be technically implemented in ISISEMD system was a collective list, addressing the overall needs. However, due to 
country specifics, as we found out already from the intermediate qualitative evaluations, some services were more 
popular (the end-users liked them most and/or considered them most important for the care provision and quality of life) 
in some of the regions than in the others. Here we presented the specifics we observed: 
i. EPs from Frederikshavn, Belfast, and Trikala are more interested in having the services for outdoor 
positioning from Lommy, compared to users in Lappeenranta; 
ii. home safety services — fire alarm and cooking monitor are considered most valuable for caregiving and 
personal safety in Frederikshavn, while in Lappeenranta, these are the Intelligent front door and Person out 
of home for too long service; 
iii. elderly users from Frederikshavn, Belfast, and Lappeenranta appreciate Memory Lane service because it 
gives them something very personal and facilitates conversations with family and other visitors;  
iv. date and time services are appreciated by EP in all regions as they reinforce the structure of the day and 
gives the elder the feeling that they manage better in daily routines, giving them more independence; 
v. elderly and relatives find the Reminders service helpful with reminder prompts, and even more the prompts 
by an external person reduced the stress and aggressiveness in the relationship EP-closest family member 
since EP was more prone to listen to the reminders coming from the system than from the family member. 
 
5.9. Secondary Outcomes — Positive Influence for the Informal Caregivers and the Elderly Persons.  
Despite of the quantitative results from the intermediate evaluations, positive socioeconomic effects were experienced by 
both EP and ICG. There are indications for the following positive influence for the informal caregivers: 
i. reduced number of phone calls by ICG to check on EPs condition; 
ii. reduced number of visits done by ICG to check on EP’s condition; 
iii. reduced number of times ICG discusses every day issues related to the illness with EP; 
iv. increased possibility for ICG to do free time or personal activities out of house; 
v. reduced time spent to drive/travel to visit the EP. 
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There are indications for the following positive influence for the elderly: 
i. EP goes out of house on him/herself more often (reduce social isolation); 
ii. reduced number of times per day EP calling on the phone to ICG; 
iii. reduced number of times per day EP asked ICG for future events. 
iv. reduced number of times per day EP asked ICG for day/time orientation. 
 
Additionally, in ISISEMD controlled study, we have found that the end users themselves provide much more information 
as to dementia care, caregiving and independent living than we had anticipated. Some end users find new uses for the 
technology or equipment that was not envisioned by the developers as well as presented useful feedback on the 
functionality of the system. Examples of this are further described in the appendix with the qualitative results from the 
study. 
 
6. Discussions of the Results from the Intermediate Evaluations 
The ISISEMD European project aims to improve the care and Quality of Life of elderly persons with cognitive problems 
or mild dementia, while evaluating the care services provided. In the context of this project, during the intermediate 
evaluations, 17 informal caregivers (ICGs) from 4 different geographical regions (Greece, Finland, Denmark, and UK) and 
their relatives with CI have been asked to evaluate the care services provided, in relation to the new assistive 
technologies, as well as the impact these have on their everyday life. The Scale of Quality of Life of Caregivers (SQLC) and 
Zarit Burden Interview (ZBI) evaluation were employed at baseline and at intermediate stages. The intermediate 
evaluation was carried out after an initial test period of 6 to 10 months. 
 
During the whole process of piloting the services in real life, we observed that even when EPs and ICGs were skeptical in 
the beginning, after giving them time to get used to the technology, the elderly and their relatives accept the technology 
and can see the opportunities for positive impact. Since the targeted population have cognitive impairments or mild 
dementia, we found that it is most beneficial if the services are introduced as early in the disease progression as possible 
and it takes about 4–6 weeks for EP to get used to the system. Of course, during this period, some effort is needed from 
ICG to remind them to refer to it. It also helps if the Carebox touch screen is placed close to a TV (a device to which all 
elderly are used to) or such place in the house where the elderly spends most of the time. The deferent levels of 
interaction with the system, presented in Section 3, also help for the individual acceptance. The Memory Lane service was 
very much appreciated by the elderly and it was also a point of reference to the Carebox. Since the service platform is 
quite flexible, a number of settings can be made in order to adjust the services to the progression of the dementia. For 
example in the initial period of having the system, the Help button on the Carebox can be visible and EP can get in 
contact with ICG. Later, it can be “removed” from the Carebox. All in all, if EP cannot interact with the system, this is not 
needed but the home safety services keep ICG informed about the safety of EP. 
 
In most of the cases, the family caregivers prefer receiving notifications and alarms by SMS instead of by email. Family 
caregivers are also less sensitive to the service cost compared to elderly. It seems that they are interested in having such a 
solution in the home in order to increase the level of independent living of their relatives. This is mainly due to the fact 
that relatives are in the middle age and they have a higher income in comparison with the elderly, and also due to the 
ICGs having spent more time and money on technology than the elderly EPs. In addition, relatives would like to have a 
system that offers a high degree of independence for the elderly. 
 
The automation degree of the services is also of a key importance for the family caregivers, as we found out. Informal 
caregivers were also willing to have very few degree of interaction with the system. This is mainly due to the fact that they 
understand, on the one hand, that elderly is not able to be familiar with the new technology and on the other hand, they 
are willing to increase the level of independence of the elderly. Their busy everyday life also plays a role. In addition, 
elderly do not want a lot of user interactions with the system, since they are not familiar with the new technology and 
have somewhat of an aversion to learning. We have also seen that this may discourage use of the system, as the EPs may 
worry that they will break the technology, so they would rather not use it at all than be the cause of expensive repairs. The 
EPs want the system to be as automatic as possible; however, they want inexpensive technological solutions. According to 
the statistical analysis of the available data, no significant differences are shown in the evaluation scores provided by 
ICGs at the intermediate evaluation after 6–10 months from the baseline period. However, we can say that this has, 
statistically, shown that ISISEMD services can at least maintain QOL in family caregivers and alleviate care-related 
stress. A relatively high satisfaction with the services is shown by both the elderly and the informal caregivers. Moreover, 
the qualitative feedback from the elderly and the informal caregivers depicts positive impacts from using the ISISEMD 
services. 
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New data are expected to become available from the final evaluation in June 2011, also including the rest of the test 
participants. We hope for that the final evaluation, involving around 60 EPs and 60 ICGs from both intervention and 
control group would allow us to support our hypothesis with a statistical significance. 
 
7. Conclusions 
As one of the formal caregivers from ISISEMD consortium stated, “it is quite a challenging task to design technology 
services to support persons with dementia living at home and their caregivers because it is not like designing services 
for physically handicapped persons.” Part of the challenges comes from the fact that each person with dementia has 
specific individual needs depending on how the disease progresses and on the support he or she gets from the closest 
family. The use of technology as support for persons with dementia living at home sets different requirements for the 
development of services. Different kinds of technology solutions are needed depending on individual personal factors. 
Furthermore, it is important that the system works with a minimal interaction and with automated operations because of 
limited learning abilities among the users or because they have very little experience with the new technologies. 
 
We would like to thank our test users whom we accept as an equal partner of the consortium. They played a very 
important role in the process of bringing the services to a mature level and improving them in all aspects in order to meet 
their needs as best as possible. We can confirm that it is of high importance that the primary user and caregivers to be 
motivated towards usage of aiding technologies in their homes. For the acceptance of the services by the elderly, a key 
role plays their family caregiver and the process is much faster and easier if the caregivers have previous experience with 
technology. 
 
We know that skeptical users are stoppers against introduction of new technologies. But our experience shows that the 
elderly and their relatives accept the technology and can see the opportunities for positive impact and added value from 
the use of the services in their everyday life after giving them time to get used to the technology, even when EPs and ICGs 
were skeptical in the beginning. It can be expected that after about one month, the elderly and the family caregiver can 
get used to the services. The most successful adoption of the services can happened when they are offered as early as 
possible in the history of the disease—in this way the technology services can be integrated in the coping and care 
strategies in the family and the elderly has highest chances to learn to refer to the Carebox with the reminders and to use 
the Lommy device. 
 
Appendix 
 
Qualitative Results from Service Use 
During the pilot operation, the researches collected a number of good stories from the test participants, showing how the 
services helped the elderly (EP) or informal caregivers (ICG) in their daily life or how the users adopted the services and 
used them in their own way to fit individual needs and desires. Some of the examples are listed below, showing the 
results from the qualitative evaluations. 
 
i. Help Button on the Carebox.  
One of the difficulties EP faces is to use the telephone to call relatives. She is now used to using the Help button on the 
Carebox to make a contact with them. When she wants to get into contact with her ICG, she presses the Help 
button on the Carebox and makes very easy contact as the help button sends a text message to the family 
caregiver’s mobile phone. If the ICG is at work, he is notified of this but in such a manner that it does not cause 
alarm. Although this service of the Help button was designed to be an easy way to contact someone if the elderly 
person needs immediate help, this particular user and her family have found that the easy functionality replaces 
her need to use the telephone, which has become too difficult for her. 
 
ii. Free Text Reminders on the Carebox.  
One ICG uses the free text reminders to write to their EP to perform different small tasks. “It is like sending a SMS 
(text message) to the elderly but it is shown in larger letters on the Carebox because elderly cannot read SMS.” 
Another ICG uses the free text service to reinforce family humor, writing inside jokes or anecdote to EP such as, 
“have a glass of wine with your evening meal.” 
 
iii. ISISEMD Services Overall.  
The formal caregivers observed that the services improve communication and relations among the elderly and family 
caregivers. The ICG can upload pictures on Memory Lane service to be seen by elderly, which also gives them 
something to discuss when they are together, “Did you see the pictures of your anniversary party on the Memory 
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Lane?”. Moreover, the reminders “spoken” from the system help reduce the stress in the relationship among the 
elderly person and the family caregiver.  
 
iv. ISISEMD Services Overall.  
One family carer who is the son of a female test person noticed savings of his time and travel costs. In his mother’s 
home, home safety services were installed (fire/smoke sensor and cooking monitor), together with the Carebox 
touch screen. Before installing the services, he was driving to visit his mother several times a week, but now he can 
see her activities via the ISISEMD web portal, and knowing that the home safety sensors will send him sms in case 
of smoke/fire or too long cooking activity, he feels much safer and does not need to drive there so often; the 
distance to her home is 7 kilometers. He does not worry all day long anymore because she knows how to contact 
him through the Help button on the Carebox if she needs anything. Only first after using the services, had the son 
realized how stressed he was in caring for his mother and the benefit that he gets from using the services is beyond 
his initial expectations. Furthermore, with dementia progression, he noticed from the overview of the daily events 
that his mother does not cook any more during the week days. For preventing of losing more weight, the sonmade 
everyday reminders to his mother via the Carebox for having regular meals. 
 
v. Outdoor Safety with Lommy.  
Another elderly who is living alone is suffering from memory problems and severe diabetes for several years. He must 
walk every day in order to get the blood pressure in his feet down. Before he received the ISISEMD services, there 
has been an incident when he left home and felt very confused during his walk and a person in the neighborhood 
helped him find his way home. Last winter he was not walking outside at all because he was afraid to get lost, 
based on this previous experience. But this winter, even though there was quite a lot of snow in Denmark, he is 
walking the dogs of his neighbors several times per day because he has the Lommy and feels safe. These 
neighbors, as informal caregivers, can “see” his position on the map on ISISEMD web portal when he walks the 
dogs. He feels safe having the Lommy along on the trips. Due to the traumatic experience he had in becoming lost 
before, he always keeps the Lommy in his pocket.When he is in the home, the cord to charge the device is 
connected to the Lommy, which remains in the pocket at all times. In this way he never forgets it. 
 
vi. Cooking Monitor.  
In the end of February, 2011, when the system was under optimization, a formal caregiver received a text message 
with “Cooking activity has been too long” (that is around 60 min of cooking activity)for one test person. It was 
afternoon and she called the test person and found out that the woman began to cook, but felt tired and lied down 
on the coach and fell asleep, forgetting the cooker. When the formal caregiver called the test person on the phone 
to check if everything was fine, she woke her up and the elderly switched the cooker off. Usually after 60 minutes 
of cooking, the Carebox would also “tell” the elderly about this alarm, but on this day, the audio feature was 
turned off due to the testing. 
 
vii. Out of Bed for Too Long.  
One elderly had several incidents where she has fallen down during the night. Her relative had received the SMS 
message where it was written that EP has been out of bed too long. The ICG went to her mother’s home first thing 
in the morning and found her mother fallen down on floor and could not get herself up. The daughter is very 
happy that she got the text messages, even though she got them during the night. 
 
viii. Person Left the House.  
One EP is not safe to leave the house by herself anymore and the daughter, as ICG, received text messages from the 
ISISEMD system that her mother had left the house. The daughter went to her mother’s place and found her 
walking on the street, confused and without knowing where to go. Particularly in Finland, this service is very 
important since during the winter it is very cold and dangerous for the elderly to go out of home for an extended 
period of time. 
 
ix. Intelligent Front Door.  
Two of the test EPs has started to receive help from local homecare services. The relatives can see on intelligent front 
door service when the homecare nurse has visited and for how long. The relatives have been very satisfied with 
this service, because they can be sure that nurse has visited as it had been agreed upon. 
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Disclaimer 
This paper reflects only the views of the authors and the European Commission is not liable for any use that might be 
made of the information contained therein. 
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Paper E:  Assessing assistive technology outcomes with dementia 
 
Carrie Beth Peterson 1, 2*, Neeli R Prasad 1, 2, Ramjee Prasad 1, 2 
1 Center for TeleInFrastruktur (CTIF) 
2 Department of Electronic Systems, Aalborg University, Aalborg, Denmark 
* Corresponding author (cpb@es.aau.dk) 
 
Purpose This article presents a review of the available evaluation of quality of life (QOL) outcomes as a result of 
assistive technology (AT) interaction among older adults with cognitive impairment and the further development of an 
outcome assessment framework specific to this area of research. The framework is based on a previous version first 
proposed by the authors in 20101 and results derived from working on the ISISEMD-project2,3. Method A literature 
review compiled relevant AT-outcomes assessments specific to QOL-results of dementia interventions, describing 
strengths and weaknesses. Furthermore, during the course of the ISISEMD-trials, issues arose that highlighted the lack 
of appropriate assessments for evaluating QOL in dementia with AT-interventions. This needed to be addressed in order 
to further develop the fields of AT-outcomes measurement, QOL-assessment, and dementia care. The original 
framework, describing the development and application of an electronic QOL-assessment format incorporating the AT-
enhanced environment for those with dementia, aims to close the variance between AT-use and AT-outcomes with 
empirical demonstration. Results & Discussion Results include: (i) Assessment of current outcomes measurement 
tools and methods; (ii) Analysis of the issues involved in AT-outcomes measurement; and (iii) Description of the 
framework and its application for dementia AT-outcomes assessment. There is a significant lack of appropriate 
measurement tools that examine QOL outcomes as a result of AT-interaction in dementia care. Through the use of the 
proposed framework, researchers and clinicians can better determine which ATs will stimulate the desired intervention 
outcomes as well as measure their effectiveness. This has implications for dementia care, technology development, 
socioeconomic benefits and policy. 
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Paper F:  The future of assistive technologies for dementia 
 
Carrie Beth Peterson 1,2*, Neeli R Prasad 1,2, Ramjee Prasad 1,2 
1 Department of Electronic Systems, Aalborg University, Aalborg, Denmark 
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* Corresponding author (cbp@es.aau.dk) 
 
Purpose The use of Assistive Technologies (ATs) for residential dementia care is increasing, yet there is a gap between 
what individuals want, what developers design, and how outcomes are evaluated. Despite widespread acceptance that 
ATs improve quality of living (QOL), there is relatively little data to support such claims. This article discusses the current 
state-of-the-art AT-design, its use and assessment in relation to dementia care and projected future trends that can be 
incorporated into research now. Method By reviewing a history of ATs used in residential dementia care, incorporating 
societal and healthcare trends and applying theories of science, a futuristic view of AT-development and use is presented. 
The theoretical foundation is rooted in phenomenology, universal design, aging in place and gerontechnology. This 
research is supported by results from a European Commission-funded project where ATs were integrated and tested in 
real life conditions and evaluated qualitatively and quantitatively by older adults with dementia as well as their formal 
and informal caregivers. Results & Discussion The results shows the need for future ATs to be more integrated into 
the environment, combined with ambient and intelligent technologies, the Internet of Things (IoT), and the potential of 
cloud computing. They will also become more personalized to individual needs and user requirements. 
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Paper G:  Zarit Burden Interview shows reduction in caregiver burden in 
European dementia study 
 
Carrie Beth Peterson, research assistant1, Lars Bo Larsen, associate professor1, Poul Svante Eriksen, associate 
professor2, Ole K Hejlesen, professor3 
 
1 Faculty of Engineering and Science, Department of Electronic Systems, Aalborg University 
2 Faculty of Engineering and Science, Department of Mathematical Sciences, Aalborg University 
3 Faculty of Medicine, Department of Health Science and Technology, Aalborg University 
 
Abstract 
Objective:  Case-control intervention analysis on the efficacy of telecare services on caregiver burden for informal 
caregivers of home-dwelling individuals with dementia after 15 months. 
Design:  Multinational, non-blinded, quasi-experimental, clinical intervention trial (nonpharmacological)  
Setting:  Homes of individuals with dementia in North Ireland, Denmark, Finland, and Greece 
Participants:  31 individuals with dementia and their caregivers are compared to 22 control dyads.   
Intervention:  A telecare system consisting of domotics with a centralized architecture aimed to support safety, 
independence, and quality of life, and to reduce caregiver burden through the transfer of tasks and care support.  
Main outcome measures:  Physical functioning (ADL and IADL), quality of life (QOL-AD and SQLC), and caregiver 
burden (ZBI). The statistical analysis applied t-tests to verify significant differences and Pearson correlations to test for 
linear relationships within the data, all using 95% Confidence Interval. The focus of this paper is on the outcomes in 
caregiver burden. 
Results:  There was a highly significant difference in caregiver burden between the technology intervention and control 
groups (p=0,03). The intervention group showed a non-significant decrease in caregiver burden (p=0,51) while the 
control group showed a highly significant increase in caregiver burden (p=0,01).  
Conclusion:  This study showed that the use of telecare technologies to support dementia care can have significant 
protective and positive effects for the informal caregivers.  
Trial registration:  The Phase I clinical intervention trial did not require registration. Trial information can be found 
for European Commission Competitiveness and Innovation Programme - Information and Communication Technology - 
Policy Support Programme pilot type B.2008.1.4 project ISISEMD; reference:  CIP-ICT-PSP-2-238914. 
http://www.isisemd.eu/   
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Paper H:  Results from a clinical trial on gerontechnology in dementia care 
and caregiver quality of life outcomes  
 
Carrie Beth Peterson cbp@es.aau.dk 
Department of Electronic Systems, Aalborg University, Aalborg, Denmark 
 
Abstract 
Background  Informal caregivers for someone with dementia experience stresses due to the intensive nature of the 
caregiving, often termed “caregiver burden,” and related declines in their quality of life. In this study, the Scale of Quality 
of Life of Caregivers was used to evaluate the effects on life quality. Assistive technologies were installed in the homes of 
the patients with dementia and the questionnaires evaluated outcomes of the care intervention.  
Methods  The SQLC assessment tool was administered at the beginning of the trial, before any care intervention, and 
again at the conclusion of the 15 month trial. The assessment was given to both the control and intervention groups by 
professional caregiving staff in each of the 4 European regions.  
Results  The results of the study show that there is not a significant difference between the intervention and control 
group outcomes as both show non-significant improvement.  
Conclusions  The results of this study indicate that using technologies to support dementia caregiving has positive 
effects for the quality of life of the caregivers, although it does not seem to be significantly better than usual care. There 
are some issues with the evaluation tools used in research on dementia care and quality of life outcomes and further 
development is required.  
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Appendix 2 Dementia types and prevalence 
 
Table 26 Description of the most prevalent types of dementia 
Type of dementia Symptoms Prevalence 
Alzheimer’s 
disease 
Plaques (beta-amyloid deposits) and tangles 
(tau protein) are hallmark symptoms of 
Alzheimer’s. Difficulty recalling names and 
remembering events, apathy, depression, 
disorientation, confusion, behavior changes, 
eventual difficulty speaking, eating, and with 
mobility. 
Up to 80% of individuals with dementia have 
Alzheimer’s disease. 
Mixed dementia 
Mixed dementia is more than one type of 
dementia occurring simultaneously, but most 
patients will have a diagnosis of the type of 
dementia with the most prevalent symptoms. 
Most likely occurring more often than 
previously thought, it is believed that more 
than 50% of individuals with dementia actually 
have coexisting dementias (pathologic 
evidence only upon autopsy).  
Vascular 
dementia 
Vascular dementia is caused by conditions that 
reduce blood flow to the brain, such as stroke, 
and cause cell death and by vascular-related 
conditions like hypertension. Impaired task 
completion and planning, trouble speaking or 
understanding others, and difficulty in social 
situations.  
Accounts for 20-30% of dementias.  
Dementia with 
Lewy bodies 
Clumps of the protein alpha-synuclein develop 
in the cortex (the same protein is evident with 
Parkinson’s disease but clumps in a different 
pattern, which may be why symptoms of the 
two are similar). Difficulty with recalling and 
remembering, sleep disturbance, muscle 
rigidity or spasms similar to those in 
Parkinson’s, confusion, and visual 
hallucinations.  
10-25% of dementia cases are Dementia with 
Lewy bodies. 
Parkinson’s 
disease dementia 
Parkinson’s dementia symptoms are similar to 
Lewy bodies but with the alpha-synuclein 
protein clumps developing in the substantia 
nigra. Problems with muscles and movements, 
impaired memory and judgment, inability to 
pay attention or complete a task, difficulty with 
visual information or hallucinations, and sleep 
disturbances.  
Around 2% of adults over 65 have Parkinson’s, 
and up to 85% of those develop Parkinson’s 
disease dementia. 
Mild Cognitive 
Impairment 
Mild cognitive impairment involves cognitive 
changes that are serious enough to be noticed 
but not serious enough to meet diagnostic 
criteria for dementia. 
Between 10-20% of adults over age 65 are 
estimated to have mild cognitive impairment; 
those individuals have a higher risk of 
developing Alzheimer’s disease or another 
dementia. 
Frontotemporal 
dementia 
Progressive cell degeneration in the frontal or 
temporal lobes causes this group of disorders 
(including progressive supranuclear palsy, 
primary progressive aphasia, Pick’s disease, 
and behavioral variant Frontotemporal 
dementia). Impaired judgment and planning, 
changes in behavior, difficulty with language, 
and changes in muscle functions are broadly 
common symptoms. 
10-15% of dementias are of this type. 
Additionally, Frontotemporal dementia 
typically develops in one’s 50s or 60s; up to 
50% of dementias in individuals under age 65 
are this type. 
Posterior Cortical 
Atrophy 
There is a gradual, progressive degeneration of 
the posterior cortex (the outer layer in the back 
of the brain). This area of the brain is 
associated with visual processing, so symptoms 
include difficulties with reading and judging 
distances, disorientation, and some experience 
hallucinations. 
Prevalence is estimated at 15%; however, it is 
yet unknown if this is a unique form of 
dementia or a variant of another type as brain 
changes resemble Dementia with Lewy bodies 
and Creutzfeldt-Jakob disease, and the 
diseased area of the brain has plaques and 
tangles similar to those in Alzheimer’s disease. 
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Creutzfeldt-
Jakob disease 
Misfolded prion protein in the brain causes this 
rapidly fatal brain disorder (prion disease), 
resulting in behavior changes, confusion, and 
impaired memory, judgment, and muscle 
coordination. 
Only about 1 in 1 million develops this type of 
dementia, of which there are 3 subtypes:  
Sporadic type makes up 85%, Familial type 
accounts for up to 15%, and Infectious type 
causes around 1% of Creutzfeldt-Jakob disease. 
Normal pressure 
hydrocephalus 
Excess cerebrospinal fluid accumulates in the 
brain’s ventricles. Difficulties in thinking, 
problems with walking, and urinary 
incontinence are the three most prevalent 
symptoms. 
The symptoms are commonly similar to other 
brain disorders so specific prevalence is 
unknown. 
Huntington’s 
disease 
A single defective gene on chromosome 4 
causes this progressive brain disorder. Severe 
declines in thinking and reasoning skills, mood 
changes, and involuntary movements are 
hallmark symptoms. 
The gene defect is dominant, so anyone who 
inherits it from a parent with the disease will 
eventually develop it, most commonly between 
ages 30-50. 
(Wernicke-) 
Korsakoff 
syndrome 
It is most commonly a result of alcohol abuse 
but can also result from AIDS, dialysis, poor 
nutrition, chronic infection, or other 
conditions. Severe deficiency in vitamin B1 
(thiamine) causes the chronic memory 
disorder. Problems in learning and memory 
(both short- and long-term) are the main 
symptoms.  
It is up to the doctor to evaluate the cause of 
the symptoms as there is no specific procedure 
to confirm diagnosis. It is unknown how many 
people have Korsakoff syndrome. 
Chronic 
Traumatic 
Encephalopathy 
Cognitive changes, difficulty learning and 
remembering, impaired thinking, planning, 
and judgment skills, and decreased 
organization of thoughts are common 
symptoms. These may continue to develop even 
years after the injury occurred. 
Evidence over the past few decades have linked 
repeated traumatic brain injuries, such as 
those sustained in boxing or American football, 
vehicle accidents, shockwaves from explosions, 
and falls with an increased risk of dementia. 
Traumatic brain injury has been shown to 
increase beta-amyloid levels and deposits of 
tau, the proteins associated with Alzheimer’s 
disease. 
Down Syndrome 
People with Down syndrome are born with an 
extra copy of chromosome 21, causing 
developmental issues and health problems. 
Reduced interest, behavior problems, 
coordination changes, and other overall 
changes to functioning and personality may be 
more common than memory problems. 
Individuals with Down syndrome typically live 
until age 60; around 75% of those who do live 
to 65 or older are have Alzheimer’s disease or 
another dementia that is very similar. Autopsy 
studies show that almost 100% of people with 
Down syndrome have plaques and tangles by 
age 40, yet not all develop symptoms. 
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Appendix 3 Methods to diagnose dementias 
Table 27 Description of the most common methods used for the diagnosis of dementias 
Diagnostic type Examples How they are performed What is identified Success rate 
Histopathological 
evidence 
Autopsy or biopsy The brain is examined 
to determine 
symptoms of and type 
of dementia. 
Medical professionals 
can determine clinical 
pathology of the type 
of dementia based on 
changes seen in the 
brain. 
Viewed as the gold 
standard in 
dementia 
diagnostics. 
Diagnostic 
manual 
DSM – the Diagnostic 
and Statistical Manual 
of Mental Disorders is 
published by the 
American 
Psychological 
Association, providing 
a nomenclature and 
standard criteria for 
mental disorder 
classification [329]. 
Intended for research, 
it is mostly used in the 
US by clinicians, 
researchers, for health 
insurance, 
pharmaceutical 
companies, and for 
legal processes. 
However, it should be 
used with caution, as 
nearly 75% of the 
current panel members 
have financial ties to 
the pharmaceutical 
industry [330]. 
Professionals should 
have extensive clinical 
training in order to use 
the DSM to assess the 
symptoms of dementia 
to determine diagnosis. 
Dementia can be 
identified and 
differentiated from 
other mental 
disorders. The DSM is 
primarily concerned 
with (superficial) 
symptoms rather than 
underlying pathology. 
There is a risk for 
over-medicalization; 
for example, normal 
cognitive aging is now 
classified as “Minor 
Neurocognitive 
Disorder,” giving the 
implication of 
(abnormal) 
pathological 
conditions. 
 
Alzheimer’s 
disease [331]: 
51% sensitivity 
97% specificity 
66% accuracy 
 
Vascular Dementia 
[332]: 
50% sensitivity 
84% specificity 
Statistical 
classification 
ICD – the International 
Classification of 
Disease and Health 
Related Problems is 
produced by the WHO 
[333]. It is the official 
clinical diagnostic tool 
for mental disorders in 
the US, but is used 
more widely in Europe, 
although it has become 
more common in the 
US in recent years, i.e. 
all HIPPA covered 
entities. It is used to 
classify health issues 
for health records, 
death certificates, 
epidemiology, 
mortality and 
morbidity statistics, 
reimbursement, and 
resource allocation. 
 
 
Trained professionals 
learn the coding and IT 
system for the ICD, 
which is also available 
for self-study on the 
WHO website. 
Diagnostic 
information on 
diseases and health 
problems are 
statistically-based (as 
opposed to symptom-
based in the DSM), 
and can be classified, 
stored, and retrieved. 
It is not limited to 
mental disorders, so 
provides a more 
realistic picture of 
comorbidities and 
context of health 
issues. 
 
 
Vascular Dementia 
[332]: 
20% sensitivity 
94% specificity 
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Diagnostic type Examples How they are performed What is identified Success rate 
Clinical criteria 
NINCDS-ADRDA – 
National Institute of 
Neurological and 
Communicative 
Disorders and Stroke 
and Alzheimer’s 
Disease and Related 
Disorders Association 
are widely used clinical 
criteria to diagnose 
dementias [334]. The 
criteria are 
recommended by the 
UK NHS and the 
American Academy of 
Neurology. 
Clinical diagnosis of 
Alzheimer’s disease are 
presented in three 
documents:  (1) core 
clinical criteria 
regarding AD 
dementia, (2) core 
clinical criteria 
regarding MCI due to 
AD, and (3) 
recommendations 
regarding preclinical 
AD. 1 and 2 are for 
clinical diagnosis while 
3 is intended only for 
research purposes. 
 
They specify eight 
cognitive domains 
that may be impaired 
in Alzheimer’s 
disease:  memory, 
language, perceptual 
skills, attention, 
constructive abilities, 
orientation, problem 
solving, and 
functional abilities. 
Probable 
Alzheimer’s 
disease [286]: 
81% sensitivity 
70% specificity 
 
Cognitive testing 
– these test the 
expressed 
functioning of 
cognitive abilities 
MMSE – the Mini-
Mental State 
Examination is one of 
the most commonly 
used assessments for 
cognitive functioning 
and dementia 
screening [285]. This 
assessment is included 
in Appendix 5. 
Trained professionals 
administer the 
assessment, which 
takes around 10 
minutes to complete. 
Gross cognitive 
functioning and 
changes are tested via 
i.e. orientation, recall, 
and language use and 
comprehension. 
Alzheimer’s 
disease [335]: 
93% sensitivity 
46% specificity 
77% accuracy 
 
Frontotemporal 
Dementia [336]: 
58% sensitivity 
88% specificity 
73% accuracy 
 
Dementia (by cut 
off score of 26) 
[337]: 
80% sensitivity 
96% specificity 
 
Mild Cognitive 
Impairment [338]: 
65% sensitivity 
89% specificity 
83% accuracy 
 
MoCA – the Montreal 
Cognitive Assessment 
is used to detect milder 
impairments, 
particularly for early 
identification as it is 
sensitive to mild 
changes [288]. This 
assessment is included 
in Appendix 5. 
The assessment takes 
5-10 minutes to 
complete and is 
designed to be 
administered even by 
lay people. 
Fine cognitive 
impairment and 
changes are assessed 
through i.e. 
orientation, memory 
and recall, 
visuospatial 
reasoning, and 
language use and 
comprehension 
Frontotemporal 
Dementia [336]: 
78% sensitivity 
98% specificity 
88% accuracy 
 
Mild Cognitive 
Impairment [338]: 
97% sensitivity 
60% specificity 
91% accuracy 
 
Alzheimer’s 
disease [287]: 
100% sensitivity 
87% specificity 
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Diagnostic type Examples How they are performed What is identified Success rate 
Structural 
imaging – these 
allow to look at the 
structure of the brain 
for dementia-related 
changes 
MRI – Magnetic 
Resonance Imaging 
employs powerful 
magnetic fields and 
radio waves to look at 
the soft tissues of the 
body, such as the brain. 
Patients lay or stand in 
an MRI machine and 
an electromagnetic 
field is used to align 
atomic nuclei in the 
body. 
Detailed images show 
changes in the brain 
tissue, such as 
atrophy. 
 
Alzheimer’s 
disease [339]: 
76,5% sensitivity 
94% specificity 
 
CT – Computed 
Tomography utilizes 
computer-processed x-
rays to generate 
“sliced,” or 
tomographic, images of 
the body. 
All CT scans involve 
ionizing radiation from 
x-rays and around 50% 
of CT scans involve 
using a radiocontrast 
agent to visualize 
vessels and changes in 
tissue. CT scans of the 
head can perceive 
infarctions, tumors, 
hemorrhage, edema, 
and other brain 
maladies. 
CT scan data can be 
used to examine 
(brain) structure and 
detect tissue damage, 
based on which areas 
block the x-rays. 
 
Alzheimer’s 
disease [339]: 
80% sensivity 
87% specificity 
Functional 
imaging – allows 
for examining the 
functioning of the 
brain and cognitive 
processes 
PET – Positron 
Emission Tomography 
uses a radioactive 
tracer isotope to emit a 
positron that will 
interact with an 
electron, creating a 
burst of light which is 
recorded. 
PET data collected by 
itself can be quite poor 
(i.e. scatter or random 
events), so it is often 
combined with CT or 
MRI imaging. The 
biologic pathway can 
be traced, meaning 
that changes in brain 
functioning due to 
molecular biology can 
be detected before 
anatomic changes 
occur. 
The flow of blood to 
different parts of the 
brain is measured, 
and this can 
distinguish 
Alzheimer’s from 
other dementias. 
Alzheimer’s 
disease [340]: 
93% sensitivity 
80% specificity 
87% accuracy 
 
Dementia [341]: 
94% sensitivity 
78% specificity 
92% accuracy 
 
fMRI – Functional 
MRI involves repeated 
scans to track the 
movement of blood 
through the brain and 
map neural activity in 
the brain. 
The repeated scans in 
fMRI allow for a 
functional image of the 
brain, as opposed to 
the static image 
through MRI. Can be 
task-related MRI (i.e. 
recall a phrase) or 
resting state MRI. 
Blood flow in the 
brain is mapped to 
identify areas used in 
i.e. listening, 
speaking, and 
sensing, and how they 
are affected by the 
dementia. 
 
Alzheimer’s 
disease [342]: 
72% sensitivity 
78% specificity 
89% accuracy 
Molecular 
imaging – 
examines the 
movement of specific 
molecules in the 
brain to determine 
dementia prevalence 
and type 
SPECT – Single Photon 
Emission Computed 
Tomography uses 
gamma rays to make 
2D cross-sectional 
slices of the brain and 
to provide 3D 
information when 
manipulated [343]. 
Patients are injected 
with a gamma-emitting 
tracer, which attaches 
to the brain and can be 
detected with the 
gamma-camera that is 
rotated around the 
patient. SPECT 
provides accurate 
localization in 3D 
space, but images 
typically have lower 
resolution than PET 
scans. 
 
 
 
 
 
Regional cerebral 
blood flow and brain 
metabolism are 
measured to diagnose 
and differentiate 
dementias. 
 
Alzheimer’s 
disease [335]: 
63% sensitivity 
75% specificity 
67% accuracy 
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Diagnostic type Examples How they are performed What is identified Success rate 
Biomarkers – 
biological markers of 
dementia can be 
found in fluid 
samples from the 
individuals 
CSF – Cerebrospinal 
Fluid is assessed for 
changes in protein 
levels. 
Patients undergo a 
lumbar puncture, 
where spinal fluid is 
extracted. Beta-
amyloid peptide and 
tau levels are studied. 
Levels of the two 
proteins are measured 
to detect Alzheimer’s 
disease. However, 
changes in these 
proteins cannot be 
correlated to levels of 
cognition (i.e. 
MMSE). 
Alzheimer’s 
disease [344]: 
85% sensitivity 
84% specificity 
 
Mild Cognitive 
Impairment 
(incipient 
Alzheimer’s 
disease) [344]: 
95% sensitivity 
83% specificity 
 
Genetic – the 
apolipoprotien E 
epsilon 4 (APOE-e4) 
allele is the largest 
(known) genetic risk 
factor for Alzheimer’s 
disease. 
Blood or tissue 
samples from the 
patients are used to 
test the genomic DNA 
for the presence of the 
APOE genotype. 
There are 3 primary 
uses of genetic testing 
for Alzheimer’s 
disease: 
Predicting in 
cognitively healthy 
individuals 
Additional diagnostic 
in individuals with 
dementia 
Selecting individuals 
with dementia for 
therapy (including 
research) 
 
Alzheimer’s 
disease [345]: 
82,5% sensitivity 
44% specificity 
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Table 28 Classification and diagnosis of dementias according to the DSM [329] and ICD [333] 
 DSM-IV-TR ICD-10 
Classification Delirium, Dementia, and Amnestic and Other 
Cognitive Disorders 
Mental and Behavioral Disorders - Organic 
and Symptomatic Mental Disorders 
Definition An overall decline in intellectual function, most 
commonly including difficulties with language, 
simple calculations, planning and judgment, and 
motor (muscular movement) skills as well as loss of 
memory. This definition is established by the pattern 
of cognitive loss and does not distinguish a prognosis 
as dementia can become more severe, remain 
unvarying or become less severe.  
Used as diagnostic criteria for research 
Diagnosis The essential feature of a dementia diagnosis is the 
development of multiple cognitive deficits that 
include memory impairment and one or more of the 
following:  aphasia, apraxia, agnosia or executive 
functioning. 
The decline should be objectively verified by 
obtaining a reliable history from an 
informant, supplemented, if possible, by 
neuropsychological tests or quantified 
cognitive assessments.  
Threshold for 
diagnosis 
Disturbances must be severe enough to cause 
problems in the person's daily life and that they must 
represent a decline from a previously higher level of 
functioning 
The decline should be present for at least 6 
months and severity, with mild impairment 
as the threshold for diagnosis. Deterioration 
from a previously higher level of performance 
should be established. 
Predominant 
symptoms 
A significant destabilization of the person’s memory 
in learning new information or recalling formerly 
learned information.  
A decline in memory, which is most evident 
in the learning of new information, although 
the recall of previously learned information 
may be also affected.  
 Aphasia is a class of language disorder involving a loss of language functions (remembering, 
speaking, reading or writing words). It can be expressed by the person using general or vague terms 
such as “that,” “thing,” or “there” because they have difficulties in recalling the exact name or word 
they are looking for. The impairment applies to both verbal and non-verbal material. 
 Apraxia is a disorder of motor planning that affects the ability to carry out deliberate actions such as 
moving an object or buttoning clothing. 
 Agnosia is characterized by the inability to identify or discern objects, people, sounds, shapes or 
scents. Despite no change in sensory functions, the brain loses the ability to make sense of the 
information and identify; it is not uncommon for those with severe agnosia to be unable to recognize 
close family or even their own faces.  
 Problems with executive functioning, such as loss of 
the ability to make plans, carry out a sequence of 
actions, make appropriate choices and assess 
circumstances. For example, a person with dementia 
may have difficulties following a procedure of 
dressing in clothes or wear inappropriate clothing for 
the weather. 
Evidence of damage to other higher cortical 
functions. A decline in other cognitive 
abilities characterized by deterioration in 
judgment and thinking, such as planning and 
organizing, and in the general processing of 
information.  
 In addition to cognitive changes, the symptoms of 
dementia may also include personality and 
behavioral changes and emotional instability. 
A decline in emotional control or motivation, 
or a change in social behavior, manifest as at 
least one of the following: 
1) emotional liability; 
2) irritability; 
3) apathy; 
4) coarsening of social behavior. 
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Appendix 4 Dementia treatments 
Table 29 Examples of treatments for dementia symptoms 
Treatment type Name Use Benefits Adverse side effects Other 
Pharmacology Acetylcho-
linesterase 
inhibitors 
[346] 
 
These medications have 
been developed to 
impede or address 
changes in the brain that 
are associated with early 
and middle stages of 
Alzheimer’s disease. 
 
They work by increasing 
the amount of 
acetylcholine, which 
helps messages to travel 
around the brain. People 
with Alzheimer’s disease 
have a shortage of this 
chemical. 
Some people find 
these drugs 
lessen their 
symptoms for a 
while. Possible 
benefits include 
improvements in 
motivation, 
anxiety levels, 
confidence, daily 
living, memory 
and thinking. 
 
Side effects 
often include 
loss of appetite, 
nausea, 
vomiting, and 
diarrhea. 
These drugs are 
sometimes given 
to people with 
mixed dementia 
or dementia with 
Lewy bodies. 
These drugs 
aren’t suitable for 
people with 
Frontotemporal 
dementia, who 
may be given 
antidepressant 
drugs for some of 
their symptoms. 
A person with 
vascular 
dementia will 
usually be 
prescribed drugs 
to treat 
underlying 
conditions, such 
as hypertension 
or heart 
problems. 
 N-Methyl-D-
aspartate 
(NMDA) 
receptor 
blockers [347] 
This medication is for 
use in the later stages of 
Alzheimer’s disease. 
 
There are often high 
levels of glutamate 
(natural substance) in 
the brains of individuals 
with Alzheimer’s disease 
and this medication 
protects the brain cells 
by blocking NMDA-type 
glutamate receptors. 
NMDA receptor 
blockers work to 
temporarily slow 
the progression 
of symptoms in 
the middle and 
later stages of 
Alzheimer’s 
disease and 
dementia with 
Lewy bodies. It 
may also help 
with agitation or 
aggressive 
behaviour. 
NMDA 
receptor 
blockers 
usually have 
fewer side 
effects, but can 
still cause 
dizziness, 
headaches, 
drowsiness, 
insomnia, 
hypertension, 
and 
constipation. 
 Selective 
Serotonin 
Reuptake 
Inhibitors 
[348] 
SSRIs reduce depression 
or anxiety and are 
prescribed to treat 
vascular dementia or 
Parkinson’s dementia, 
particularly in the early 
stages of dementia. 
These 
antidepressant 
drugs change the 
chemical levels in 
the brain by 
inhibiting 
serotonin 
reuptake in cells. 
They often help 
to control 
neuropsychiatric 
symptoms. 
Common side 
effects can 
include 
appetite and 
weight 
changes, 
fatigue, tremor, 
difficulty 
concentrating, 
nausea, vivid or 
strange 
dreams, sleep 
changes, and 
increased 
suicidal 
thoughts. 
 
 
 
 
 
 
 
 
 
 
 
Some research 
shows that 
common 
antidepressants 
don’t work as well 
for people with 
dementia as for 
those without 
dementia. 
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Treatment type Name Use Benefits Adverse side effects Other 
Non-
pharmacological 
Interventions 
Exercise 
(Aerobic, 
Strength 
training) 
[244] 
Exercise increases the 
body’s natural 
functioning and can be a 
form of rehabilitative 
therapy. 
Exercise has 
protective effects 
against further 
decline. Regular 
exercise can 
improve 
behavior, 
physical 
functioning, 
reduce 
depression, and 
can improve 
cognitive 
functioning. 
Doctors should 
be consulted 
before starting 
an exercise 
routine to rule 
out or 
minimize risk 
of injury due to 
cardiac or 
physical 
exertion. 
 
Group exercise 
classes also 
provides an 
opportunity for 
socialization. 
 Music therapy 
[254] 
Music is played for or by 
the person with 
dementia. 
Music therapy 
has been found to 
calm, soothe, and 
engage 
individuals with 
dementia. 
  
 Aromatherapy 
[349] 
Specific aromas are used 
to elicit certain 
responses, such as 
relaxation or alertness. 
Lemon balm and 
lavender have 
been particularly 
beneficial in 
dementia 
treatment. 
The oils can be 
irritating to the 
eyes, nose, and 
mouth if too 
concentrated. 
 
 Animal-
assisted 
therapy [350] 
Trained animals and 
therapists interact with 
the individual. 
It can be directed 
behavior, such as 
brushing the 
animal to 
practice gross 
motor skills, or 
free form 
interaction. 
Individuals 
may have 
allergies or 
aversions to 
animals. 
 
 Patient and 
family 
education 
[351] 
Individuals and families 
can receive education on 
dementia and symptom 
management (prognosis, 
treatment plans, safety 
considerations and 
environmental 
adjustments, financial 
and legal actions to take, 
and care support 
options). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients have the 
opportunity to 
make their 
wishes known to 
family and all 
engage in a 
discussion on the 
diagnosis and 
what it will 
entail. 
Difficult, 
sensitive, or 
uncomfortable 
family issues 
can arise. 
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Treatment type Name Use Benefits Adverse side effects Other 
 Talking 
therapy [351] 
Counselors listen to 
problems in a non-
judgmental and 
supportive way. They 
support people to talk 
about their difficulties 
and identify solutions. 
 
Talking therapies, such 
as counseling or 
psychotherapy, give 
people the chance to 
speak in confidence to a 
qualified professional 
about problems or issues 
that might be bothering 
them. They might help 
someone to come to 
terms with a diagnosis 
and identify ways to live 
well with dementia. 
Talking therapies may 
also help with symptoms 
of depression or anxiety. 
Talking therapies 
typically involve regular 
sessions with a therapist, 
either one-to-one or 
sometimes in a group. 
They can be face-to-face, 
over the phone or online. 
Some people will have 
just one session while 
others will have therapy 
that continues for many 
months. 
Psychotherapists 
help people to 
understand how 
their 
personalities and 
life experiences 
influence 
relationships, 
thoughts, feelings 
and behavior. 
Understanding 
this can make it 
easier for people 
to deal with 
difficulties. 
Psychotherapy 
may help to treat 
depression, 
anxiety and 
problematic 
behavior in 
people with 
dementia. 
 
Family therapy 
can also be 
helpful to resolve 
problems arising 
due to changes in 
relationships. 
Difficult, 
sensitive, or 
uncomfortable 
family issues 
can arise. 
There are several 
different types of 
psychotherapy. 
One of the most 
common types is 
cognitive 
behavioral 
therapy (CBT). 
 Cognitive 
training or 
therapy [351] 
 
The activities can be 
done alone, one-on-one, 
or in groups.  Cognitive 
activities can include 
Cognitive Stimulation 
Therapy (CST), 
Cognitive Behavioral 
Therapy (CBT), word or 
number puzzles, and 
current events for 
orientation. 
 
CBT usually involves 
between five and 20 
sessions. A carer might 
attend the sessions too 
so they can then help the 
person with dementia to 
use the techniques at 
home. 
Cognitive 
stimulation 
approaches have 
improved mental 
abilities and 
quality of life, 
including 
memory, 
reasoning, and 
ADLs. 
 
CBT aims to help 
people make 
changes to how 
they think 
(cognition) and 
what they do 
(behavior). CBT 
suggests ways of 
focusing on the 
here and now.  
 
 
 
 
 
 
Individuals 
may become 
agitated if 
overstimulated. 
CBT is widely 
used to treat 
depression and 
anxiety. There is 
growing evidence 
that it can also 
help people with 
dementia and 
depression. 
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 Reminiscence 
therapy and 
life story work 
[352] 
This type of therapy 
involves talking about 
things and people from 
the past, often using 
photos, scrap books, 
artifacts from their past, 
or music as cues. 
There is evidence 
that this type of 
therapy can 
improve mood, 
well-being, and 
mental abilities 
such as memory. 
Through talking 
about who they 
are, individuals 
with dementia 
help others to 
focus on them as 
a person and not 
their dementia. 
Discussing 
loved ones who 
have passed 
may cause 
some 
temporary 
negative 
emotional-
behavioral 
responses. 
Techniques like 
this are popular 
because they 
draw on early 
memories, which 
people with 
dementia tend to 
retain best. 
Gerontechnology 
Interventions 
[200] 
Home 
automation 
A range of technologies 
in the home can 
automate functions to 
ensure safety and 
security. 
The individual 
can be supported 
by appliances 
automatically 
shutting off after 
use or lights 
activated by 
motion sensors. 
Someone 
(caregiver or 
authorities) will 
be notified if 
there is an 
emergency 
situation in the 
home, such as 
wandering 
outdoors or a 
fire. 
False alarms 
and system 
instability can 
induce worry 
and foster lack 
of trust in the 
technology. 
 
 Interactive 
devices 
Devices such as robotics, 
electronic photo albums 
or puzzles, or surfing the 
internet can encourage 
cognitive functioning 
and interaction with the 
environment. 
Using devices 
that are designed 
for individuals 
with dementia 
can provide 
stimulation, 
entertainment, 
and support the 
enjoyment of 
activities. 
Some may 
become 
frustrated or 
discouraged if 
the technology 
highlights 
deficiencies 
rather than 
abilities. 
Introducing new 
technologies in 
later stages of 
dementia may 
require a longer 
learning time. 
 GPS If the individual with 
dementia has a GPS-
enabled device with 
them when they leave 
the home, they can be 
located by caregivers or 
authorities. 
The main benefit 
is locating the 
individual if they 
would wander 
from the home or 
otherwise 
become lost. 
There is a risk 
of breach in 
data 
confidentiality. 
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Appendix 5 Assessment tools used in the research 
Table 30 Overview of the assessments used  
Variable Tools Example of what is evaluated 
Score 
range Score interpretation 
Cognition 
MMSE 
Changes in cognition, 
memory, orientation, and 
visuo-construction 
0 to30 
>26 = Normal 
19-25,5 = Mild impairment 
10-18,5 = Moderate impairment 
0-9,5 = Severe impairment 
MoCA 
Milder changes in cognition, 
attention, abstraction, and 
delayed recall 
0 to30 
> 26 = Normal 
19-25,5 = Mild impairment 
10-18,5 = Moderate impairment 
0-9,5 = Severe impairment 
Physical 
functioning and 
independence 
ADL 
Bathing, eating, continence, 
and basic physical functioning 
independence 
0 to 6 
Higher score = higher independence 
3-4 = moderate dependence 
0-2 = severe dependence 
IADL 
Food preparation, medication 
management, and higher level 
physical functioning 
independence 
0 to 8 Higher score = higher independence 
Quality of life 
QOL-AD 
QOL of person with dementia, 
health, living situation, and 
ability to do things for fun 
13 to 52 Higher score = higher quality of life 
SQLC 
QOL of the caregiver, 
professional activities, social 
and leisure activities, and 
caregiving responsibilities 
0 to 
149 
141-149 = Effective adaptation of the 
caregiver 
100-140 = Mild effect on QOL 
86-99 = Moderate effect on QOL 
<85 = Severe effect on QOL 
Caregiver burden 12-item ZBI Personal strain and role strain 0 to 48 
Higher score means higher burden 
>17 = clinically significant burden 
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Assessment 1:  Mini-Mental State Examination (MMSE) 
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Table 31 Median scores by age and education level on the Mini-Mental State Examination [353] 
Years of age Education level 
4th grade 8th grade High School College 
18-24 22 27 29 29 
25-29 25 27 29 29 
30-34 25 26 29 29 
35-39 23 26 28 29 
40-44 23 27 28 29 
45-49 23 26 28 29 
50-54 23 27 28 29 
55-59 23 26 28 29 
60-64 23 26 28 29 
65-69 22 26 28 29 
70-74 22 25 27 29 
75-79 21 25 27 28 
80-84 20 25 25 27 
85+ 19 23 26 27 
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Assessment 2:  Montreal Cognitive Assessment (MoCA) 
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Assessment 3:  Activities of Daily Living (ADL) 
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Assessment 4:  Instrumental Activities of Daily Living (IADL) 
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Assessment 5:  Quality of Life-Alzheimer’s disease (QOL-AD) 
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Assessment 6:  Scale of Quality of Life of Caregivers (SQLC) 
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Assessment 7:  Zarit Burden Interview (ZBI) 
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Assessment 8:  Non-standardized questions on global outcomes 
 
1. Your overall change in feeling of quality of life by using 
the services 
3. It increases more than I thought it would 
2. It increases 
1. No change, no influence 
0. It decreases 
 
5. Your overall feeling of safety about the home 
environment 
3. I feel significantly safer 
2. I feel safer 
1. I do not feel safer 
0. I feel less safe 
2. Overall change in feeling of quality of life for your 
relative by using the services 
3. It increases more than I thought it would 
2. It increases 
1. No change, no influence 
0. It decreases 
 
6. Your overall feeling of satisfaction about the system 
3. I am more satisfied than I thought I would be 
2. I am satisfied 
1. I am not satisfied 
0. I am disappointed 
3. Overall support in independent living by using the 
services 
3. It increases more than I thought it would 
2. It increases 
1. No change, no influence 
0. It decreases 
7. Would you want to use a system like this one after the 
study? 
3. I definitely would use a system like this  
2. I would consider using a system like this 
1. I would not consider using a system like this 
0. I would not use a system like this 
 
4. Your overall feeling of care responsibilities by using 
the services 
3. It decreases more than I thought it would 
2. It decreases 
1. No changes, no influence 
0. It increases 
8. Would you be willing to pay for a service system like 
this?  
3. I would definitely pay for all of these services 
2. I would definitely pay for some of these services 
1. I would consider paying for some of these services 
0. I would not pay for these services at all 
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Appendix 6 ISISEMD system architecture 
Table 32 Physical architecture components in ISISEMD [280] 
Server name Services controlled through the server 
Portal 
 Daily activities  
o the Carebox acts as the domotics controller and 
a communication device) 
Ecosystem server 
 Cooking monitor 
 Smoke detector 
 Water reminders 
 Refrigerator alarm 
 Sleeping sensor 
 Intelligent front door 
HP Multimedia Reminder System 
 Activity list 
 Reminders 
 Calendar 
Lommy Flex Server  Supports Lommy services 
Lommy Application Server 
 GPS/GSM/mobile telephony 
 Outdoor localization 
 Panic button 
 Fall alarm 
X-Diagnostic (X-report server)  Memory Lane  Remote care data 
X-Diagnotic video communication 
(MCU and My Teamwork Server) 
 Remote medical videoconferencing 
 Brain Games 
 Videophone 
Figure 33 ISISEMD server physical architecture [280] 
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Appendix 7 Data from the participants 
The following tables include the raw data that was analyzed from the participants in the ISISEMD study. The raw scores at baseline and final evaluation are given, including the range, 
mode, median, standard deviation, and mean. Additionally, gender, age, living arrangement of the person with dementia, and the caregiver’s relationship to the person with dementia 
are given. The black boxes indicate where data is missing; B=Baseline score; and F=Final score. 
 
Data set i:  Belfast, North Ireland  
Table 33 North Ireland intervention group, n=7 
Dyad B MMSE F MMSE B MoCA F MoCA B ADL F ADL B IADL F IADL B QOL F QOL B SQLC F SQLC B ZBI F ZBI EP Sex ICG Sex EP Age ICG Age Living Status Relation Days Use 
1 23 18 7 9 6 6 6 4 36,33 29,33 92 93 9 13 F F 75 39 Alone Child 324 
2 27 21 23 14 6 6 4 4 44,67 35,33 88 93 20 21 F F 75 62 Share Spouse 238 
3     6 2 4 0 44,00 33,67 33 27 20 18 M M 75 50 Share Child 198 
4 19 16 9 9 6 6 3 2 36,67 32,00 69 97 31 34 F F 72 41 Share Child 137 
5 15    3 3 3 0 30,67 23,00 63 56 29 28 F M 69 69 Share Spouse 102 
6 29 30 26 29 6 5 3 4 33,33 37,67 85 108 23 31 M F 70 69 Share Spouse 86 
7 29 19 23 20 6 6 4 4 45,33 43,33 93 107 15 15 M M 83 82 Share Spouse 37 
                      
Min 15,00 16,00 7,00 9,00 3,00 2,00 3,00 0,00 30,67 23,00 33,00 27,00 9,00 13,00 4 F 4 F 69,0 39,0 1 Alone 3 Child 37,0 
Max 29,00 30,00 26,00 29,00 6,00 6,00 6,00 4,00 45,33 43,33 93,00 108,00 31,00 34,00 3 M 3 M 83,0 82,0 6 Share 4 Spouse 324,0 
Mode 29,00 N/A 23,00 9,00 6,00 6,00 4,00 4,00 N/A N/A N/A 93,00 20,00 N/A   75,0 69,0   N/A 
Median 25,00 19,00 23,00 14,00 6,00 6,00 4,00 4,00 36,67 33,67 85,00 93,00 20,00 21,00   75,0 62,0   137,0 
SD 5,75 5,45 8,88 8,47 1,13 1,68 1,07 1,90 5,93 6,42 21,70 30,17 7,64 8,19   4,6 16,0   99,1 
Mean 23,67 20,80 17,60 16,20 5,57 4,86 3,86 2,57 38,71 33,48 74,71 83,00 21,00 22,86   74,1 58,9   160,3 
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Table 34 North Ireland control group, n=9 
Dyad B MMSE F MMSE B MoCA F MoCA B ADL F ADL B IADL F IADL B QOL F QOL B SQLC F SQLC B ZBI F ZBI EP Sex ICG Sex EP Age ICG Age Living Status Relation 
1 29 28 24 26 6 6 8 6 38,00 33,33 103 100 10 12 M F 62 62 Share Spouse 
2 28 26 21 20 6 6 6 6 44,00 38,33 99 119 3 0 F M 80 80 Share Spouse 
3 30 29 21 29 6 6 8 8 36,67 33,67 107 119 8 13 F F 76 48 Alone Child 
4 30 27 18 20 6 6 4 3 32,67 33,67 101 102 17 18 M F 82 79 Share Spouse 
5 25 23 18 18 6 6 5 4 39,33 41,67 94 95 0 2 F M 80 80 Share Spouse 
6 19 19   3 4 0 1 29,00 30,00 77 77 12 12 M F 87 79 Share Spouse 
7 22 25 17 15 6 6 6 7 27,67 31,33 113 88 2 10 F F 67 37 Share Child 
8 29 29 23 24 6 6 4 4 34,67 35,33 103 103 1 3 M F 85 82 Share Spouse 
9 29 27 18  6 6 8 7 44,67 36,00 113 110 14 18 F M 77 38 Alone Child 
                     
Min 19,00 19,00 17,00 15,00 3,00 4,00 0,00 1,00 27,67 30,00 77,00 77,00 0,00 0,00 5 F 6 F 62,0 37,0 2 Alone 3 Child 
Max 30,00 29,00 24,00 29,00 6,00 6,00 8,00 8,00 44,67 41,67 113,00 119,00 17,00 18,00 4 M 3 M 87,0 82,0 7 Share 6 Spouse 
Mode 29,00 29,00 18,00 20,00 6,00 6,00 8,00 6,00 N/A 33,67 103,00 119,00 N/A 12,00   80,0 80,0   
Median 29,00 27,00 19,50 20,00 6,00 6,00 6,00 6,00 36,67 33,67 103,00 102,00 8,00 12,00   80,0 79,0   
SD 3,93 3,22 2,62 4,86 1,00 0,67 2,60 2,26 5,97 3,56 10,96 13,76 6,21 6,69   8,2 19,2   
Mean 26,78 25,89 20,00 21,71 5,67 5,78 5,44 5,11 36,30 34,81 101,11 101,44 7,44 9,78   77,3 65,0   
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Data set ii:  Frederikshavn, Denmark  
Table 35 Denmark intervention group, n=6 
Dyad B MMSE F MMSE B MoCA F MoCA B ADL F ADL B IADL F IADL B QOL F QOL B SQLC F SQLC B ZBI F ZBI EP Sex ICG Sex EP Age ICG Age Living Status Relation Days use 
3 22 27 19 20 5 6 2 3 34,67 34,33 106 105 4 4 M F 66 67 Share Spouse 256 
4     6 6 8 7 35,83 39,33 104 130 5 0 M F 81  Alone Other 240 
5 22 23 14 17 6 6 3 3 37,67 39,00 114 115 0 1 M F 86  Alone Other 245 
6 25 27 20 16 6 6 4 4 32,67 36,33 116 107 6 23 F M 82 59 Alone Child 203 
7 24 24 21 20 6 6 3 4 38,67 35,33 88 91 13 4 F M 77  Share Spouse 203 
8 30 29 22 20 6 6 7 7 39,00 38,67 78 112 1 0 F M 83  Alone Other 143 
                      
Min 22,00 23,00 14,00 16,00 5,00 6,00 2,00 3,00 32,67 34,33 78,00 91,00 0,00 0,00 3 F 3 F 66,0 59,0 4 Alone 1 Child 143,0 
Max 30,00 29,00 22,00 20,00 6,00 6,00 8,00 7,00 39,00 39,33 116,00 130,00 13,00 23,00 3 M 3 M 86,0 67,0 2 Share 2 Spouse 256,0 
Mode 22,00 27,00 N/A 20,00 6,00 6,00 3,00 3,00 N/A N/A N/A N/A N/A 4,00   N/A N/A  3 Other 203,0 
Median 24,00 27,00 20,00 20,00 6,00 6,00 3,50 4,00 36,75 37,50 105,00 109,50 4,50 2,50   81,5 63,0   221,5 
SD 3,29 2,45 3,11 1,95 0,41 0,00 2,43 1,86 2,48 2,12 15,01 12,84 4,62 8,85   7,1 5,7   41,7 
Mean 24,60 26,00 19,20 18,60 5,83 6,00 4,50 4,67 36,42 37,17 101,00 110,00 4,83 5,33   79,2 63,0   215,0 
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Data set iii:  Lappeenranta, Finland  
Table 36 Finland intervention group, n=8 
Dyad B MMSE F MMSE B MoCA F MoCA B ADL F ADL B IADL F IADL B QOL F QOL B SQLC F SQLC B ZBI F ZBI EP Sex ICG Sex EP Age ICG Age Living Status Relation Days use 
1 21 19 19 13 6 6 6 4 34,67 35,00 105 78 14 9 F F 65 64 Alone Other 412 
4 19 25 16 15 6 6 4 3 37,67 30,67 92 81 9 17 F F 72 44 Alone Child 267 
5 24 21 18 18 6 5 6 3 41,00 36,00 84 91 17 24 F F 83 57 Alone Child 288 
6 19 23 18 16 6 6 6 3 32,67 33,00 108 92 12 14 F M 82 50 Alone Child 274 
7 29 29 18 23 5 4 3 3 28,33 25,67 74 68 20 22 F M 82 81 Share Spouse 290 
8 23 21 19 15 6 6 8 7 36,67 31,67 110 99 9 13 F F 73 46 Alone Child 276 
9 22 29 16 21 6 3 5 3 35,00 27,00 102 94 24 22 F F 90 57 Alone Child 269 
10 23 20 17 14 5 6 3 3 25,00 23,33 74 94 15 10 F F 73 57 Alone Child 106 
                      
Min 19,00 19,00 16,00 13,00 5,00 3,00 3,00 3,00 25,00 23,33 74,00 68,00 9,00 9,00 8 F 6 F 65,0 44,0 7 Alone 6 Child 106,0 
Max 29,00 29,00 19,00 23,00 6,00 6,00 8,00 7,00 41,00 36,00 110,00 99,00 24,00 24,00 0 M 2 M 90,0 81,0 1 Share 1 Spouse 412,0 
Mode 19,00 21,00 18,00 15,00 6,00 6,00 6,00 3,00 N/A N/A 74,00 94,00 9,00 22,00   82,0 57,0  1 Other N/A 
Median 22,50 22,00 18,00 15,50 6,00 6,00 5,50 3,00 34,83 31,17 97,00 91,50 14,50 15,50   77,5 57,0   275,0 
SD 3,21 3,93 1,19 3,52 0,46 1,16 1,73 1,41 5,15 4,55 14,83 10,43 5,24 5,78   8,1 11,7   82,6 
Mean 22,50 23,38 17,63 16,88 5,75 5,25 5,13 3,63 33,88 30,29 93,63 87,13 15,00 16,38   77,5 57,0   272,8 
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Table 37 Finland control group, n=8 
Dyad B MMSE F MMSE B MoCA F MoCA B ADL F ADL B IADL F IADL B QOL F QOL B SQLC F SQLC B ZBI F ZBI EP Sex ICG Sex EP Age ICG Age Living Status Relation 
1 20 18 15 15 6 6 6 7 35,00 34,33 92 108 15 13 M F 83 79 Share Spouse 
5 29 30 24 27 6 6 6 4 33,00 35,00 95 93 7 9 M F 79 57 Alone Child 
6 23 28 18 18 6 6 6 3 26,67 24,00 74 107 13 20 F F 87 57 Alone Child 
7 16 16 18 12 6 6 4 3 27,33 29,00 92 84 12 19 F F 88 64 Alone Child 
8 26 24 21 21 6 6 2 2 26,00 33,00 72 82 6 20 M F 84 84 Share Spouse 
9 24 27 22 20 6 6 4 4 30,33 32,67 97 107 14 13 M F 91 64 Share Spouse 
10 18 16 13 11 6 5 2 2 25,00 22,33 73 82 11 11 F M 82 55 Alone Child 
11 18 16 14 13 4 4 2 2 23,67 23,33 78 78 23 19 F F 84 57 Alone Child 
                     
Min 16,00 16,00 13,00 11,00 4,00 4,00 2,00 2,00 23,67 22,33 72,00 78,00 6,00 9,00 4 F 7 F 79,0 55,0 5 Alone 5 Child 
Max 29,00 30,00 24,00 27,00 6,00 6,00 6,00 7,00 35,00 35,00 97,00 108,00 23,00 20,00 4 M 1 M 91,0 84,0 3 Share 3 Spouse 
Mode 18,00 16,00 18,00 N/A 6,00 6,00 6,00 2,00 N/A N/A 92,00 107,00 N/A 13,00   84,0 57,0   
Median 21,50 21,00 18,00 16,50 6,00 6,00 4,00 3,00 27,00 30,83 85,00 88,50 12,50 16,00   84,0 60,5   
SD 4,50 6,01 3,98 5,44 0,71 0,74 1,85 1,69 4,01 5,28 10,82 12,89 5,26 4,47   3,8 11,0   
Mean 21,75 21,88 18,13 17,13 5,75 5,63 4,00 3,38 28,38 29,21 84,13 92,63 12,63 15,50   84,8 64,6   
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Data set iv:  Trikala, Greece  
Table 38 Greece intervention group, n=10 
Dyad B MMSE F MMSE B MoCA F MoCA B ADL F ADL B IADL F IADL B QOL F QOL B SQLC F SQLC B ZBI F ZBI EP Sex ICG Sex EP Age ICG Age Living Status Relation Days use 
1 23 22 13 13 5 5 6 7 36,00 33,67 97 102 12 5 F M 75 30 Alone Other 204 
2 18 16 12 11 5 5 4 6 36,00 29,67 82 84 16 10 M M 91 52 Alone Child 233 
3 15 14 11 11 4 4 1 2 26,33 30,67 73 78 21 10 F F 82 57 Share Child 219 
4 20 19 16 16 5 3 5 1 24,00 31,33 85 99 13 10 F M 86 55 Alone Child 191 
5 20 20 16 16 5 5 5 6 25,33 27,33 65 68 25 24 F M 86 40 Share Other 143 
6 18 18 11 11 4 5 5 5 35,33 37,00 73 74 32 26 F F 73 45 Share Child 16 
7 19 19 14 14 0 0 2 3 34,67 35,00 38 40 33 22 M F 79 46 Share Child 129 
8 23 23 20 20 5 5 5 5 33,33 33,67 97 100 23 19 M F 69 46 Share Spouse 115 
9 19 19 16 16 5 5 4 4 29,33 27,67 72 67 17 17 F M 68 36 Share Child 72 
10 20 20 19 19 5 5 4 4 23,00 23,67 59 59 21 21 M F 74 64 Share Spouse 50 
                      
Min 15,00 14,00 11,00 11,00 0,00 0,00 1,00 1,00 23,00 23,67 38,00 40,00 12,00 5,00 6 F 5 F 68,0 30,0 3 Alone 5 Child 16,0 
Max 23,00 23,00 20,00 20,00 5,00 5,00 6,00 7,00 36,00 37,00 97,00 102,00 33,00 26,00 4 M 5 M 91,0 64,0 7 Share 2 Spouse 233,0 
Mode 20,00 19,00 16,00 11,00 5,00 5,00 5,00 6,00 36,00 33,67 97,00 N/A 21,00 10,00   86,0 46,0  3 Other N/A 
Median 19,50 19,00 15,00 15,00 5,00 5,00 4,50 4,50 31,33 31,00 73,00 76,00 21,00 18,00   77,0 46,0   136,0 
SD 2,37 2,62 3,16 3,27 1,57 1,62 1,52 1,89 5,30 4,04 17,80 19,92 7,23 7,17   7,8 10,2   74,8 
Mean 19,50 19,00 14,80 14,70 4,30 4,20 4,10 4,30 30,33 30,97 74,10 77,10 21,30 16,40   78,3 47,1   137,2 
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Table 39 Greece control group, n=5 
Dyad B MMSE F MMSE B MoCA F MoCA B ADL F ADL B IADL F IADL B QOL F QOL B SQLC F SQLC B ZBI F ZBI EP Sex ICG Sex EP Age ICG Age Living Status Relation 
1 16 14 12 11 6 6 7 6 37,67 33,00 88 86 10 13 F F 80 52 Share Child 
2 17 16 13 12 6 6 7 6 41,00 33,00 88 86 10 14 F F 76 52 Share Child 
3 19 18 14 14 5 5 6 5 35,00 31,33 72 72 33 35 F F 69 57 Share Spouse 
4 19 16 16 14 5 4 5 5 42,33 38,67 80 84 34 34 M F 81 65 Share Spouse 
5 19 19 16 16 4 3 3 3 31,33 31,33 85 85 19 20 F M 94 63 Share Child 
                     
Min 1,00 14,00 12,00 11,00 4,00 3,00 3,00 3,00 31,33 31,33 72,00 72,00 10,00 13,00 4 F 4 F 69,0 52,0 0 Alone 3 Child 
Max 5,00 19,00 16,00 16,00 6,00 6,00 7,00 6,00 42,33 38,67 88,00 86,00 34,00 35,00 1 M 1 M 94,0 65,0 5 Share 2 Spouse 
Mode N/A 16,00 16,00 14,00 6,00 6,00 7,00 6,00 N/A 33,00 88,00 86,00 10,00 N/A   N/A 52,0   
Median 3,00 16,00 14,00 14,00 5,00 5,00 6,00 5,00 37,67 33,00 85,00 85,00 19,00 20,00   80,0 57,0   
SD 1,58 1,95 1,79 1,95 0,84 1,30 1,67 1,22 4,47 3,02 6,77 5,98 11,82 10,66   9,1 6,1   
Mean 3,00 16,60 14,20 13,40 5,20 4,80 5,60 5,00 37,47 33,47 82,60 82,60 21,20 23,20   80,0 57,8   
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Data set v:  All Intervention data 
Table 40 Intervention group data, n=31 
Dyad B MMSE 
F 
MMSE 
B 
MoCA 
F 
MoCA B ADL F ADL B IADL F IADL B QOL F QOL B SQLC F SQLC B ZBI F ZBI EP Sex ICG Sex 
EP 
Age 
ICG 
Age 
Living 
Status Relation 
Days 
use 
Sum 640 611 473 456 163 154 136 118 1063,8 1009,3 2619 2709 509 487 21 Female 
18 
Female 2397 1465 15 Alone 9 Spouse 5966 
Diff  -29  -17  -9  -18  -54,5  90  -22 
10 
Males 13 Male   16 Share 15 Child  
Min 15 14 7 9 0 0 1 0 23 23 33 27 0 0   65 30  7 Other 16 
Max 30 30 26 29 6 6 8 7 45,33 43,33 116 130 33 34   91 82   412 
Mode 23 19 16 20 6 6 4 4 34,67 33,67 92 93 9 10   75 57   203 
Median 22 21 17,5 16 6 5 4 4 35,00 33,67 85 93 16 17   75 55   203 
SD 3,99 4,32 4,43 4,47 1,24 1,45 1,69 1,85 5,78 5,04 20,33 22,27 8,80 9,13   7,0 12,9   92,8 
Mean 22,07 21,82 16,89 16,29 5,26 4,97 4,39 3,81 34,32 32,56 84,48 87,39 16,42 15,71   77,3 54,3   192,5 
Diff  -0,25  -0,61  -0,29  -0,58  -1,76  2,90  -0,71        
Data set vi:  All Control data 
Table 41 Control group data, n=22 
Dyad B MMSE F MMSE B MoCA F MoCA B ADL F ADL B IADL F IADL B QOL F QOL B SQLC F SQLC B ZBI F ZBI EP Sex ICG Sex EP Age 
ICG 
Age 
Living 
Status Relation 
Sum 505 491 376 356 123 121 109 98 741 714,33 1996 2067 274 328 13 Female 17 Female 1774 1391 7 Alone 11 Spouse 
Diff  -14  -20  -2  -11  -26,67  71  54 9 Male 5 Male   15 Share 11 Child 
Min 16 14 12 11 3 3 0 1 23,67 22,33 72 72 0 0   62 37   
Max 30 30 24 29 6 6 8 8 44,67 41,67 113 119 34 35   94 84   
Mode 29 16 18 20 6 6 6 6 35 31,33 103 119 10 13   80 57   
Median 22,50 23,50 18 17 6 6 5,50 4 33,83 33 92 90,50 11,50 13   81,5 62,5   
SD 5,07 5,48 3,71 5,48 0,85 0,91 2,19 1,97 6,31 4,74 13,12 13,78 8,92 8,55   7,6 14   
Mean 22,95 22,32 17,90 17,80 5,59 5,50 4,95 4,45 33,68 32,47 90,73 93,95 12,45 14,91   80,6 63,2   
Diff  -0,64  -0,10  -0,09  -0,50  -1,21  3,23  2,45       
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Data set vii:  Distribution fit of assessment outcomes 
 
Figure 34 Control MSME and Intervention MMSE 
  
Control mean change -0,64 
95% CI [-1,55 to 0,28] 
p=0,16 
Intervention mean change -0,50 
95% CI [-1,85 to 0,85] 
p=0,46 
 
Figure 35 Control MoCA and Intervention MoCA 
  
Control mean change -0,10 
95% CI [-1,36 to 1,16] 
p=0,87 
Intervention -0,61 
95% CI [-1,76 to 0,55] 
p=0,29 
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Figure 36 Control and Intervention ADL 
  
Control mean change -0,09 
95% CI [-0,28 to 0,10] 
p=0,33 
Intervention mean change -0,29 
95% CI [-0,67 to 0,09] 
p=0,13 
 
Figure 37 Control and Intervention IADL 
  
Control mean change -0,50 
95% CI [-0,95 to -0,05] 
p=0,03* 
Intervention mean change -0,58 
95% CI [-1,16 to 0,001] 
p=0,05* 
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Figure 38 Control and Intervention QOL-AD 
  
Control mean change -1,21 
95% CI [-2,93 to 0,51] 
p=0,16 
Intervention mean change -1,76 
95% CI [-3,39 to -0,13] 
p=0,04* 
 
Figure 39 Control and Intervention SQLC 
  
Control mean change 3,23 
95% CI [-1,78 to 8,23] 
p=0,19 
Intervention mean change 2,90 
95% CI [-2,00 to 7,80] 
p=0,24 
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Figure 40 Control and intervention ZBI 
  
Control mean change 2,45 
95% CI [0,66 to 4,25] 
p=0,01** 
Intervention mean change -0,71 
95% CI [-2,89 to 1,47] 
p=0,51 
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Data set viii:  Pearson’s correlations 
Results are given in p-value significance. Green highlighted boxes indicate significant correlations. 
Table 42 Control group Pearson’s correlations, n=22 
 MMSE MoCA ADL IADL QOL-AD SQLC ZBI EP AGE ICG AGE 
MMSE          
MoCA 0,72         
ADL 0,26 0,37        
IADL 0,30 0,53 0,72       
QOL-AD 0,24 0,69 0,06 0,19      
SQLC 0,72 0,33 0,86 0,35 0,48     
ZBI 0,21 0,97 0,93 0,33 0,16 0,53    
EP AGE 0,53 0,21 0,93 0,42 0,12 0,07 0,53   
ICG AGE 0,21 0,90 0,05* 0,37 0,05* 0,11 0,42 0,06  
Table 43 Intervention group Pearson’s correlations, n=31 
 MMSE MoCA ADL IADL QOL-AD SQLC ZBI LENGTH SHORT LONG EP AGE ICG AGE 
MMSE             
MoCA 0,01**            
ADL 0,21 0,02**           
IADL 0,83 0,87 0,001**          
QOL-AD 0,45 0,52 0,14 0,18         
SQLC 0,03* 0,56 0,59 0,21 0,18        
ZBI 0,49 0,87 0,67 0,22 0,59 0,59       
LENGTH 0,31 0,71 0,31 0,10 0,19 0,01** 0,49      
SHORT 0,42 0,84 0,008** 0,04* 0,66 0,63 0,79      
LONG 0,56 0,80 0,65 0,007** 0,57 0,02** 0,73      
EP AGE 0,98 0,19 0,08 0,96 0,59 0,36 0,80 0,49 0,21 0,11   
ICG AGE 0,42 0,92 0,67 0,92 0,67 0,96 0,40 0,99 0,27 0,41 0,71  
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Data set ix:  Subgroup analysis 
Table 44 Subgroup analysis outcomes 
Subgrouping Control Subgroup 
Intervention 
Subgroup Significant differences between groups Significant differences within groups 
Effects in caregiver 
burden Positive effects  
Highly significant difference in ZBI and IADL outcomes 
Non-significant improvement in ZBI, highly 
significant decline in MoCA, and significant 
improvement in SQLC. 
 Negative effects  Significant decline in IADL. 
  Positive effects Highly significant difference in ZBI outcomes and length of 
use. 
 
Highly significant improvement in ZBI.  
  Negative effects Highly significant decline in ZBI and IADL. 
Age 
Younger 
participants with 
dementia 
 Highly significant differences in the age of the person with 
dementia, the caregiver ages, and in QOL-AD outcomes. 
 
Highly significant decrease in IADL and QOL-AD, 
and a highly significant increase in ZBI. 
 Older participants with dementia  No significant differences from baseline. 
 Younger caregivers  Highly significant differences in the age of the person with 
dementia and in caregiver age, and a significant difference in 
QOL-AD outcomes. 
 
Highly significant decline in IADL, significant 
decline in QOL-AD, and highly significant increase 
in ZBI. 
 Older caregivers  No significant differences from baseline. 
  
Younger 
participants with 
dementia Highly significant differences in age of the person with 
dementia. 
Highly significant decline in QOL-AD. 
  Older participants with dementia No significant differences from baseline. 
  Younger caregivers 
Highly significant difference in caregiver age. 
Significant decline in QOL-AD. 
  Older caregivers No significant differences from baseline. 
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Subgrouping Control Subgroup 
Intervention 
Subgroup Significant differences between groups Significant differences within groups 
Living arrangement Alone  Significant differences in caregiver ages (alone group is an 
average of 13,95 years younger). 
 
No significant differences from baseline. 
 Cohabitating  No significant differences from baseline. 
  Alone Highly significant difference in length of use (alone group 
used an average of 101,8 days longer). 
 
Highly significant decline in IADL. 
  Cohabitating No significant differences from baseline. 
Caregiver 
relationship Spouses  Highly significant difference in caregiver age (spouses are an 
average of 21 years older). 
Significant decline in MMSE and significant 
increase in SQLC.  
 Adult children  Significant decline in IADL and a highly significant increase in ZBI 
  Spouses 
Spouses are highly significantly older than adult children (by 
an average of 17,8 years) and other caregivers (by an average 
of 22,8 years).  
 
 
No significant differences from baseline. 
  Adult children Significant decline in IADL. 
  Other Highly significant improvement in ZBI. 
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Appendix 8 Overview of significant results 
Table 45 Analysis of the data, significant results, and hypothesis testing 
Research question Test Group Results Hypothesis Interpretation 
Are there significant 
changes within the 
intervention group? 
Paired t-tests on 
baseline to final scores Intervention 
IADL declined p=0,05*. 
QOL-AD declined p=0,04*.  
Yes, there are significant declines 
in independent functioning and 
QOL of the person with 
dementia. 
Are there significant 
changes within the control 
group? 
Paired t-tests on 
baseline to final scores Control 
IADL declined p=0,03*. 
ZBI increased (declined) p=0,01**.  
Yes, there is significant decline in 
independent functioning and 
significant increase in caregiver 
burden. 
Are there significant 
differences between the 
intervention and control 
group outcomes? 
Independent t-tests for 
score changes from 
baseline to final 
Between 
Intervention and 
Control 
Highly significant difference in ZBI 
p=0,03**. 
Intervention group will 
show improvement or 
less decline in than the 
control group 
Hypothesis is supported 
Will using gerontechnology 
have positive effects on 
physical functioning? 
ADL 
Between 
Intervention and 
Control 
The two groups do not show significant 
differences in ADL (p=0,40) . 
Intervention group will 
show improvement or 
less decline in ADL than 
the control group 
Null hypothesis cannot be rejected 
Will using gerontechnology 
have positive effects on 
independent functioning? 
IADL 
Between 
Intervention and 
Control 
The two groups do not show significant 
differences in IADL (p=0,83) outcomes. 
Intervention group will 
show improvement or 
less decline in IADL 
than the control group 
Null hypothesis cannot be rejected 
Will using gerontechnology 
have positive effects on 
independent living? 
Non-standardized 
questionnaire on feeling 
of change in 
independent living for 
the person with 
dementia 
Intervention 
61,3% reported increased 
independent living. 
37,1% report maintained 
independence . 
Intervention group will 
report an increase in 
independent living 
Gerontechnology has positive 
effects on independent living. 
Hypothesis is supported 
Will using gerontechnology 
have positive effects on QOL 
in the person with 
dementia? 
QOL-AD 
Between 
Intervention and 
Control 
Non-significant difference between the 
two groups, p=0,64. 
Intervention group will 
show improvement or 
less decline in QOL-AD 
than the control group 
No, there is not a significant 
difference between the two 
groups in QOL outcomes of the 
person with dementia 
Null hypothesis cannot be rejected 
 
Non-standardized 
questionnaire on feeling 
of change in person 
with dementia’s QOL 
Intervention 
The intervention group shows an 
increased QOL for 62,9% of 
participants with dementia and 
maintained QOL for the 
remaining 37,1%. 
 
ICT services will increase 
QOL for 50% of 
participants with 
dementia 
Yes, gerontechnology has positive 
effects on QOL in the majority of 
the participants with dementia. 
Hypothesis is supported 
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Research question Test Group Results Hypothesis Interpretation 
Will using gerontechnology 
have positive effects on QOL 
in the caregivers? 
SQLC 
Between 
Intervention and 
Control 
Non-significant difference between the 
two groups, p=0,93. 
Intervention group will 
show improvement or 
less decline in SQLC 
than the control group 
No, there is not a strong difference 
between the two, they 
experienced similar increases in 
QOL. 
Null hypothesis cannot be rejected 
 
Non-standardized 
questionnaire on feeling 
of change in caregiver 
QOL 
Intervention 
The intervention group shows an 
increase in QOL for 70,9% of 
caregivers and maintained QOL 
for the remaining 19,4%. 
ICT services will increase 
QOL for 70% of 
caregivers 
Yes, gerontechnology has positive 
effects on QOL in all of the 
caregivers. 
Hypothesis is supported 
Will using gerontechnology 
have positive effects on 
caregiver burden? 
Independent t-tests on 
ZBI outcomes 
Between 
Intervention and 
Control 
Significant difference is ZBI p=0,03* 
(intervention group improved, control 
declined). 
 
Intervention group will 
show improvement or 
less decline in ZBI than 
the control group 
Hypothesis is supported 
 
Non-standardized 
questionnaire on feeling 
of change in care 
responsibilities 
Intervention 
100% of caregivers reported 
positive effects on care 
responsibilities. 
 61,3% reported decreased 
responsibilities 
 35,5% reported maintained 
responsibilities 
ICT services will reduce 
burden in 60% of the 
caregivers 
Yes, gerontechnology has reduced 
burden in all of the caregivers. 
Hypothesis is supported 
Is there a linear relationship 
between independent 
functioning and caregiver 
burden? 
Pearson’s correlation 
between IADL and ZBI 
score changes 
Intervention Non-significant, negative relationship p=0,22.  
No, There is no evidence of a 
strong correlation. 
 
Pearson’s correlation 
between IADL and ZBI 
score changes 
Control Non-significant, negative relationship p=0,32.  
No, There is no evidence of a 
strong correlation. 
Will using gerontechnology 
have positive effects on 
physical and/or 
independent functioning? 
 
 
Pearson’s correlation 
between ADL and IADL 
change 
Intervention Strong, positive relationship in decline, p=0,001**. 
 
No, the intervention group did not 
show improvement or less 
decline than the control group. 
 
Pearson’s correlation 
between ADL and IADL 
change 
Control Non-significant, negative relationship in decline p=0,99. 
Does independent 
functioning influence QOL 
in the person with 
dementia? 
Pearson’s correlation 
between IADL and 
QOL-AD 
Intervention Non-significant positive relationship in decline p=0,18.  
No, there is not a strong linear 
relationship between 
independent functioning and 
QOL of the person with 
dementia. 
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Research question Test Group Results Hypothesis Interpretation 
 
Pearson’s correlation 
between IADL and 
QOL-AD 
Control Non-significant, positive relationship in decline p=0,19.  
No, there is not a linear 
relationship between 
independent functioning and 
QOL of the person with 
dementia. 
 
Pearson’s correlation 
between QOL-AD and 
IADL 
Intervention 
dichotomized by 
positive and 
negative QOL-AD 
outcomes 
Those with positive QOL-AD outcomes 
had non-significant negative 
relationship (p=0,45). Those with 
negative QOL-AD outcomes had positive 
relationship in decline (p=0,01**). 
 
No, improvement in QOL-AD was 
not influenced by IADL. 
Yes, declines in IADL are highly 
correlated with declines in QOL-
AD. 
 
Pearson’s correlation 
between QOL-AD and 
IADL 
Control 
dichotomized by 
positive and 
negative QOL-AD 
outcomes 
Non-significant, positive relationships 
(positive effects in QOL-AD p=0,72; 
negative effects in QOL-AD p=0,31. 
 No, there is no evidence of strong correlations. 
Are there significant 
differences in outcomes 
within the intervention 
group dichotomized by ZBI?  
Independent t-tests of 
the difference in score 
changes between 
groups 
Intervention, 
dichotomized by 
positive/negative 
effects in ZBI 
No significant difference in assessment 
scores (other than ZBI); length of use 
p=0,04*. 
 
No, there are no significant 
differences in those who have 
positive and those who have 
negative effects in ZBI. 
Are there significant 
differences in outcomes 
within the control group 
dichotomized by ZBI?  
Independent t-tests of 
the difference in score 
changes between 
groups 
Control, 
dichotomized by 
positive/negative 
effects in ZBI 
Only significant difference aside from 
ZBI was in IADL p=0,01**, the group 
who had positive effects in ZBI had an 
increase in IADL and those who had 
negative effects in ZBI had decreases in 
IADL. 
 
Yes, positive effects in ZBI were 
associated with positive effects in 
IADL, and negative effects in ZBI 
were associated with negative 
effects in IADL. 
Are there significant 
differences in IADL 
outcomes within the 
intervention group 
dichotomized by ZBI? 
Paired t-tests on IADL 
changes from baseline 
to final in both groups 
Intervention (incl 
DK), dichotomized 
by 
positive/negative 
effects in ZBI 
In the positive effect group, IADL 
p=0,31. 
In the negative effect group, IADL 
p=0,04*. 
 
Yes, those with negative effects in 
ZBI have highly significant 
declines in IADL. 
Are there significant 
differences in IADL 
outcomes within the control 
group dichotomized by ZBI 
outcomes? 
Paired t-tests on IADL 
changes from baseline 
to final in both groups 
Control, 
dichotomized by 
positive/negative 
effects in ZBI 
IADL decline p=0,004** for the group 
who had increases in ZBI (negative 
effects), and non-significant 
improvement in IADL (p=0,17) in the 
subgroup with positive effects in ZBI. 
 
Yes, those with negative effects in 
ZBI have highly significant 
declines in IADL. 
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Research question Test Group Results Hypothesis Interpretation 
Are there linear 
relationships in assessment 
outcomes within the 
intervention group when 
dichotomized by length of 
use?  
Pearson’s correlation in 
outcomes by length of 
use 
Intervention (incl 
DK), dichotomized 
by length of use 
The short use group has a highly 
significant positive relationship in ADL 
and IADL declines (p=0,01**) and in 
MMSE and MoCA declines (p=0,01**), 
and significant negative relationships 
between length of use and ADL 
(p=0,01**) and IADL (p=0,04*). 
The long use group has highly 
significant negative correlations 
between length of use and IADL 
(p=0,01**) and SQLC (p=0,02**). 
 
Yes, there are significant linear 
relationships found when 
dichotomized by length of use. 
Are there significant 
differences between the 
intervention group who had 
longer and shorter use of 
the intervention?  
Independent t-tests on 
differences between 
long and short use 
groups 
Intervention, 
dichotomized by 
length of use 
Only significant difference was in SQLC 
p=0,02**, short group improved and 
long group declined. 
 
Yes, there is a highly significant 
difference in caregiver QOL, 
where the short use group 
improved and the long use group 
declined. 
Will participants be 
satisfied with the 
gerontechnology services? 
Non-standardized 
questionnaire on user 
satisfaction 
Intervention 88,7% of participants are satisfied with the intervention services. 
75% of intervention 
participants will report 
satisfaction with the 
services 
Yes, more than ¾ of the 
participants are satisfied with 
the intervention. 
Will using gerontechnology 
have positive effects on a 
feeling of safety? 
Non-standardized 
questionnaire on feeling 
of safety 
Intervention 
The intervention group shows an 
increase in feeling of safety in 80,6% of 
participants and maintained feeling of 
safety in the remaining 19,4%. 
Intervention participants 
will report an increase 
in feeling of safety in 
30% of the participants 
Yes, participants, especially the 
caregivers, feel safer with the 
gerontechnology. 
Would people want to use 
services like these? 
Non-standardized 
questionnaire on 
acceptance 
Intervention 
90,3% of participants would consider or 
definitely want to use an intervention 
like this. 
75% of intervention 
caregivers will report a 
desire to continue using 
services 
Yes, more than ¾ of participants 
would want to use services like 
this. 
Will end users be willing to 
pay for gerontechnology 
services? 
Non-standardized 
questionnaire on user 
willingness to pay 
Intervention 
53,2% of participants are willing to pay 
for these services 
58,1% of the adults with dementia and 
48,48% of the caregivers (12,9% did not 
answer). 
Participants will report 
willingness to pay for 
telecare services. 
Yes, the majority of participants 
are willing to pay for telecare 
services like these. 
Overall difference ADL, IADL, QOL-AD, SQLC, and ZBI 
Compared mean 
changes between 
the groups 
The two types of care do not show 
significant differences in outcomes 
(p=0,48). 
Intervention group 
participants will have 
significantly different 
(better) outcomes. 
The null hypothesis cannot be 
rejected. 
 
